,CUI1,CUI2,label
0,Immunotherapy,Localized Askin Tumor,0
1,defects aspect,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2,Disease,adenoid cystic carcinoma of lung,0
3,Purple,Extracranial Neuroblastoma,0
4,Malignant - descriptor,Breast Ductal Adenoma,0
5,Left sided,mucinous adenocarcinoma of gallbladder,0
6,Body tissue,Acantholytic squamous cell carcinoma,0
7,Females,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8,Multiple sexual contacts,Human Papillomavirus-Related Carcinoma,0
9,Group A (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10,Histopathologic Grade differentiation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11,Communicable Diseases,Human Papillomavirus-Related Carcinoma,0
12,white blood cell type,Malignant Neoplasm with Regional Lymph Node Involvement,0
13,Affecting,Primary Cutaneous Plasmablastic Lymphoma,0
14,Slow,Liver Cavernous Hemangioma,0
15,Disease,Mucinous adenocarcinoma gastric,0
16,Lymphoma,Childhood Lymphoma,0
17,Molecule,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18,Medical Device Material Separation,Childhood Cerebellar Neoplasm,0
19,Synonym,Acute lymphadenitis,0
20,Container status - Identified,Thymic Clear Cell Carcinoma,0
21,Deep (qualifier value),Adult Alveolar Soft Part Sarcoma,0
22,gene therapy,Ichthyoses,0
23,Fresh (qualifier value),Mucinous adenocarcinoma gastric,0
24,Present,Digestive System Hodgkin Lymphoma,0
25,Autosome,Ichthyoses,0
26,Relational and Item-Specific Encoding Task,Refractory Barrett Esophagus,0
27,Removal of bladder,Intestinal Metaplasia of Bladder Urothelium,0
28,How Often Vomiting,Mucinous adenocarcinoma gastric,0
29,Rare,mucinous adenocarcinoma of gallbladder,0
30,Skin Specimen,Acantholytic squamous cell carcinoma,0
31,Inhibition,Unresectable Rhabdomyosarcoma,0
32,Common Specifications in HL7 V3 Publishing,Acantholytic squamous cell carcinoma,0
33,Part of,Adenocarcinoma of the prostate metastatic,0
34,Bacteria,Digestive System Hodgkin Lymphoma,0
35,Occurrence,Malignant melanoma of eyelid,0
36,Dangerousness,Malignant melanoma of eyelid,0
37,Laminar,Adult Fibrolamellar Carcinoma,0
38,Five-year Survival Rate,Intestinal Metaplasia of Bladder Urothelium,0
39,per year,Malignant Testicular Sertoli Cell Tumor,0
40,Third,Endometrial Small Cell Carcinoma,0
41,Common Specifications in HL7 V3 Publishing,Refractory Barrett Esophagus,0
42,Screening Study,Mucinous adenocarcinoma gastric,0
43,Tissue Specimen Code,Intestinal Neuroendocrine Carcinoma,0
44,Symptoms aspect,Choroid Necrotic Melanoma,0
45,Woman,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
46,Sometimes,Undifferentiated Endocervical Sarcoma,0
47,Experimental Result,Thymic Clear Cell Carcinoma,0
48,Tumor cells,Intestinal Neuroendocrine Carcinoma,0
49,Occurrence,Contact dermatitis due to alkali,0
50,Involvement with,mucinous adenocarcinoma of gallbladder,0
51,Age,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
52,500,Neonatal leukemia,0
53,Diagnosis,Recurrent Testicular Lymphoma,0
54,Cells panel,Heavy Chain Deposition Disease,0
55,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Localized Askin Tumor,0
56,Biomaterial Treatment,Acantholytic squamous cell carcinoma,0
57,Choose (action),Breast Ductal Adenoma,0
58,Cell Count,Stage IB Pancreatic Cancer AJCC v8,0
59,Gram per Deciliter,Recurrent Testicular Lymphoma,0
60,Evidence,Heavy Chain Deposition Disease,0
61,Term (lexical),Cartilaginous exostosis,0
62,Abnormal Reference Range,Recurrent Testicular Lymphoma,0
63,radiotherapeutic,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
64,Times,Recurrent Uveal Melanoma,0
65,Collection (action),Liver Cavernous Hemangioma,0
66,Subtype (attribute),Mucinous adenocarcinoma gastric,0
67,Endothelium,Angiosarcoma of liver,0
68,Telephone Extension Number,Leptomeningeal sarcoma,0
69,Spreading (qualifier value),Granular Cell Leiomyosarcoma,0
70,Usual Severity Weight Loss,Stage IB Lung Cancer AJCC v7,0
71,vascular inflammations,Acute lymphadenitis,0
72,Divide,Mucinous adenocarcinoma gastric,0
73,Progress,Choroid Necrotic Melanoma,0
74,Encode (action),BRCA2 Syndrome,0
75,Used by,Testicular cancer metastatic,0
76,High,BRCA2 Syndrome,0
77,Test Result,Benign Carotid Body Paraganglioma,0
78,Chemotherapy,Malignant melanoma of eyelid,0
79,Benign Neoplasm,Benign Carotid Body Paraganglioma,0
80,Patient Reported Outcome Stem,Intracortical osteosarcoma,0
81,Fatigue,Stage I Adult Non-Hodgkin Lymphoma,0
82,Cosmetics,Maxillary Sinus Adenocarcinoma,0
83,Negation,Liver Cavernous Hemangioma,0
84,Back structure,Recurrent Uveal Melanoma,0
85,Specimen Source Codes - Tube,Grade 1 Clear Cell Renal Cell Carcinoma,0
86,Benign condition,Recurrent Testicular Lymphoma,0
87,Diagnosis Study,Uterine Cancer,0
88,Graph Node,Tonsillar Carcinoma,0
89,Skin,Malignant melanoma of eyelid,0
90,Suspected qualifier,Uterine Cancer,0
91,Carcinoma of bladder,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
92,Channel,Adult Alveolar Soft Part Sarcoma,0
93,Cancer Genus,Recurrent Testicular Lymphoma,0
94,Anatomic Structure,Benign neoplasm of thorax,0
95,Show,squamous cell carcinoma of the thyroid gland,0
96,Time,Leptomeningeal sarcoma,0
97,various antiinfectives and antiseptics for local oral treatment,Extra-Adrenal Paraganglioma,0
98,Term (temporal),Granular Cell Leiomyosarcoma,0
99,Back structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
100,Compleat Liquid Nutrition,Carcinoma of urinary bladder,0
101,Hematologic Tests,Acute Undifferentiated Leukemia,0
102,Malignant Central Nervous System Neoplasm,Refractory Glioma,0
103,analysis aspect,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
104,To,Clonal Hematopoiesis of Indeterminate Potential,0
105,Papule,Spongiotic dermatitis,0
106,Bounded by,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
107,Patients,Tonsillar Carcinoma,0
108,Times,Cancer of Urinary Tract,0
109,Vomiting,Mucinous adenocarcinoma gastric,0
110,Molecular Mass,Anterior Urethral Malignant Neoplasm,0
111,Carcinoma,Endometrial Small Cell Carcinoma,0
112,Overall,Clonal Hematopoiesis of Indeterminate Potential,0
113,Extension,Leptomeningeal sarcoma,0
114,KIAA1549L gene,Pilocytic astrocytoma of cerebellum,0
115,Published Comment,Refractory Barrett Esophagus,0
116,International Statistical Classification of Diseases and Related Health Problems,Secondary malignant neoplasm of lymph node,0
117,Adenocarcinoma,Bladder squamous cell carcinoma stage I,0
118,Cancer Remission,Primary Cutaneous Plasmablastic Lymphoma,0
119,More,Clonal Hematopoiesis of Indeterminate Potential,0
120,Dilated,Undifferentiated Endocervical Sarcoma,0
121,Aspects of disease screening,Endometrial Small Cell Carcinoma,0
122,Persons,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
123,Persons,Adult Hepatocellular Carcinoma,0
124,As Much as Desired,Malignant Neoplasm of Lung - Multiple Primary Sites,0
125,diagnosis aspect,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
126,Lymphoid Tissue,Methotrexate-Associated Hodgkin Lymphoma,0
127,Group A (qualifier value),Intestinal Neuroendocrine Carcinoma,0
128,Precancerous Conditions,Secondary malignant neoplasm of lymph node,0
129,Official,BRCA2 Syndrome,0
130,Array Feature,Blepharal carcinoma,0
131,Present,Tonsillar Carcinoma,0
132,Tobacco smoking behavior,Human Papillomavirus-Related Carcinoma,0
133,Time (foundation metadata concept),GIANT PIGMENTED HAIRY NEVUS,0
134,Pharmaceutical Preparations,Diffuse malignant mesothelioma,0
135,Pharmaceutical Preparations,de novo Myelodysplastic Syndrome,0
136,Regulation,Collecting Duct Carcinoma of the Kidney,0
137,Subject Risk,FIGO Stage II Ovarian Cancer,0
138,High,Acantholytic squamous cell carcinoma,0
139,Pelvic Pain,Undifferentiated Endocervical Sarcoma,0
140,Area,Mucinous adenocarcinoma gastric,0
141,More,Recurrent Uveal Melanoma,0
142,Science of Etiology,Spongiotic dermatitis,0
143,Tissue Specimen Code,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
144,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
145,Uncontrolled,Stage IB Lung Cancer AJCC v7,0
146,Cell (compartment),Breast Ductal Adenoma,0
147,Linear,Diffuse malignant mesothelioma,0
148,Meibomian Cyst,Benign Apocrine Neoplasm,0
149,Occur (action),Childhood Central Nervous System Immature Teratoma,0
150,Feature,Blepharal carcinoma,0
151,Continuance of life,adenoid cystic carcinoma of lung,0
152,Increased,Undifferentiated Endocervical Sarcoma,0
153,Feel Tired question,Malignant Neoplasm with Regional Lymph Node Involvement,0
154,In Blood,Liver Cavernous Hemangioma,0
155,Manufactured form,Malignant neoplasm of thalamus,0
156,Broken skin,Malignant melanoma of eyelid,0
157,Hematochezia,Mucinous adenocarcinoma gastric,0
158,Administration procedure,Maxillary Sinus Adenocarcinoma,0
159,Adult Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
160,Approximate,Diffuse malignant mesothelioma,0
161,Seed entity,Extracranial Neuroblastoma,0
162,Country number,Endometrial Small Cell Carcinoma,0
163,Chemotherapy Regimen,Endometrial Small Cell Carcinoma,0
164,TP53 gene,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
165,Qualitative form,Anterior Urethral Malignant Neoplasm,0
166,Qualitative form,Adult Fibrolamellar Carcinoma,0
167,Physical findings,Malignant melanoma of eyelid,0
168,Valid,Noninfiltrating Intraductal Carcinoma,0
169,Illness: Cannot describe symptoms,FIGO Stage II Ovarian Cancer,0
170,Usual,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
171,Approximate,Localized Askin Tumor,0
172,Definitely Related to Intervention,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
173,Maybe,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
174,Thyroid carcinoma,papillary carcinoma of penis,0
175,International Classification of Diseases for Oncology,Intracortical osteosarcoma,0
176,Surgical aspects,Bladder squamous cell carcinoma stage I,0
177,Room of building - Study,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
178,Interferes with,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
179,Variable (uniformity),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
180,Visible,Maxillary Sinus Adenocarcinoma,0
181,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Childhood Lymphoma,0
182,Malignant neoplasm of kidney,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
183,Mixed Tumor,Carcinoma ex pleomorphic adenoma of parotid gland,0
184,Metastatic Neoplasm,Familial Adenomatous Polyposis Associated Medulloblastoma,0
185,Usually,Malignant Neoplasm with Regional Lymph Node Involvement,0
186,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,FIGO Stage II Ovarian Cancer,0
187,Meaning,Granular Cell Leiomyosarcoma,0
188,Pharmacotherapy,Mucinous adenocarcinoma gastric,0
189,Biomaterial Treatment,Adult Hepatocellular Carcinoma,0
190,Project,Advanced Uterine Corpus Carcinosarcoma,0
191,Call (Instruction),Adenocarcinoma of the prostate metastatic,0
192,/40,Clonal Hematopoiesis of Indeterminate Potential,0
193,Pelvis,Localized Askin Tumor,0
194,Diabetes Mellitus,Uterine Cancer,0
195,Stat (do immediately),Unfavorable Non-Hodgkin Lymphoma,0
196,Pediculus (eukaryote),Noninfiltrating Intraductal Carcinoma,0
197,Endometrial Carcinoma,Endometrial Small Cell Carcinoma,0
198,Blood group A (finding),Malignant Neoplasm with Regional Lymph Node Involvement,0
199,ovarian,Endometrial Small Cell Carcinoma,0
200,Tumor cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
201,60%,Unfavorable Non-Hodgkin Lymphoma,0
202,Togo,Pancreatic Intraepithelial Neoplasia-3,0
203,Inflammatory Breast Carcinoma,Female Breast Carcinoma,0
204,Biological Response Modifier Therapy,Malignant melanoma of eyelid,0
205,Occur (action),FIGO Stage II Ovarian Cancer,0
206,Rest,Colorectal Neuroendocrine Tumor G2,0
207,Formation,Recurrent Testicular Lymphoma,0
208,Togo,benign mature teratoma of pancreas,0
209,cancer classification,Female Breast Carcinoma,0
210,Usual,Breast Ductal Adenoma,0
211,Sweat,Methotrexate-Associated Hodgkin Lymphoma,0
212,Spindle,Giant cell angiofibroma,0
213,Formation,Mucinous neoplasm,0
214,cervical cancer,Undifferentiated Endocervical Sarcoma,0
215,MM genotype,Deep Leiomyoma,0
216,Exposure to,Acantholytic squamous cell carcinoma,0
217,Treating,Metastatic Carcinoma in the Lung,0
218,Skin Specimen,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
219,Nuclear hyperchromasia,Angiosarcoma of liver,0
220,Intestines,Leiomyoma of Gallbladder,0
221,aspects of adverse effects,Breast Ductal Adenoma,0
222,Europe,Recurrent Testicular Lymphoma,0
223,suggestion,Clonal Hematopoiesis of Indeterminate Potential,0
224,shared attribute,Recurrent Uveal Melanoma,0
225,shared attribute,Malignant Neoplasm with Regional Lymph Node Involvement,0
226,2+,FIGO Stage II Ovarian Cancer,0
227,Bound (value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
228,To,Hemangioma,0
229,First (number),Acute Undifferentiated Leukemia,0
230,Polyp of large intestine,Colorectal Mucin Poor Hyperplastic Polyp,0
231,Sweating,Methotrexate-Associated Hodgkin Lymphoma,0
232,Cardiac Arrest,Unresectable Rhabdomyosarcoma,0
233,shared attribute,Colorectal Neuroendocrine Tumor G2,0
234,About The Same,Recurrent Testicular Lymphoma,0
235,Cause of death:Find:Pt:^Patient:Nom,Adult Hepatocellular Carcinoma,0
236,Including (qualifier),Intracortical osteosarcoma,0
237,Breathing Distress Question,Larynx carcinoma recurrent,0
238,Feel Pain,Localized Askin Tumor,0
239,Thyroid carcinoma,squamous cell carcinoma of the thyroid gland,0
240,Surgery specialty,Mucinous adenocarcinoma gastric,0
241,Foot,Cartilaginous exostosis,0
242,operate <remove>,Digestive System Hodgkin Lymphoma,0
243,radiotherapeutic,Bladder squamous cell carcinoma stage I,0
244,Removing (action),Digestive System Hodgkin Lymphoma,0
245,Liver and Intrahepatic Biliary Tract Carcinoma,Adult Hepatocellular Carcinoma,0
246,Negative Surgical Margin,Thymic Clear Cell Carcinoma,0
247,Geographic Locations,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
248,Symptoms aspect,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
249,Removed,Stage IB Pancreatic Cancer AJCC v8,0
250,Usual,Female Breast Carcinoma,0
251,Decrease,FIGO Stage II Ovarian Cancer,0
252,ASIP protein,Adult Alveolar Soft Part Sarcoma,0
253,health and disease,Leptomeningeal sarcoma,0
254,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Testicular cancer metastatic,0
255,Screening procedure,FIGO Stage II Ovarian Cancer,0
256,Neuroendocrine Tumors,Benign Carotid Body Paraganglioma,0
257,Skeletal bone,Adult Alveolar Soft Part Sarcoma,0
258,Return to (contextual qualifier) (qualifier value),Digestive System Hodgkin Lymphoma,0
259,Upper urinary tract structure,Colorectal cancer,0
260,80%,Refractory Glioma,0
261,Type - attribute,Pancreatic Intraepithelial Neoplasia-3,0
262,Type - attribute,Hodgkin lymphoma,0
263,Small cell carcinoma of lung,adenosquamous carcinoma of breast,0
264,risk factors - observation list,Cancer of Urinary Tract,0
265,Malignant Cell Count,Heavy Chain Deposition Disease,0
266,Fishes,Ichthyosis,0
267,biopsy characteristics,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
268,Monitoring - action,Mucinous neoplasm,0
269,Building process,Diffuse malignant mesothelioma,0
270,Image Feature,Colorectal Neuroendocrine Tumor G2,0
271,Liver Flavor,Mucinous adenocarcinoma gastric,0
272,Tube - unit dose,Grade 1 Clear Cell Renal Cell Carcinoma,0
273,Three,Advanced Uterine Corpus Carcinosarcoma,0
274,Common (qualifier value),Human Papillomavirus-Related Carcinoma,0
275,status - In progress,Choroid Necrotic Melanoma,0
276,Overall,Endometrial Small Cell Carcinoma,0
277,Present,BRCA2 Syndrome,0
278,Resulting in,Refractory Barrett Esophagus,0
279,Free of (attribute),Breast Ductal Adenoma,0
280,Poverty,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
281,Array Feature,Colorectal Neuroendocrine Tumor G2,0
282,Anterior chest wall structure,Thymic Clear Cell Carcinoma,0
283,Diagnosis,Malignant Testicular Sertoli Cell Tumor,0
284,Atla (fungus),Advanced Uterine Corpus Carcinosarcoma,0
285,United States,Endometrial Small Cell Carcinoma,0
286,Drain number:ID:Pt:^Patient:Nom,Digestive System Hodgkin Lymphoma,0
287,Glycoproteins,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
288,Major,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
289,Cell of Claudius,Adenocarcinoma,0
290,Diagnosis,Recurrent Uveal Melanoma,0
291,Poor - grade value,Recurrent Uveal Melanoma,0
292,Life Threatening or Disabling Adverse Event,Neonatal leukemia,0
293,Etiology aspects,mucinous adenocarcinoma of gallbladder,0
294,Affecting,Malignant Testicular Sertoli Cell Tumor,0
295,Diagnosis,Carcinoma of urinary bladder,0
296,Death NOS,FIGO Stage II Ovarian Cancer,0
297,Cancer Remission,Acute Undifferentiated Leukemia,0
298,CD69 wt Allele,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
299,Organ,squamous cell carcinoma of the thyroid gland,0
300,Risk,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
301,Participation Type - origin,Carcinoma ex pleomorphic adenoma of parotid gland,0
302,Pharmacotherapy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
303,Group A (blood group),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
304,In Blood,Cancer of Urinary Tract,0
305,Form:Finding:Point in time:{Setting}:Document:{Role},Acantholytic squamous cell carcinoma,0
306,Include (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
307,Development,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
308,Type - attribute,GIANT PIGMENTED HAIRY NEVUS,0
309,Source,mucinous adenocarcinoma of gallbladder,0
310,Relationships,BRCA2 Syndrome,0
311,Abnormal,Spongiotic dermatitis,0
312,Part of,Leiomyoma of Gallbladder,0
313,Index,Familial Hemophagocytic Lymphocytosis,0
314,Benign,Childhood Central Nervous System Immature Teratoma,0
315,Direct (qualifier),Digestive System Hodgkin Lymphoma,0
316,Secretory Vesicles,Colorectal Neuroendocrine Tumor G2,0
317,Increased erythropoietin,Metastatic Neoplasm to the Gallbladder,0
318,Urinary Bladder,Anterior Urethral Malignant Neoplasm,0
319,Classification,Secondary malignant neoplasm of lymph node,0
320,Decision,Larynx carcinoma recurrent,0
321,FAMILIAL ADENOMATOUS POLYPOSIS,Familial Adenomatous Polyposis Associated Medulloblastoma,0
322,*Type - Kind of quantity,Bladder squamous cell carcinoma stage I,0
323,Both kidneys,Sarcomatoid Renal Cell Carcinoma,0
324,Term Birth,Neonatal leukemia,0
325,day,Cancer of Urinary Tract,0
326,Appearance,Carcinoma ex pleomorphic adenoma of parotid gland,0
327,Previous,Malignant Testicular Sertoli Cell Tumor,0
328,Cure (remedy),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
329,Two,Malignant Neoplasm with Regional Lymph Node Involvement,0
330,Occurrence Indicator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
331,Characterization,Adult Fibrolamellar Carcinoma,0
332,Dyspareunia,Endometrial Small Cell Carcinoma,0
333,Cell Count,Adult Alveolar Soft Part Sarcoma,0
334,Lifestyle changes,Refractory Barrett Esophagus,0
335,Beginning,Carcinoma ex pleomorphic adenoma of parotid gland,0
336,Togo,FIGO Stage II Ovarian Cancer,0
337,Frequently,Malignant melanoma of eyelid,0
338,Cover (physical object),Malignant Neoplasm of Lung - Multiple Primary Sites,0
339,Lower - spatial qualifier,Diffuse malignant mesothelioma,0
340,Total thymectomy,Thymic Clear Cell Carcinoma,0
341,Healthy,Colorectal High Grade B-Cell Lymphoma,0
342,Manifestation of,Recurrent Testicular Lymphoma,0
343,Tears body substance,Blepharal carcinoma,0
344,Main,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
345,PCYT1A wt Allele,Anterior Urethral Malignant Neoplasm,0
346,First sign,Undifferentiated Endocervical Sarcoma,0
347,PELVIS irradiation,Uterine Cancer,0
348,seen,Intestinal Metaplasia of Bladder Urothelium,0
349,Basis - conceptual entity,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
350,Derived value,benign mature teratoma of pancreas,0
351,In situ,Acantholytic squamous cell carcinoma,0
352,Dog family,Angiosarcoma of liver,0
353,Limited stage (cancer stage),Undifferentiated Endocervical Sarcoma,0
354,Muscle Tissue,Anterior Urethral Malignant Neoplasm,0
355,Biomaterial Treatment,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
356,Adjacent,Cartilaginous exostosis,0
357,peripheral blood,Clonal Hematopoiesis of Indeterminate Potential,0
358,Body structure,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
359,Two,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
360,Smoking,Stage II Carcinoma of Penis,0
361,Body part,Pancreatic Intraepithelial Neoplasia-3,0
362,Often - answer to question,Acantholytic squamous cell carcinoma,0
363,gastrointestinal gas,Angiosarcoma of liver,0
364,Malignant neoplasm of pancreas,Stage IB Pancreatic Cancer AJCC v8,0
365,include - SetOperator,Undifferentiated Endocervical Sarcoma,0
366,Brain Neoplasms,Malignant neoplasm of thalamus,0
367,PREVENT (product),Diffuse malignant mesothelioma,0
368,Mucosa-Associated Lymphoid Tissue Lymphoma,Digestive System Hodgkin Lymphoma,0
369,Mathematical Factor,Human Papillomavirus-Related Carcinoma,0
370,Swollen Lymph Node,Malignant Neoplasm with Regional Lymph Node Involvement,0
371,cell growth,Stage IB Lung Cancer AJCC v7,0
372,Volume Measurement,Larynx carcinoma recurrent,0
373,Malignant tumor of cervix,Human Papillomavirus-Related Carcinoma,0
374,Before,Metastatic Carcinoma in the Lung,0
375,3+ Score,Mucinous adenocarcinoma gastric,0
376,Assisted (qualifier value),Thymic Clear Cell Carcinoma,0
377,Tumor cells,Colorectal Neuroendocrine Tumor G2,0
378,Negation,Clonal Hematopoiesis of Indeterminate Potential,0
379,Pediculus (eukaryote),Contact dermatitis due to alkali,0
380,Symptoms,Uterine Cancer,0
381,pharmacotherapeutic,Diffuse malignant mesothelioma,0
382,Biopsy,FIGO Stage II Ovarian Cancer,0
383,Mathematical Operator,BRCA2 Syndrome,0
384,Most,Unfavorable Non-Hodgkin Lymphoma,0
385,Togo,Stage II Carcinoma of Penis,0
386,Additional,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
387,Physical findings,Pancreatic Intraepithelial Neoplasia-3,0
388,common procedures,Human Papillomavirus-Related Carcinoma,0
389,Object Attribute,Refractory Barrett Esophagus,0
390,Common Specifications in HL7 V3 Publishing,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
391,VIPR1 wt Allele,Malignant Neoplasm of Lung - Multiple Primary Sites,0
392,Males,gliosarcoma,0
393,depend,Clonal Hematopoiesis of Indeterminate Potential,0
394,Life threatening - Event Consequence,Female Breast Carcinoma,0
395,Science of Etiology,Malignant melanoma of eyelid,0
396,Neoadjuvant Therapy Clinical Trial Setting,Lung squamous cell carcinoma stage I,0
397,300,Benign Carotid Body Paraganglioma,0
398,Family illness,Uterine Cancer,0
399,Chemotherapy Regimen,Uterine Cancer,0
400,Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
401,Feelings,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
402,Recurrence,Acute Undifferentiated Leukemia,0
403,Togo,mucinous adenocarcinoma of gallbladder,0
404,Retinoic Acid Response Element,Colorectal High Grade B-Cell Lymphoma,0
405,survive,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
406,Skin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
407,Poles,Adult Alveolar Soft Part Sarcoma,0
408,Kind of quantity - Taste,Refractory Barrett Esophagus,0
409,described,BRCA2 Syndrome,0
410,Pregnancy,Refractory Barrett Esophagus,0
411,Diagnosis Study,Refractory Barrett Esophagus,0
412,Therapeutic radiology procedure,Bladder squamous cell carcinoma stage I,0
413,Accepted,Localized Askin Tumor,0
414,Known,adenosquamous carcinoma of breast,0
415,10%,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
416,Desmoplastic fibroma,Giant cell angiofibroma,0
417,Females,Giant cell angiofibroma,0
418,Changing,Testicular cancer metastatic,0
419,Surgical reduction,FIGO Stage II Ovarian Cancer,0
420,Lymphoma,Recurrent Testicular Lymphoma,0
421,Chest Pain,adenosquamous carcinoma of breast,0
422,Taxonomic,Rhabdomyosarcoma with ganglionic differentiation,0
423,Case unit dose,Uterine Cancer,0
424,Science of Etiology,Localized Askin Tumor,0
425,Aggressive Non-Hodgkin Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
426,Fever,Stage I Adult Non-Hodgkin Lymphoma,0
427,How Much Distress Weight Loss,Stage I Adult Non-Hodgkin Lymphoma,0
428,Invasive Ductal Breast Carcinoma,Metastatic Ductal Breast Carcinoma,0
429,Back Pain,Pancreatic Intraepithelial Neoplasia-3,0
430,Classification of information,Rhabdomyosarcoma with ganglionic differentiation,0
431,Tissue of urinary bladder,Carcinoma of urinary bladder,0
432,Initial Usage,Testicular cancer metastatic,0
433,Percent of Abnormal Cells,Heavy Chain Deposition Disease,0
434,Giant Cell Fibroblastoma,Giant cell angiofibroma,0
435,Including (qualifier),Human Papillomavirus-Related Carcinoma,0
436,Including (qualifier),Benign Carotid Body Paraganglioma,0
437,use of ultrasonography,Anterior Urethral Malignant Neoplasm,0
438,seen,Carcinoma of urinary bladder,0
439,Inhibition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
440,regional,adenoid cystic carcinoma of lung,0
441,Make - Instruction Imperative,Mucinous adenocarcinoma gastric,0
442,High Mitosis-Karyorrhexis Index,Acantholytic squamous cell carcinoma,0
443,Breast,adenoid cystic carcinoma of lung,0
444,Killing,Unresectable Rhabdomyosarcoma,0
445,trauma qualifier,Giant cell angiofibroma,0
446,Mode of inheritance,Ichthyoses,0
447,Australia,Malignant melanoma of eyelid,0
448,Online Mendelian Inheritance In Man,benign mature teratoma of pancreas,0
449,site-specific telomere resolvase activity,Intestinal Neuroendocrine Carcinoma,0
450,Surgical aspects,Malignant Testicular Sertoli Cell Tumor,0
451,Persons,Maxillary Sinus Adenocarcinoma,0
452,Poor - qualifier,Refractory Barrett Esophagus,0
453,Secondary Neoplasm,gliosarcoma,0
454,error,BRCA2 Syndrome,0
455,Common (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
456,Adult human body,Colorectal Neuroendocrine Tumor G2,0
457,Location of Pharyngeal Residue Following Swallowing,Anterior Urethral Malignant Neoplasm,0
458,Treatment Epoch,Acantholytic squamous cell carcinoma,0
459,Stem of plant,Noninfiltrating Intraductal Carcinoma,0
460,Free (available (qualifier)),Familial Hemophagocytic Lymphocytosis,0
461,Autosomal dominant inheritance,benign mature teratoma of pancreas,0
462,Irregular,Recurrent Uveal Melanoma,0
463,Aim (idea),Ichthyosis,0
464,Cure (remedy),Primary Cutaneous Plasmablastic Lymphoma,0
465,Diagnosis,Metastatic Ductal Breast Carcinoma,0
466,Common (qualifier value),Diffuse malignant mesothelioma,0
467,high - ActExposureLevelCode,Diffuse malignant mesothelioma,0
468,Blood Products Laboratory Testing,Benign neoplasm of thorax,0
469,photoreactivating enzyme activity,Lung squamous cell carcinoma stage I,0
470,Concept Attribute,Refractory Barrett Esophagus,0
471,Administration procedure,Cancer of Urinary Tract,0
472,alone - group size,Cancer of Urinary Tract,0
473,Death Related to Adverse Event,Angiosarcoma of liver,0
474,Reciprocal translocation,Localized Askin Tumor,0
475,Screening procedure,Endometrial Small Cell Carcinoma,0
476,Growth action,adenosquamous carcinoma of breast,0
477,Age,Clonal Hematopoiesis of Indeterminate Potential,0
478,Adenomatous Polyposis Coli,Familial Adenomatous Polyposis Associated Medulloblastoma,0
479,Exposure to,Undifferentiated Endocervical Sarcoma,0
480,Stop brand of fluoride,Mucinous adenocarcinoma gastric,0
481,Chemotherapy,FIGO Stage II Ovarian Cancer,0
482,Exogenous Factors,Spongiotic dermatitis,0
483,Inferior,Childhood Cerebellar Neoplasm,0
484,Coating (film),Diffuse malignant mesothelioma,0
485,New Zealand,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
486,Device system,Digestive System Hodgkin Lymphoma,0
487,Supernumerary,Digestive System Hodgkin Lymphoma,0
488,Count of entities,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
489,Include (action),Localized Askin Tumor,0
490,Surface,Human Papillomavirus-Related Carcinoma,0
491,Array Feature,benign mature teratoma of pancreas,0
492,Genus Homo,Human Papillomavirus-Related Carcinoma,0
493,Basis - conceptual entity,Malignant Testicular Sertoli Cell Tumor,0
494,Illness (finding),Maxillary Sinus Adenocarcinoma,0
495,International Classification of Disease,Familial Hemophagocytic Lymphocytosis,0
496,Malignant - descriptor,Anterior Urethral Malignant Neoplasm,0
497,shared attribute,Carcinoma ex pleomorphic adenoma of parotid gland,0
498,shared attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
499,Over (spatial),Human Papillomavirus-Related Carcinoma,0
500,Infrequent,Extra-Adrenal Paraganglioma,0
501,Estrogens,Undifferentiated Endocervical Sarcoma,0
502,Sweating,Benign Apocrine Neoplasm,0
503,Beginning,Localized Askin Tumor,0
504,System (unit of presentation),Collecting Duct Carcinoma of the Kidney,0
505,Type - attribute,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
506,Divide,Female Breast Carcinoma,0
507,Never (frequency),FIGO Stage II Ovarian Cancer,0
508,Childhood Hodgkin Lymphoma,Childhood Lymphoma,0
509,Adult Non-Hodgkin Lymphoma,Recurrent Testicular Lymphoma,0
510,Common (qualifier value),BRCA2 Syndrome,0
511,90%,Stage IB Pancreatic Cancer AJCC v8,0
512,Neither Satisfied nor Dissatisfied,Clonal Hematopoiesis of Indeterminate Potential,0
513,Formation,Neonatal leukemia,0
514,Decision,Acute lymphadenitis,0
515,What subject filter - Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
516,Up,Cancer of Urinary Tract,0
517,Often - answer to question,Methotrexate-Associated Hodgkin Lymphoma,0
518,contextual factors,Ichthyosis,0
519,Treating,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
520,Squamous cell carcinoma,Intestinal Metaplasia of Bladder Urothelium,0
521,Severe (severity modifier),Cartilaginous exostosis,0
522,Run-in Period,Mucinous adenocarcinoma gastric,0
523,Only - dosing instruction fragment,Stage IB Pancreatic Cancer AJCC v8,0
524,cell type,Granular Cell Leiomyosarcoma,0
525,treatment - ActInformationManagementReason,Carcinoma of urinary bladder,0
526,Rate,Bladder squamous cell carcinoma stage I,0
527,Physiology,Unresectable Rhabdomyosarcoma,0
528,Positive,Heavy Chain Deposition Disease,0
529,Uterine Fibroids,Leiomyoma of Gallbladder,0
530,Immature Lymphocytes Measurement,Acute Undifferentiated Leukemia,0
531,Controlled by,Breast Ductal Adenoma,0
532,No status change,Recurrent Testicular Lymphoma,0
533,Antibiotics for systemic use,Cancer of Urinary Tract,0
534,Primary malignant neoplasm of lung,Stage IB Lung Cancer AJCC v7,0
535,Continuous,Testicular cancer metastatic,0
536,Neck,Tonsillar Carcinoma,0
537,Melanoma Pathway,Acantholytic squamous cell carcinoma,0
538,Divide,Primary Cutaneous Plasmablastic Lymphoma,0
539,Physical shape,Leptomeningeal sarcoma,0
540,Thin (qualifier value),Blepharal carcinoma,0
541,Good,Blepharal carcinoma,0
542,One,Recurrent Testicular Lymphoma,0
543,Telephone Extension Number,Noninfiltrating Intraductal Carcinoma,0
544,Exposure to,Blepharal carcinoma,0
545,Night time,Malignant Neoplasm with Regional Lymph Node Involvement,0
546,Rare,Pancreatic Intraepithelial Neoplasia-3,0
547,Science of Etiology,Recurrent Testicular Lymphoma,0
548,Patient Reported Outcome Stem,Noninfiltrating Intraductal Carcinoma,0
549,X-Ray Computed Tomography,Diffuse malignant mesothelioma,0
550,Type - attribute,Colorectal High Grade B-Cell Lymphoma,0
551,MOSTLY,Digestive System Hodgkin Lymphoma,0
552,1960s,Thymic Clear Cell Carcinoma,0
553,Tumor cells,Unresectable Rhabdomyosarcoma,0
554,Night sweats,Stage I Adult Non-Hodgkin Lymphoma,0
555,Result,Refractory Barrett Esophagus,0
556,Body part,Endometrial Small Cell Carcinoma,0
557,Disease,Recurrent Uveal Melanoma,0
558,Lymphocyte component of blood,Methotrexate-Associated Hodgkin Lymphoma,0
559,Wall of lymphatic vessel,Testicular cancer metastatic,0
560,Therapeutic procedure,Female Breast Carcinoma,0
561,Work,Angiosarcoma of liver,0
562,Similarity,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
563,New Zealand Rabbits,Recurrent Uveal Melanoma,0
564,Functional Relationship,Childhood Thyroid Gland Follicular Carcinoma,0
565,Social group,Metastatic Ductal Breast Carcinoma,0
566,Active License,Recurrent Uveal Melanoma,0
567,Ewings sarcoma,Localized Askin Tumor,0
568,Linear,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
569,Ovary,Childhood Central Nervous System Immature Teratoma,0
570,Include (action),Choroid Necrotic Melanoma,0
571,Chicken laying egg for human food,Diffuse malignant mesothelioma,0
572,Sequence Arm,Hodgkin lymphoma,0
573,pharmacotherapeutic,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
574,Endometrium,Endometrial Small Cell Carcinoma,0
575,Persons,Benign neoplasm of thorax,0
576,Cessation of life,adenoid cystic carcinoma of lung,0
577,Malignant - descriptor,Benign neoplasm of thorax,0
578,Woman,Undifferentiated Endocervical Sarcoma,0
579,Less often,Recurrent Testicular Lymphoma,0
580,diagnosis aspect,FIGO Stage II Ovarian Cancer,0
581,bony process,Intracortical osteosarcoma,0
582,Pesticides,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
583,Significant,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
584,combination of objects,Bladder squamous cell carcinoma stage I,0
585,filter information process,Digestive System Hodgkin Lymphoma,0
586,Imaging Techniques,Mucinous adenocarcinoma gastric,0
587,Primary malignant neoplasm,Acute Undifferentiated Leukemia,0
588,lymph nodes,Digestive System Hodgkin Lymphoma,0
589,Poverty,Malignant melanoma of eyelid,0
590,Covers (device),FIGO Stage II Ovarian Cancer,0
591,Smear - instruction imperative,Adult Alveolar Soft Part Sarcoma,0
592,Spreading (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
593,Excision,Familial Adenomatous Polyposis Associated Medulloblastoma,0
594,Tissue Growth,Stage IB Lung Cancer AJCC v7,0
595,Wounds and Injuries,Giant cell angiofibroma,0
596,Most,Carcinoma of urinary bladder,0
597,Process,FIGO Stage II Ovarian Cancer,0
598,Adolescent (age group),Thymic Clear Cell Carcinoma,0
599,Approach,Breast Ductal Adenoma,0
600,Sodium Tetradecyl Sulfate,Ichthyosis,0
601,Tonsillar Carcinoma,Tonsillar Carcinoma,0
602,Virus,Tonsillar Carcinoma,0
603,What subject filter - Result,Refractory Barrett Esophagus,0
604,Neoplasms,Localized Askin Tumor,0
605,Body tissue,Intestinal Metaplasia of Bladder Urothelium,0
606,Metastatic Disease Clinical Trial Setting,Granular Cell Leiomyosarcoma,0
607,Relate - vinyl resin,Blepharal carcinoma,0
608,Cancer Genus,Adult Alveolar Soft Part Sarcoma,0
609,Administration procedure,Malignant Testicular Sertoli Cell Tumor,0
610,Known,Atypical Lobular Breast Hyperplasia,0
611,Far East,Mucinous adenocarcinoma gastric,0
612,Consultation,Maxillary Sinus Adenocarcinoma,0
613,Tryptophanase,Methotrexate-Associated Hodgkin Lymphoma,0
614,Category Type,Malignant Neoplasm with Regional Lymph Node Involvement,0
615,Medical History,Malignant melanoma of eyelid,0
616,Partial,Carcinoma of urinary bladder,0
617,depend,Malignant neoplasm of thalamus,0
618,Esophageal Stricture,Refractory Barrett Esophagus,0
619,Prognostic Factors,Female Breast Carcinoma,0
620,Characteristics,Adenocarcinoma of the prostate metastatic,0
621,Genetic,Diffuse malignant mesothelioma,0
622,Sequence Data Type,Human Papillomavirus-Related Carcinoma,0
623,Time,Human Papillomavirus-Related Carcinoma,0
624,curative treatment,Testicular cancer metastatic,0
625,Asia,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
626,Brain,Acute Undifferentiated Leukemia,0
627,Chemotherapy Regimen,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
628,Case (situation),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
629,Occurrence Indicator,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
630,Vaginal mass,Uterine Cancer,0
631,Protocol Agent,Testicular cancer metastatic,0
632,Optic Nerve Glioma,Pilocytic astrocytoma of cerebellum,0
633,Ability,Pancreatic Intraepithelial Neoplasia-3,0
634,Presence (property),Atypical Mesothelial Hyperplasia,0
635,Patterns,Adult Alveolar Soft Part Sarcoma,0
636,Antineoplastic Agents,Recurrent Testicular Lymphoma,0
637,High risk of,Angiosarcoma of liver,0
638,Usually Need Help from Another Person for Arising,Adult Alveolar Soft Part Sarcoma,0
639,+2,Localized Askin Tumor,0
640,Form:Finding:Point in time:{Setting}:Document:{Role},Maxillary Sinus Adenocarcinoma,0
641,Immunotherapy for cancer,Unresectable Rhabdomyosarcoma,0
642,Biomaterial Treatment,Intestinal Metaplasia of Bladder Urothelium,0
643,Talpidae,Malignant melanoma of eyelid,0
644,Second edition,Noninfiltrating Intraductal Carcinoma,0
645,Malignant Neoplasms,Acantholytic squamous cell carcinoma,0
646,Tryptophanase,Female Breast Carcinoma,0
647,<90,Stage IB Pancreatic Cancer AJCC v8,0
648,Cancer Genus,Acantholytic squamous cell carcinoma,0
649,Nausea Visual Analogue Scale,Mucinous adenocarcinoma gastric,0
650,Common (qualifier value),Carcinoma of urinary bladder,0
651,Risk,FIGO Stage II Ovarian Cancer,0
652,Certain (qualifier value),Bladder squamous cell carcinoma stage I,0
653,Epithelial Cells,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
654,Adult human body,squamous cell carcinoma of the thyroid gland,0
655,Often - answer to question,Pancreatic Intraepithelial Neoplasia-3,0
656,Often - answer to question,Hodgkin lymphoma,0
657,Neuron spine,Refractory Glioma,0
658,Primary malignant neoplasm of endometrium,Undifferentiated Endocervical Sarcoma,0
659,Skeletal bone,Heavy Chain Deposition Disease,0
660,Breaking down,Malignant melanoma of eyelid,0
661,Often - answer to question,Thymic Clear Cell Carcinoma,0
662,Two,Malignant neoplasm of thalamus,0
663,Minor salivary gland structure,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
664,migrated,Adult Alveolar Soft Part Sarcoma,0
665,Togo,Benign Apocrine Neoplasm,0
666,Frequently,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
667,Firstly,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
668,Fungus (lab result),Cancer of Urinary Tract,0
669,Involvement with,Malignant Testicular Sertoli Cell Tumor,0
670,Distant,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
671,Physical findings,Female Breast Carcinoma,0
672,Combined,Endometrial Small Cell Carcinoma,0
673,Dietary Lead,Recurrent Testicular Lymphoma,0
674,Usual Severity Weight Loss,Hodgkin lymphoma,0
675,combination - answer to question,Uterine Cancer,0
676,various allergen extracts,Placental aromatase deficiency,0
677,various antiseptic throat preparations,Neonatal leukemia,0
678,Derivation,Clonal Hematopoiesis of Indeterminate Potential,0
679,Old,FIGO Stage II Ovarian Cancer,0
680,Immature Lymphocytes Measurement,Thymic Clear Cell Carcinoma,0
681,shared attribute,Intestinal Neuroendocrine Carcinoma,0
682,Fungi,Cancer of Urinary Tract,0
683,Occurrence,Mucinous adenocarcinoma gastric,0
684,North America,Intestinal Metaplasia of Bladder Urothelium,0
685,Parotid Neoplasms,Carcinoma ex pleomorphic adenoma of parotid gland,0
686,Arm of chromosome,BRCA2 Syndrome,0
687,Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
688,Concept model range (foundation metadata concept),Recurrent Testicular Lymphoma,0
689,Infection,Cancer of Urinary Tract,0
690,Equine laminitis,Clonal Hematopoiesis of Indeterminate Potential,0
691,Patient Reported Outcome Stem,Clonal Hematopoiesis of Indeterminate Potential,0
692,Exposure to,Angiosarcoma of liver,0
693,Lymphocyte component of blood,Papillary cystic tumor,0
694,Skin,Airway Hemangioma,0
695,Often - answer to question,Testicular cancer metastatic,0
696,Including (qualifier),Mastocytosis,0
697,Have Weight Loss,Hodgkin lymphoma,0
698,Cell division,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
699,Common (qualifier value),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
700,Process,Testicular cancer metastatic,0
701,*Activity (kind of quantity),Thymic Clear Cell Carcinoma,0
702,Two,Stage IB Pancreatic Cancer AJCC v8,0
703,diagnosis aspect,Metastatic Ductal Breast Carcinoma,0
704,Valid,Leptomeningeal sarcoma,0
705,penis,Human Papillomavirus-Related Carcinoma,0
706,Difficult (qualifier value),Cancer of Urinary Tract,0
707,low confidentiality,Clonal Hematopoiesis of Indeterminate Potential,0
708,Body tissue,adenosquamous carcinoma of breast,0
709,Chemotherapy Regimen,Malignant Testicular Sertoli Cell Tumor,0
710,Catch - Finding of sensory dimension of pain,FIGO Stage II Ovarian Cancer,0
711,Blood capillaries,Digestive System Hodgkin Lymphoma,0
712,Thoracic Duct,Digestive System Hodgkin Lymphoma,0
713,Neck Pain Score 2,Cartilaginous exostosis,0
714,Occurrence Indicator,Adenocarcinoma of the prostate metastatic,0
715,Call (Instruction),Benign Apocrine Neoplasm,0
716,Specific qualifier value,Recurrent Testicular Lymphoma,0
717,Therapeutic procedure,Bladder squamous cell carcinoma stage I,0
718,Characterization,Stage IB Lung Cancer AJCC v7,0
719,Present,Colorectal High Grade B-Cell Lymphoma,0
720,unknown vaccine or immune globulin,Adult Alveolar Soft Part Sarcoma,0
721,Critical,Neonatal leukemia,0
722,Act Status - obsolete,Recurrent Testicular Lymphoma,0
723,Common (qualifier value),Acute Undifferentiated Leukemia,0
724,Down Syndrome,Neonatal leukemia,0
725,3+ Score,Mucinous adenocarcinoma gastric,0
726,85,Lung squamous cell carcinoma stage I,0
727,Anterior portion of neck,Human Papillomavirus-Related Carcinoma,0
728,CD44 wt Allele,Thymic Clear Cell Carcinoma,0
729,Specimen,Undifferentiated Endocervical Sarcoma,0
730,Involvement with,BRCA2 Syndrome,0
731,Dictionary [Publication Type],Ampulla of Vater Tubular Adenoma,0
732,Left sided,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
733,shared attribute,Colorectal cancer,0
734,Folded structure,Neonatal leukemia,0
735,Similarity,gliosarcoma,0
736,Male population group,Cancer of Urinary Tract,0
737,Spreading (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
738,Sweating,Blepharal carcinoma,0
739,Genes,Breast Ductal Adenoma,0
740,Esthesia,Malignant neoplasm of thalamus,0
741,Availability of,Breast Ductal Adenoma,0
742,depend,Cartilaginous exostosis,0
743,Fatigue,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
744,Bacteria,Cancer of Urinary Tract,0
745,Adult Angiosarcoma,Angiosarcoma of liver,0
746,Cells,Hemangioma,0
747,System - kit,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
748,NIN gene,Unresectable Rhabdomyosarcoma,0
749,Cancer Remission,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
750,Sometimes,Maxillary Sinus Adenocarcinoma,0
751,Group A (blood group),Malignant Neoplasm with Regional Lymph Node Involvement,0
752,Known,Mucinous adenocarcinoma gastric,0
753,Body site,Benign Carotid Body Paraganglioma,0
754,International Classification of Diseases for Oncology,Rhabdomyosarcoma with ganglionic differentiation,0
755,removal technique,Familial Adenomatous Polyposis Associated Medulloblastoma,0
756,Low Grade,mucinous adenocarcinoma of gallbladder,0
757,Benign Neoplasm,Malignant Neoplasm of Lung - Multiple Primary Sites,0
758,To,Stage IB Pancreatic Cancer AJCC v8,0
759,Collections (publication),Liver Cavernous Hemangioma,0
760,Primary operation,Granular Cell Leiomyosarcoma,0
761,Premalignant,Acantholytic squamous cell carcinoma,0
762,head of bed,Refractory Barrett Esophagus,0
763,Bibliographic Reference,BRCA2 Syndrome,0
764,Notable,Acute Undifferentiated Leukemia,0
765,Uterine Cancer,Uterine Cancer,0
766,Agent,Testicular cancer metastatic,0
767,Early stage,Endometrial Small Cell Carcinoma,0
768,Array Feature,Metastatic Ductal Breast Carcinoma,0
769,Retraction (finding),Stage II Carcinoma of Penis,0
770,Serious,Acute lymphadenitis,0
771,6/3,Recurrent Testicular Lymphoma,0
772,Personal appearance,Female Breast Carcinoma,0
773,Occurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
774,Transmitted by,Human Papillomavirus-Related Carcinoma,0
775,Medical Device Emits Smoke,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
776,Others - Allergy,FIGO Stage II Ovarian Cancer,0
777,China,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
778,Original Regulatory Submission,Ampulla of Vater Tubular Adenoma,0
779,Oral,Giant cell angiofibroma,0
780,Bacterial Infections,Cancer of Urinary Tract,0
781,How Often Weight Loss,Malignant Neoplasm with Regional Lymph Node Involvement,0
782,Alternative,Extracranial Neuroblastoma,0
783,Five-year Survival Rate,Carcinoma of urinary bladder,0
784,Neoplasms,Leptomeningeal sarcoma,0
785,Good,Pilocytic astrocytoma of cerebellum,0
786,Changing,Unresectable Rhabdomyosarcoma,0
787,include - SetOperator,squamous cell carcinoma of the thyroid gland,0
788,Unknown,Acute Undifferentiated Leukemia,0
789,combination of objects,Endometrial Small Cell Carcinoma,0
790,Effusion of blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
791,Universal restriction modifier (core metadata concept),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
792,Tryptophanase,Intestinal Metaplasia of Bladder Urothelium,0
793,Palatine Tonsil,Recurrent Testicular Lymphoma,0
794,Coitus,Stage II Carcinoma of Penis,0
795,Clear,Giant cell angiofibroma,0
796,Gastroenterologist,Refractory Barrett Esophagus,0
797,family of origin,Ichthyoses,0
798,Social Networks,Digestive System Hodgkin Lymphoma,0
799,contextual factors,Atypical Lobular Breast Hyperplasia,0
800,year,Cancer of Urinary Tract,0
801,Feelings,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
802,Financial Account,Human Papillomavirus-Related Carcinoma,0
803,Factor,FIGO Stage II Ovarian Cancer,0
804,Person Name,Extracranial Neuroblastoma,0
805,Arranged (transportation),Atypical Lobular Breast Hyperplasia,0
806,Bio-Informatics,Advanced Uterine Corpus Carcinosarcoma,0
807,Unit - NCI Thesaurus Property,Childhood Thyroid Gland Follicular Carcinoma,0
808,Young,FIGO Stage II Ovarian Cancer,0
809,Operation excision,Malignant melanoma of eyelid,0
810,Occurrence,Childhood Central Nervous System Immature Teratoma,0
811,First (number),Pilocytic astrocytoma of cerebellum,0
812,Due to,Human Papillomavirus-Related Carcinoma,0
813,South,Bladder squamous cell carcinoma stage I,0
814,Frequently,Diffuse malignant mesothelioma,0
815,East,Blepharal carcinoma,0
816,Estimated,Extra-Adrenal Paraganglioma,0
817,shared attribute,adenosquamous carcinoma of breast,0
818,Table Cell Vertical Align - middle,Human Papillomavirus-Related Carcinoma,0
819,Malignant Neoplasms,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
820,Destruction (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
821,CDISC SEND Tumor Findings Results Terminology,Malignant neoplasm of thalamus,0
822,Classical (qualifier value),Metastatic Neoplasm to the Gallbladder,0
823,Gene Mutation,BRCA2 Syndrome,0
824,Adult human body,Placental aromatase deficiency,0
825,20%,Digestive System Hodgkin Lymphoma,0
826,Legal Adult,Thymic Clear Cell Carcinoma,0
827,Lower (action),Diffuse malignant mesothelioma,0
828,Left,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
829,Case (situation),Acute Undifferentiated Leukemia,0
830,Liquid substance,Diffuse malignant mesothelioma,0
831,Frequently,Localized Askin Tumor,0
832,Second edition,Leptomeningeal sarcoma,0
833,Type A,Adenocarcinoma,0
834,Have Weight Loss,Childhood Lymphoma,0
835,Benign neoplasm of paraganglion,Extra-Adrenal Paraganglioma,0
836,Approximate,Malignant Neoplasm with Regional Lymph Node Involvement,0
837,In Blood,Clonal Hematopoiesis of Indeterminate Potential,0
838,Gastrointestinal tract structure,squamous cell carcinoma of the thyroid gland,0
839,Contusions,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
840,Linear,Uterine Cancer,0
841,Experimental Result,Malignant melanoma of eyelid,0
842,status - In progress,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
843,Enlargement procedure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
844,Laboratory Procedures,Benign Carotid Body Paraganglioma,0
845,Neoplasms,Benign neoplasm of thorax,0
846,low exposure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
847,Aspects of signs,Recurrent Uveal Melanoma,0
848,Susceptible,Mastocytosis,0
849,Five-year Survival Rate,Mucinous adenocarcinoma gastric,0
850,Symptoms aspect,Malignant Neoplasm with Regional Lymph Node Involvement,0
851,Significant,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
852,Specimen Type - Genital,Human Papillomavirus-Related Carcinoma,0
853,Pesticides,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
854,Medical Device Emits Smoke,Stage II Carcinoma of Penis,0
855,Bruising,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
856,Thigh structure,Adult Alveolar Soft Part Sarcoma,0
857,Present,Anterior Urethral Malignant Neoplasm,0
858,Speaking (activity),Malignant neoplasm of thalamus,0
859,Vagina Carcinoma,papillary carcinoma of penis,0
860,leukemia,Malignant Neoplasm with Regional Lymph Node Involvement,0
861,Functional,Childhood Thyroid Gland Follicular Carcinoma,0
862,Australia,Diffuse malignant mesothelioma,0
863,Urine looks dark,Stage IB Pancreatic Cancer AJCC v8,0
864,Primary malignant neoplasm,Recurrent Testicular Lymphoma,0
865,Biopsy,Anterior Urethral Malignant Neoplasm,0
866,Woman,Malignant melanoma of eyelid,0
867,Magnetic Resonance Imaging Study File,Anterior Urethral Malignant Neoplasm,0
868,Xeroderma Pigmentosum,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
869,Form:Finding:Point in time:{Setting}:Document:{Role},Metastatic Neoplasm to the Gallbladder,0
870,Therapeutic radiology procedure,Recurrent Uveal Melanoma,0
871,Basal cell carcinoma,Acantholytic squamous cell carcinoma,0
872,symbol - solid dosage form,BRCA2 Syndrome,0
873,Reported Term,Neonatal leukemia,0
874,various other agents for local oral treatment in ATC,Placental aromatase deficiency,0
875,Control function,Primary Cutaneous Plasmablastic Lymphoma,0
876,Known,Choroid Necrotic Melanoma,0
877,Treating,Primary Cutaneous Plasmablastic Lymphoma,0
878,Malignant Neoplasms,Adenocarcinoma of the prostate metastatic,0
879,Group A (blood group),Metastatic Ductal Breast Carcinoma,0
880,Known,Familial Adenomatous Polyposis Associated Medulloblastoma,0
881,Including (qualifier),Noninfiltrating Intraductal Carcinoma,0
882,Lower - spatial qualifier,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
883,Identity,Heavy Chain Deposition Disease,0
884,Manufactured sign,Angiosarcoma of liver,0
885,Cornea,Blepharal carcinoma,0
886,Pallor of skin,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
887,Same,Adult Alveolar Soft Part Sarcoma,0
888,examination of cervix,Human Papillomavirus-Related Carcinoma,0
889,Affect (mental function),Spongiotic dermatitis,0
890,Kidney Infection,Cancer of Urinary Tract,0
891,Present,Recurrent Testicular Lymphoma,0
892,Malignant neoplasm of stomach,Mucinous adenocarcinoma gastric,0
893,Tryptophanase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
894,Growth,Stage IB Lung Cancer AJCC v7,0
895,Delight,Extracranial Neuroblastoma,0
896,90 - 100%,Benign neoplasm of thorax,0
897,Before,Undifferentiated Endocervical Sarcoma,0
898,Pleura,Diffuse malignant mesothelioma,0
899,Architecture,Carcinoma ex pleomorphic adenoma of parotid gland,0
900,classical example,Refractory Barrett Esophagus,0
901,Recent,Clonal Hematopoiesis of Indeterminate Potential,0
902,*Type - Kind of quantity,Stage IB Pancreatic Cancer AJCC v8,0
903,Smear - instruction imperative,Stage IB Lung Cancer AJCC v7,0
904,Epithelial cell count (procedure),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
905,Relationships,Undifferentiated Endocervical Sarcoma,0
906,Iodides,Atypical Lobular Breast Hyperplasia,0
907,Spreading (qualifier value),Stage IB Lung Cancer AJCC v7,0
908,Diffuse Large B-Cell Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
909,Color,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
910,Five-year Survival Rate,Malignant melanoma of eyelid,0
911,Person Name,Clonal Hematopoiesis of Indeterminate Potential,0
912,Metastasis,adenosquamous carcinoma of breast,0
913,Subtype (attribute),Malignant Neoplasm with Regional Lymph Node Involvement,0
914,3+ Score,Recurrent Uveal Melanoma,0
915,Glioblastoma Multiforme,Advanced Uterine Corpus Carcinosarcoma,0
916,Genus Cygnus,Giant cell angiofibroma,0
917,Blood group antibody I,Recurrent Testicular Lymphoma,0
918,Persistent,Human Papillomavirus-Related Carcinoma,0
919,Urinary tract,Cancer of Urinary Tract,0
920,Down Syndrome,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
921,Primary malignant neoplasm,Methotrexate-Associated Hodgkin Lymphoma,0
922,genetic aspects,Diffuse malignant mesothelioma,0
923,Infrequent,Neonatal leukemia,0
924,Most,Malignant Testicular Sertoli Cell Tumor,0
925,Numerous,Acute Undifferentiated Leukemia,0
926,Bathing,Digestive System Hodgkin Lymphoma,0
927,Mature,Thymic Clear Cell Carcinoma,0
928,Analysis,Malignant melanoma of eyelid,0
929,Itchiness,Malignant melanoma of eyelid,0
930,Merkel cell carcinoma,Stage II Carcinoma of Penis,0
931,Make - Instruction Imperative,Stage IB Pancreatic Cancer AJCC v8,0
932,Body tissue,Liver Cavernous Hemangioma,0
933,Curettage procedure,Endometrial Small Cell Carcinoma,0
934,Plasma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
935,include - SetOperator,Acute lymphadenitis,0
936,Primary malignant neoplasm,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
937,Group A (qualifier value),Methotrexate-Associated Hodgkin Lymphoma,0
938,Fatigue,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
939,Primary malignant neoplasm of lung,adenosquamous carcinoma of breast,0
940,Membrane Device,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
941,M+ (tumor staging),Testicular cancer metastatic,0
942,Cancer Genus,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
943,Rare,Stage II Carcinoma of Penis,0
944,risk factors,Uterine Cancer,0
945,Occur (action),Malignant Testicular Sertoli Cell Tumor,0
946,United States Military Commissioned Officer O4,Stage I Adult Non-Hodgkin Lymphoma,0
947,DNA,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
948,neck gland,Childhood Thyroid Gland Follicular Carcinoma,0
949,Within,Granular Cell Leiomyosarcoma,0
950,Identifier,Recurrent Testicular Lymphoma,0
951,shared attribute,Tonsillar Carcinoma,0
952,Percent of Abnormal Cells,Endometrial Small Cell Carcinoma,0
953,Benign,Choroid Necrotic Melanoma,0
954,Carbohydrate nutrients,Unresectable Rhabdomyosarcoma,0
955,Males,Placental aromatase deficiency,0
956,Skin,Deep Leiomyoma,0
957,Weight decreased,adenosquamous carcinoma of breast,0
958,Referring,Testicular cancer metastatic,0
959,Common (qualifier value),Recurrent Uveal Melanoma,0
960,Symptoms aspect,Stage II Carcinoma of Penis,0
961,Circulatory Process,Neonatal leukemia,0
962,Low Level,Primary Cutaneous Plasmablastic Lymphoma,0
963,morphological,Leptomeningeal sarcoma,0
964,Treatment Epoch,Female Breast Carcinoma,0
965,Abnormally high,Diffuse malignant mesothelioma,0
966,subscriber - self,Acute lymphadenitis,0
967,melanocyte,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
968,Science of genetics,Diffuse malignant mesothelioma,0
969,Togo,Recurrent Testicular Lymphoma,0
970,predictive factor,Breast Ductal Adenoma,0
971,SLC35G1 gene,Metastatic Carcinoma in the Lung,0
972,A Codes,Familial Hemophagocytic Lymphocytosis,0
973,Chromosome band,Childhood Thyroid Gland Follicular Carcinoma,0
974,Fever,Stage I Adult Non-Hodgkin Lymphoma,0
975,Extrinsic,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
976,Area,Acantholytic squamous cell carcinoma,0
977,Fertility Domain,Spermatocytic seminoma,0
978,Fibroid Tumor,Leiomyoma of Gallbladder,0
979,Nodule,Atypical Mesothelial Hyperplasia,0
980,Proliferation,Neonatal leukemia,0
981,Child,Neonatal leukemia,0
982,Ethanol,Adult Hepatocellular Carcinoma,0
983,point - UnitsOfMeasure,Cancer of Urinary Tract,0
984,Show,gliosarcoma,0
985,Fertility,Spermatocytic seminoma,0
986,Chemotherapy,Lung squamous cell carcinoma stage I,0
987,Malignant epithelioma,Female Breast Carcinoma,0
988,Duct (organ) structure,Female Breast Carcinoma,0
989,Malignant neoplasm of oropharynx,Tonsillar Carcinoma,0
990,radiotherapeutic,Carcinoma of urinary bladder,0
991,Negation,Thymic Clear Cell Carcinoma,0
992,Family (taxonomic),Mucinous adenocarcinoma gastric,0
993,Cells,Stage IB Pancreatic Cancer AJCC v8,0
994,structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
995,pharmacotherapeutic,Endometrial Small Cell Carcinoma,0
996,Eighth,FIGO Stage II Ovarian Cancer,0
997,Reduced,Diffuse malignant mesothelioma,0
998,More Often than Once a Day,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
999,Bilateral salpingectomy with oophorectomy,Endometrial Small Cell Carcinoma,0
1000,physiological aspects,BRCA2 Syndrome,0
1001,Developing Countries,Adult Hepatocellular Carcinoma,0
1002,Aim (idea),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1003,regional,Digestive System Hodgkin Lymphoma,0
1004,NCI CTEP SDC Mesothelioma Sub-Category Terminology,Diffuse malignant mesothelioma,0
1005,Nursing interventions,Unfavorable Non-Hodgkin Lymphoma,0
1006,Long-term Follow-up,Benign Carotid Body Paraganglioma,0
1007,Type - attribute,adenosquamous carcinoma of breast,0
1008,Certain (qualifier value),Recurrent Testicular Lymphoma,0
1009,Elbow joint structure,Cartilaginous exostosis,0
1010,Progress,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1011,How Much Distress Weight Loss,Hodgkin lymphoma,0
1012,CLEC4D gene,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1013,Circulating,Recurrent Testicular Lymphoma,0
1014,Adenocarcinoma,Adenocarcinoma,0
1015,Treated with,Breast Ductal Adenoma,0
1016,Used by,Human Papillomavirus-Related Carcinoma,0
1017,Abnormal cell,Testicular cancer metastatic,0
1018,Skin,papillary carcinoma of penis,0
1019,Occurrence,Localized Askin Tumor,0
1020,Lung,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1021,Tests (qualifier value),Breast Ductal Adenoma,0
1022,lymph nodes,Papillary cystic tumor,0
1023,Occurrence Indicator,Acute Undifferentiated Leukemia,0
1024,Childhood Gliosarcoma,gliosarcoma,0
1025,soft tissue,Adult Alveolar Soft Part Sarcoma,0
1026,Age of Onset,Angiosarcoma of liver,0
1027,Therapeutic radiology procedure,Diffuse malignant mesothelioma,0
1028,Tired,Stage I Adult Non-Hodgkin Lymphoma,0
1029,Natures,Giant cell angiofibroma,0
1030,Manufactured form,Anterior Urethral Malignant Neoplasm,0
1031,Michigan alcoholism screening test,Mastocytosis,0
1032,Diabetes Mellitus,Undifferentiated Endocervical Sarcoma,0
1033,Have Sweats,Methotrexate-Associated Hodgkin Lymphoma,0
1034,Australia,Recurrent Uveal Melanoma,0
1035,Infrequent,Diffuse malignant mesothelioma,0
1036,Administration procedure,Uterine Cancer,0
1037,6000,Ichthyosis,0
1038,Interstitial Route of Drug Administration,Digestive System Hodgkin Lymphoma,0
1039,Present,Colorectal Neuroendocrine Tumor G2,0
1040,Present,Hemangioma,0
1041,Common Specifications in HL7 V3 Publishing,Tonsillar Carcinoma,0
1042,factor A,Localized Askin Tumor,0
1043,Immature,Acute Undifferentiated Leukemia,0
1044,Universal,Cartilaginous exostosis,0
1045,*Type - Kind of quantity,GIANT PIGMENTED HAIRY NEVUS,0
1046,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,Mucinous adenocarcinoma gastric,0
1047,Exposure to,Endometrial Small Cell Carcinoma,0
1048,Associated with,Unfavorable Non-Hodgkin Lymphoma,0
1049,Changing,Malignant neoplasm of thalamus,0
1050,Classical (qualifier value),Leiomyoma of Gallbladder,0
1051,second (number),Secondary malignant neoplasm of lymph node,0
1052,Surgical aspects,Carcinoma of urinary bladder,0
1053,Derivation,benign mature teratoma of pancreas,0
1054,Common (qualifier value),Methotrexate-Associated Hodgkin Lymphoma,0
1055,melanoma,Malignant melanoma of eyelid,0
1056,Pure Spanish horse breed (organism),Metastatic Carcinoma in the Lung,0
1057,Bothered by Night Sweats,Childhood Lymphoma,0
1058,bony process,Stage IB Lung Cancer AJCC v7,0
1059,Secretory Vesicles,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1060,Endothelial Cells,Angiosarcoma of liver,0
1061,Malignant - descriptor,Extra-Adrenal Paraganglioma,0
1062,Geographic Locations,GIANT PIGMENTED HAIRY NEVUS,0
1063,Code System Type - Internal,Spongiotic dermatitis,0
1064,Circulating Tumor Cell Count,Testicular cancer metastatic,0
1065,Reduction (chemical),FIGO Stage II Ovarian Cancer,0
1066,Telephone Extension Number,Intracortical osteosarcoma,0
1067,Notable,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1068,Tissue Type Code - Basal cell carcinoma,Acantholytic squamous cell carcinoma,0
1069,Ductal,Metastatic Ductal Breast Carcinoma,0
1070,Ultrasonics (sound),Malignant Testicular Sertoli Cell Tumor,0
1071,Usual Severity Itching,Malignant Neoplasm with Regional Lymph Node Involvement,0
1072,Source,Malignant melanoma of eyelid,0
1073,Half,Spermatocytic seminoma,0
1074,Disease Response,Breast Ductal Adenoma,0
1075,Common Specifications in HL7 V3 Publishing,Intestinal Neuroendocrine Carcinoma,0
1076,Hematuria,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1077,Hand,Adult Alveolar Soft Part Sarcoma,0
1078,Bodily secretions,Benign Apocrine Neoplasm,0
1079,Tanning of leather,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1080,transport (device),Grade 1 Clear Cell Renal Cell Carcinoma,0
1081,radiotherapeutic,Intestinal Metaplasia of Bladder Urothelium,0
1082,Social Role,BRCA2 Syndrome,0
1083,User Group,Heavy Chain Deposition Disease,0
1084,Hematological Disease,Clonal Hematopoiesis of Indeterminate Potential,0
1085,veterans alcoholism screening test (VAST),adenosquamous carcinoma of breast,0
1086,<50,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1087,Complication Aspects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1088,Structure of collecting tubule,Collecting Duct Carcinoma of the Kidney,0
1089,Walled,Neonatal leukemia,0
1090,Lock Device,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1091,CEL gene,squamous cell carcinoma of the thyroid gland,0
1092,high - ActExposureLevelCode,BRCA2 Syndrome,0
1093,Occur (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1094,Tired,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1095,treatment options,Refractory Barrett Esophagus,0
1096,Therapeutic procedure,Cancer of Urinary Tract,0
1097,Persons,Human Papillomavirus-Related Carcinoma,0
1098,Persons,Benign Carotid Body Paraganglioma,0
1099,Observation of attack,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1100,Veins,Digestive System Hodgkin Lymphoma,0
1101,style,BRCA2 Syndrome,0
1102,Esophagus,Leiomyoma of Gallbladder,0
1103,Lung,papillary carcinoma of penis,0
1104,70%,Human Papillomavirus-Related Carcinoma,0
1105,Genital system,Human Papillomavirus-Related Carcinoma,0
1106,Immune System Processes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1107,Topical surface,Spongiotic dermatitis,0
1108,Concept model range (foundation metadata concept),Deep Leiomyoma,0
1109,Communicable Diseases,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1110,Usually,Stage IB Pancreatic Cancer AJCC v8,0
1111,Body tissue,Digestive System Hodgkin Lymphoma,0
1112,Infection caused by Helicobacter pylori,Mucinous adenocarcinoma gastric,0
1113,Science of Etiology,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1114,Human body structure,Maxillary Sinus Adenocarcinoma,0
1115,In Blood,Acute Undifferentiated Leukemia,0
1116,Overall Publication Type,Extra-Adrenal Paraganglioma,0
1117,Tissue membrane,Neonatal leukemia,0
1118,Known,Acute lymphadenitis,0
1119,Malignant neoplasm of thyroid,papillary carcinoma of penis,0
1120,Thymus Gland,Digestive System Hodgkin Lymphoma,0
1121,Different,papillary carcinoma of penis,0
1122,Blood Products Laboratory Testing,Benign Carotid Body Paraganglioma,0
1123,Hemochromatosis,Adult Hepatocellular Carcinoma,0
1124,Stage Grouping,Metastatic Ductal Breast Carcinoma,0
1125,Late stage,Primary Cutaneous Plasmablastic Lymphoma,0
1126,Adult,Acute Undifferentiated Leukemia,0
1127,Affecting,Refractory Barrett Esophagus,0
1128,Name,BRCA2 Syndrome,0
1129,include - SetOperator,Colorectal High Grade B-Cell Lymphoma,0
1130,Apocrine Glands,Benign Apocrine Neoplasm,0
1131,Primary malignant neoplasm,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1132,Present,Acantholytic squamous cell carcinoma,0
1133,Malignant Neoplasms,Malignant neoplasm of thalamus,0
1134,Carcinoma,Carcinoma of urinary bladder,0
1135,Walls of a building,Testicular cancer metastatic,0
1136,Intestines,Malignant melanoma of eyelid,0
1137,genetic risk factors,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1138,Operative Surgical Procedures,Localized Askin Tumor,0
1139,Carcinoma,Breast Ductal Adenoma,0
1140,CDISC SEND Body System Terminology,Secondary malignant neoplasm of lymph node,0
1141,insensitivity,Metastatic Carcinoma in the Lung,0
1142,Kidney Tubules,Sarcomatoid Renal Cell Carcinoma,0
1143,Occupations,Tonsillar Carcinoma,0
1144,Endometrium,Undifferentiated Endocervical Sarcoma,0
1145,Corticosteroid [EPC],Spongiotic dermatitis,0
1146,To,Blepharal carcinoma,0
1147,Biomedicine,de novo Myelodysplastic Syndrome,0
1148,Blood Proteins,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1149,Male Reproductive System Part,Malignant Testicular Sertoli Cell Tumor,0
1150,Human Cells,FIGO Stage II Ovarian Cancer,0
1151,Malignant Neoplasms,Stage II Fallopian Tube Cancer,0
1152,Result,Endometrial Small Cell Carcinoma,0
1153,More,Primary Cutaneous Plasmablastic Lymphoma,0
1154,Table Cell Horizontal Align - left,mucinous adenocarcinoma of gallbladder,0
1155,Subgroup A Nepoviruses,Female Breast Carcinoma,0
1156,cancer classification,Breast Ductal Adenoma,0
1157,CEL gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1158,Retinoic Acid Response Element,adenoid cystic carcinoma of lung,0
1159,Study Site,Urethral Carcinoma,0
1160,Neoplasms,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
1161,Usually,Airway Hemangioma,0
1162,Vagina,papillary carcinoma of penis,0
1163,Irregular,Malignant melanoma of eyelid,0
1164,Catabolism,Cartilaginous exostosis,0
1165,Possible,Metastatic Carcinoma in the Lung,0
1166,Stage Grouping,Heavy Chain Deposition Disease,0
1167,Only - dosing instruction fragment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1168,Unknown,Adult Hepatocellular Carcinoma,0
1169,N+ (tumor staging),squamous cell carcinoma of the thyroid gland,0
1170,Common Specifications in HL7 V3 Publishing,Metastatic Neoplasm to the Gallbladder,0
1171,As Much as Desired,Secondary malignant neoplasm of lymph node,0
1172,Indolent Non-Hodgkin Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
1173,Most,Leiomyoma of Gallbladder,0
1174,Central African Republic,Anterior Urethral Malignant Neoplasm,0
1175,Tears - SpecimenType,Benign Apocrine Neoplasm,0
1176,Operative Surgical Procedures,Atypical Lobular Breast Hyperplasia,0
1177,Followed by,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1178,European race,Malignant melanoma of eyelid,0
1179,Concept model domain,Noninfiltrating Intraductal Carcinoma,0
1180,Have Itch,Methotrexate-Associated Hodgkin Lymphoma,0
1181,Megakaryocyte Count,Neonatal leukemia,0
1182,Cell Communication,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1183,Primary malignant neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1184,Cessation of life,Undifferentiated Endocervical Sarcoma,0
1185,Death NOS,mucinous adenocarcinoma of gallbladder,0
1186,Togo,Carcinoma of urinary bladder,0
1187,shared attribute,Diffuse malignant mesothelioma,0
1188,Circumscribe (action),Deep Leiomyoma,0
1189,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Acute Undifferentiated Leukemia,0
1190,Q13,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1191,Childhood Non-Hodgkin Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
1192,World Health Organization,Neonatal leukemia,0
1193,Chemotherapy Regimen,Diffuse malignant mesothelioma,0
1194,Testing,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1195,CD5L wt Allele,Acute Undifferentiated Leukemia,0
1196,3+ Score,Uterine Cancer,0
1197,Blue color,Extracranial Neuroblastoma,0
1198,United States,Intestinal Metaplasia of Bladder Urothelium,0
1199,Pleurodesis,Diffuse malignant mesothelioma,0
1200,Detected (finding),Heavy Chain Deposition Disease,0
1201,Skin lesion,Recurrent Uveal Melanoma,0
1202,Appearance of eyelid,Blepharal carcinoma,0
1203,United States,Unfavorable Non-Hodgkin Lymphoma,0
1204,Physical findings,Methotrexate-Associated Hodgkin Lymphoma,0
1205,Usual Severity Weight Loss,Diffuse malignant mesothelioma,0
1206,Most,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1207,Occurrence,Uterine Cancer,0
1208,Infrequent,Childhood Thyroid Gland Follicular Carcinoma,0
1209,3+ Answer to Question,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1210,Nictitating Membrane,Blepharal carcinoma,0
1211,low,Human Papillomavirus-Related Carcinoma,0
1212,Colorectal Cancer,Colorectal High Grade B-Cell Lymphoma,0
1213,1960s,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1214,Dominant,Recurrent Testicular Lymphoma,0
1215,Mass of body structure,Tonsillar Carcinoma,0
1216,Common (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
1217,Detection,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1218,Tanning of leather,Malignant melanoma of eyelid,0
1219,To,Recurrent Testicular Lymphoma,0
1220,Logical Condition,Cancer of Urinary Tract,0
1221,survival aspects,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1222,Therapeutic procedure,Mucinous adenocarcinoma gastric,0
1223,Derived value,Airway Hemangioma,0
1224,Analysis of substances,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1225,1+,Metastatic Neoplasm to the Gallbladder,0
1226,Third revision,Leptomeningeal sarcoma,0
1227,Cohort Studies,adenoid cystic carcinoma of lung,0
1228,Tumor cells,Adult Alveolar Soft Part Sarcoma,0
1229,Term Birth,Testicular cancer metastatic,0
1230,Occur (action),Carcinoma of urinary bladder,0
1231,Electromagnetic Fields,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1232,vinyl chloride,Angiosarcoma of liver,0
1233,non-recurrent,Primary Cutaneous Plasmablastic Lymphoma,0
1234,Nodulus cerebelli,Atypical Mesothelial Hyperplasia,0
1235,Onset of Action,Human Papillomavirus-Related Carcinoma,0
1236,Food,Mucinous adenocarcinoma gastric,0
1237,Beginning,Pancreatic Intraepithelial Neoplasia-3,0
1238,Treated with,Female Breast Carcinoma,0
1239,Tryptophanase,Undifferentiated Endocervical Sarcoma,0
1240,common types,squamous cell carcinoma of the thyroid gland,0
1241,Beginning,Thymic Clear Cell Carcinoma,0
1242,Qualifier (concept),Cartilaginous exostosis,0
1243,Vaginal,squamous cell carcinoma of the thyroid gland,0
1244,melanoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1245,Portion of urine,Sarcomatoid Renal Cell Carcinoma,0
1246,best (quality),Breast Ductal Adenoma,0
1247,Type - attribute,Adult Hepatocellular Carcinoma,0
1248,Retinoic Acid Response Element,Neonatal leukemia,0
1249,To,Breast Ductal Adenoma,0
1250,Cells,Liver Cavernous Hemangioma,0
1251,International Classification of Diseases for Oncology,Leptomeningeal sarcoma,0
1252,Most,Intestinal Metaplasia of Bladder Urothelium,0
1253,Immunotherapy,Acute Undifferentiated Leukemia,0
1254,Asbestos,Diffuse malignant mesothelioma,0
1255,Inflammation,Giant cell angiofibroma,0
1256,Tobacco smoking behavior,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1257,Act Reason - Error,BRCA2 Syndrome,0
1258,Associated with,Endometrial Small Cell Carcinoma,0
1259,Symptoms,Malignant Testicular Sertoli Cell Tumor,0
1260,Glioblastoma Multiforme,gliosarcoma,0
1261,Solid,Pilocytic astrocytoma of cerebellum,0
1262,therapeutic aspects,Spermatocytic seminoma,0
1263,Case unit dose,Acantholytic squamous cell carcinoma,0
1264,Per Millimeter,Deep Leiomyoma,0
1265,Individual,Maxillary Sinus Adenocarcinoma,0
1266,Digital Content Category,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1267,Science of Etiology,Cancer of Urinary Tract,0
1268,Bone Marrow Examination,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1269,Treating,Localized Askin Tumor,0
1270,Neoplasm Metastasis,Recurrent Uveal Melanoma,0
1271,Diagnosis,Refractory Barrett Esophagus,0
1272,Light Microscopy,Carcinoma ex pleomorphic adenoma of parotid gland,0
1273,Probable diagnosis,benign mature teratoma of pancreas,0
1274,Hour,Refractory Barrett Esophagus,0
1275,Disease remission,Primary Cutaneous Plasmablastic Lymphoma,0
1276,seen,Pilocytic astrocytoma of cerebellum,0
1277,General surgery specialty,Diffuse malignant mesothelioma,0
1278,Skeletal bone,Anterior Urethral Malignant Neoplasm,0
1279,What subject filter - Result,Cancer of Urinary Tract,0
1280,Location of Oral Residue Following Swallowing,Anterior Urethral Malignant Neoplasm,0
1281,Symptom:Find:Pt:^Patient:Nom,Tonsillar Carcinoma,0
1282,Post Device,Tonsillar Carcinoma,0
1283,Fresh Water,Digestive System Hodgkin Lymphoma,0
1284,Effective,Breast Ductal Adenoma,0
1285,Asia,Intestinal Metaplasia of Bladder Urothelium,0
1286,65+,Carcinoma of urinary bladder,0
1287,Most,Angiosarcoma of liver,0
1288,Tumor cells,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1289,Laboratory Procedures,Extra-Adrenal Paraganglioma,0
1290,One,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1291,84,Intestinal Metaplasia of Bladder Urothelium,0
1292,Eye,Recurrent Uveal Melanoma,0
1293,Make - Instruction Imperative,Acantholytic squamous cell carcinoma,0
1294,alone - group size,Primary Cutaneous Plasmablastic Lymphoma,0
1295,history (of) disease family,Malignant Testicular Sertoli Cell Tumor,0
1296,Version,Familial Hemophagocytic Lymphocytosis,0
1297,Erythropoiesis,Acute Undifferentiated Leukemia,0
1298,Alveolus,Adult Alveolar Soft Part Sarcoma,0
1299,Version (morphologic abnormality),Secondary malignant neoplasm of lymph node,0
1300,High,Malignant melanoma of eyelid,0
1301,Include (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1302,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Childhood Thyroid Gland Follicular Carcinoma,0
1303,Combined,Uterine Cancer,0
1304,Weight decreased,Unfavorable Non-Hodgkin Lymphoma,0
1305,Woman,Recurrent Uveal Melanoma,0
1306,Treating,Advanced Uterine Corpus Carcinosarcoma,0
1307,Residential flat,Atypical Mesothelial Hyperplasia,0
1308,interstitial,Digestive System Hodgkin Lymphoma,0
1309,Infantile hemangioma,Airway Hemangioma,0
1310,member,Recurrent Uveal Melanoma,0
1311,Left sided,Primary Cutaneous Plasmablastic Lymphoma,0
1312,Metaplasia,Testicular cancer metastatic,0
1313,Pharmacotherapy,Malignant melanoma of eyelid,0
1314,Type - attribute,Colorectal Neuroendocrine Tumor G2,0
1315,shared attribute,Stage IB Lung Cancer AJCC v7,0
1316,>90,Blepharal carcinoma,0
1317,Symptoms aspect,Stage IB Lung Cancer AJCC v7,0
1318,Etiology aspects,Spongiotic dermatitis,0
1319,Primary malignant neoplasm,Adult Alveolar Soft Part Sarcoma,0
1320,Human Papilloma Virus Vaccine,Human Papillomavirus-Related Carcinoma,0
1321,Process,adenosquamous carcinoma of breast,0
1322,Escherichia coli,Cancer of Urinary Tract,0
1323,0%,Secondary malignant neoplasm of lymph node,0
1324,Pharmacotherapy,Metastatic Carcinoma in the Lung,0
1325,Stem cell transplant,Acute Undifferentiated Leukemia,0
1326,1980s,Endometrial Small Cell Carcinoma,0
1327,Free of (attribute),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1328,Fibroid Tumor,Metastatic Neoplasm to the Gallbladder,0
1329,Detected (finding),Human Papillomavirus-Related Carcinoma,0
1330,Fourth ventricle structure,Malignant neoplasm of choroid,0
1331,Followed by,Intestinal Metaplasia of Bladder Urothelium,0
1332,Tissue Specimen Code,Stage IB Lung Cancer AJCC v7,0
1333,Page (document),Familial Hemophagocytic Lymphocytosis,0
1334,Suspected diagnosis,Uterine Cancer,0
1335,Symptoms aspect,Endometrial Small Cell Carcinoma,0
1336,Adenocarcinoma,Colorectal High Grade B-Cell Lymphoma,0
1337,Sunlight,Acantholytic squamous cell carcinoma,0
1338,Skin,Recurrent Uveal Melanoma,0
1339,Not Otherwise Specified,Neonatal leukemia,0
1340,Assisted (qualifier value),BRCA2 Syndrome,0
1341,Malignant tumor of colon,Colorectal cancer,0
1342,Surgical aspects,Uterine Cancer,0
1343,Genus Labia,Maxillary Sinus Adenocarcinoma,0
1344,Cell Count,Giant cell angiofibroma,0
1345,Small,Recurrent Testicular Lymphoma,0
1346,Melanins,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1347,Causing,Liver Cavernous Hemangioma,0
1348,low exposure,Clonal Hematopoiesis of Indeterminate Potential,0
1349,Minor (person),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1350,Account number:Identifier:Point in time:^Patient:Nominal,Mucinous adenocarcinoma gastric,0
1351,Pruritus,Malignant Neoplasm with Regional Lymph Node Involvement,0
1352,Site of,Digestive System Hodgkin Lymphoma,0
1353,Renal Cell Carcinoma Pathway,Sarcomatoid Renal Cell Carcinoma,0
1354,To,Thymic Clear Cell Carcinoma,0
1355,application of research,Unresectable Rhabdomyosarcoma,0
1356,Extrinsic,Unresectable Rhabdomyosarcoma,0
1357,How Much Nausea During This Period,Unfavorable Non-Hodgkin Lymphoma,0
1358,Pilocytic Astrocytoma,Pilocytic astrocytoma of cerebellum,0
1359,Long-term,Cancer of Urinary Tract,0
1360,Vaginal intraepithelial neoplasia,Secondary malignant neoplasm of lymph node,0
1361,Tissue Specimen Code,Female Breast Carcinoma,0
1362,cell growth,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1363,More,Pancreatic Intraepithelial Neoplasia-3,0
1364,Logical Condition,Mucinous adenocarcinoma gastric,0
1365,Pure Spanish horse breed (organism),Lung squamous cell carcinoma stage I,0
1366,Medical pathologist,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1367,How Much Distress Weight Loss,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1368,Case unit dose,Malignant Testicular Sertoli Cell Tumor,0
1369,Part,Childhood Cerebellar Neoplasm,0
1370,More,Thymic Clear Cell Carcinoma,0
1371,As Much as Desired,Deep Leiomyoma,0
1372,Woman,FIGO Stage II Ovarian Cancer,0
1373,Bronchi,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1374,Offspring,Pilocytic astrocytoma of cerebellum,0
1375,Lower (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1376,Prognosis:Find:Pt:^Patient:Nom,papillary carcinoma of penis,0
1377,Pancreas part,Stage IB Pancreatic Cancer AJCC v8,0
1378,Abdominal Cavity,Benign Carotid Body Paraganglioma,0
1379,Discover,de novo Myelodysplastic Syndrome,0
1380,Diabetes Mellitus,Endometrial Small Cell Carcinoma,0
1381,Fever symptoms (finding),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1382,Collection (action),Hemangioma,0
1383,Providing presence (regime/therapy),Atypical Mesothelial Hyperplasia,0
1384,Percent of Abnormal Cells,Atypical Lobular Breast Hyperplasia,0
1385,PAGR1 wt Allele,Angiosarcoma of liver,0
1386,Value Above Reference Range,BRCA2 Syndrome,0
1387,Frequently,Blepharal carcinoma,0
1388,various antiseptic throat preparations,Benign Carotid Body Paraganglioma,0
1389,Germ Layers,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1390,Blood group antibody I,Neonatal leukemia,0
1391,Telling untruths,Refractory Barrett Esophagus,0
1392,Age of Onset,Diffuse malignant mesothelioma,0
1393,Uveal melanoma,Recurrent Uveal Melanoma,0
1394,Vaginal clear cell adenocarcinoma,Adenocarcinoma,0
1395,What subject filter - Result,Uterine Cancer,0
1396,Myasthenia Gravis,Thymic Clear Cell Carcinoma,0
1397,Infrequent,Angiosarcoma of liver,0
1398,Allergens,Contact dermatitis due to alkali,0
1399,Term (temporal),Neonatal leukemia,0
1400,35,Cancer of Urinary Tract,0
1401,Sometimes,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1402,International Classification of Diseases for Oncology,Rhabdomyosarcoma with ganglionic differentiation,0
1403,Often - answer to question,Mucinous adenocarcinoma gastric,0
1404,Process (qualifier value),Stage IB Lung Cancer AJCC v7,0
1405,Diagnosis Study,Carcinoma of urinary bladder,0
1406,Documented,Cancer of Urinary Tract,0
1407,Aim (idea),Acute Undifferentiated Leukemia,0
1408,Medications:-:Point in time:^Patient:-,Diffuse malignant mesothelioma,0
1409,lobe,Childhood Thyroid Gland Follicular Carcinoma,0
1410,Microscopy,Malignant Testicular Sertoli Cell Tumor,0
1411,Diagnosis Study,Recurrent Uveal Melanoma,0
1412,month,Acute Undifferentiated Leukemia,0
1413,Menstruation,Endometrial Small Cell Carcinoma,0
1414,MUTYH gene,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1415,Agreement,Breast Ductal Adenoma,0
1416,Document completion status - Documented,Cancer of Urinary Tract,0
1417,Symptoms,Undifferentiated Endocervical Sarcoma,0
1418,Include (action),Benign Apocrine Neoplasm,0
1419,Diagnosis Study,Malignant Testicular Sertoli Cell Tumor,0
1420,Financial Account,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1421,Weight Loss,Methotrexate-Associated Hodgkin Lymphoma,0
1422,Molecular Mass,Pancreatic Intraepithelial Neoplasia-3,0
1423,Known,Leiomyoma of Gallbladder,0
1424,Communicable Diseases,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1425,year,Recurrent Testicular Lymphoma,0
1426,Extension,Noninfiltrating Intraductal Carcinoma,0
1427,Case unit dose,Airway Hemangioma,0
1428,treatment options,Endometrial Small Cell Carcinoma,0
1429,eTMF Content Model Code,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1430,Cutaneous (intended site),Deep Leiomyoma,0
1431,Carcinoma of lung,Metastatic Carcinoma in the Lung,0
1432,Formation,Maxillary Sinus Adenocarcinoma,0
1433,Series - set of composite instances,Collecting Duct Carcinoma of the Kidney,0
1434,Virus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1435,Decision,Tonsillar Carcinoma,0
1436,Spreading (qualifier value),Acantholytic squamous cell carcinoma,0
1437,Weight decreased,Diffuse malignant mesothelioma,0
1438,combination of objects,Uterine Cancer,0
1439,Carcinoma of lung,Lung squamous cell carcinoma stage I,0
1440,Recent,Recurrent Testicular Lymphoma,0
1441,Fungal,Cancer of Urinary Tract,0
1442,Infrequent,Anterior Urethral Malignant Neoplasm,0
1443,Occur (action),Contact dermatitis due to alkali,0
1444,Treatment Epoch,Ichthyosis,0
1445,various allergen extracts,Recurrent Testicular Lymphoma,0
1446,Europe,Intestinal Metaplasia of Bladder Urothelium,0
1447,Female Reproductive System,Undifferentiated Endocervical Sarcoma,0
1448,Infrequent,Malignant melanoma of eyelid,0
1449,Response to treatment,squamous cell carcinoma of the thyroid gland,0
1450,Mechanism Component of Device,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1451,Retinoic Acid Response Element,Extra-Adrenal Paraganglioma,0
1452,Insect Bite Specimen Code,Spongiotic dermatitis,0
1453,Source of radiation (attribute),Acantholytic squamous cell carcinoma,0
1454,Therapeutic radiology procedure,Malignant melanoma of eyelid,0
1455,/hour,Mucinous adenocarcinoma gastric,0
1456,Targeted Therapy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1457,Range,Deep Leiomyoma,0
1458,Atypical Ductal Breast Hyperplasia,Atypical Lobular Breast Hyperplasia,0
1459,Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
1460,Various patch test substance,Neonatal leukemia,0
1461,Heartburn,Mucinous adenocarcinoma gastric,0
1462,Greater than one,Mucinous adenocarcinoma gastric,0
1463,Tubal Ligation,FIGO Stage II Ovarian Cancer,0
1464,Upper Extremity,Adult Alveolar Soft Part Sarcoma,0
1465,Age,Giant cell angiofibroma,0
1466,radiotherapeutic,Malignant melanoma of eyelid,0
1467,Burkina Faso,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1468,Responsible to,BRCA2 Syndrome,0
1469,row - Table,Blepharal carcinoma,0
1470,Deoxyribonucleic Acid Measurement,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1471,Tryptophanase,Acute Undifferentiated Leukemia,0
1472,Result,Uterine Cancer,0
1473,Occurrence,Pilocytic astrocytoma of cerebellum,0
1474,Occurrence Indicator,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1475,Site of,Serous cystadenocarcinoma ovary,0
1476,Extrinsic,gliosarcoma,0
1477,Contain (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1478,Common Specifications in HL7 V3 Publishing,Urethral Carcinoma,0
1479,Treatment Epoch,Diffuse malignant mesothelioma,0
1480,Healthy,Clonal Hematopoiesis of Indeterminate Potential,0
1481,Tryptophanase,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1482,Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1483,Html Link Type - index,Familial Hemophagocytic Lymphocytosis,0
1484,Common Specifications in HL7 V3 Publishing,Colorectal cancer,0
1485,Call (Instruction),BRCA2 Syndrome,0
1486,therapeutic aspects,Human Papillomavirus-Related Carcinoma,0
1487,Squamous cell carcinoma,Bladder squamous cell carcinoma stage I,0
1488,Physical assessment findings,Female Breast Carcinoma,0
1489,Infected,Adult Hepatocellular Carcinoma,0
1490,Standard Treatment,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1491,Entity Determiner - specific,Metastatic Ductal Breast Carcinoma,0
1492,Infrequent,adenoid cystic carcinoma of lung,0
1493,Three,Benign Apocrine Neoplasm,0
1494,therapeutic aspects,Spongiotic dermatitis,0
1495,To,Mucinous adenocarcinoma gastric,0
1496,How Often Itching,Mastocytosis,0
1497,Gases,Angiosarcoma of liver,0
1498,CDISC SEND Tumor Findings Results Terminology,Serous cystadenocarcinoma ovary,0
1499,Formation,FIGO Stage II Ovarian Cancer,0
1500,Geographic Locations,Malignant neoplasm of choroid,0
1501,Thorotrast,Angiosarcoma of liver,0
1502,2+ Score,FIGO Stage II Ovarian Cancer,0
1503,Vision,Airway Hemangioma,0
1504,Body structure,Airway Hemangioma,0
1505,Skin Pigmentation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1506,Singular,Anterior Urethral Malignant Neoplasm,0
1507,Neurofibromatosis 1,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1508,Cough Frequency,Diffuse malignant mesothelioma,0
1509,Esophageal pH Monitoring,Refractory Barrett Esophagus,0
1510,Categories,Familial Hemophagocytic Lymphocytosis,0
1511,Acute Myeloid Leukemia Pathway,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1512,Binding action,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1513,Stem cell transplant,Localized Askin Tumor,0
1514,Intervention regimes,Unfavorable Non-Hodgkin Lymphoma,0
1515,90%,Uterine Cancer,0
1516,geographic population,Blepharal carcinoma,0
1517,bacteria aspects,Digestive System Hodgkin Lymphoma,0
1518,Younger child,benign mature teratoma of pancreas,0
1519,Percent (qualifier value),Diffuse malignant mesothelioma,0
1520,MALIGNANT benign,Benign Carotid Body Paraganglioma,0
1521,French-American-British Classification,Neonatal leukemia,0
1522,Qualitative form,Leiomyoma of Gallbladder,0
1523,Aim,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1524,Immune,Unresectable Rhabdomyosarcoma,0
1525,Common Specifications in HL7 V3 Publishing,Human Papillomavirus-Related Carcinoma,0
1526,Spreading (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
1527,Presentation,gliosarcoma,0
1528,Melanocytic nevus,Recurrent Uveal Melanoma,0
1529,Web Site,Secondary malignant neoplasm of lymph node,0
1530,Complete Agreement,Clonal Hematopoiesis of Indeterminate Potential,0
1531,Bothered by Vomiting,Malignant neoplasm of thalamus,0
1532,transport (device),Sarcomatoid Renal Cell Carcinoma,0
1533,Suspected qualifier,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1534,Lead,Placental aromatase deficiency,0
1535,Connect,Collecting Duct Carcinoma of the Kidney,0
1536,Overall,Testicular cancer metastatic,0
1537,Interferes with,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1538,Decision,Digestive System Hodgkin Lymphoma,0
1539,Manufactured form,Maxillary Sinus Adenocarcinoma,0
1540,Glycation End Products,Uterine Cancer,0
1541,therapeutic aspects,Cancer of Urinary Tract,0
1542,SLC6A2 wt Allele,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1543,Form:Finding:Point in time:{Setting}:Document:{Role},FIGO Stage II Ovarian Cancer,0
1544,Major,Female Breast Carcinoma,0
1545,Anorexia,FIGO Stage II Ovarian Cancer,0
1546,Juvenile,Pilocytic astrocytoma of cerebellum,0
1547,Survival Rate,Spermatocytic seminoma,0
1548,Peritoneum,Atypical Mesothelial Hyperplasia,0
1549,Carcinoma,gliosarcoma,0
1550,Medicine,Unresectable Rhabdomyosarcoma,0
1551,Diagnostic Imaging,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1552,QPCT wt Allele,Childhood Central Nervous System Immature Teratoma,0
1553,Involvement with,Recurrent Uveal Melanoma,0
1554,Etiology aspects,Ichthyoses,0
1555,Fever,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1556,Substance amount,Familial Hemophagocytic Lymphocytosis,0
1557,Nausea,Mucinous adenocarcinoma gastric,0
1558,Continuance of life,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1559,Endometrial scraping,Uterine Cancer,0
1560,Diffuse Large B-Cell Lymphoma,ALK positive large B-cell lymphoma,0
1561,Surgery specialty,Malignant Testicular Sertoli Cell Tumor,0
1562,Prior Chemotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1563,Manufactured sign,Pancreatic Intraepithelial Neoplasia-3,0
1564,Classification,Leptomeningeal sarcoma,0
1565,Hyperplasia,Atypical Mesothelial Hyperplasia,0
1566,Procedure (set of actions),Undifferentiated Endocervical Sarcoma,0
1567,Include (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1568,Fever,Malignant Neoplasm with Regional Lymph Node Involvement,0
1569,Type A,Hodgkin lymphoma,0
1570,Result,Cancer of Urinary Tract,0
1571,Infrequent,Adult Fibrolamellar Carcinoma,0
1572,Aspects of signs,Stage IB Pancreatic Cancer AJCC v8,0
1573,Malignant tumor of colon,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1574,P450-aromatase Deficiency,Placental aromatase deficiency,0
1575,Orbital region,Recurrent Uveal Melanoma,0
1576,SPINK5 gene,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1577,Status post,Acantholytic squamous cell carcinoma,0
1578,Therapeutic procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1579,Help document,Thymic Clear Cell Carcinoma,0
1580,Mean Percent of Normal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1581,shared attribute,adenoid cystic carcinoma of lung,0
1582,Much,Mucinous adenocarcinoma gastric,0
1583,Diagnosis Study,Acantholytic squamous cell carcinoma,0
1584,Cavitation,Hemangioma,0
1585,Along edge (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1586,Tryptophanase,Stage IB Pancreatic Cancer AJCC v8,0
1587,Usually,Neonatal leukemia,0
1588,Experimental Result,Undifferentiated Endocervical Sarcoma,0
1589,Consistency,Collecting Duct Carcinoma of the Kidney,0
1590,Full,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1591,Most,mucinous adenocarcinoma of gallbladder,0
1592,Feelings,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1593,Type A,Adult Alveolar Soft Part Sarcoma,0
1594,Consistency,Giant cell angiofibroma,0
1595,Cancer Genus,Testicular cancer metastatic,0
1596,Anterior portion of neck,Tonsillar Carcinoma,0
1597,BLNK gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1598,Occurrence,Diffuse malignant mesothelioma,0
1599,Singular,Pancreatic Intraepithelial Neoplasia-3,0
1600,Primary operation,Grade 1 Clear Cell Renal Cell Carcinoma,0
1601,Carcinoma,Adenocarcinoma of the prostate metastatic,0
1602,ALLERGENS IDENTIFIED:PRESENCE OR IDENTITY:POINT IN TIME:SERUM:NOMINAL,Contact dermatitis due to alkali,0
1603,Medical Devices,Recurrent Uveal Melanoma,0
1604,Northern Europe,Malignant melanoma of eyelid,0
1605,Office Visits,Spongiotic dermatitis,0
1606,Form of bone,Localized Askin Tumor,0
1607,Include (action),Unfavorable Non-Hodgkin Lymphoma,0
1608,Lymphatic System,mucinous adenocarcinoma of gallbladder,0
1609,Persons,Angiosarcoma of liver,0
1610,Thymoma,Thymic Clear Cell Carcinoma,0
1611,Dryness of eye,Blepharal carcinoma,0
1612,Serving,Breast Ductal Adenoma,0
1613,Usual,Neonatal leukemia,0
1614,IPSS Risk Category Low,Primary Cutaneous Plasmablastic Lymphoma,0
1615,Antidepressant Measurement,Refractory Barrett Esophagus,0
1616,Blood,Cancer of Urinary Tract,0
1617,Tobacco smoking behavior,Stage IB Pancreatic Cancer AJCC v8,0
1618,20%,Acantholytic squamous cell carcinoma,0
1619,Vaginal,papillary carcinoma of penis,0
1620,chronic,Acantholytic squamous cell carcinoma,0
1621,white blood cell type,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1622,Malignant Neoplasms,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1623,Body part,Adult Alveolar Soft Part Sarcoma,0
1624,Cover - action,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1625,Measurement,Refractory Barrett Esophagus,0
1626,Singular,Blepharal carcinoma,0
1627,Affect (mental function),Angiosarcoma of liver,0
1628,PSA Level Greater than Fifty,Acute Undifferentiated Leukemia,0
1629,WHO Central Nervous System Grade I,Malignant neoplasm of choroid,0
1630,Associated with,BRCA2 Syndrome,0
1631,brain cell,Refractory Glioma,0
1632,Diagnosis,Mucinous adenocarcinoma gastric,0
1633,Place - dosing instruction imperative,Testicular cancer metastatic,0
1634,85,Metastatic Carcinoma in the Lung,0
1635,Right lymphatic duct,Digestive System Hodgkin Lymphoma,0
1636,Upper surface of body of first segment of coccyx,benign mature teratoma of pancreas,0
1637,Account number:Identifier:Point in time:^Patient:Nominal,Human Papillomavirus-Related Carcinoma,0
1638,high - ActExposureLevelCode,Tonsillar Carcinoma,0
1639,Soluble (qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1640,Birth,Airway Hemangioma,0
1641,Obese build,Anterior Urethral Malignant Neoplasm,0
1642,Manufactured form,Stage IB Pancreatic Cancer AJCC v8,0
1643,Yellow complexion,Stage IB Pancreatic Cancer AJCC v8,0
1644,Result,mucinous adenocarcinoma of gallbladder,0
1645,Biopsy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1646,Tumor Antigens,Unresectable Rhabdomyosarcoma,0
1647,Fever symptoms (finding),Acute Undifferentiated Leukemia,0
1648,Immunotherapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1649,300,Extra-Adrenal Paraganglioma,0
1650,Better,Malignant Testicular Sertoli Cell Tumor,0
1651,Before,Thymic Clear Cell Carcinoma,0
1652,ethnic european,Extracranial Neuroblastoma,0
1653,Have Been Vomiting,Malignant neoplasm of thalamus,0
1654,Malignant neoplasm of urinary bladder,Bladder squamous cell carcinoma stage I,0
1655,Neoplasms,Pilocytic astrocytoma of cerebellum,0
1656,Experimental Result,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1657,Abdomen,Pancreatic Intraepithelial Neoplasia-3,0
1658,Benign Vascular Neoplasm,Hemangioma,0
1659,Mutation,benign mature teratoma of pancreas,0
1660,Genetic Predisposition to Disease,Tonsillar Carcinoma,0
1661,Malignant Neoplasms,Colorectal cancer,0
1662,Pain,Hodgkin lymphoma,0
1663,Type A,Colorectal cancer,0
1664,In Blood,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1665,Increase,Breast Ductal Adenoma,0
1666,Time (foundation metadata concept),Rhabdomyosarcoma with ganglionic differentiation,0
1667,Childhood Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
1668,Manufactured form,Female Breast Carcinoma,0
1669,Ultraviolet Rays,Malignant melanoma of eyelid,0
1670,Include (action),Rhabdomyosarcoma with ganglionic differentiation,0
1671,Tumor Mass,Granular Cell Leiomyosarcoma,0
1672,Most,Cancer of Urinary Tract,0
1673,Affecting,Stage I Adult Non-Hodgkin Lymphoma,0
1674,Tryptophanase,Clonal Hematopoiesis of Indeterminate Potential,0
1675,Present,Atypical Lobular Breast Hyperplasia,0
1676,Show,Angiosarcoma of liver,0
1677,Use of,Diffuse malignant mesothelioma,0
1678,Affecting,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1679,Immune System Finding,Thymic Clear Cell Carcinoma,0
1680,Hour Times Percent,Mucinous adenocarcinoma gastric,0
1681,Symptoms,Intestinal Metaplasia of Bladder Urothelium,0
1682,Poverty,Recurrent Uveal Melanoma,0
1683,Aspect - Kind of quantity,Female Breast Carcinoma,0
1684,To,Metastatic Ductal Breast Carcinoma,0
1685,Affecting,Spermatocytic seminoma,0
1686,Neoplasms,Choroid Necrotic Melanoma,0
1687,Occur (action),Acute Undifferentiated Leukemia,0
1688,Asia,Adult Hepatocellular Carcinoma,0
1689,NCI Thesaurus Qualifier,Cartilaginous exostosis,0
1690,High Level,Diffuse malignant mesothelioma,0
1691,Times,Recurrent Testicular Lymphoma,0
1692,Pharmacotherapy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1693,Involvement with,Localized Askin Tumor,0
1694,Extreme,Recurrent Testicular Lymphoma,0
1695,Arising in,Intestinal Metaplasia of Bladder Urothelium,0
1696,Symptoms aspect,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1697,Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
1698,Immune System Finding,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1699,Arsenic measurement,Blepharal carcinoma,0
1700,Pigment cell,Recurrent Uveal Melanoma,0
1701,Alleles,BRCA2 Syndrome,0
1702,Occur (action),Clonal Hematopoiesis of Indeterminate Potential,0
1703,body system,Secondary malignant neoplasm of lymph node,0
1704,Historical aspects qualifier,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1705,Homo sapiens,BRCA2 Syndrome,0
1706,Tryptophanase,Recurrent Testicular Lymphoma,0
1707,Most,Tonsillar Carcinoma,0
1708,Immunoproliferative Disorders,Malignant Neoplasm with Regional Lymph Node Involvement,0
1709,Retinoic Acid Response Element,Angiosarcoma of liver,0
1710,Active License,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1711,unknown vaccine or immune globulin,Adult Hepatocellular Carcinoma,0
1712,Lymphadenopathy,Methotrexate-Associated Hodgkin Lymphoma,0
1713,Either,Blepharal carcinoma,0
1714,Further,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1715,Diagnosis Study,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1716,Body Excretions,Collecting Duct Carcinoma of the Kidney,0
1717,Unknown,Malignant neoplasm of thalamus,0
1718,Gait normal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1719,Asbestos,Tonsillar Carcinoma,0
1720,Therapeutic radiology procedure,Malignant Testicular Sertoli Cell Tumor,0
1721,Language Ability - Sign,Acute lymphadenitis,0
1722,Increase,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1723,Neoplasms by Site,Malignant neoplasm of choroid,0
1724,Linear,papillary carcinoma of penis,0
1725,Multiple Myeloma,Methotrexate-Associated Hodgkin Lymphoma,0
1726,Known,Metastatic Neoplasm to the Gallbladder,0
1727,status - In progress,Malignant neoplasm of thalamus,0
1728,Affecting,Mastocytosis,0
1729,Cell Count,Carcinoma of urinary bladder,0
1730,Child,Malignant neoplasm of choroid,0
1731,Smear - instruction imperative,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1732,Able (finding),Testicular cancer metastatic,0
1733,Infrequent,Recurrent Uveal Melanoma,0
1734,Immunotherapy,Malignant melanoma of eyelid,0
1735,Out (direction),Stage IB Pancreatic Cancer AJCC v8,0
1736,cell growth,adenosquamous carcinoma of breast,0
1737,Neurofibromatosis 1,Pilocytic astrocytoma of cerebellum,0
1738,Occurrence,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1739,protein body,Thymic Clear Cell Carcinoma,0
1740,Urinary Diversion,Bladder squamous cell carcinoma stage I,0
1741,Major,Breast Ductal Adenoma,0
1742,Followed by,Testicular cancer metastatic,0
1743,Mutation,BRCA2 Syndrome,0
1744,Etiology aspects,Recurrent Uveal Melanoma,0
1745,Anorexia,Stage IB Pancreatic Cancer AJCC v8,0
1746,Did not receive therapy or drug for,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1747,Togo,Blepharal carcinoma,0
1748,Breathing Distress Question,Refractory Barrett Esophagus,0
1749,Network Device,Digestive System Hodgkin Lymphoma,0
1750,Skin,Recurrent Uveal Melanoma,0
1751,treatment - ActInformationManagementReason,Ichthyosis,0
1752,Lower (action),Malignant Testicular Sertoli Cell Tumor,0
1753,Arising,Intestinal Metaplasia of Bladder Urothelium,0
1754,Supportive assistance,gliosarcoma,0
1755,Type of complication:Type:Pt:^Patient:Nom,mucinous adenocarcinoma of gallbladder,0
1756,Melanocytic nevus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1757,combination - answer to question,Endometrial Small Cell Carcinoma,0
1758,Milliampere second,benign mature teratoma of pancreas,0
1759,Room of building - Study,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1760,Plaque (lesion),Contact dermatitis due to alkali,0
1761,Levator palpebrae superioris structure,Blepharal carcinoma,0
1762,Usual,Malignant neoplasm of choroid,0
1763,Fertility Agents,FIGO Stage II Ovarian Cancer,0
1764,Techniques,Mucinous adenocarcinoma gastric,0
1765,Complete Pharyngeal Contraction,Carcinoma of urinary bladder,0
1766,Complete Trisomy 21 Syndrome,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1767,Enlargement procedure,Childhood Lymphoma,0
1768,Responsible to,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
1769,risk factors - observation list,Refractory Barrett Esophagus,0
1770,Neuron spine,Recurrent Diffuse Intrinsic Pontine Glioma,0
1771,Lower (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1772,Specific qualifier value,Female Breast Carcinoma,0
1773,Known,Extracranial Neuroblastoma,0
1774,Skin,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1775,Feelings,Childhood Lymphoma,0
1776,Therapeutic procedure,Unresectable Rhabdomyosarcoma,0
1777,Analysis,Adult Alveolar Soft Part Sarcoma,0
1778,% bound (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1779,X-linked inheritance,Ichthyoses,0
1780,year,Primary Cutaneous Plasmablastic Lymphoma,0
1781,Lymphocyte,Digestive System Hodgkin Lymphoma,0
1782,Deterioration of status,FIGO Stage II Ovarian Cancer,0
1783,Stomach,Refractory Barrett Esophagus,0
1784,Left,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1785,Major,Hodgkin lymphoma,0
1786,Itchiness,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1787,Cerebrum,gliosarcoma,0
1788,Squamous cell carcinoma - category,Bladder squamous cell carcinoma stage I,0
1789,% Ercs,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1790,Adult Pilocytic Astrocytoma,Pilocytic astrocytoma of cerebellum,0
1791,Vegetables,Mucinous adenocarcinoma gastric,0
1792,Tumor cells,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
1793,therapeutic aspects,Maxillary Sinus Adenocarcinoma,0
1794,risk factors,Refractory Barrett Esophagus,0
1795,Entity Determiner - specific,Breast Ductal Adenoma,0
1796,Others - Allergy,Mucinous adenocarcinoma gastric,0
1797,Often - answer to question,Primary Cutaneous Plasmablastic Lymphoma,0
1798,Hematologic Neoplasms,Heavy Chain Deposition Disease,0
1799,Classification of information,Breast Ductal Adenoma,0
1800,Therapy Object (animal model),Neonatal leukemia,0
1801,Colonic Polyps,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1802,soft tissue,Localized Askin Tumor,0
1803,Heart,Thymic Clear Cell Carcinoma,0
1804,Neck,Benign neoplasm of thorax,0
1805,Brain Neoplasms,Refractory Glioma,0
1806,Fluid behavior,Diffuse malignant mesothelioma,0
1807,Body Site Modifier - Lower,Diffuse malignant mesothelioma,0
1808,Condition,Placental aromatase deficiency,0
1809,Possible diagnosis,Testicular cancer metastatic,0
1810,Percent of Bacteria,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1811,Negation,Cancer of Urinary Tract,0
1812,Case (situation),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1813,<90,Uterine Cancer,0
1814,Occur (action),Choroid Necrotic Melanoma,0
1815,Known,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1816,Joints,Cartilaginous exostosis,0
1817,Reduced,Mucinous adenocarcinoma gastric,0
1818,Study Element,Testicular cancer metastatic,0
1819,Worker,Angiosarcoma of liver,0
1820,50%,Extracranial Neuroblastoma,0
1821,Cancer Genus,Endometrial Small Cell Carcinoma,0
1822,Overall,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1823,Make - Instruction Imperative,de novo Myelodysplastic Syndrome,0
1824,Biomaterial Treatment,Diffuse malignant mesothelioma,0
1825,Primary malignant neoplasm,Stage II Fallopian Tube Cancer,0
1826,Adult Classical Hodgkin Lymphoma,Childhood Lymphoma,0
1827,Blood,Liver Cavernous Hemangioma,0
1828,Metabolic Syndrome X,Uterine Cancer,0
1829,Family history,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1830,Disease Outcome,Breast Ductal Adenoma,0
1831,Diagnosis,Acantholytic squamous cell carcinoma,0
1832,Adult Glioblastoma,gliosarcoma,0
1833,1+ Score,Mucinous adenocarcinoma gastric,0
1834,include - SetOperator,Rhabdomyosarcoma with ganglionic differentiation,0
1835,Average of Value Derivation Technique,FIGO Stage II Ovarian Cancer,0
1836,Standard Treatment,Acute Undifferentiated Leukemia,0
1837,Feel Tired question,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1838,Family history,Uterine Cancer,0
1839,Monitor,Primary Cutaneous Plasmablastic Lymphoma,0
1840,Pancreatic ductal cell,Mucinous neoplasm,0
1841,Neuroendocrine Tumors,Extra-Adrenal Paraganglioma,0
1842,Symptoms aspect,Undifferentiated Endocervical Sarcoma,0
1843,Entity Determiner - specific,Recurrent Testicular Lymphoma,0
1844,Retinoic Acid Response Element,Benign neoplasm of thorax,0
1845,Hodgkin Disease,Primary Cutaneous Plasmablastic Lymphoma,0
1846,Concept History,Uterine Cancer,0
1847,Pancreas,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
1848,Body structure,Placental aromatase deficiency,0
1849,Sometimes,Cancer of Urinary Tract,0
1850,Including (qualifier),Acantholytic squamous cell carcinoma,0
1851,65,Carcinoma of urinary bladder,0
1852,Childhood Renal Cell Carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1853,Disease,Heavy Chain Deposition Disease,0
1854,Most,Airway Hemangioma,0
1855,<3 (qualifier value),BRCA2 Syndrome,0
1856,CD5L wt Allele,Ichthyosis,0
1857,Variant,Breast Ductal Adenoma,0
1858,Mismatch Repair,Colorectal cancer,0
1859,Death (finding),Acute Undifferentiated Leukemia,0
1860,Glandular stomach,Pancreatic Intraepithelial Neoplasia-3,0
1861,pharmacotherapeutic,Intestinal Metaplasia of Bladder Urothelium,0
1862,risk factors - observation list,Malignant Testicular Sertoli Cell Tumor,0
1863,System - kit,Collecting Duct Carcinoma of the Kidney,0
1864,Numbers,Undifferentiated Endocervical Sarcoma,0
1865,Alcohol consumption,Tonsillar Carcinoma,0
1866,Astrocytoma,Pilocytic astrocytoma of cerebellum,0
1867,Testing,Benign Carotid Body Paraganglioma,0
1868,List,Noninfiltrating Intraductal Carcinoma,0
1869,year,Benign neoplasm of thorax,0
1870,Damage,BRCA2 Syndrome,0
1871,Jack Device,Extracranial Neuroblastoma,0
1872,Breast,Female Breast Carcinoma,0
1873,Inguinal part of abdomen,Benign Apocrine Neoplasm,0
1874,Etiology aspects,Acute lymphadenitis,0
1875,Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
1876,Lymphadenopathy,Recurrent Testicular Lymphoma,0
1877,Universal HL7CMETAttribution,Cartilaginous exostosis,0
1878,Stage,Primary Cutaneous Plasmablastic Lymphoma,0
1879,Colorectal Cancer Pathway,Colorectal High Grade B-Cell Lymphoma,0
1880,Condition,Mucinous adenocarcinoma gastric,0
1881,Benign neoplasm of paraganglion,Benign neoplasm of thorax,0
1882,Negative Selection,Thymic Clear Cell Carcinoma,0
1883,Feel Tired question,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1884,Treatment Epoch,Human Papillomavirus-Related Carcinoma,0
1885,Decision,Childhood Thyroid Gland Follicular Carcinoma,0
1886,Myoepithelial,Carcinoma ex pleomorphic adenoma of parotid gland,0
1887,Decision,Stage I Adult Non-Hodgkin Lymphoma,0
1888,removal technique,Lung squamous cell carcinoma stage I,0
1889,Involvement with,gliosarcoma,0
1890,Western Europe,Carcinoma of urinary bladder,0
1891,Laboratory method,Heavy Chain Deposition Disease,0
1892,Special,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1893,American College of Cardiology/American Heart Association Lesion Complexity Score C,FIGO Stage II Ovarian Cancer,0
1894,Type A,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1895,Often - answer to question,Diffuse malignant mesothelioma,0
1896,Rare,Uterine Cancer,0
1897,Divide,Adult Alveolar Soft Part Sarcoma,0
1898,Deletion (action),Ichthyosis,0
1899,Cutaneous Route of Drug Administration,Deep Leiomyoma,0
1900,year,adenoid cystic carcinoma of lung,0
1901,Pancreatic Hormones,Pancreatic Intraepithelial Neoplasia-3,0
1902,Primary malignant neoplasm,Leiomyoma of Gallbladder,0
1903,Widening,Recurrent Testicular Lymphoma,0
1904,Large,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1905,Line Unit of Length,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1906,Negation,FIGO Stage II Ovarian Cancer,0
1907,Tumor Mass,Female Breast Carcinoma,0
1908,Experimental Result,Endometrial Small Cell Carcinoma,0
1909,Adult,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1910,Active,Recurrent Uveal Melanoma,0
1911,Laryngeal papillomatosis,Human Papillomavirus-Related Carcinoma,0
1912,Term Birth,Granular Cell Leiomyosarcoma,0
1913,Approximate,Undifferentiated Endocervical Sarcoma,0
1914,Tryptophanase,Carcinoma of urinary bladder,0
1915,N not otherwise specified Antibody,Adenocarcinoma,0
1916,Increased,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1917,Contain (action),Angiosarcoma of liver,0
1918,control substance,Primary Cutaneous Plasmablastic Lymphoma,0
1919,Low Back Pain,Bladder squamous cell carcinoma stage I,0
1920,Tissue Specimen Code,Diffuse malignant mesothelioma,0
1921,Cessation of life,Malignant melanoma of eyelid,0
1922,Occur (action),adenoid cystic carcinoma of lung,0
1923,Fluid Balance,Collecting Duct Carcinoma of the Kidney,0
1924,various other agents for local oral treatment in ATC,Benign neoplasm of thorax,0
1925,Aim (idea),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1926,*Type - Kind of quantity,Adult Hepatocellular Carcinoma,0
1927,Followed by,Mucinous adenocarcinoma gastric,0
1928,Benign,Giant cell angiofibroma,0
1929,Present,Giant cell angiofibroma,0
1930,Formed,Neonatal leukemia,0
1931,Position of phenotypic abnormality,BRCA2 Syndrome,0
1932,Line Specimen,Angiosarcoma of liver,0
1933,Malignant - descriptor,Refractory Glioma,0
1934,System,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1935,Chemotherapy,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1936,Pilomyxoid astrocytoma,Pilocytic astrocytoma of cerebellum,0
1937,Primary malignant neoplasm,mucinous adenocarcinoma of gallbladder,0
1938,Array Feature,mucinous adenocarcinoma of gallbladder,0
1939,T prime,Recurrent Testicular Lymphoma,0
1940,Test Result,Extra-Adrenal Paraganglioma,0
1941,Abnormal cell,Malignant neoplasm of thalamus,0
1942,Usual Severity Shortness of Breath,Diffuse malignant mesothelioma,0
1943,Oral region,Maxillary Sinus Adenocarcinoma,0
1944,Diagnosis Study,Stage IB Pancreatic Cancer AJCC v8,0
1945,Smear - instruction imperative,Human Papillomavirus-Related Carcinoma,0
1946,Neoplasm Metastasis,Tonsillar Carcinoma,0
1947,research subject screening,Mucinous adenocarcinoma gastric,0
1948,Cryptorchidism,Malignant Testicular Sertoli Cell Tumor,0
1949,Neoplasms,Noninfiltrating Intraductal Carcinoma,0
1950,Lower urinary tract infectious disease,Cancer of Urinary Tract,0
1951,Food allergenic extracts,Larynx carcinoma recurrent,0
1952,Mass of body region,Stage IB Pancreatic Cancer AJCC v8,0
1953,Forecast of outcome,Adult Hepatocellular Carcinoma,0
1954,Cure (remedy),Malignant melanoma of eyelid,0
1955,Cancer Genus,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
1956,House (environment),Larynx carcinoma recurrent,0
1957,Call (Instruction),Extracranial Neuroblastoma,0
1958,Case (situation),Undifferentiated Endocervical Sarcoma,0
1959,Value Above Reference Range,Tonsillar Carcinoma,0
1960,What subject filter - Result,papillary carcinoma of penis,0
1961,Administration procedure,Bladder squamous cell carcinoma stage I,0
1962,week,Airway Hemangioma,0
1963,27,BRCA2 Syndrome,0
1964,Blood Circulation,Testicular cancer metastatic,0
1965,Both ovaries,Endometrial Small Cell Carcinoma,0
1966,Symptoms aspect,Malignant Testicular Sertoli Cell Tumor,0
1967,Plasma Cell Neoplasm,Heavy Chain Deposition Disease,0
1968,Stomach,Anterior Urethral Malignant Neoplasm,0
1969,Version,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1970,Grade,Female Breast Carcinoma,0
1971,Increased erythropoietin,Leiomyoma of Gallbladder,0
1972,shared attribute,FIGO Stage II Ovarian Cancer,0
1973,Set (Psychology),Malignant Neoplasm of Lung - Multiple Primary Sites,0
1974,Drainage procedure,Digestive System Hodgkin Lymphoma,0
1975,Malignant Neoplasms,Endometrial Small Cell Carcinoma,0
1976,Epidermal cells,Spongiotic dermatitis,0
1977,Lesion,Giant cell angiofibroma,0
1978,Obesity,Uterine Cancer,0
1979,Count of entities,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1980,Mass of body region,benign mature teratoma of pancreas,0
1981,Pitch (deviation),Larynx carcinoma recurrent,0
1982,Carbohydrates,Unresectable Rhabdomyosarcoma,0
1983,Medical Device Emits Smoke,Mucinous adenocarcinoma gastric,0
1984,various antiinfectives and antiseptics for local oral treatment,Benign Carotid Body Paraganglioma,0
1985,Metabolic Syndrome X,Adult Hepatocellular Carcinoma,0
1986,Stomach,mucinous adenocarcinoma of gallbladder,0
1987,Indeterminate,Clonal Hematopoiesis of Indeterminate Potential,0
1988,Thymectomy,Thymic Clear Cell Carcinoma,0
1989,Smear - instruction imperative,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1990,Frequently,Mucinous adenocarcinoma gastric,0
1991,Loss of Appetite question,Mucinous adenocarcinoma gastric,0
1992,Tryptophanase,Familial Adenomatous Polyposis Associated Medulloblastoma,0
1993,Ichthyoses,Ichthyoses,0
1994,Males,Acantholytic squamous cell carcinoma,0
1995,Common (qualifier value),Bladder squamous cell carcinoma stage I,0
1996,Reaching,FIGO Stage II Ovarian Cancer,0
1997,Specimen Source Codes - tumor,Angiosarcoma of liver,0
1998,Characterization,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1999,Mechanism (attribute),Localized Askin Tumor,0
2000,body system,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2001,Nervous system structure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2002,Relocation of home or business,Digestive System Hodgkin Lymphoma,0
2003,Obsolete - EditStatus,Recurrent Testicular Lymphoma,0
2004,CDISC SEND Tumor Findings Results Terminology,Choroid Necrotic Melanoma,0
2005,IPSS Risk Category High,Mucinous adenocarcinoma gastric,0
2006,Medical service,FIGO Stage II Ovarian Cancer,0
2007,Neoplasm Metastasis,Anterior Urethral Malignant Neoplasm,0
2008,Two,Cancer of Urinary Tract,0
2009,classical example,Heavy Chain Deposition Disease,0
2010,Communicable Diseases,Acute Undifferentiated Leukemia,0
2011,Laboratory,de novo Myelodysplastic Syndrome,0
2012,Leading,Recurrent Testicular Lymphoma,0
2013,Genetic Risk,FIGO Stage II Ovarian Cancer,0
2014,Examination,Germinoma,0
2015,Possible,Refractory Barrett Esophagus,0
2016,Specimen Source Codes - Mucosa,Maxillary Sinus Adenocarcinoma,0
2017,Collections (publication),Hemangioma,0
2018,Free (available (qualifier)),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2019,Hereditary Diseases,Pancreatic Intraepithelial Neoplasia-3,0
2020,Eating,Refractory Barrett Esophagus,0
2021,Relationships,Noninfiltrating Intraductal Carcinoma,0
2022,Spectrum,Heavy Chain Deposition Disease,0
2023,Biopsy,Spongiotic dermatitis,0
2024,Gram per Deciliter,Unresectable Rhabdomyosarcoma,0
2025,Previous,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2026,Childhood Diffuse Large B-Cell Lymphoma,Recurrent Testicular Lymphoma,0
2027,To,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2028,Sarcomatous Component Present,gliosarcoma,0
2029,Pancreas part,Pancreatic Intraepithelial Neoplasia-3,0
2030,North America,Carcinoma of urinary bladder,0
2031,Case (situation),Human Papillomavirus-Related Carcinoma,0
2032,Thyroid Gland Follicular Cell,Childhood Thyroid Gland Follicular Carcinoma,0
2033,Subject Risk,Malignant melanoma of eyelid,0
2034,Neuroendocrine Tumors,Benign neoplasm of thorax,0
2035,To,mucinous adenocarcinoma of gallbladder,0
2036,Sometimes,Localized Askin Tumor,0
2037,Monoclonal Antibodies,Heavy Chain Deposition Disease,0
2038,Person 1,Neonatal leukemia,0
2039,Needs,Cancer of Urinary Tract,0
2040,Most,Bladder squamous cell carcinoma stage I,0
2041,High Risk Acute Leukemia,FIGO Stage II Ovarian Cancer,0
2042,Short Value,Extracranial Neuroblastoma,0
2043,Infection,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2044,Anaplasia,Testicular cancer metastatic,0
2045,Orthologous Gene,BRCA2 Syndrome,0
2046,Follicle,Childhood Thyroid Gland Follicular Carcinoma,0
2047,Line Specimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2048,Solid Dose Form,Pilocytic astrocytoma of cerebellum,0
2049,Accounting (activity),Neonatal leukemia,0
2050,Tumor cells,Testicular cancer metastatic,0
2051,Metastatic Disease Clinical Trial Setting,Testicular cancer metastatic,0
2052,Iodides,Recurrent Testicular Lymphoma,0
2053,Cure (remedy),Recurrent Uveal Melanoma,0
2054,Brain part,Malignant neoplasm of thalamus,0
2055,Complete excision,Undifferentiated Endocervical Sarcoma,0
2056,Age,Stage IB Pancreatic Cancer AJCC v8,0
2057,Smear - instruction imperative,Unfavorable Non-Hodgkin Lymphoma,0
2058,Analysis of substances,Malignant melanoma of eyelid,0
2059,Three,Refractory Barrett Esophagus,0
2060,Coloring Excipient,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2061,Red color,Maxillary Sinus Adenocarcinoma,0
2062,Malignant neoplasm of gastrointestinal tract,Recurrent Testicular Lymphoma,0
2063,3+ Score,Recurrent Uveal Melanoma,0
2064,therapeutic aspects,Intestinal Metaplasia of Bladder Urothelium,0
2065,Death (finding),Diffuse malignant mesothelioma,0
2066,Increase,FIGO Stage II Ovarian Cancer,0
2067,World Health Organization,Malignant Neoplasm with Regional Lymph Node Involvement,0
2068,Support,Liver Cavernous Hemangioma,0
2069,Sample Range,Deep Leiomyoma,0
2070,Involvement with,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2071,Packaging Case,Spongiotic dermatitis,0
2072,Chest wall pain,Diffuse malignant mesothelioma,0
2073,Secondary Neoplasm,Testicular cancer metastatic,0
2074,Infective cystitis,Intestinal Metaplasia of Bladder Urothelium,0
2075,Symptoms aspect,Acute Undifferentiated Leukemia,0
2076,PSA Level Less than Two,FIGO Stage II Ovarian Cancer,0
2077,Analysis of substances,Adult Alveolar Soft Part Sarcoma,0
2078,per year,Cancer of Urinary Tract,0
2079,disease transmission,Human Papillomavirus-Related Carcinoma,0
2080,Angiofibroma,Giant cell angiofibroma,0
2081,Sweat,Blepharal carcinoma,0
2082,Used by,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2083,Infrequent,Benign neoplasm of thorax,0
2084,Sequence Arm,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2085,Fasting Status Indicator,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2086,Precipitating Factors,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2087,Administration procedure,Spermatocytic seminoma,0
2088,International Classification of Disease for Oncology,Leptomeningeal sarcoma,0
2089,Prognosis:Find:Pt:^Patient:Nom,squamous cell carcinoma of the thyroid gland,0
2090,Substance,Mastocytosis,0
2091,Tryptophanase,Metastatic Ductal Breast Carcinoma,0
2092,Individual,Heavy Chain Deposition Disease,0
2093,Common (qualifier value),Clonal Hematopoiesis of Indeterminate Potential,0
2094,Case unit dose,Endometrial Small Cell Carcinoma,0
2095,Unknown,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2096,Frequently,Stage IB Pancreatic Cancer AJCC v8,0
2097,Pharyngeal structure,Tonsillar Carcinoma,0
2098,Known,Recurrent Uveal Melanoma,0
2099,Persons,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2100,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Recurrent Testicular Lymphoma,0
2101,Observation Interpretation - intermediate,Blepharal carcinoma,0
2102,Type - attribute,Spongiotic dermatitis,0
2103,Application procedure,Acantholytic squamous cell carcinoma,0
2104,Nervous system structure,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2105,Case unit dose,Stage IB Lung Cancer AJCC v7,0
2106,Blood,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2107,World Health Organization,Secondary malignant neoplasm of lymph node,0
2108,Screening Study,Undifferentiated Endocervical Sarcoma,0
2109,Cell Device,Breast Ductal Adenoma,0
2110,Structure of parenchyma of lung,Stage IB Lung Cancer AJCC v7,0
2111,Ultraviolet Rays,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2112,Pain NOS,Localized Askin Tumor,0
2113,Clone,Heavy Chain Deposition Disease,0
2114,Togo,Atypical Lobular Breast Hyperplasia,0
2115,Cancer Etiology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2116,Allergen (brand of diphenylpyraline),Contact dermatitis due to alkali,0
2117,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Testicular Lymphoma,0
2118,Greater Than,Endometrial Small Cell Carcinoma,0
2119,United States,Bladder squamous cell carcinoma stage I,0
2120,Code,Secondary malignant neoplasm of lymph node,0
2121,Unmarried,adenoid cystic carcinoma of lung,0
2122,Type - attribute,Ichthyoses,0
2123,Formation,papillary carcinoma of penis,0
2124,Uterine Corpus Sarcoma,Undifferentiated Endocervical Sarcoma,0
2125,Therapeutic radiology procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2126,Deoxyribonucleic Acid Measurement,Clonal Hematopoiesis of Indeterminate Potential,0
2127,Bone Pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2128,Physical shape,Noninfiltrating Intraductal Carcinoma,0
2129,Complication,Localized Askin Tumor,0
2130,Common (qualifier value),Adult Hepatocellular Carcinoma,0
2131,Immunotherapy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2132,Malignant Neoplasms,adenoid cystic carcinoma of lung,0
2133,Version (morphologic abnormality),Malignant Neoplasm of Lung - Multiple Primary Sites,0
2134,Childbirth,Airway Hemangioma,0
2135,Primary malignant neoplasm,Secondary malignant neoplasm of lymph node,0
2136,Smear - instruction imperative,Pancreatic Intraepithelial Neoplasia-3,0
2137,Including (qualifier),Refractory Barrett Esophagus,0
2138,Mass of body structure,Acantholytic squamous cell carcinoma,0
2139,Pelvic pain female,FIGO Stage II Ovarian Cancer,0
2140,Benign Vascular Neoplasm,Liver Cavernous Hemangioma,0
2141,Number of birth,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2142,Death (finding),Human Papillomavirus-Related Carcinoma,0
2143,melanocyte,Recurrent Uveal Melanoma,0
2144,Common (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2145,Translocation of object,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2146,Deletion Mutation,Ichthyosis,0
2147,Description,Atypical Lobular Breast Hyperplasia,0
2148,English race,Metastatic Neoplasm to the Gallbladder,0
2149,Overall,FIGO Stage II Ovarian Cancer,0
2150,High Level,Malignant melanoma of eyelid,0
2151,Time (foundation metadata concept),Extracranial Neuroblastoma,0
2152,pharmacotherapeutic,Uterine Cancer,0
2153,Usual,Serous cystadenocarcinoma ovary,0
2154,Experimental Result,Human Papillomavirus-Related Carcinoma,0
2155,Treating,Ichthyosis,0
2156,Type - attribute,Carcinoma ex pleomorphic adenoma of parotid gland,0
2157,Less Than,Female Breast Carcinoma,0
2158,Type A,Recurrent Uveal Melanoma,0
2159,Type A,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2160,Osteoporosis,Placental aromatase deficiency,0
2161,Probable diagnosis,Acantholytic squamous cell carcinoma,0
2162,Human papillomavirus typing (procedure),Human Papillomavirus-Related Carcinoma,0
2163,Lymphocyte component of blood,Stage I Adult Non-Hodgkin Lymphoma,0
2164,Form:Finding:Point in time:{Setting}:Document:{Role},papillary carcinoma of penis,0
2165,Usual,Intestinal Metaplasia of Bladder Urothelium,0
2166,Lymphocyte,Stage I Adult Non-Hodgkin Lymphoma,0
2167,Abnormal Cell Count,Human Papillomavirus-Related Carcinoma,0
2168,70%,Localized Askin Tumor,0
2169,Chest,Airway Hemangioma,0
2170,Synonym (core metadata concept),Recurrent Testicular Lymphoma,0
2171,Body Site Modifier - Lower,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2172,National Cancer Institute,Ampulla of Vater Tubular Adenoma,0
2173,3+ Score,Uterine Cancer,0
2174,Lower eyelid,Benign Apocrine Neoplasm,0
2175,Diagnosis Study,FIGO Stage II Ovarian Cancer,0
2176,High risk,Colorectal cancer,0
2177,Disease,Stage IB Pancreatic Cancer AJCC v8,0
2178,Fever,Acute Undifferentiated Leukemia,0
2179,Bone marrow: lymphocytes (finding),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2180,Age at diagnosis:Time:Pt:^Patient:Qn,Acantholytic squamous cell carcinoma,0
2181,Anus,Human Papillomavirus-Related Carcinoma,0
2182,Moist,Blepharal carcinoma,0
2183,Case (situation),Carcinoma of urinary bladder,0
2184,Complex,Recurrent Testicular Lymphoma,0
2185,incidence of cases,Adult Hepatocellular Carcinoma,0
2186,Slightly Agree,Recurrent Uveal Melanoma,0
2187,Rapid,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2188,Over (spatial),Heavy Chain Deposition Disease,0
2189,Agent,Tonsillar Carcinoma,0
2190,Numbers,Stage IB Pancreatic Cancer AJCC v8,0
2191,Most,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2192,Biologic Development,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2193,Chest Pain,Refractory Barrett Esophagus,0
2194,Evidence,Mucinous adenocarcinoma gastric,0
2195,Unknown GENC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2196,depend,Human Papillomavirus-Related Carcinoma,0
2197,Increase,Acute Undifferentiated Leukemia,0
2198,Statistical Prevalence,Recurrent Testicular Lymphoma,0
2199,Surgical aspects,Refractory Barrett Esophagus,0
2200,Immunotherapy,Carcinoma of urinary bladder,0
2201,Cells,Giant cell angiofibroma,0
2202,Round shape,Deep Leiomyoma,0
2203,High Level,Mucinous adenocarcinoma gastric,0
2204,Tired,Childhood Lymphoma,0
2205,Type A,Benign Apocrine Neoplasm,0
2206,Body part,Thymic Clear Cell Carcinoma,0
2207,N not otherwise specified Antibody,squamous cell carcinoma of the thyroid gland,0
2208,Primary malignant neoplasm,Human Papillomavirus-Related Carcinoma,0
2209,Male population group,Recurrent Uveal Melanoma,0
2210,Bone Marrow,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2211,Divide,Breast Ductal Adenoma,0
2212,Base - General Qualifier,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2213,Study Site,Angiosarcoma of liver,0
2214,Affecting,gliosarcoma,0
2215,Overall Publication Type,Undifferentiated Endocervical Sarcoma,0
2216,Neoplasm Metastasis,Benign Carotid Body Paraganglioma,0
2217,Cancer Genus,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2218,Therapeutic radiology procedure,Uterine Cancer,0
2219,True primary (qualifier value),Granular Cell Leiomyosarcoma,0
2220,Experimental Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2221,leukemia,Neonatal leukemia,0
2222,Diffuse Large B-Cell Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
2223,Permanent,Primary Cutaneous Plasmablastic Lymphoma,0
2224,>90,Malignant Neoplasm with Regional Lymph Node Involvement,0
2225,Non-Small Cell Lung Carcinoma,Lung squamous cell carcinoma stage I,0
2226,Primary malignant neoplasm,Unresectable Rhabdomyosarcoma,0
2227,Bodily secretions,Blepharal carcinoma,0
2228,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
2229,Well Differentiated,adenoid cystic carcinoma of lung,0
2230,Hyperplastic Polyp,Colorectal Mucin Poor Hyperplastic Polyp,0
2231,Clinical Item,Human Papillomavirus-Related Carcinoma,0
2232,Chemotherapy,Localized Askin Tumor,0
2233,Chemotherapy Regimen,Bladder squamous cell carcinoma stage I,0
2234,Presence (property),Giant cell angiofibroma,0
2235,radiotherapeutic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2236,low exposure,Recurrent Uveal Melanoma,0
2237,Two,Human Papillomavirus-Related Carcinoma,0
2238,Etiology aspects,Cartilaginous exostosis,0
2239,Administration procedure,Diffuse malignant mesothelioma,0
2240,OTULIN gene,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2241,Present,de novo Myelodysplastic Syndrome,0
2242,Direct (qualifier),Human Papillomavirus-Related Carcinoma,0
2243,Pallor of skin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2244,Group Object,Neonatal leukemia,0
2245,Persistent embryonic structure,Human Papillomavirus-Related Carcinoma,0
2246,Lower - spatial qualifier,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2247,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Refractory Barrett Esophagus,0
2248,Adult Hodgkin Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
2249,Lesion,Atypical Lobular Breast Hyperplasia,0
2250,Negation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2251,To,Advanced Uterine Corpus Carcinosarcoma,0
2252,To,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2253,Body structure,squamous cell carcinoma of the thyroid gland,0
2254,various antiinfectives and antiseptics for local oral treatment,Neonatal leukemia,0
2255,Near,adenosquamous carcinoma of breast,0
2256,Containing (qualifier),Digestive System Hodgkin Lymphoma,0
2257,Visual Impairment,Malignant neoplasm of thalamus,0
2258,Tryptophanase,Testicular cancer metastatic,0
2259,Biopsy,Malignant melanoma of eyelid,0
2260,Vomiting,Malignant neoplasm of thalamus,0
2261,Metastasis,Stage IB Lung Cancer AJCC v7,0
2262,Autosomal dominant hereditary disorder,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2263,Phase,Spermatocytic seminoma,0
2264,respiratory gaseous exchange in organisms,Larynx carcinoma recurrent,0
2265,Pediatrics,Neonatal leukemia,0
2266,Feel Tired question,Acute Undifferentiated Leukemia,0
2267,Worsening pattern,FIGO Stage II Ovarian Cancer,0
2268,Pain in scrotum,Malignant Testicular Sertoli Cell Tumor,0
2269,Brain,Liver Cavernous Hemangioma,0
2270,survival aspects,adenoid cystic carcinoma of lung,0
2271,Prolonged menses,Angiosarcoma of liver,0
2272,Morbidity - disease rate,Diffuse malignant mesothelioma,0
2273,Lymphatic vessel,Testicular cancer metastatic,0
2274,lymph nodes,Malignant melanoma of eyelid,0
2275,Leg,Localized Askin Tumor,0
2276,aggressive cancer,Breast Ductal Adenoma,0
2277,Most,Colorectal High Grade B-Cell Lymphoma,0
2278,Only - dosing instruction fragment,adenoid cystic carcinoma of lung,0
2279,Show,Adenocarcinoma,0
2280,Singular,Primary Cutaneous Plasmablastic Lymphoma,0
2281,Time,Stage IB Pancreatic Cancer AJCC v8,0
2282,Infection of kidney,Cancer of Urinary Tract,0
2283,Experimental Result,Recurrent Uveal Melanoma,0
2284,Abnormal,Heavy Chain Deposition Disease,0
2285,Condition,Cancer of Urinary Tract,0
2286,Exposure to radiation,Acantholytic squamous cell carcinoma,0
2287,Affect (mental function),Undifferentiated Endocervical Sarcoma,0
2288,Occur (action),Neonatal leukemia,0
2289,Malignant Neoplasms,mucinous adenocarcinoma of gallbladder,0
2290,Symptoms aspect,papillary carcinoma of penis,0
2291,Skin,papillary carcinoma of penis,0
2292,Extreme Response,Placental aromatase deficiency,0
2293,Lung,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2294,Inguinal region,Recurrent Testicular Lymphoma,0
2295,indolent,Primary Cutaneous Plasmablastic Lymphoma,0
2296,Hardness,Uterine Cancer,0
2297,Yellow complexion,Pancreatic Intraepithelial Neoplasia-3,0
2298,Blood Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2299,Trial Screening,Undifferentiated Endocervical Sarcoma,0
2300,Tissue Specimen Code,Intestinal Metaplasia of Bladder Urothelium,0
2301,presently,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2302,Make - Instruction Imperative,Female Breast Carcinoma,0
2303,Skin Pigmentation,Malignant melanoma of eyelid,0
2304,Gene Deletion Abnormality,Ichthyosis,0
2305,Adult Gliosarcoma,gliosarcoma,0
2306,Type A,papillary carcinoma of penis,0
2307,Type - attribute,Extra-Adrenal Paraganglioma,0
2308,Mass of body region,Anterior Urethral Malignant Neoplasm,0
2309,Mesothelium,Diffuse malignant mesothelioma,0
2310,Series,Collecting Duct Carcinoma of the Kidney,0
2311,Constant (qualifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
2312,Benzene,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2313,Blood,Hemangioma,0
2314,Pyelonephritis,Cancer of Urinary Tract,0
2315,To,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
2316,Term Birth,Maxillary Sinus Adenocarcinoma,0
2317,Abnormally high,Mucinous adenocarcinoma gastric,0
2318,American College of Cardiology/American Heart Association Lesion Complexity Score C,Colorectal cancer,0
2319,To,benign mature teratoma of pancreas,0
2320,Further,Secondary malignant neoplasm of lymph node,0
2321,photoreactivating enzyme activity,Metastatic Carcinoma in the Lung,0
2322,Buildup,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2323,Abnormal cell,Choroid Necrotic Melanoma,0
2324,Further,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2325,Measures,Cancer of Urinary Tract,0
2326,Context,Ichthyosis,0
2327,% volume (qualifier value),Familial Hemophagocytic Lymphocytosis,0
2328,include - SetOperator,Methotrexate-Associated Hodgkin Lymphoma,0
2329,Trachea,Larynx carcinoma recurrent,0
2330,radiotherapeutic,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2331,Malignant Neoplasms,Localized Askin Tumor,0
2332,Acids,Refractory Barrett Esophagus,0
2333,Skin Lymphangiosarcoma,Angiosarcoma of liver,0
2334,N+ (tumor staging),Tonsillar Carcinoma,0
2335,Blood,Acute Undifferentiated Leukemia,0
2336,GCFC2 gene,Giant cell angiofibroma,0
2337,Vaginal Hemorrhage,Uterine Cancer,0
2338,More common in males,Adult Hepatocellular Carcinoma,0
2339,occurrence characteristics,Serous cystadenocarcinoma ovary,0
2340,Excision,Lung squamous cell carcinoma stage I,0
2341,Removing (action),Familial Adenomatous Polyposis Associated Medulloblastoma,0
2342,Universal restriction modifier (core metadata concept),Acute Undifferentiated Leukemia,0
2343,Severe (severity modifier),Breast Ductal Adenoma,0
2344,Age of Onset,Acantholytic squamous cell carcinoma,0
2345,Childhood Hodgkin Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
2346,Complete,Intestinal Metaplasia of Bladder Urothelium,0
2347,Hereditary Diffuse Gastric Cancer,Mucinous adenocarcinoma gastric,0
2348,Togo,Cartilaginous exostosis,0
2349,How Much Distress Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2350,Geographic Locations,Digestive System Hodgkin Lymphoma,0
2351,therapeutic aspects,Uterine Cancer,0
2352,Neoplasms,Adenocarcinoma of the prostate metastatic,0
2353,Main,Malignant Neoplasm with Regional Lymph Node Involvement,0
2354,Spreading (qualifier value),Recurrent Uveal Melanoma,0
2355,Common (qualifier value),Cancer of Urinary Tract,0
2356,Incidental,Atypical Mesothelial Hyperplasia,0
2357,Superkingdom (taxonomic category),Intracortical osteosarcoma,0
2358,Sometimes,Stage IB Pancreatic Cancer AJCC v8,0
2359,Abnormal Cell Count,Malignant neoplasm of thalamus,0
2360,Malignant Neoplasms,Stage I Adult Non-Hodgkin Lymphoma,0
2361,Thin (qualifier value),Diffuse malignant mesothelioma,0
2362,Result,Human Papillomavirus-Related Carcinoma,0
2363,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Localized Askin Tumor,0
2364,Pancreatic carcinoma,Stage IB Pancreatic Cancer AJCC v8,0
2365,Type A,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
2366,Following,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2367,40%,Pancreatic Intraepithelial Neoplasia-3,0
2368,Microplate Well,Pilocytic astrocytoma of cerebellum,0
2369,Abnormally high,Malignant melanoma of eyelid,0
2370,Make - Instruction Imperative,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2371,Cancer Registry,Noninfiltrating Intraductal Carcinoma,0
2372,Secreted,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2373,1000000,Mucinous adenocarcinoma gastric,0
2374,Block (unit of measure),Unresectable Rhabdomyosarcoma,0
2375,Malignant lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
2376,Bladder Neoplasm,Intestinal Metaplasia of Bladder Urothelium,0
2377,Filters,Digestive System Hodgkin Lymphoma,0
2378,Apply (administration method),Advanced Uterine Corpus Carcinosarcoma,0
2379,Aspect (characteristic),Breast Ductal Adenoma,0
2380,Act Mood - intent,Lung squamous cell carcinoma stage I,0
2381,*Type - Kind of quantity,FIGO Stage II Ovarian Cancer,0
2382,Vagina,Human Papillomavirus-Related Carcinoma,0
2383,Left,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2384,Prognosis:Find:Pt:^Patient:Nom,Adult Hepatocellular Carcinoma,0
2385,60%,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2386,Mother (person),Placental aromatase deficiency,0
2387,Different,adenoid cystic carcinoma of lung,0
2388,Workers,Angiosarcoma of liver,0
2389,Blood Circulation,Neonatal leukemia,0
2390,Value Above Reference Range,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2391,Function Axis,Blepharal carcinoma,0
2392,Disease,Recurrent Testicular Lymphoma,0
2393,Covers (device),Familial Hemophagocytic Lymphocytosis,0
2394,Risk,Recurrent Uveal Melanoma,0
2395,Eating,Mucinous adenocarcinoma gastric,0
2396,Bone Pain,Acute Undifferentiated Leukemia,0
2397,Often - answer to question,Intestinal Neuroendocrine Carcinoma,0
2398,Chemotherapy Regimen,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2399,Debris,Blepharal carcinoma,0
2400,Table Cell Horizontal Align - left,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2401,Tryptophanase,benign mature teratoma of pancreas,0
2402,Stop (qualifier value),Clonal Hematopoiesis of Indeterminate Potential,0
2403,week,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2404,Primary malignant neoplasm,Malignant neoplasm of thalamus,0
2405,Negation,Stage IB Pancreatic Cancer AJCC v8,0
2406,Methods aspects,Acantholytic squamous cell carcinoma,0
2407,Childhood Diffuse Large B-Cell Lymphoma,ALK positive large B-cell lymphoma,0
2408,Transection (procedure),Recurrent Testicular Lymphoma,0
2409,Dropping,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2410,75,Intestinal Metaplasia of Bladder Urothelium,0
2411,More,Recurrent Testicular Lymphoma,0
2412,Occurrence Indicator,Childhood Central Nervous System Immature Teratoma,0
2413,Sodium Chloride,Mucinous adenocarcinoma gastric,0
2414,Chemotherapy,Recurrent Uveal Melanoma,0
2415,Pediculus (eukaryote),Intracortical osteosarcoma,0
2416,Neoplasm Metastasis,Malignant neoplasm of thalamus,0
2417,Abdomen,FIGO Stage II Ovarian Cancer,0
2418,Internal,Airway Hemangioma,0
2419,Specimen Source Codes - Genital,Human Papillomavirus-Related Carcinoma,0
2420,Coding,Noninfiltrating Intraductal Carcinoma,0
2421,Usually,benign mature teratoma of pancreas,0
2422,Cause of Death,Mucinous adenocarcinoma gastric,0
2423,To,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2424,Urine,Heavy Chain Deposition Disease,0
2425,Time,Malignant melanoma of eyelid,0
2426,How Often Nausea,Unfavorable Non-Hodgkin Lymphoma,0
2427,Affecting,Diffuse malignant mesothelioma,0
2428,Formation,Heavy Chain Deposition Disease,0
2429,CDISC Relationship Class,Malignant neoplasm of choroid,0
2430,Absence (morphologic abnormality),Placental aromatase deficiency,0
2431,Increased,FIGO Stage II Ovarian Cancer,0
2432,Body tissue,Thymic Clear Cell Carcinoma,0
2433,Mutation,Advanced Uterine Corpus Carcinosarcoma,0
2434,classic behavior,Refractory Barrett Esophagus,0
2435,Cancer Other,Stage IB Pancreatic Cancer AJCC v8,0
2436,Togo,Unfavorable Non-Hodgkin Lymphoma,0
2437,Leads (device),Malignant neoplasm of choroid,0
2438,Account number:Identifier:Point in time:^Patient:Nominal,Endometrial Small Cell Carcinoma,0
2439,Blood flow,Hemangioma,0
2440,Skin Erosion,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2441,risk factors - observation list,Stage IB Pancreatic Cancer AJCC v8,0
2442,Manifested by,Spongiotic dermatitis,0
2443,intent,Primary Cutaneous Plasmablastic Lymphoma,0
2444,Characteristics,Colorectal Neuroendocrine Tumor G2,0
2445,Result,Undifferentiated Endocervical Sarcoma,0
2446,Indication,Atypical Lobular Breast Hyperplasia,0
2447,Count of entities,Mucinous adenocarcinoma gastric,0
2448,Malignant Neoplasms,Acute lymphadenitis,0
2449,Cervix carcinoma,Human Papillomavirus-Related Carcinoma,0
2450,Usually,Cancer of Urinary Tract,0
2451,Critical,Thymic Clear Cell Carcinoma,0
2452,Cell Count,Testicular cancer metastatic,0
2453,Usual,benign mature teratoma of pancreas,0
2454,Together,Undifferentiated Endocervical Sarcoma,0
2455,United States,Malignant melanoma of eyelid,0
2456,Act Relationship Subset - previous,Acantholytic squamous cell carcinoma,0
2457,Major <insect>,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2458,HLA Complex,Thymic Clear Cell Carcinoma,0
2459,United States,Carcinoma of urinary bladder,0
2460,Supportive assistance,FIGO Stage II Ovarian Cancer,0
2461,Appearance,Colorectal High Grade B-Cell Lymphoma,0
2462,Form:Finding:Point in time:{Setting}:Document:{Role},Anterior Urethral Malignant Neoplasm,0
2463,Cancer Genus,adenosquamous carcinoma of breast,0
2464,Social group,Heavy Chain Deposition Disease,0
2465,Skin lesion,Malignant melanoma of eyelid,0
2466,Tumor Mass,Testicular cancer metastatic,0
2467,Tobacco smoking behavior,Mucinous adenocarcinoma gastric,0
2468,Subtype (attribute),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2469,Data operation - complete,Intestinal Metaplasia of Bladder Urothelium,0
2470,Recurrence,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2471,Response to treatment,Acantholytic squamous cell carcinoma,0
2472,Result,papillary carcinoma of penis,0
2473,Surface of bone,Cartilaginous exostosis,0
2474,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Stage I Adult Non-Hodgkin Lymphoma,0
2475,High,Recurrent Testicular Lymphoma,0
2476,Amount type - Percentage,Recurrent Testicular Lymphoma,0
2477,Act Relationship Subset - previous,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2478,Lumen,Childhood Thyroid Gland Follicular Carcinoma,0
2479,Eye protection,Blepharal carcinoma,0
2480,physiological aspects,Digestive System Hodgkin Lymphoma,0
2481,Occurrence,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2482,Risk,Diffuse malignant mesothelioma,0
2483,Cancer Genus,Hodgkin lymphoma,0
2484,various other agents for local oral treatment in ATC,Benign Carotid Body Paraganglioma,0
2485,Cancer Genus,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2486,Gene Mutation,Ichthyosis,0
2487,Manufactured form,FIGO Stage II Ovarian Cancer,0
2488,% of total,Acantholytic squamous cell carcinoma,0
2489,Pain,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2490,Qualitative form,Breast Ductal Adenoma,0
2491,Breast,Testicular cancer metastatic,0
2492,atypia morphology,Atypical Lobular Breast Hyperplasia,0
2493,Nuclear (nucleus),Angiosarcoma of liver,0
2494,Disease Screening,Endometrial Small Cell Carcinoma,0
2495,Leg,Recurrent Uveal Melanoma,0
2496,VARIOUS DRUG CLASSES IN ATC,Neonatal leukemia,0
2497,majority,Stage IB Pancreatic Cancer AJCC v8,0
2498,Retinoic Acid Response Element,Urethral Carcinoma,0
2499,survival aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2500,Cell Count,papillary carcinoma of penis,0
2501,Rate,Diffuse malignant mesothelioma,0
2502,High risk of,FIGO Stage II Ovarian Cancer,0
2503,Histologic type,Breast Ductal Adenoma,0
2504,Occurrence,GIANT PIGMENTED HAIRY NEVUS,0
2505,Chemicals,Intestinal Metaplasia of Bladder Urothelium,0
2506,Body part,Anterior Urethral Malignant Neoplasm,0
2507,Plant seeds,Extracranial Neuroblastoma,0
2508,Age-Years,Carcinoma of urinary bladder,0
2509,Structure of thyroid follicle,Childhood Thyroid Gland Follicular Carcinoma,0
2510,Case (situation),Colorectal High Grade B-Cell Lymphoma,0
2511,Risk,Endometrial Small Cell Carcinoma,0
2512,Due to,Undifferentiated Endocervical Sarcoma,0
2513,Cells,Intestinal Metaplasia of Bladder Urothelium,0
2514,Chemical or Textual Reference to Actual Test or Parameter,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2515,Compleat Liquid Nutrition,Bladder squamous cell carcinoma stage I,0
2516,Disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2517,risk factors,FIGO Stage II Ovarian Cancer,0
2518,Chemotherapy,Metastatic Carcinoma in the Lung,0
2519,<3 (qualifier value),Malignant melanoma of eyelid,0
2520,Smaller,Female Breast Carcinoma,0
2521,Neoplasm Metastasis,Angiosarcoma of liver,0
2522,Blood Platelets,Neonatal leukemia,0
2523,Persons,Diffuse malignant mesothelioma,0
2524,Adult Lymphoma,Mucinous adenocarcinoma gastric,0
2525,algorithm,Female Breast Carcinoma,0
2526,Femur length,Recurrent Testicular Lymphoma,0
2527,Account number:Identifier:Point in time:^Patient:Nominal,Lung squamous cell carcinoma stage I,0
2528,Qualitative form,Recurrent Testicular Lymphoma,0
2529,Biomaterial Treatment,FIGO Stage II Ovarian Cancer,0
2530,Line Unit of Length,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2531,Large,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2532,Similarity,Testicular cancer metastatic,0
2533,Neoadjuvant Therapy,Metastatic Carcinoma in the Lung,0
2534,IPSS Risk Category Low,Clonal Hematopoiesis of Indeterminate Potential,0
2535,Chest Wall Pain,Diffuse malignant mesothelioma,0
2536,Most,Neonatal leukemia,0
2537,Basis - conceptual entity,Acute Undifferentiated Leukemia,0
2538,Aging,Clonal Hematopoiesis of Indeterminate Potential,0
2539,<50,Acute Undifferentiated Leukemia,0
2540,Term (temporal),Testicular cancer metastatic,0
2541,Intravascular line,Angiosarcoma of liver,0
2542,Support,Hemangioma,0
2543,Body tissue,Anterior Urethral Malignant Neoplasm,0
2544,Malignant neoplasm of salivary gland,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2545,Entity Determiner - specific,Noninfiltrating Intraductal Carcinoma,0
2546,risk factors - observation list,FIGO Stage II Ovarian Cancer,0
2547,Together,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2548,International Statistical Classification of Diseases and Related Health Problems,Noninfiltrating Intraductal Carcinoma,0
2549,chronic,Tonsillar Carcinoma,0
2550,Test - temporal region,Extra-Adrenal Paraganglioma,0
2551,cell transformation,Recurrent Testicular Lymphoma,0
2552,Assortment,Giant cell angiofibroma,0
2553,Tests (qualifier value),Extra-Adrenal Paraganglioma,0
2554,Nausea,Mucinous adenocarcinoma gastric,0
2555,Form of joint,Cartilaginous exostosis,0
2556,respiratory gaseous exchange in organisms,Airway Hemangioma,0
2557,algorithm,Breast Ductal Adenoma,0
2558,Classification of information,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2559,Abnormal,Atypical Lobular Breast Hyperplasia,0
2560,Epithelial ovarian cancer,Adenocarcinoma,0
2561,Liver Cirrhosis,Adult Hepatocellular Carcinoma,0
2562,Formation,Adult Alveolar Soft Part Sarcoma,0
2563,Mammal liver preparation,FIGO Stage II Ovarian Cancer,0
2564,Supportive assistance,Liver Cavernous Hemangioma,0
2565,Imaging Techniques,Intestinal Metaplasia of Bladder Urothelium,0
2566,treatment - ActInformationManagementReason,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2567,Normal hair follicles,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2568,Continuous,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2569,Triggered by,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2570,Back structure,Malignant melanoma of eyelid,0
2571,Malignant - descriptor,Benign Carotid Body Paraganglioma,0
2572,Cancer Genus,Malignant Testicular Sertoli Cell Tumor,0
2573,Approximate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2574,Include (action),Recurrent Uveal Melanoma,0
2575,More,Diffuse malignant mesothelioma,0
2576,Leukocytes,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2577,glycosylation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2578,Pressure (property),Anterior Urethral Malignant Neoplasm,0
2579,Human papillomavirus 11,Human Papillomavirus-Related Carcinoma,0
2580,Primary malignant neoplasm,Colorectal High Grade B-Cell Lymphoma,0
2581,Tissue Specimen Code,Uterine Cancer,0
2582,Tumor site,Localized Askin Tumor,0
2583,Blue - answer to question,Extracranial Neuroblastoma,0
2584,Negation,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2585,Frequently,Contact dermatitis due to alkali,0
2586,high - ActExposureLevelCode,Acantholytic squamous cell carcinoma,0
2587,Genus Homo,Blepharal carcinoma,0
2588,Asymptomatic,Giant cell angiofibroma,0
2589,Malignant neoplasm of urinary bladder,Intestinal Metaplasia of Bladder Urothelium,0
2590,Involvement with,Mastocytosis,0
2591,Child,FIGO Stage II Ovarian Cancer,0
2592,Physical findings,Diffuse malignant mesothelioma,0
2593,Include (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2594,Present,gliosarcoma,0
2595,Breast,Angiosarcoma of liver,0
2596,Complete Agreement,Colorectal High Grade B-Cell Lymphoma,0
2597,Face (spatial concept),Benign Apocrine Neoplasm,0
2598,80%,Malignant Testicular Sertoli Cell Tumor,0
2599,Capillary Action,Digestive System Hodgkin Lymphoma,0
2600,Universal restriction modifier (core metadata concept),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2601,Malignant neoplasm of appendix,mucinous adenocarcinoma of gallbladder,0
2602,mesenchymal,Adult Alveolar Soft Part Sarcoma,0
2603,Feel Tired question,Childhood Lymphoma,0
2604,Frequently,Colorectal Neuroendocrine Tumor G2,0
2605,Specimen Source Codes - Serum,Heavy Chain Deposition Disease,0
2606,Tryptophanase,Unresectable Rhabdomyosarcoma,0
2607,Interventional procedure,Undifferentiated Endocervical Sarcoma,0
2608,Type - attribute,Endometrial Small Cell Carcinoma,0
2609,Carcinoid Tumor,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2610,Poor - qualifier,Human Papillomavirus-Related Carcinoma,0
2611,Neck,Extra-Adrenal Paraganglioma,0
2612,Double eyelid,Blepharal carcinoma,0
2613,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Hodgkin lymphoma,0
2614,Death NOS,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2615,Body Site Modifier - Lower,Malignant Testicular Sertoli Cell Tumor,0
2616,Can Do Very Little,Grade 1 Clear Cell Renal Cell Carcinoma,0
2617,Glioblastoma,gliosarcoma,0
2618,Coloring Excipient,Acute Undifferentiated Leukemia,0
2619,Administration procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2620,Early,Clonal Hematopoiesis of Indeterminate Potential,0
2621,findings aspects,Diffuse malignant mesothelioma,0
2622,Ursidae Family,Cancer of Urinary Tract,0
2623,Cardiac Lead Procedure,Malignant neoplasm of choroid,0
2624,Sufficient,Endometrial Small Cell Carcinoma,0
2625,Monitoring Device,Primary Cutaneous Plasmablastic Lymphoma,0
2626,Arising in,Bladder squamous cell carcinoma stage I,0
2627,Involvement with,Spermatocytic seminoma,0
2628,Antifungal Antibiotics,Cancer of Urinary Tract,0
2629,Initially,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2630,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Sarcomatoid Renal Cell Carcinoma,0
2631,Presentation,Neonatal leukemia,0
2632,Aim,Ichthyosis,0
2633,Frequently,Stage II Fallopian Tube Cancer,0
2634,Pathogenic,Testicular cancer metastatic,0
2635,Spreading (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2636,Metastatic malignant neoplasm to brain,Choroid Necrotic Melanoma,0
2637,Immune System Part,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2638,Have Weight Loss,Diffuse malignant mesothelioma,0
2639,Death (finding),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2640,Taxonomic,Leptomeningeal sarcoma,0
2641,Etiology aspects,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2642,Including (qualifier),Digestive System Hodgkin Lymphoma,0
2643,Body of penis,Maxillary Sinus Adenocarcinoma,0
2644,Five,FIGO Stage II Ovarian Cancer,0
2645,Therapeutic procedure,Human Papillomavirus-Related Carcinoma,0
2646,Therapeutic radiology procedure,Tonsillar Carcinoma,0
2647,Human body structure,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2648,inflammatory,Mastocytosis,0
2649,Part of,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2650,Five,Extra-Adrenal Paraganglioma,0
2651,Neoplasm Metastasis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2652,Hyperlink,Angiosarcoma of liver,0
2653,General surgery specialty,Refractory Barrett Esophagus,0
2654,Status post,Diffuse malignant mesothelioma,0
2655,Containing (qualifier),Spongiotic dermatitis,0
2656,Most,Acantholytic squamous cell carcinoma,0
2657,Severe Extremity Pain,Heavy Chain Deposition Disease,0
2658,Smear - instruction imperative,Anterior Urethral Malignant Neoplasm,0
2659,Most,Cartilaginous exostosis,0
2660,Bowen's Disease,Acantholytic squamous cell carcinoma,0
2661,Cover (physical object),Familial Hemophagocytic Lymphocytosis,0
2662,True,Breast Ductal Adenoma,0
2663,Publishing,Rhabdomyosarcoma with ganglionic differentiation,0
2664,Tumor cells,Colorectal High Grade B-Cell Lymphoma,0
2665,Primary malignant neoplasm,Endometrial Small Cell Carcinoma,0
2666,Genetic syndrome,Mucinous adenocarcinoma gastric,0
2667,Use of,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2668,<90,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2669,Alveolar Soft Part Sarcoma,Adult Alveolar Soft Part Sarcoma,0
2670,Uterus,Undifferentiated Endocervical Sarcoma,0
2671,Subtype (attribute),Methotrexate-Associated Hodgkin Lymphoma,0
2672,1960s,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2673,Body tissue,Carcinoma of urinary bladder,0
2674,include - SetOperator,Choroid Necrotic Melanoma,0
2675,treatment - ActInformationManagementReason,Malignant Testicular Sertoli Cell Tumor,0
2676,Confirmed by,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2677,Dual,Carcinoma ex pleomorphic adenoma of parotid gland,0
2678,Onset of illness,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2679,Classification,Granular Cell Leiomyosarcoma,0
2680,Give - dosing instruction imperative,Clonal Hematopoiesis of Indeterminate Potential,0
2681,CDISC SEND Tumor Findings Results Terminology,benign mature teratoma of pancreas,0
2682,include - SetOperator,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2683,Therapeutic procedure,Diffuse malignant mesothelioma,0
2684,Liver,Mucinous adenocarcinoma gastric,0
2685,Wash (cleansing action),Diffuse malignant mesothelioma,0
2686,Malignant Central Nervous System Neoplasm,Recurrent Diffuse Intrinsic Pontine Glioma,0
2687,Screening procedure,Mucinous adenocarcinoma gastric,0
2688,Qualitative form,Acantholytic squamous cell carcinoma,0
2689,Percent of Abnormal Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2690,Appearance,Cancer of Urinary Tract,0
2691,True Control Status,Primary Cutaneous Plasmablastic Lymphoma,0
2692,occurrence characteristics,Maxillary Sinus Adenocarcinoma,0
2693,Object Class,Lung squamous cell carcinoma stage I,0
2694,Diagnosis,Malignant melanoma of eyelid,0
2695,Laparoscopy,Atypical Mesothelial Hyperplasia,0
2696,Original,Testicular cancer metastatic,0
2697,Blood Vessel,Hemangioma,0
2698,Eye lid,Blepharal carcinoma,0
2699,Reaching,Blepharal carcinoma,0
2700,Body part,Intestinal Metaplasia of Bladder Urothelium,0
2701,35,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2702,Body part,Carcinoma of urinary bladder,0
2703,Good,Primary Cutaneous Plasmablastic Lymphoma,0
2704,High Level,Recurrent Uveal Melanoma,0
2705,Screening for cancer,Mucinous adenocarcinoma gastric,0
2706,Enneking High Surgical Grade,mucinous adenocarcinoma of gallbladder,0
2707,Acute Undifferentiated Leukemia,Acute Undifferentiated Leukemia,0
2708,0%,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2709,Asymptomatic Diseases,Recurrent Testicular Lymphoma,0
2710,Internal,Spongiotic dermatitis,0
2711,Subject Risk,Adult Hepatocellular Carcinoma,0
2712,General surgery specialty,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2713,Exertion,Mucinous adenocarcinoma gastric,0
2714,Division (action),Recurrent Testicular Lymphoma,0
2715,Diameter (qualifier value),Deep Leiomyoma,0
2716,Tests (qualifier value),FIGO Stage II Ovarian Cancer,0
2717,Palmitic Acid,Anterior Urethral Malignant Neoplasm,0
2718,Rate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2719,Menopause present (finding),Endometrial Small Cell Carcinoma,0
2720,Soft Tissue Route of Drug Administration,Angiosarcoma of liver,0
2721,Feelings,Malignant Neoplasm with Regional Lymph Node Involvement,0
2722,antibiotics,Cancer of Urinary Tract,0
2723,Entity Determiner - specific,Rhabdomyosarcoma with ganglionic differentiation,0
2724,Persons,Uterine Cancer,0
2725,Incidental Findings,Atypical Mesothelial Hyperplasia,0
2726,Techniques,Acantholytic squamous cell carcinoma,0
2727,Genetic,Pancreatic Intraepithelial Neoplasia-3,0
2728,Incidence,Benign neoplasm of thorax,0
2729,Including (qualifier),Pilocytic astrocytoma of cerebellum,0
2730,Term (lexical),Granular Cell Leiomyosarcoma,0
2731,Estrogen [EPC],Undifferentiated Endocervical Sarcoma,0
2732,Head and neck structure,GIANT PIGMENTED HAIRY NEVUS,0
2733,How Much Distress Vomiting,Malignant neoplasm of thalamus,0
2734,Shin,Cartilaginous exostosis,0
2735,Tumor Mass,Breast Ductal Adenoma,0
2736,Chemotherapy Regimen,Acute Undifferentiated Leukemia,0
2737,Brain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2738,include - SetOperator,Malignant Testicular Sertoli Cell Tumor,0
2739,In Blood,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2740,Slow Growing,Primary Cutaneous Plasmablastic Lymphoma,0
2741,How Often Shortness of Breath,Diffuse malignant mesothelioma,0
2742,LMOD1 gene,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2743,Contusions,Acute Undifferentiated Leukemia,0
2744,Related personal status,Ampulla of Vater Tubular Adenoma,0
2745,Problems - What subject filter,Intracortical osteosarcoma,0
2746,DNA,BRCA2 Syndrome,0
2747,Suspected qualifier,Diffuse malignant mesothelioma,0
2748,Portion of urine,Heavy Chain Deposition Disease,0
2749,cell transformation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2750,Long,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2751,low confidentiality,Primary Cutaneous Plasmablastic Lymphoma,0
2752,Current (present time),Leptomeningeal sarcoma,0
2753,Specific qualifier value,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2754,Abnormal,Endometrial Small Cell Carcinoma,0
2755,Include (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2756,Account number:Identifier:Point in time:^Patient:Nominal,Undifferentiated Endocervical Sarcoma,0
2757,Spreading (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
2758,With intensity,Spongiotic dermatitis,0
2759,Usually Need Help from Another Person for Eating,Mucinous adenocarcinoma gastric,0
2760,Upper arm,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2761,Version,Methotrexate-Associated Hodgkin Lymphoma,0
2762,What subject filter - Result,Endometrial Small Cell Carcinoma,0
2763,Junonia,Extracranial Neuroblastoma,0
2764,Unknown GENC,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2765,Cell (compartment),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
2766,Accidental Falls,Neonatal leukemia,0
2767,International Aspects,Thymic Clear Cell Carcinoma,0
2768,Skin Specimen,Deep Leiomyoma,0
2769,Shortened,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2770,Skin,squamous cell carcinoma of the thyroid gland,0
2771,Aspect - Kind of quantity,Breast Ductal Adenoma,0
2772,Rest,Intestinal Neuroendocrine Carcinoma,0
2773,Idle,Extracranial Neuroblastoma,0
2774,Most,gliosarcoma,0
2775,invasive cancer,Testicular cancer metastatic,0
2776,SLC6A2 protein,Intestinal Neuroendocrine Carcinoma,0
2777,Cerebral hemisphere structure (body structure),gliosarcoma,0
2778,Oral contraception,Endometrial Small Cell Carcinoma,0
2779,Chemotherapy,Bladder squamous cell carcinoma stage I,0
2780,Science of Etiology,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2781,Therapeutic procedure,Uterine Cancer,0
2782,Medications,Refractory Barrett Esophagus,0
2783,To,Carcinoma of urinary bladder,0
2784,Child,Acute Undifferentiated Leukemia,0
2785,Moll's gland cyst,Benign Apocrine Neoplasm,0
2786,Beginning,Granular Cell Leiomyosarcoma,0
2787,Heartburn,Refractory Barrett Esophagus,0
2788,Surgical Replantation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2789,Heightened,Blepharal carcinoma,0
2790,Person 3,Diffuse malignant mesothelioma,0
2791,Increase,Undifferentiated Endocervical Sarcoma,0
2792,Symptoms aspect,Mastocytosis,0
2793,1000000,Diffuse malignant mesothelioma,0
2794,Chemical Association,Heavy Chain Deposition Disease,0
2795,Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal,Cartilaginous exostosis,0
2796,month,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2797,Large blood vessel structure,Digestive System Hodgkin Lymphoma,0
2798,ASIP wt Allele,Adult Alveolar Soft Part Sarcoma,0
2799,True primary (qualifier value),Malignant melanoma of eyelid,0
2800,Relationships,Leptomeningeal sarcoma,0
2801,Source (property) (qualifier value),Ampulla of Vater Tubular Adenoma,0
2802,Blood flow,Liver Cavernous Hemangioma,0
2803,Occur (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2804,Close,Mucinous neoplasm,0
2805,Optical filter,Digestive System Hodgkin Lymphoma,0
2806,Qualitative form,Cancer of Urinary Tract,0
2807,Treating,Malignant melanoma of eyelid,0
2808,Simple,Refractory Barrett Esophagus,0
2809,IPSS Risk Category High,Tonsillar Carcinoma,0
2810,Initially,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2811,Superfamily,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2812,Including (qualifier),Acute Undifferentiated Leukemia,0
2813,Early,Stage II Carcinoma of Penis,0
2814,Back Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2815,How Much Distress Weight Loss,adenosquamous carcinoma of breast,0
2816,Specimen Source Codes - tumor,Granular Cell Leiomyosarcoma,0
2817,Rare Diseases,Mastocytosis,0
2818,Cavern,Hemangioma,0
2819,Platelets Product,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2820,CD69 wt Allele,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2821,Subgroup A Nepoviruses,Breast Ductal Adenoma,0
2822,Rate,Undifferentiated Endocervical Sarcoma,0
2823,Numbers,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2824,Rare Diseases,Stage IB Pancreatic Cancer AJCC v8,0
2825,Causing,Ichthyosis,0
2826,Binding (Molecular Function),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2827,Large,Cartilaginous exostosis,0
2828,Lumpectomy of breast,Female Breast Carcinoma,0
2829,Operative Surgical Procedures,Diffuse malignant mesothelioma,0
2830,Color change,Recurrent Uveal Melanoma,0
2831,Enlarged,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2832,shared attribute,Airway Hemangioma,0
2833,Only - dosing instruction fragment,Pancreatic Intraepithelial Neoplasia-3,0
2834,Traumatic injury,Giant cell angiofibroma,0
2835,Eye foreign bodies,Blepharal carcinoma,0
2836,Intravascular line,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2837,Cell (compartment),squamous cell carcinoma of the thyroid gland,0
2838,Then,Recurrent Testicular Lymphoma,0
2839,Approximate,Recurrent Uveal Melanoma,0
2840,Age of Onset,Bladder squamous cell carcinoma stage I,0
2841,per year,Adult Fibrolamellar Carcinoma,0
2842,Procedure (set of actions),Endometrial Small Cell Carcinoma,0
2843,Three,Spongiotic dermatitis,0
2844,Neck of organ,Larynx carcinoma recurrent,0
2845,Adult Myelodysplastic Syndrome,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2846,Cell Count,Recurrent Testicular Lymphoma,0
2847,Screening,Undifferentiated Endocervical Sarcoma,0
2848,Specimen Source Codes - tumor,adenoid cystic carcinoma of lung,0
2849,Overall Publication Type,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2850,risk factors,Stage II Carcinoma of Penis,0
2851,Did not receive therapy or drug for,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2852,Usual,Atypical Mesothelial Hyperplasia,0
2853,Containing (qualifier),Colorectal High Grade B-Cell Lymphoma,0
2854,Areas <moth>,Acantholytic squamous cell carcinoma,0
2855,Treating,mucinous adenocarcinoma of gallbladder,0
2856,Include (action),Carcinoma of urinary bladder,0
2857,Times,Malignant melanoma of eyelid,0
2858,Chemotherapy,Carcinoma of urinary bladder,0
2859,Precision - second,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2860,Cell Count,Hemangioma,0
2861,Colon <insect>,Anterior Urethral Malignant Neoplasm,0
2862,World,Malignant Testicular Sertoli Cell Tumor,0
2863,Common Specifications in HL7 V3 Publishing,Carcinoma of urinary bladder,0
2864,Make - Instruction Imperative,Metastatic Ductal Breast Carcinoma,0
2865,monomer,Angiosarcoma of liver,0
2866,Offspring,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2867,Characteristics,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
2868,Primary malignant neoplasm,Hodgkin lymphoma,0
2869,Including (qualifier),Rhabdomyosarcoma with ganglionic differentiation,0
2870,Primary malignant neoplasm,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2871,Approximate,Acantholytic squamous cell carcinoma,0
2872,Human body structure,Airway Hemangioma,0
2873,In Urine,Heavy Chain Deposition Disease,0
2874,Focal,Advanced Uterine Corpus Carcinosarcoma,0
2875,Sweat,Malignant Neoplasm with Regional Lymph Node Involvement,0
2876,Object Relationship,Malignant neoplasm of choroid,0
2877,100%,FIGO Stage II Ovarian Cancer,0
2878,Common Specifications in HL7 V3 Publishing,Colorectal Neuroendocrine Tumor G2,0
2879,Weight Loss,Mucinous adenocarcinoma gastric,0
2880,shared attribute,Localized Askin Tumor,0
2881,Primitive Streak,benign mature teratoma of pancreas,0
2882,>5,Mucinous adenocarcinoma gastric,0
2883,Historical aspects qualifier,Uterine Cancer,0
2884,More,Colorectal High Grade B-Cell Lymphoma,0
2885,eTMF Content Model Code,Intracortical osteosarcoma,0
2886,Help document,Cancer of Urinary Tract,0
2887,900,Acantholytic squamous cell carcinoma,0
2888,Smaller,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2889,Name Given at Birth,Adult Hepatocellular Carcinoma,0
2890,Pain Distress Question,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2891,unknown vaccine or immune globulin,Choroid Necrotic Melanoma,0
2892,Administration procedure,Intestinal Metaplasia of Bladder Urothelium,0
2893,Cancer Genus,Leiomyoma of Gallbladder,0
2894,Muscle Tissue,Adult Alveolar Soft Part Sarcoma,0
2895,Synonym,Recurrent Testicular Lymphoma,0
2896,Entity Determiner - specific,Female Breast Carcinoma,0
2897,Pitch - substance,Larynx carcinoma recurrent,0
2898,Vomiting,Mucinous adenocarcinoma gastric,0
2899,Negation,Giant cell angiofibroma,0
2900,Fatigue,Acute Undifferentiated Leukemia,0
2901,Neoplasms,Colorectal High Grade B-Cell Lymphoma,0
2902,Lung,Angiosarcoma of liver,0
2903,Cervix carcinoma,Endometrial Small Cell Carcinoma,0
2904,treatment - ActInformationManagementReason,FIGO Stage II Ovarian Cancer,0
2905,Pigment cell,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2906,With shape,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2907,per second,Secondary malignant neoplasm of lymph node,0
2908,Adult Lymphoma,Methotrexate-Associated Hodgkin Lymphoma,0
2909,Usually,Spermatocytic seminoma,0
2910,Ovary,Colorectal cancer,0
2911,Cancer Genus,Colorectal High Grade B-Cell Lymphoma,0
2912,Leading,Endometrial Small Cell Carcinoma,0
2913,Logical Condition,Uterine Cancer,0
2914,Encounter due to family history of colonic polyps,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2915,Supine Position,Refractory Barrett Esophagus,0
2916,Anatomic structures,Cancer of Urinary Tract,0
2917,United States Military Commissioned Officer O4,Childhood Lymphoma,0
2918,Smear - instruction imperative,Malignant Testicular Sertoli Cell Tumor,0
2919,apply - action,Advanced Uterine Corpus Carcinosarcoma,0
2920,Entity Determiner - specific,Adult Hepatocellular Carcinoma,0
2921,Skin,Acantholytic squamous cell carcinoma,0
2922,Intermediate,Blepharal carcinoma,0
2923,Red blood cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2924,Morphology,Leptomeningeal sarcoma,0
2925,Present,Mucinous adenocarcinoma gastric,0
2926,Heart,Diffuse malignant mesothelioma,0
2927,Qualitative form,papillary carcinoma of penis,0
2928,Childhood Non-Hodgkin Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
2929,criteria,Breast Ductal Adenoma,0
2930,artesunate,Blepharal carcinoma,0
2931,Sometimes,Pancreatic Intraepithelial Neoplasia-3,0
2932,year,Diffuse malignant mesothelioma,0
2933,Diagnosis Study,Metastatic Ductal Breast Carcinoma,0
2934,Subtype (attribute),Granular Cell Leiomyosarcoma,0
2935,50%,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2936,Resolution,Human Papillomavirus-Related Carcinoma,0
2937,Suspected diagnosis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2938,Advanced phase,Stage IB Pancreatic Cancer AJCC v8,0
2939,peripheral blood,gliosarcoma,0
2940,shared attribute,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2941,control aspects,Stage IB Pancreatic Cancer AJCC v8,0
2942,User Group,Metastatic Ductal Breast Carcinoma,0
2943,Carcinoma,Female Breast Carcinoma,0
2944,Case (situation),Papillary cystic tumor,0
2945,Interventional procedure,Endometrial Small Cell Carcinoma,0
2946,65+,Intestinal Metaplasia of Bladder Urothelium,0
2947,Diabetes Mellitus,Cancer of Urinary Tract,0
2948,Testis,Childhood Central Nervous System Immature Teratoma,0
2949,Areas <moth>,Recurrent Uveal Melanoma,0
2950,Used by,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2951,Usual Severity Itching,Mastocytosis,0
2952,Death (finding),Endometrial Small Cell Carcinoma,0
2953,Case (situation),Adult Fibrolamellar Carcinoma,0
2954,How Much Distress Pain,Localized Askin Tumor,0
2955,Risk,Malignant melanoma of eyelid,0
2956,Manufactured form,Blepharal carcinoma,0
2957,Supportive assistance,Hemangioma,0
2958,Hydrocephalus,Malignant neoplasm of choroid,0
2959,Main,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2960,Chemotherapy Regimen,Recurrent Uveal Melanoma,0
2961,Better than Others,Malignant Testicular Sertoli Cell Tumor,0
2962,Surface,Unresectable Rhabdomyosarcoma,0
2963,survive,Blepharal carcinoma,0
2964,Disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2965,Trauma,Giant cell angiofibroma,0
2966,CD5 Positive,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2967,Cell Proliferation,Atypical Lobular Breast Hyperplasia,0
2968,Usual Severity Weight Loss,Malignant Neoplasm with Regional Lymph Node Involvement,0
2969,Network,Digestive System Hodgkin Lymphoma,0
2970,Infection,Acute lymphadenitis,0
2971,status - In progress,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2972,parent,Endometrial Small Cell Carcinoma,0
2973,Malignant neoplasm of lung,Metastatic Carcinoma in the Lung,0
2974,Usual,Bladder squamous cell carcinoma stage I,0
2975,Deeply - dosing instruction fragment,Deep Leiomyoma,0
2976,Chemotherapy,Metastatic Carcinoma in the Lung,0
2977,Type A,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2978,Normal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2979,various antiseptic throat preparations,Placental aromatase deficiency,0
2980,various allergen extracts,Neonatal leukemia,0
2981,Slightly (qualifier value),Malignant melanoma of eyelid,0
2982,Occurrence Indicator,Granular Cell Leiomyosarcoma,0
2983,per second,Colorectal cancer,0
2984,Non-Small Cell Lung Carcinoma,Stage IB Lung Cancer AJCC v7,0
2985,treatment - ActInformationManagementReason,Malignant melanoma of eyelid,0
2986,Logical Condition,Malignant melanoma of eyelid,0
2987,How Often Weight Loss,adenosquamous carcinoma of breast,0
2988,Adrenal Medulla,Collecting Duct Carcinoma of the Kidney,0
2989,Vaginal (intended site),squamous cell carcinoma of the thyroid gland,0
2990,Symptoms,Unfavorable Non-Hodgkin Lymphoma,0
2991,South,Carcinoma of urinary bladder,0
2992,Breaking down,Cartilaginous exostosis,0
2993,High Level,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2994,Disease,FIGO Stage II Ovarian Cancer,0
2995,Pharmacotherapy,FIGO Stage II Ovarian Cancer,0
2996,NCI CTEP SDC Melanoma Sub-Category Terminology,Acantholytic squamous cell carcinoma,0
2997,Recommendation,Extra-Adrenal Paraganglioma,0
2998,therapeutic aspects,Bladder squamous cell carcinoma stage I,0
2999,Forecast of outcome,Neonatal leukemia,0
3000,AKR1A1 wt Allele,Hodgkin lymphoma,0
3001,NCI CTEP SDC Melanoma Sub-Category Terminology,Malignant melanoma of eyelid,0
3002,Symptoms aspect,Localized Askin Tumor,0
3003,Variety (taxon),Hemangioma,0
3004,Known,Uterine Cancer,0
3005,Human Cells,Stage IB Lung Cancer AJCC v7,0
3006,How Much Distress Weight Loss,Mucinous adenocarcinoma gastric,0
3007,Thymus Gland,Thymic Clear Cell Carcinoma,0
3008,Immature,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3009,eTMF Content Model Code,Familial Hemophagocytic Lymphocytosis,0
3010,Breast Carcinoma,Atypical Lobular Breast Hyperplasia,0
3011,N not otherwise specified Antibody,Tonsillar Carcinoma,0
3012,TARSAL-CARPAL COALITION SYNDROME,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3013,FDA Establishment Activity Terminology,Thymic Clear Cell Carcinoma,0
3014,Hepatitis C,Adult Hepatocellular Carcinoma,0
3015,diagnosis aspect,Bladder squamous cell carcinoma stage I,0
3016,Detectable,Testicular cancer metastatic,0
3017,Genome - anatomical entity,Advanced Uterine Corpus Carcinosarcoma,0
3018,site-specific telomere resolvase activity,Colorectal Neuroendocrine Tumor G2,0
3019,Lung,Mucinous adenocarcinoma gastric,0
3020,Multiplication,Testicular cancer metastatic,0
3021,Intravascular line,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3022,Abnormally high,Tonsillar Carcinoma,0
3023,Angioma,Liver Cavernous Hemangioma,0
3024,Firstly,Digestive System Hodgkin Lymphoma,0
3025,Affect (mental function),Ichthyosis,0
3026,Specimen Source Codes - tumor,Breast Ductal Adenoma,0
3027,Liver,gliosarcoma,0
3028,Person Name,BRCA2 Syndrome,0
3029,Including (qualifier),Recurrent Uveal Melanoma,0
3030,Complete Pharyngeal Contraction,Intestinal Metaplasia of Bladder Urothelium,0
3031,Perianal Squamous Intraepithelial Neoplasia,Acantholytic squamous cell carcinoma,0
3032,Used by,Intracortical osteosarcoma,0
3033,Apply (instruction),Advanced Uterine Corpus Carcinosarcoma,0
3034,Similarity,Benign Apocrine Neoplasm,0
3035,Two,Childhood Thyroid Gland Follicular Carcinoma,0
3036,Two,Stage I Adult Non-Hodgkin Lymphoma,0
3037,Hyperlink,Tonsillar Carcinoma,0
3038,Non-Metastatic Childhood Soft Tissue Sarcoma,Adult Alveolar Soft Part Sarcoma,0
3039,Platelets,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3040,Symptoms aspect,Human Papillomavirus-Related Carcinoma,0
3041,Formation,Choroid Necrotic Melanoma,0
3042,Normal hemostatic function,Neonatal leukemia,0
3043,Osteogenesis,Cartilaginous exostosis,0
3044,Prostate,Granular Cell Leiomyosarcoma,0
3045,Version,Secondary malignant neoplasm of lymph node,0
3046,Primary,Granular Cell Leiomyosarcoma,0
3047,63,FIGO Stage II Ovarian Cancer,0
3048,How Much Distress Nausea,Mucinous adenocarcinoma gastric,0
3049,False Discovery Rate,FIGO Stage II Ovarian Cancer,0
3050,Essential,Larynx carcinoma recurrent,0
3051,Topical Corticosteroid Therapy,Spongiotic dermatitis,0
3052,Frequently,Uterine Cancer,0
3053,Term (temporal),Recurrent Testicular Lymphoma,0
3054,Affecting,Acute lymphadenitis,0
3055,Cardiovascular System Part,Digestive System Hodgkin Lymphoma,0
3056,Qualitative form,Blepharal carcinoma,0
3057,Seeding,Extracranial Neuroblastoma,0
3058,CD69 protein,Ichthyosis,0
3059,Benign,Benign Carotid Body Paraganglioma,0
3060,Continuance of life,Malignant melanoma of eyelid,0
3061,Containing (qualifier),BRCA2 Syndrome,0
3062,Cancer Genus,squamous cell carcinoma of the thyroid gland,0
3063,Inspiration function,Larynx carcinoma recurrent,0
3064,Sample Range,Cartilaginous exostosis,0
3065,Used by,Stage IB Pancreatic Cancer AJCC v8,0
3066,Shortness of Breath Visual Analogue Scale,adenosquamous carcinoma of breast,0
3067,Experimental Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3068,Skin,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3069,Covers (device),Secondary malignant neoplasm of lymph node,0
3070,Experimental Result,Contact dermatitis due to alkali,0
3071,high - ActExposureLevelCode,Mucinous adenocarcinoma gastric,0
3072,Staining (finding),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3073,Etiology aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3074,Covers (device),Malignant Neoplasm of Lung - Multiple Primary Sites,0
3075,Decision,Benign Apocrine Neoplasm,0
3076,Often - answer to question,Recurrent Testicular Lymphoma,0
3077,Not Otherwise Specified,Metastatic Ductal Breast Carcinoma,0
3078,Type - attribute,Human Papillomavirus-Related Carcinoma,0
3079,Type - attribute,Benign Carotid Body Paraganglioma,0
3080,Fluid behavior,Digestive System Hodgkin Lymphoma,0
3081,appendiceal,mucinous adenocarcinoma of gallbladder,0
3082,Binding Sites,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3083,Leg,Adult Alveolar Soft Part Sarcoma,0
3084,Lung,Colorectal Neuroendocrine Tumor G2,0
3085,Feelings,Acute Undifferentiated Leukemia,0
3086,biopsy characteristics,Recurrent Uveal Melanoma,0
3087,Child,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3088,lymph nodes,FIGO Stage II Ovarian Cancer,0
3089,Frequently,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3090,Megakaryoblast Cell Count,Neonatal leukemia,0
3091,Chemotherapy,Undifferentiated Endocervical Sarcoma,0
3092,Antibody Formation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3093,peripheral blood,Liver Cavernous Hemangioma,0
3094,potential,Bladder squamous cell carcinoma stage I,0
3095,Operative Surgical Procedures,Intestinal Metaplasia of Bladder Urothelium,0
3096,Numbers,Pancreatic Intraepithelial Neoplasia-3,0
3097,Lumpectomy of breast,Atypical Lobular Breast Hyperplasia,0
3098,Derivation,Childhood Central Nervous System Immature Teratoma,0
3099,exception - ResponseLevel,Heavy Chain Deposition Disease,0
3100,Disease,Carcinoma of urinary bladder,0
3101,Illness: Cannot describe symptoms,Cancer of Urinary Tract,0
3102,Glycation End Products,Neonatal leukemia,0
3103,Usual Severity Shortness of Breath,adenosquamous carcinoma of breast,0
3104,Manufactured form,Adult Alveolar Soft Part Sarcoma,0
3105,Biological Response Modifiers,Localized Askin Tumor,0
3106,Progress,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3107,Disseminated Malignant Neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3108,Line Specimen,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3109,shared attribute,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3110,Infection,Human Papillomavirus-Related Carcinoma,0
3111,Have Nausea,Mucinous adenocarcinoma gastric,0
3112,various other intestinal adsorbents in ATC,Extra-Adrenal Paraganglioma,0
3113,Male population group,Malignant melanoma of eyelid,0
3114,Egg of order Phthiraptera,Adult Alveolar Soft Part Sarcoma,0
3115,Cancer Genus,Advanced Uterine Corpus Carcinosarcoma,0
3116,Cystoscopy,Intestinal Metaplasia of Bladder Urothelium,0
3117,Immunotherapy,Unresectable Rhabdomyosarcoma,0
3118,Prognosis:Find:Pt:^Patient:Nom,Primary Cutaneous Plasmablastic Lymphoma,0
3119,Aspects of signs,Malignant melanoma of eyelid,0
3120,Structure of parenchyma of lung,adenosquamous carcinoma of breast,0
3121,Slow,Hemangioma,0
3122,International Aspects,Blepharal carcinoma,0
3123,Sunlight,Recurrent Uveal Melanoma,0
3124,Experimental Result,Malignant Testicular Sertoli Cell Tumor,0
3125,Sometimes,Endometrial Small Cell Carcinoma,0
3126,Melanins,Malignant melanoma of eyelid,0
3127,What subject filter - Result,squamous cell carcinoma of the thyroid gland,0
3128,Secondary Neoplasm,Extra-Adrenal Paraganglioma,0
3129,Linear,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3130,Dermoid Cyst,benign mature teratoma of pancreas,0
3131,Malignant Neoplasms,Malignant Testicular Sertoli Cell Tumor,0
3132,Current (present time),Rhabdomyosarcoma with ganglionic differentiation,0
3133,Image Feature,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3134,Body Fluids,Diffuse malignant mesothelioma,0
3135,Squamous cell carcinoma,Stage II Carcinoma of Penis,0
3136,Skin,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3137,Therapeutic procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3138,Advanced phase,Mucinous adenocarcinoma gastric,0
3139,Genetic syndrome,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3140,Most,Recurrent Uveal Melanoma,0
3141,newly,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3142,Limited stage (cancer stage),Primary Cutaneous Plasmablastic Lymphoma,0
3143,Changed status,Choroid Necrotic Melanoma,0
3144,Line Specimen,Acute Undifferentiated Leukemia,0
3145,Tryptophanase,Pancreatic Intraepithelial Neoplasia-3,0
3146,Large,Ichthyosis,0
3147,Administration procedure,Ichthyosis,0
3148,Bilateral salpingectomy with oophorectomy,Undifferentiated Endocervical Sarcoma,0
3149,Related personal status,Acantholytic squamous cell carcinoma,0
3150,criteria,Female Breast Carcinoma,0
3151,Base - General Qualifier,Malignant Testicular Sertoli Cell Tumor,0
3152,Mammary Gland Parenchyma,Granular Cell Leiomyosarcoma,0
3153,Sufficient,Undifferentiated Endocervical Sarcoma,0
3154,include - SetOperator,Malignant neoplasm of thalamus,0
3155,Often - answer to question,Colorectal Neuroendocrine Tumor G2,0
3156,Diffuse Large B-Cell Lymphoma,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
3157,Lymphocyte component of blood,Digestive System Hodgkin Lymphoma,0
3158,Supportive assistance,Digestive System Hodgkin Lymphoma,0
3159,Reparative closure,Refractory Barrett Esophagus,0
3160,Diagnosis of exclusion,Metastatic Ductal Breast Carcinoma,0
3161,Table Cell Horizontal Align - left,Acute Undifferentiated Leukemia,0
3162,Cells,Recurrent Testicular Lymphoma,0
3163,Top (position),Acantholytic squamous cell carcinoma,0
3164,Stomach,Colorectal cancer,0
3165,Physical Examination,Malignant Testicular Sertoli Cell Tumor,0
3166,Descending,Malignant melanoma of eyelid,0
3167,Call (Instruction),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
3168,Renal carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3169,Immunocompromised Host,Tonsillar Carcinoma,0
3170,Diagnosis,Spongiotic dermatitis,0
3171,Condition:Find:Pt:^Patient:Nom,Maxillary Sinus Adenocarcinoma,0
3172,low,mucinous adenocarcinoma of gallbladder,0
3173,Cells,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3174,Status post,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3175,Cell Device,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3176,Mixed Salivary Gland Tumor,Carcinoma ex pleomorphic adenoma of parotid gland,0
3177,Cancer Genus,Acute lymphadenitis,0
3178,Therapeutic radiology procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3179,pump (device),Digestive System Hodgkin Lymphoma,0
3180,Food allergenic extracts,Mucinous adenocarcinoma gastric,0
3181,include - SetOperator,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3182,Biologic Development,Acute Undifferentiated Leukemia,0
3183,Asp snake,Adult Alveolar Soft Part Sarcoma,0
3184,Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3185,Highest,Carcinoma of urinary bladder,0
3186,Group Object,Metastatic Ductal Breast Carcinoma,0
3187,Common (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3188,Therapeutic radiology procedure,Primary Cutaneous Plasmablastic Lymphoma,0
3189,Manufactured form,Secondary malignant neoplasm of lymph node,0
3190,Direct type of relationship,Human Papillomavirus-Related Carcinoma,0
3191,inferiority,Childhood Cerebellar Neoplasm,0
3192,Most,Metastatic Neoplasm to the Gallbladder,0
3193,Aspects of disease screening,Undifferentiated Endocervical Sarcoma,0
3194,New,FIGO Stage II Ovarian Cancer,0
3195,Diagnosis Study,Acute Undifferentiated Leukemia,0
3196,shared attribute,BRCA2 Syndrome,0
3197,Case (situation),Stage IB Pancreatic Cancer AJCC v8,0
3198,Symptoms,squamous cell carcinoma of the thyroid gland,0
3199,Common Specifications in HL7 V3 Publishing,Airway Hemangioma,0
3200,Sufficiently defined concept definition status (core metadata concept),Adenocarcinoma of the prostate metastatic,0
3201,Basis,Advanced Uterine Corpus Carcinosarcoma,0
3202,Disease,Endometrial Small Cell Carcinoma,0
3203,Term Birth,Recurrent Testicular Lymphoma,0
3204,Usually,FIGO Stage II Ovarian Cancer,0
3205,Pharmacotherapy,Malignant Testicular Sertoli Cell Tumor,0
3206,Metastatic Neoplasm,Adult Alveolar Soft Part Sarcoma,0
3207,History,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3208,Stem cell transplant,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3209,Lymphocyte component of blood,Malignant Neoplasm with Regional Lymph Node Involvement,0
3210,Logical Condition,Refractory Barrett Esophagus,0
3211,Present,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
3212,active (HL7 RoleLink),Thymic Clear Cell Carcinoma,0
3213,Biological Response Modifier Therapy,Acantholytic squamous cell carcinoma,0
3214,Persons,Recurrent Uveal Melanoma,0
3215,Enlarged,Childhood Lymphoma,0
3216,Greater,Ichthyosis,0
3217,Metastasis,Malignant melanoma of eyelid,0
3218,apply - action,Human Papillomavirus-Related Carcinoma,0
3219,Personal Contact,Human Papillomavirus-Related Carcinoma,0
3220,Fatal,Angiosarcoma of liver,0
3221,Family member,Malignant melanoma of eyelid,0
3222,Microvolt,Malignant melanoma of eyelid,0
3223,Infertility study,Spermatocytic seminoma,0
3224,Testicular Germ Cell Tumor,Spermatocytic seminoma,0
3225,Embryonic Development,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3226,Human papilloma virus infection,Human Papillomavirus-Related Carcinoma,0
3227,Fibrous connective tissue,Giant cell angiofibroma,0
3228,Cerebral hemisphere structure (body structure),Pilocytic astrocytoma of cerebellum,0
3229,Work,Diffuse malignant mesothelioma,0
3230,SLC6A2 protein,Colorectal Neuroendocrine Tumor G2,0
3231,Smaller,FIGO Stage II Ovarian Cancer,0
3232,Abnormal host response,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3233,Lymphangitis,Acute lymphadenitis,0
3234,Medical Devices,Malignant melanoma of eyelid,0
3235,Only - dosing instruction fragment,Human Papillomavirus-Related Carcinoma,0
3236,Annual,Extracranial Neuroblastoma,0
3237,Reported Term,Stage IB Pancreatic Cancer AJCC v8,0
3238,Severe Extremity Pain,Cartilaginous exostosis,0
3239,World Health Organization,Methotrexate-Associated Hodgkin Lymphoma,0
3240,Space - property,Malignant neoplasm of choroid,0
3241,Natural,Maxillary Sinus Adenocarcinoma,0
3242,Latin America,Malignant melanoma of eyelid,0
3243,Adult Lymphoma,Hodgkin lymphoma,0
3244,Device system,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3245,Multiple malignancy,Intestinal Metaplasia of Bladder Urothelium,0
3246,Case unit dose,Unfavorable Non-Hodgkin Lymphoma,0
3247,Pancreatic carcinoma,Mucinous neoplasm,0
3248,Folded structure,Clonal Hematopoiesis of Indeterminate Potential,0
3249,LATS1 wt Allele,Human Papillomavirus-Related Carcinoma,0
3250,To,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3251,Malignant epithelioma,gliosarcoma,0
3252,Singular,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3253,Poor - qualifier,Recurrent Uveal Melanoma,0
3254,diagnosis aspect,Pancreatic Intraepithelial Neoplasia-3,0
3255,Mucoepidermoid Carcinoma,adenoid cystic carcinoma of lung,0
3256,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,Cancer of Urinary Tract,0
3257,Surgery specialty,FIGO Stage II Ovarian Cancer,0
3258,Fluid behavior,Anterior Urethral Malignant Neoplasm,0
3259,Public Domain,Ampulla of Vater Tubular Adenoma,0
3260,Animals,Blepharal carcinoma,0
3261,Code System Type - Internal,Diffuse malignant mesothelioma,0
3262,various antiseptic throat preparations,Benign neoplasm of thorax,0
3263,Numerous,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3264,Special,Thymic Clear Cell Carcinoma,0
3265,Involvement with,Hodgkin lymphoma,0
3266,Birth,Adult Hepatocellular Carcinoma,0
3267,Metastatic Neoplasm,Extra-Adrenal Paraganglioma,0
3268,Both ovaries,Undifferentiated Endocervical Sarcoma,0
3269,Weight decreased,Stage I Adult Non-Hodgkin Lymphoma,0
3270,Intravascular line,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3271,Leading,Malignant neoplasm of choroid,0
3272,Spreading (qualifier value),Undifferentiated Endocervical Sarcoma,0
3273,Maintenance,Tonsillar Carcinoma,0
3274,Original,Ampulla of Vater Tubular Adenoma,0
3275,Death (finding),Uterine Cancer,0
3276,Stem of plant,Rhabdomyosarcoma with ganglionic differentiation,0
3277,First (number),Airway Hemangioma,0
3278,Treatment Epoch,Spongiotic dermatitis,0
3279,Connective Tissue,Granular Cell Leiomyosarcoma,0
3280,Accumulation,Mastocytosis,0
3281,described,Placental aromatase deficiency,0
3282,International Classification of Diseases for Oncology,Noninfiltrating Intraductal Carcinoma,0
3283,Smear - instruction imperative,Stage IB Pancreatic Cancer AJCC v8,0
3284,Categories,Malignant Neoplasm with Regional Lymph Node Involvement,0
3285,Bothered by Vomiting,Choroid Necrotic Melanoma,0
3286,Involvement with,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3287,Electromagnetic Fields,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3288,PREVENT (product),Advanced Uterine Corpus Carcinosarcoma,0
3289,metastatic qualifier,Testicular cancer metastatic,0
3290,AKR1A1 wt Allele,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3291,status - In progress,Anterior Urethral Malignant Neoplasm,0
3292,Vasopressin (USP),Collecting Duct Carcinoma of the Kidney,0
3293,70%,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3294,Etiology aspects,Mastocytosis,0
3295,Admission Level of Care Code - Improved,Recurrent Testicular Lymphoma,0
3296,Geographic Locations,Pilocytic astrocytoma of cerebellum,0
3297,3+ Answer to Question,Mucinous adenocarcinoma gastric,0
3298,Cells,Adult Alveolar Soft Part Sarcoma,0
3299,Cessation of life,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3300,Warts,Human Papillomavirus-Related Carcinoma,0
3301,Thyroid Gland,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3302,Therapeutic procedure,Neonatal leukemia,0
3303,Small,Adult Alveolar Soft Part Sarcoma,0
3304,Symptoms aspect,Stage IB Pancreatic Cancer AJCC v8,0
3305,Referring,Carcinoma ex pleomorphic adenoma of parotid gland,0
3306,Relational and Item-Specific Encoding Task,Endometrial Small Cell Carcinoma,0
3307,Kissing,Extracranial Neuroblastoma,0
3308,Including (qualifier),Benign neoplasm of thorax,0
3309,Take,Undifferentiated Endocervical Sarcoma,0
3310,Distal (qualifier value),Adult Hepatocellular Carcinoma,0
3311,Operative Surgical Procedures,FIGO Stage II Ovarian Cancer,0
3312,54,gliosarcoma,0
3313,Transurethral Resection,Intestinal Metaplasia of Bladder Urothelium,0
3314,Manufactured form,Airway Hemangioma,0
3315,Deficiency of sulfatase,Ichthyosis,0
3316,Cell Count,squamous cell carcinoma of the thyroid gland,0
3317,Biopsy,Mucinous adenocarcinoma gastric,0
3318,75,Bladder squamous cell carcinoma stage I,0
3319,Tentorium cerebelli,Childhood Cerebellar Neoplasm,0
3320,Identified,Thymic Clear Cell Carcinoma,0
3321,Daily,Digestive System Hodgkin Lymphoma,0
3322,Fatigue,Diffuse malignant mesothelioma,0
3323,Specific qualifier value,adenoid cystic carcinoma of lung,0
3324,described,Refractory Barrett Esophagus,0
3325,School Grade,Primary Cutaneous Plasmablastic Lymphoma,0
3326,NCI CTEP SDC Mastocytosis Sub-Category Terminology,Mastocytosis,0
3327,Very Much,Placental aromatase deficiency,0
3328,Evidence,Female Breast Carcinoma,0
3329,Type - attribute,Intestinal Metaplasia of Bladder Urothelium,0
3330,Intestines,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3331,Females,Diffuse malignant mesothelioma,0
3332,Tumor cells,Heavy Chain Deposition Disease,0
3333,Name (property) (qualifier value),Extracranial Neuroblastoma,0
3334,Plasma Product,Digestive System Hodgkin Lymphoma,0
3335,More,Intestinal Metaplasia of Bladder Urothelium,0
3336,development aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3337,Receptors,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3338,fish - non-drug agent,Ichthyosis,0
3339,Cell Count,Liver Cavernous Hemangioma,0
3340,Females,Localized Askin Tumor,0
3341,Characteristics,benign mature teratoma of pancreas,0
3342,Malignant tumor of cervix,Undifferentiated Endocervical Sarcoma,0
3343,Empty (qualifier),Familial Hemophagocytic Lymphocytosis,0
3344,Result,Recurrent Uveal Melanoma,0
3345,Diabetes,Stage IB Pancreatic Cancer AJCC v8,0
3346,<50,FIGO Stage II Ovarian Cancer,0
3347,Cancer Genus,papillary carcinoma of penis,0
3348,Sacrifice,Unresectable Rhabdomyosarcoma,0
3349,analysis aspect,Colorectal High Grade B-Cell Lymphoma,0
3350,Chest,Benign neoplasm of thorax,0
3351,How Often Weight Loss,Hodgkin lymphoma,0
3352,Skin,Acantholytic squamous cell carcinoma,0
3353,Fragment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3354,Application Dosing Unit,Acantholytic squamous cell carcinoma,0
3355,Activation action,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3356,Togo,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3357,Inspiration function,Airway Hemangioma,0
3358,Biopsy,Acantholytic squamous cell carcinoma,0
3359,Acid reflux SYMPTOMS,Refractory Barrett Esophagus,0
3360,90%,Methotrexate-Associated Hodgkin Lymphoma,0
3361,diagnosis aspect,Anterior Urethral Malignant Neoplasm,0
3362,Night sweats,Childhood Lymphoma,0
3363,Older child,benign mature teratoma of pancreas,0
3364,Normal,Undifferentiated Endocervical Sarcoma,0
3365,Skin Erosion,Malignant melanoma of eyelid,0
3366,Classical Hodgkin's Lymphoma,Childhood Lymphoma,0
3367,combination - answer to question,Carcinoma of urinary bladder,0
3368,Beginning,Refractory Glioma,0
3369,Negation,Recurrent Testicular Lymphoma,0
3370,How Often Felt Normal question,Undifferentiated Endocervical Sarcoma,0
3371,Back Pain,Pancreatic Intraepithelial Neoplasia-3,0
3372,Histamine H2 Receptor Antagonists [MoA],Refractory Barrett Esophagus,0
3373,Including (qualifier),squamous cell carcinoma of the thyroid gland,0
3374,Screening procedure,Human Papillomavirus-Related Carcinoma,0
3375,Decrease,Endometrial Small Cell Carcinoma,0
3376,Surgical aspects,FIGO Stage II Ovarian Cancer,0
3377,Support,Uterine Cancer,0
3378,List,Human Papillomavirus-Related Carcinoma,0
3379,Phonation,Larynx carcinoma recurrent,0
3380,Hip structure,Cartilaginous exostosis,0
3381,Cells,Clonal Hematopoiesis of Indeterminate Potential,0
3382,solid substance,Pilocytic astrocytoma of cerebellum,0
3383,Data operation - complete,Bladder squamous cell carcinoma stage I,0
3384,Assortment,Hemangioma,0
3385,Tryptophanase,Endometrial Small Cell Carcinoma,0
3386,Cancer Genus,Choroid Necrotic Melanoma,0
3387,Articular system,Cartilaginous exostosis,0
3388,Aggressive behavior,Recurrent Testicular Lymphoma,0
3389,Bone Marrow Examination,Acute Undifferentiated Leukemia,0
3390,Endometrial Carcinoma,Colorectal cancer,0
3391,god,Digestive System Hodgkin Lymphoma,0
3392,Seizures,Malignant neoplasm of thalamus,0
3393,Negation,Endometrial Small Cell Carcinoma,0
3394,Obesity,Stage IB Pancreatic Cancer AJCC v8,0
3395,Dyspnea,Diffuse malignant mesothelioma,0
3396,Stage,Mucinous adenocarcinoma gastric,0
3397,What subject filter - Result,mucinous adenocarcinoma of gallbladder,0
3398,Intraventricular,Malignant neoplasm of choroid,0
3399,Drop measurement,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3400,Treating,Mucinous adenocarcinoma gastric,0
3401,Renal Cell Carcinoma,Sarcomatoid Renal Cell Carcinoma,0
3402,Benign neoplasm of paraganglion,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3403,Causing,Hemangioma,0
3404,cancer-predisposing genes,BRCA2 Syndrome,0
3405,Fever,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3406,Childhood Lymphoma,Childhood Lymphoma,0
3407,removal technique,Acantholytic squamous cell carcinoma,0
3408,Abnormal size,Acute lymphadenitis,0
3409,Diagnosis Study,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3410,Occurrence,Leiomyoma of Gallbladder,0
3411,Cystitis,Cancer of Urinary Tract,0
3412,per second,Recurrent Testicular Lymphoma,0
3413,Group A (blood group),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3414,Common Specifications in HL7 V3 Publishing,Malignant Testicular Sertoli Cell Tumor,0
3415,Protein antibody,Unresectable Rhabdomyosarcoma,0
3416,Symptoms,Diffuse malignant mesothelioma,0
3417,pharmacotherapeutic,Undifferentiated Endocervical Sarcoma,0
3418,Body part,adenosquamous carcinoma of breast,0
3419,Receive,Unresectable Rhabdomyosarcoma,0
3420,Persons,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3421,Carcinoid Tumor,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3422,Common (qualifier value),Carcinoma ex pleomorphic adenoma of parotid gland,0
3423,Usually,Anterior Urethral Malignant Neoplasm,0
3424,Less Than,Malignant melanoma of eyelid,0
3425,site-specific telomere resolvase activity,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3426,Plant nodule,Airway Hemangioma,0
3427,abnormal growth by tissue,Anterior Urethral Malignant Neoplasm,0
3428,Fatigue,Hodgkin lymphoma,0
3429,Including (qualifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
3430,Tumor cells,Adult Fibrolamellar Carcinoma,0
3431,Have Shortness of Breath question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3432,Include (action),Acute lymphadenitis,0
3433,Sequence Data Type,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3434,Body Site Modifier - Lower,Acute Undifferentiated Leukemia,0
3435,Broken skin,Recurrent Uveal Melanoma,0
3436,Consistency,gliosarcoma,0
3437,Beginning,Acantholytic squamous cell carcinoma,0
3438,Common Specifications in HL7 V3 Publishing,Acute lymphadenitis,0
3439,Severe Extremity Pain,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3440,Cell Count,Thymic Clear Cell Carcinoma,0
3441,Legal Adult,Neonatal leukemia,0
3442,National origin,Granular Cell Leiomyosarcoma,0
3443,Neoplastic Glandular Cell,Carcinoma ex pleomorphic adenoma of parotid gland,0
3444,Scar Tissue,Diffuse malignant mesothelioma,0
3445,700,Human Papillomavirus-Related Carcinoma,0
3446,World Health Organization,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3447,Known,benign mature teratoma of pancreas,0
3448,Formation,Malignant neoplasm of thalamus,0
3449,Death (finding),Malignant melanoma of eyelid,0
3450,Oral (intended site),Giant cell angiofibroma,0
3451,peripheral blood,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3452,Stage Grouping,Neonatal leukemia,0
3453,Organ,Metastatic Neoplasm to the Gallbladder,0
3454,Irritant behavior,Contact dermatitis due to alkali,0
3455,Biological Response Modifiers,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3456,Molecular Mass,Stage IB Pancreatic Cancer AJCC v8,0
3457,Attenuation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3458,Image Feature,benign mature teratoma of pancreas,0
3459,Unexplained weight loss,Pancreatic Intraepithelial Neoplasia-3,0
3460,Detection,Unresectable Rhabdomyosarcoma,0
3461,Salivary Glands,Carcinoma ex pleomorphic adenoma of parotid gland,0
3462,Used by,Leptomeningeal sarcoma,0
3463,Manufactured form,Breast Ductal Adenoma,0
3464,3+ Score,Malignant melanoma of eyelid,0
3465,Seminoma,Spermatocytic seminoma,0
3466,Normal function,BRCA2 Syndrome,0
3467,Two,Refractory Barrett Esophagus,0
3468,Further,Acute Undifferentiated Leukemia,0
3469,Mass of body structure,Stage IB Pancreatic Cancer AJCC v8,0
3470,Anaphylactic shock,Mastocytosis,0
3471,Form:Finding:Point in time:{Setting}:Document:{Role},Heavy Chain Deposition Disease,0
3472,Often - answer to question,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3473,Biological Transport,Sarcomatoid Renal Cell Carcinoma,0
3474,Tumor type,Serous cystadenocarcinoma ovary,0
3475,Age - 16,Cancer of Urinary Tract,0
3476,Structure of subclavian vein,Digestive System Hodgkin Lymphoma,0
3477,Blood,gliosarcoma,0
3478,Decade,Giant cell angiofibroma,0
3479,Cartilaginous exostosis,Cartilaginous exostosis,0
3480,Kidney Tubules,Grade 1 Clear Cell Renal Cell Carcinoma,0
3481,nonmyeloablative allogeneic hematopoietic stem cell transplantation,Metastatic Ductal Breast Carcinoma,0
3482,Bone Pain,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3483,Laparotomy,Atypical Mesothelial Hyperplasia,0
3484,Adult Classical Hodgkin Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
3485,Chemotherapy Regimen,Metastatic Carcinoma in the Lung,0
3486,External exotoses,Cartilaginous exostosis,0
3487,Death (finding),FIGO Stage II Ovarian Cancer,0
3488,Pharmacotherapy,Acute Undifferentiated Leukemia,0
3489,alone - group size,Endometrial Small Cell Carcinoma,0
3490,Stage,Spermatocytic seminoma,0
3491,Eyelid structure,Blepharal carcinoma,0
3492,Closed,Mucinous neoplasm,0
3493,Pancreatic Hormones,Stage IB Pancreatic Cancer AJCC v8,0
3494,First (number),Digestive System Hodgkin Lymphoma,0
3495,Common (qualifier value),FIGO Stage II Ovarian Cancer,0
3496,Microscopic,Adult Alveolar Soft Part Sarcoma,0
3497,Symptoms,papillary carcinoma of penis,0
3498,Include (action),Refractory Barrett Esophagus,0
3499,Chemotherapy,Uterine Cancer,0
3500,Act Relationship Subset - previous,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3501,Recurrence,Cancer of Urinary Tract,0
3502,20%,Malignant Testicular Sertoli Cell Tumor,0
3503,treatment - ActInformationManagementReason,Recurrent Uveal Melanoma,0
3504,Array Feature,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3505,Primary,Methotrexate-Associated Hodgkin Lymphoma,0
3506,More,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3507,Palmitic Acid,Granular Cell Leiomyosarcoma,0
3508,treatment - ActInformationManagementReason,Uterine Cancer,0
3509,Immune System Processes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3510,Aggressive course,Recurrent Testicular Lymphoma,0
3511,Term Birth,Heavy Chain Deposition Disease,0
3512,Common Specifications in HL7 V3 Publishing,Colorectal High Grade B-Cell Lymphoma,0
3513,Communicable Diseases,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3514,Genomics,Advanced Uterine Corpus Carcinosarcoma,0
3515,Process (qualifier value),FIGO Stage II Ovarian Cancer,0
3516,Usual Severity Weight Loss,Stage I Adult Non-Hodgkin Lymphoma,0
3517,How Often Difficulty Swallowing,Mucinous adenocarcinoma gastric,0
3518,More,Anterior Urethral Malignant Neoplasm,0
3519,ovarian,Undifferentiated Endocervical Sarcoma,0
3520,Face,Extracranial Neuroblastoma,0
3521,Surgical aspects,Mucinous adenocarcinoma gastric,0
3522,Very Much,FIGO Stage II Ovarian Cancer,0
3523,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
3524,Case unit dose,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3525,disease history,Uterine Cancer,0
3526,Smear test,Recurrent Uveal Melanoma,0
3527,Estrogens,Endometrial Small Cell Carcinoma,0
3528,Body tissue,Intestinal Neuroendocrine Carcinoma,0
3529,Pale color,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3530,precancerous lesions,Human Papillomavirus-Related Carcinoma,0
3531,Ancestry-Informative Marker,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3532,Benign tumor of salivary gland,Papillary cystic tumor,0
3533,Dermatologic disorders,Ichthyoses,0
3534,Major <insect>,Hodgkin lymphoma,0
3535,Skin,Spongiotic dermatitis,0
3536,Malignant neoplasm of breast,Metastatic Ductal Breast Carcinoma,0
3537,Neoplasm Metastasis,mucinous adenocarcinoma of gallbladder,0
3538,Surface of skin,papillary carcinoma of penis,0
3539,International Foot,Cartilaginous exostosis,0
3540,Currarino triad,benign mature teratoma of pancreas,0
3541,Respiration,Airway Hemangioma,0
3542,Malignant neoplasm of soft tissue,Adult Alveolar Soft Part Sarcoma,0
3543,Including (qualifier),Mucinous neoplasm,0
3544,Aggressive course,Colorectal High Grade B-Cell Lymphoma,0
3545,described,Cancer of Urinary Tract,0
3546,Tryptophanase,Colorectal High Grade B-Cell Lymphoma,0
3547,Bothered by Nausea,Mucinous adenocarcinoma gastric,0
3548,Precancerous Conditions,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3549,Slightly Agree,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3550,Type A,GIANT PIGMENTED HAIRY NEVUS,0
3551,Including (qualifier),Secondary malignant neoplasm of lymph node,0
3552,Including (qualifier),Stage IB Lung Cancer AJCC v7,0
3553,Benign Teratoma,benign mature teratoma of pancreas,0
3554,HL7PublishingSubSection <practice>,Acute lymphadenitis,0
3555,include - SetOperator,Stage II Carcinoma of Penis,0
3556,Further,Acantholytic squamous cell carcinoma,0
3557,Partial,Intestinal Metaplasia of Bladder Urothelium,0
3558,How Much Distress Sweats,Methotrexate-Associated Hodgkin Lymphoma,0
3559,Symptoms aspect,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3560,Binding action,Unresectable Rhabdomyosarcoma,0
3561,Exons,BRCA2 Syndrome,0
3562,Human Cells,Collecting Duct Carcinoma of the Kidney,0
3563,Steroids,Ichthyosis,0
3564,Cell Count,BRCA2 Syndrome,0
3565,Smoking,Intestinal Metaplasia of Bladder Urothelium,0
3566,Occurrence Indicator,Pilocytic astrocytoma of cerebellum,0
3567,Experimental Result,Mucinous adenocarcinoma gastric,0
3568,Deterioration of status,Choroid Necrotic Melanoma,0
3569,Links List,Angiosarcoma of liver,0
3570,Percent of Abnormal Cells,Spongiotic dermatitis,0
3571,Target Awareness - partial,Bladder squamous cell carcinoma stage I,0
3572,Cervical lymph node group,Acute lymphadenitis,0
3573,Polymerization,Angiosarcoma of liver,0
3574,Descending,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3575,Cancer Genus,Localized Askin Tumor,0
3576,human AVP protein,Atypical Lobular Breast Hyperplasia,0
3577,Pruritus,Hodgkin lymphoma,0
3578,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Uterine Cancer,0
3579,Sexually active,Human Papillomavirus-Related Carcinoma,0
3580,Certainties,Tonsillar Carcinoma,0
3581,Tryptophanase,Uterine Cancer,0
3582,Brain,Hemangioma,0
3583,Taxonomic,Noninfiltrating Intraductal Carcinoma,0
3584,Therapeutic procedure,Maxillary Sinus Adenocarcinoma,0
3585,High,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3586,Common wart,Human Papillomavirus-Related Carcinoma,0
3587,Sometimes,Heavy Chain Deposition Disease,0
3588,Count of entities,papillary carcinoma of penis,0
3589,Low Mitosis-Karyorrhexis Index,mucinous adenocarcinoma of gallbladder,0
3590,Chemotherapy,Endometrial Small Cell Carcinoma,0
3591,Severe (severity modifier),mucinous adenocarcinoma of gallbladder,0
3592,Known,Acantholytic squamous cell carcinoma,0
3593,Body structure,Intestinal Neuroendocrine Carcinoma,0
3594,Responsible to,ALK positive large B-cell lymphoma,0
3595,Unknown GENC,Acute Undifferentiated Leukemia,0
3596,Different,Breast Ductal Adenoma,0
3597,Participation Type - origin,Granular Cell Leiomyosarcoma,0
3598,predictive factor,Female Breast Carcinoma,0
3599,Five,Benign neoplasm of thorax,0
3600,Concept History,Malignant melanoma of eyelid,0
3601,Value Above Reference Range,FIGO Stage II Ovarian Cancer,0
3602,anaphylaxis,Mastocytosis,0
3603,Diagnosis,Pancreatic Intraepithelial Neoplasia-3,0
3604,Five,Undifferentiated Endocervical Sarcoma,0
3605,anatomical layer,Adult Alveolar Soft Part Sarcoma,0
3606,Generation (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3607,Have Weight Loss,Stage I Adult Non-Hodgkin Lymphoma,0
3608,Sequence Arm,Childhood Lymphoma,0
3609,Aim,Acute Undifferentiated Leukemia,0
3610,International Statistical Classification of Diseases and Related Health Problems,Intracortical osteosarcoma,0
3611,day,Digestive System Hodgkin Lymphoma,0
3612,Abnormally high,Recurrent Uveal Melanoma,0
3613,Characteristics,mucinous adenocarcinoma of gallbladder,0
3614,risk factors - observation list,Mucinous adenocarcinoma gastric,0
3615,Body part,Bladder squamous cell carcinoma stage I,0
3616,Treatment intent,Uterine Cancer,0
3617,Specimen Source Codes - Tears,Benign Apocrine Neoplasm,0
3618,Definition,Female Breast Carcinoma,0
3619,Tryptophanase,Human Papillomavirus-Related Carcinoma,0
3620,Occurrence,Clonal Hematopoiesis of Indeterminate Potential,0
3621,Cause of Death,Endometrial Small Cell Carcinoma,0
3622,Membrane Device,Neonatal leukemia,0
3623,Population Group,Clonal Hematopoiesis of Indeterminate Potential,0
3624,Medical Devices,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3625,Tired,Hodgkin lymphoma,0
3626,85,Human Papillomavirus-Related Carcinoma,0
3627,Tunnel structure,Adult Alveolar Soft Part Sarcoma,0
3628,Morphology,Recurrent Testicular Lymphoma,0
3629,*Type - Kind of quantity,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3630,Occurrence Indicator,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
3631,Abnormal,Recurrent Testicular Lymphoma,0
3632,Immunocompromised Host,Primary Cutaneous Plasmablastic Lymphoma,0
3633,Well Differentiated,Germinoma,0
3634,To,Colorectal High Grade B-Cell Lymphoma,0
3635,Domain (area of knowledge),Noninfiltrating Intraductal Carcinoma,0
3636,Poor - grade value,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3637,Known,Localized Askin Tumor,0
3638,Hormone Therapy,Undifferentiated Endocervical Sarcoma,0
3639,Head - Component of Device,Adult Alveolar Soft Part Sarcoma,0
3640,Disease,Malignant Testicular Sertoli Cell Tumor,0
3641,Pharmacotherapy,Diffuse malignant mesothelioma,0
3642,3+ Answer to Question,Uterine Cancer,0
3643,Common (qualifier value),Colorectal cancer,0
3644,Update,Female Breast Carcinoma,0
3645,risk factors,Mucinous adenocarcinoma gastric,0
3646,Measurement,Cancer of Urinary Tract,0
3647,Entity Determiner - specific,Childhood Lymphoma,0
3648,Tests (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3649,Availability of,Female Breast Carcinoma,0
3650,Following,Diffuse malignant mesothelioma,0
3651,Spreading (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3652,Progress,Malignant neoplasm of thalamus,0
3653,Child,Adult Alveolar Soft Part Sarcoma,0
3654,Reporting,Tonsillar Carcinoma,0
3655,First sign,Endometrial Small Cell Carcinoma,0
3656,Front of neck,Childhood Thyroid Gland Follicular Carcinoma,0
3657,Characteristics,Blepharal carcinoma,0
3658,Necrosis,Angiosarcoma of liver,0
3659,Speaking (activity),Choroid Necrotic Melanoma,0
3660,Acute Megakaryocytic Leukemias,Neonatal leukemia,0
3661,Breast,Breast Ductal Adenoma,0
3662,shared attribute,Malignant Testicular Sertoli Cell Tumor,0
3663,Hereditary Diseases,Advanced Uterine Corpus Carcinosarcoma,0
3664,Physical shape,Rhabdomyosarcoma with ganglionic differentiation,0
3665,Appearance of breast,Female Breast Carcinoma,0
3666,Etiology aspects,Stage II Carcinoma of Penis,0
3667,Primary,Grade 1 Clear Cell Renal Cell Carcinoma,0
3668,Usual Severity Difficulty Swallowing,Mucinous adenocarcinoma gastric,0
3669,Divide,Malignant neoplasm of thalamus,0
3670,3+ Score,Malignant melanoma of eyelid,0
3671,Then,Testicular cancer metastatic,0
3672,Vaginal,Human Papillomavirus-Related Carcinoma,0
3673,Biological Response Modifier Therapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3674,Digestion,mucinous adenocarcinoma of gallbladder,0
3675,Function (attribute),mucinous adenocarcinoma of gallbladder,0
3676,Administration procedure,Human Papillomavirus-Related Carcinoma,0
3677,Urinary Bladder,Cancer of Urinary Tract,0
3678,Dangerousness,Recurrent Uveal Melanoma,0
3679,contextual factors,Benign Carotid Body Paraganglioma,0
3680,In Blood,Recurrent Testicular Lymphoma,0
3681,Blood Cells,Acute Undifferentiated Leukemia,0
3682,Qualitative form,Malignant neoplasm of thalamus,0
3683,Flow,Angiosarcoma of liver,0
3684,Egg of order Phthiraptera,Leptomeningeal sarcoma,0
3685,Increased,Angiosarcoma of liver,0
3686,Various patch test substance,Benign Carotid Body Paraganglioma,0
3687,International Classification of Disease for Oncology,Secondary malignant neoplasm of lymph node,0
3688,Bacteria,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3689,Smear - instruction imperative,Intestinal Metaplasia of Bladder Urothelium,0
3690,Thought,benign mature teratoma of pancreas,0
3691,System,mucinous adenocarcinoma of gallbladder,0
3692,Body tissue,Childhood Thyroid Gland Follicular Carcinoma,0
3693,Carcinoma of lung,squamous cell carcinoma of the thyroid gland,0
3694,Aspects of signs,Pancreatic Intraepithelial Neoplasia-3,0
3695,Cessation of life,Intestinal Metaplasia of Bladder Urothelium,0
3696,MOSTLY,Malignant melanoma of eyelid,0
3697,Qualitative form,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3698,65+,Bladder squamous cell carcinoma stage I,0
3699,Common (qualifier value),Acantholytic squamous cell carcinoma,0
3700,Multiplication,Stage IB Pancreatic Cancer AJCC v8,0
3701,Malignant Neoplasms,Stage IB Lung Cancer AJCC v7,0
3702,Country number:Find:Pt:^Patient:Nom,Undifferentiated Endocervical Sarcoma,0
3703,Mediator brand of benfluorex hydrochloride,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3704,Pale color,Maxillary Sinus Adenocarcinoma,0
3705,Singular,Undifferentiated Endocervical Sarcoma,0
3706,More,Undifferentiated Endocervical Sarcoma,0
3707,Astrocytes,Pilocytic astrocytoma of cerebellum,0
3708,Associated with,Thymic Clear Cell Carcinoma,0
3709,pharmacotherapeutic,Localized Askin Tumor,0
3710,Common (qualifier value),Malignant melanoma of eyelid,0
3711,Nature,Giant cell angiofibroma,0
3712,Mechanism Component of Device,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3713,Solid,Anterior Urethral Malignant Neoplasm,0
3714,Manufactured sign,Stage IB Pancreatic Cancer AJCC v8,0
3715,Type - attribute,Malignant neoplasm of thalamus,0
3716,Valid,Intracortical osteosarcoma,0
3717,Western Europe,Bladder squamous cell carcinoma stage I,0
3718,Lymphadenopathy,Malignant Neoplasm with Regional Lymph Node Involvement,0
3719,Data Type - Point In Time,Acantholytic squamous cell carcinoma,0
3720,Clonality,Heavy Chain Deposition Disease,0
3721,Basal Cell Cancer,Acantholytic squamous cell carcinoma,0
3722,Giant Cells,Giant cell angiofibroma,0
3723,PSA Level Greater than Fifty,FIGO Stage II Ovarian Cancer,0
3724,Wall of blood vessel,Angiosarcoma of liver,0
3725,Examination,Atypical Mesothelial Hyperplasia,0
3726,Gender Status - Intact,Spermatocytic seminoma,0
3727,Chemotherapy Regimen,FIGO Stage II Ovarian Cancer,0
3728,Osteoporosis,Placental aromatase deficiency,0
3729,Classification of information,Female Breast Carcinoma,0
3730,Rating (action),Bladder squamous cell carcinoma stage I,0
3731,Average,FIGO Stage II Ovarian Cancer,0
3732,Disease remission,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3733,Poor - qualifier,Mucinous adenocarcinoma gastric,0
3734,Process,Collecting Duct Carcinoma of the Kidney,0
3735,Main,Acantholytic squamous cell carcinoma,0
3736,Contain (action),BRCA2 Syndrome,0
3737,diagnosis aspect,Diffuse malignant mesothelioma,0
3738,Removal of bladder,Bladder squamous cell carcinoma stage I,0
3739,Abnormal Cell Count,FIGO Stage II Ovarian Cancer,0
3740,development aspects,Tonsillar Carcinoma,0
3741,Frequently,FIGO Stage II Ovarian Cancer,0
3742,Qualitative form,FIGO Stage II Ovarian Cancer,0
3743,800,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3744,Death (finding),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3745,Human papillomavirus 16,Tonsillar Carcinoma,0
3746,Anterior thoracic region,Airway Hemangioma,0
3747,Trimethoprim-Sulfamethoxazole Combination,Cancer of Urinary Tract,0
3748,Unknown (origin) (qualifier value),Acute lymphadenitis,0
3749,Symptoms aspect,Clonal Hematopoiesis of Indeterminate Potential,0
3750,Fordyce's disease,Maxillary Sinus Adenocarcinoma,0
3751,Colorectal Carcinoma,Colorectal High Grade B-Cell Lymphoma,0
3752,various other agents for local oral treatment in ATC,Extra-Adrenal Paraganglioma,0
3753,Case unit dose,Placental aromatase deficiency,0
3754,Differentiation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3755,Retinoic Acid Response Element,Diffuse malignant mesothelioma,0
3756,Subject Risk,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3757,Choroid Plexus Papilloma,Malignant neoplasm of choroid,0
3758,0%,Leiomyoma of Gallbladder,0
3759,shared attribute,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
3760,Mediator brand of benfluorex hydrochloride,Heavy Chain Deposition Disease,0
3761,Occurrence,Cancer of Urinary Tract,0
3762,radiotherapeutic,Undifferentiated Endocervical Sarcoma,0
3763,Colon structure (body structure),Familial Adenomatous Polyposis Associated Medulloblastoma,0
3764,Togo,Thymic Clear Cell Carcinoma,0
3765,Swelling,Localized Askin Tumor,0
3766,+2,FIGO Stage II Ovarian Cancer,0
3767,Five-year Survival Rate,Malignant Testicular Sertoli Cell Tumor,0
3768,Patients,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3769,Greeks,Ichthyosis,0
3770,Occurrence Indicator,Contact dermatitis due to alkali,0
3771,Five-year Survival Rate,Endometrial Small Cell Carcinoma,0
3772,Scheme,Female Breast Carcinoma,0
3773,second (number),Testicular cancer metastatic,0
3774,Young Child [Disease/Finding],Neonatal leukemia,0
3775,Occurrence,Choroid Necrotic Melanoma,0
3776,Etiology aspects,Liver Cavernous Hemangioma,0
3777,Species,BRCA2 Syndrome,0
3778,THM gene,Thymic Clear Cell Carcinoma,0
3779,Slightly (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3780,Symptom severity level,Ichthyoses,0
3781,Cell (compartment),Clonal Hematopoiesis of Indeterminate Potential,0
3782,Including (qualifier),Stage IB Pancreatic Cancer AJCC v8,0
3783,ICD-9,Familial Hemophagocytic Lymphocytosis,0
3784,Limited stage (cancer stage),FIGO Stage II Ovarian Cancer,0
3785,Attenuated by (contextual qualifier),Familial Adenomatous Polyposis Associated Medulloblastoma,0
3786,Hemangioma,Liver Cavernous Hemangioma,0
3787,Moveable,Deep Leiomyoma,0
3788,Skin Specimen,Acute Undifferentiated Leukemia,0
3789,Targeted Therapy,Mucinous adenocarcinoma gastric,0
3790,Body Parts - Canal,Collecting Duct Carcinoma of the Kidney,0
3791,Earache,Tonsillar Carcinoma,0
3792,Pilot Projects,Advanced Uterine Corpus Carcinosarcoma,0
3793,<3 (qualifier value),Uterine Cancer,0
3794,Histopathologic Grade,Female Breast Carcinoma,0
3795,Cause of death.underlying,Acute Undifferentiated Leukemia,0
3796,Complete Pharyngeal Contraction,Bladder squamous cell carcinoma stage I,0
3797,Always (frequency),Female Breast Carcinoma,0
3798,Malignant neoplasm of salivary gland,adenoid cystic carcinoma of lung,0
3799,3+ Answer to Question,Malignant melanoma of eyelid,0
3800,Role,BRCA2 Syndrome,0
3801,System (unit of presentation),mucinous adenocarcinoma of gallbladder,0
3802,Very rare,Adult Alveolar Soft Part Sarcoma,0
3803,Interventional procedure,Unfavorable Non-Hodgkin Lymphoma,0
3804,Term (temporal),Cartilaginous exostosis,0
3805,Management procedure,Mucinous neoplasm,0
3806,71,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3807,second (number),Malignant Neoplasm of Lung - Multiple Primary Sites,0
3808,Scheme,Breast Ductal Adenoma,0
3809,Etiology aspects,Choroid Necrotic Melanoma,0
3810,Treatment Epoch,Recurrent Uveal Melanoma,0
3811,therapeutic aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3812,Malignant Neoplasms,FIGO Stage II Ovarian Cancer,0
3813,Increased Immunologic Activity [PE],Unresectable Rhabdomyosarcoma,0
3814,Treating,Carcinoma of urinary bladder,0
3815,Presacral,benign mature teratoma of pancreas,0
3816,Malignant neoplasm of endometrium,Uterine Cancer,0
3817,Primary malignant neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3818,Treatment Epoch,Malignant Testicular Sertoli Cell Tumor,0
3819,Operation excision,Recurrent Uveal Melanoma,0
3820,Diffuse Large B-Cell Lymphoma,ALK positive large B-cell lymphoma,0
3821,Neoplasms,Malignant neoplasm of thalamus,0
3822,Decreasing,Endometrial Small Cell Carcinoma,0
3823,Persons,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3824,Firstly,Testicular cancer metastatic,0
3825,Usually,Atypical Mesothelial Hyperplasia,0
3826,Elements,Testicular cancer metastatic,0
3827,Does communicate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3828,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3829,Sample Mean,Cartilaginous exostosis,0
3830,Etiology aspects,Neonatal leukemia,0
3831,Tumor Mass,Colorectal High Grade B-Cell Lymphoma,0
3832,Medulla Oblongata,Collecting Duct Carcinoma of the Kidney,0
3833,newly,Recurrent Testicular Lymphoma,0
3834,Factory,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3835,Inferior esophageal sphincter structure,Refractory Barrett Esophagus,0
3836,Neoplasms,Adult Hepatocellular Carcinoma,0
3837,Unknown GENC,Malignant neoplasm of thalamus,0
3838,Always (frequency),Breast Ductal Adenoma,0
3839,Stomach structure,Anterior Urethral Malignant Neoplasm,0
3840,Malignant neoplasm of thymus,Thymic Clear Cell Carcinoma,0
3841,Five,Acute Undifferentiated Leukemia,0
3842,Pancreatic carcinoma,Pancreatic Intraepithelial Neoplasia-3,0
3843,Reactive fibrous tissue proliferation,Giant cell angiofibroma,0
3844,Used by,Metastatic Carcinoma in the Lung,0
3845,Malignant neoplasm of ovary,FIGO Stage II Ovarian Cancer,0
3846,Second edition,Rhabdomyosarcoma with ganglionic differentiation,0
3847,Dilate procedure,Endometrial Small Cell Carcinoma,0
3848,Does carry,Angiosarcoma of liver,0
3849,Percent of Bacteria,Cancer of Urinary Tract,0
3850,Occurrence,Malignant Testicular Sertoli Cell Tumor,0
3851,Leading,Placental aromatase deficiency,0
3852,VARIOUS DRUG CLASSES IN ATC,Extra-Adrenal Paraganglioma,0
3853,therapeutic aspects,Diffuse malignant mesothelioma,0
3854,Spherical shape,Childhood Thyroid Gland Follicular Carcinoma,0
3855,Cancer/Testis Antigen,Anterior Urethral Malignant Neoplasm,0
3856,Cure (remedy),Metastatic Carcinoma in the Lung,0
3857,epithelial,Lung squamous cell carcinoma stage I,0
3858,blood neoplasm,Angiosarcoma of liver,0
3859,Present,Mucinous neoplasm,0
3860,Vision,Recurrent Testicular Lymphoma,0
3861,Lock - Remote control command,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3862,bony process,Leptomeningeal sarcoma,0
3863,Others - Allergy,Blepharal carcinoma,0
3864,Absence (morphologic abnormality),Female Breast Carcinoma,0
3865,high - ActExposureLevelCode,FIGO Stage II Ovarian Cancer,0
3866,Only - dosing instruction fragment,Undifferentiated Endocervical Sarcoma,0
3867,Neurofibromatosis 1,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3868,Numbers,Mucinous adenocarcinoma gastric,0
3869,Biospecimen,Endometrial Small Cell Carcinoma,0
3870,Specific qualifier value,Childhood Lymphoma,0
3871,Menopause,Endometrial Small Cell Carcinoma,0
3872,Study,Localized Askin Tumor,0
3873,Qualitative form,Pancreatic Intraepithelial Neoplasia-3,0
3874,Qualitative form,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3875,Case (situation),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3876,Left,Acute Undifferentiated Leukemia,0
3877,Money or percentage indicator - Percentage,Diffuse malignant mesothelioma,0
3878,Intestinal Obstruction,mucinous adenocarcinoma of gallbladder,0
3879,True primary (qualifier value),Serous cystadenocarcinoma ovary,0
3880,Subtype (attribute),Colorectal High Grade B-Cell Lymphoma,0
3881,Include (action),Mucinous adenocarcinoma gastric,0
3882,Factor,Human Papillomavirus-Related Carcinoma,0
3883,Most,Malignant Neoplasm with Regional Lymph Node Involvement,0
3884,Males,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3885,Usual,Acute lymphadenitis,0
3886,physiological aspects,Unresectable Rhabdomyosarcoma,0
3887,Coding,Intracortical osteosarcoma,0
3888,Name (property) (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
3889,Proteins,BRCA2 Syndrome,0
3890,Carcinoma,Intestinal Metaplasia of Bladder Urothelium,0
3891,Usually,Female Breast Carcinoma,0
3892,Severities,Spongiotic dermatitis,0
3893,Nine,Human Papillomavirus-Related Carcinoma,0
3894,Observation of color of skin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3895,Breaking down,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3896,Occurrence Indicator,Uterine Cancer,0
3897,Heel Spur,Cartilaginous exostosis,0
3898,Malignant - descriptor,Testicular cancer metastatic,0
3899,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Malignant Neoplasm with Regional Lymph Node Involvement,0
3900,therapeutic aspects,Primary Cutaneous Plasmablastic Lymphoma,0
3901,Primary,Sarcomatoid Renal Cell Carcinoma,0
3902,Presence of cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3903,Rating (action),Diffuse malignant mesothelioma,0
3904,Presence (property),Liver Cavernous Hemangioma,0
3905,Cystadenoma,Benign Apocrine Neoplasm,0
3906,Death (finding),Intestinal Metaplasia of Bladder Urothelium,0
3907,Poverty,Mucinous adenocarcinoma gastric,0
3908,Sharing (Social Behavior),benign mature teratoma of pancreas,0
3909,90%,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3910,Treating,Acantholytic squamous cell carcinoma,0
3911,Effective,Acantholytic squamous cell carcinoma,0
3912,Qualitative form,Adult Alveolar Soft Part Sarcoma,0
3913,Dorsal,Airway Hemangioma,0
3914,Two,Undifferentiated Endocervical Sarcoma,0
3915,Chemotherapy Regimen,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3916,Childhood Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
3917,1960s,Malignant melanoma of eyelid,0
3918,Togo,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
3919,Interventional procedure,Diffuse malignant mesothelioma,0
3920,Squamous Epithelial Cells,papillary carcinoma of penis,0
3921,Disease remission,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3922,Excision biopsy,Atypical Lobular Breast Hyperplasia,0
3923,Asia,Malignant melanoma of eyelid,0
3924,Term (lexical),Digestive System Hodgkin Lymphoma,0
3925,Spreading (qualifier value),Extracranial Neuroblastoma,0
3926,NCI CTEP SDC Melanoma Sub-Category Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3927,Specific qualifier value,Primary Cutaneous Plasmablastic Lymphoma,0
3928,Largest,Thymic Clear Cell Carcinoma,0
3929,Most,Methotrexate-Associated Hodgkin Lymphoma,0
3930,Difficulty walking,Choroid Necrotic Melanoma,0
3931,Liver Flavor,Angiosarcoma of liver,0
3932,Fighting,Unresectable Rhabdomyosarcoma,0
3933,Human body,Placental aromatase deficiency,0
3934,Blood Vessel,Liver Cavernous Hemangioma,0
3935,Myeloid,Heavy Chain Deposition Disease,0
3936,Due to,Mucinous adenocarcinoma gastric,0
3937,Rare Diseases,Pancreatic Intraepithelial Neoplasia-3,0
3938,Specimen Source Codes - tumor,Testicular cancer metastatic,0
3939,Progestins,Endometrial Small Cell Carcinoma,0
3940,Plasmacytoma - category,Heavy Chain Deposition Disease,0
3941,Vaginal intraepithelial neoplasia,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3942,Measures,FIGO Stage II Ovarian Cancer,0
3943,Cancer Remission,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3944,Sebaceous Glands,Maxillary Sinus Adenocarcinoma,0
3945,Cancer Other,Benign Carotid Body Paraganglioma,0
3946,ocular sphere,Adult Alveolar Soft Part Sarcoma,0
3947,Pruritus,Methotrexate-Associated Hodgkin Lymphoma,0
3948,unknown vaccine or immune globulin,Localized Askin Tumor,0
3949,Call (Instruction),Endometrial Small Cell Carcinoma,0
3950,survive,Uterine Cancer,0
3951,Therapeutic procedure,Malignant melanoma of eyelid,0
3952,Unknown,Localized Askin Tumor,0
3953,Lymphatic Spread,mucinous adenocarcinoma of gallbladder,0
3954,Elderly (population group),Endometrial Small Cell Carcinoma,0
3955,Renal Cell Carcinoma,Grade 1 Clear Cell Renal Cell Carcinoma,0
3956,low confidentiality,Placental aromatase deficiency,0
3957,Sweating,Malignant Neoplasm with Regional Lymph Node Involvement,0
3958,Malignant neoplasm of skin,squamous cell carcinoma of the thyroid gland,0
3959,Thickened,Ichthyoses,0
3960,Result,squamous cell carcinoma of the thyroid gland,0
3961,How Much Distress Cough,Diffuse malignant mesothelioma,0
3962,Environmental risk factor,Acute Undifferentiated Leukemia,0
3963,Family,Mucinous adenocarcinoma gastric,0
3964,With intensity,Primary Cutaneous Plasmablastic Lymphoma,0
3965,Cyperus papyrus,Cancer of Urinary Tract,0
3966,IPSS Risk Category Low,Placental aromatase deficiency,0
3967,health and disease,Rhabdomyosarcoma with ganglionic differentiation,0
3968,Occurrence,Malignant neoplasm of choroid,0
3969,Bloody,Cancer of Urinary Tract,0
3970,Very,Leiomyoma of Gallbladder,0
3971,Blood group A (finding),Methotrexate-Associated Hodgkin Lymphoma,0
3972,Funds,Advanced Uterine Corpus Carcinosarcoma,0
3973,Experimental Result,mucinous adenocarcinoma of gallbladder,0
3974,Tumor tissue sample,Colorectal High Grade B-Cell Lymphoma,0
3975,Biomaterial Treatment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3976,shared attribute,Mucinous adenocarcinoma gastric,0
3977,other medicated shampoos in ATC,Mucinous adenocarcinoma gastric,0
3978,Case (situation),Localized Askin Tumor,0
3979,Cell Count,Clonal Hematopoiesis of Indeterminate Potential,0
3980,Dental White Spot,Maxillary Sinus Adenocarcinoma,0
3981,Weight decreased,Hodgkin lymphoma,0
3982,Precision - characteristic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3983,To,Localized Askin Tumor,0
3984,Biologic Development,Tonsillar Carcinoma,0
3985,Mass of pancreas,Serous cystadenocarcinoma ovary,0
3986,General surgery specialty,Malignant Testicular Sertoli Cell Tumor,0
3987,Skin,Spongiotic dermatitis,0
3988,Urine looks dark,Pancreatic Intraepithelial Neoplasia-3,0
3989,Frequently,Undifferentiated Endocervical Sarcoma,0
3990,Defense,Digestive System Hodgkin Lymphoma,0
3991,Code System Type - Internal,Airway Hemangioma,0
3992,Biomaterial Treatment,Recurrent Testicular Lymphoma,0
3993,Less Than,Recurrent Uveal Melanoma,0
3994,Weight Loss,Hodgkin lymphoma,0
3995,To,Stage II Carcinoma of Penis,0
3996,Death (finding),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3997,One,Acute lymphadenitis,0
3998,Cerebral cortex,Collecting Duct Carcinoma of the Kidney,0
3999,Tissue Specimen Code,Breast Ductal Adenoma,0
4000,Most,Pilocytic astrocytoma of cerebellum,0
4001,Regurgitates after swallowing,Refractory Barrett Esophagus,0
4002,Fall,Neonatal leukemia,0
4003,derivation calculation,Heavy Chain Deposition Disease,0
4004,Literature,Placental aromatase deficiency,0
4005,Childhood Lymphoma,Colorectal High Grade B-Cell Lymphoma,0
4006,Fraction of,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4007,Duct (organ) structure,Digestive System Hodgkin Lymphoma,0
4008,Following,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4009,chapter,Familial Hemophagocytic Lymphocytosis,0
4010,Volume,Familial Hemophagocytic Lymphocytosis,0
4011,Operative Surgical Procedures,Bladder squamous cell carcinoma stage I,0
4012,Moved from,Digestive System Hodgkin Lymphoma,0
4013,Surface of skin,squamous cell carcinoma of the thyroid gland,0
4014,Lymphoid organ structure,Digestive System Hodgkin Lymphoma,0
4015,Group A (qualifier value),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4016,Severe (severity modifier),Female Breast Carcinoma,0
4017,Administration occupational activities,Mucinous neoplasm,0
4018,Testiculo-,Malignant Testicular Sertoli Cell Tumor,0
4019,Including (qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4020,Worried,Maxillary Sinus Adenocarcinoma,0
4021,Common (qualifier value),Heavy Chain Deposition Disease,0
4022,*Type - Kind of quantity,Intestinal Metaplasia of Bladder Urothelium,0
4023,Specimen Type - Serum,Heavy Chain Deposition Disease,0
4024,Pages,Familial Hemophagocytic Lymphocytosis,0
4025,Excessive,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4026,Retinoic Acid Response Element,Stage II Carcinoma of Penis,0
4027,CEL gene,Adenocarcinoma,0
4028,shared attribute,Unfavorable Non-Hodgkin Lymphoma,0
4029,To,Unfavorable Non-Hodgkin Lymphoma,0
4030,bony process,Clonal Hematopoiesis of Indeterminate Potential,0
4031,High Mitosis-Karyorrhexis Index,Mucinous adenocarcinoma gastric,0
4032,advanced disease,Mucinous adenocarcinoma gastric,0
4033,Minor (value),Acute lymphadenitis,0
4034,Severe (severity modifier),Hodgkin lymphoma,0
4035,Hereditary Nonpolyposis Colorectal Cancer,Colorectal cancer,0
4036,Range,Recurrent Testicular Lymphoma,0
4037,diagnosis aspect,Unfavorable Non-Hodgkin Lymphoma,0
4038,Symptoms,Methotrexate-Associated Hodgkin Lymphoma,0
4039,Skin,Colorectal cancer,0
4040,Precursor Cell Lymphoblastic Leukemia Lymphoma,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4041,Estimated,Breast Ductal Adenoma,0
4042,Used by,Acute Undifferentiated Leukemia,0
4043,Central,Thymic Clear Cell Carcinoma,0
4044,Occur (action),Adenocarcinoma of the prostate metastatic,0
4045,Vertebral column,Recurrent Diffuse Intrinsic Pontine Glioma,0
4046,Obesity,Stage IB Pancreatic Cancer AJCC v8,0
4047,Use of,Recurrent Uveal Melanoma,0
4048,Smear - instruction imperative,mucinous adenocarcinoma of gallbladder,0
4049,Occurrence Indicator,Mucinous adenocarcinoma gastric,0
4050,Tryptophanase,Digestive System Hodgkin Lymphoma,0
4051,Anatomic Site,Giant cell angiofibroma,0
4052,Financial Account,Endometrial Small Cell Carcinoma,0
4053,Mild pain,Cartilaginous exostosis,0
4054,New,Adult Fibrolamellar Carcinoma,0
4055,aromatase activity,Placental aromatase deficiency,0
4056,Occur (action),Stage IB Pancreatic Cancer AJCC v8,0
4057,biopsy characteristics,FIGO Stage II Ovarian Cancer,0
4058,Brain,Choroid Necrotic Melanoma,0
4059,Life Threatening or Disabling Adverse Event,Breast Ductal Adenoma,0
4060,Country number:Find:Pt:^Patient:Nom,Endometrial Small Cell Carcinoma,0
4061,Science of Etiology,Acute Undifferentiated Leukemia,0
4062,Treating,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
4063,Various patch test substance,Recurrent Testicular Lymphoma,0
4064,Increased,Acute Undifferentiated Leukemia,0
4065,Have Difficulty Swallowing,Mucinous adenocarcinoma gastric,0
4066,Skin Specimen,Colorectal cancer,0
4067,Fever symptoms (finding),Childhood Lymphoma,0
4068,Tryptophanase,Liver Cavernous Hemangioma,0
4069,Medical Device Emits Smoke,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4070,Occurrence Indicator,Clonal Hematopoiesis of Indeterminate Potential,0
4071,Sore Throat,Tonsillar Carcinoma,0
4072,Cell Count,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4073,Benign Neoplasm,Secondary malignant neoplasm of lymph node,0
4074,Closed,Clonal Hematopoiesis of Indeterminate Potential,0
4075,1+,gliosarcoma,0
4076,Used by,Atypical Lobular Breast Hyperplasia,0
4077,Hospice and Palliative Care Nursing,Mucinous adenocarcinoma gastric,0
4078,Lung,Adenocarcinoma,0
4079,Soft Tissue Route of Drug Administration,Adult Alveolar Soft Part Sarcoma,0
4080,Diagnostic tests,Cancer of Urinary Tract,0
4081,Lung,FIGO Stage II Ovarian Cancer,0
4082,Active License,Malignant melanoma of eyelid,0
4083,Sexual function,Spermatocytic seminoma,0
4084,Widening,Malignant Neoplasm with Regional Lymph Node Involvement,0
4085,Genetic,Ichthyoses,0
4086,per second,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4087,Manufactured sign,Malignant Neoplasm with Regional Lymph Node Involvement,0
4088,*Type - Kind of quantity,Spongiotic dermatitis,0
4089,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Hodgkin lymphoma,0
4090,Extra-location,Spermatocytic seminoma,0
4091,Symptoms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4092,Catalogs,Advanced Uterine Corpus Carcinosarcoma,0
4093,Tumor type,benign mature teratoma of pancreas,0
4094,Etiology aspects,Human Papillomavirus-Related Carcinoma,0
4095,Aggressive course,Primary Cutaneous Plasmablastic Lymphoma,0
4096,Antacids,Refractory Barrett Esophagus,0
4097,Space - property,Spongiotic dermatitis,0
4098,Symptoms,Stage I Adult Non-Hodgkin Lymphoma,0
4099,foreign,Blepharal carcinoma,0
4100,morphological,Intracortical osteosarcoma,0
4101,diagnosis aspect,Uterine Cancer,0
4102,combination of objects,Undifferentiated Endocervical Sarcoma,0
4103,Treating,Malignant Testicular Sertoli Cell Tumor,0
4104,Tests (qualifier value),Benign neoplasm of thorax,0
4105,Decrease,Mucinous adenocarcinoma gastric,0
4106,Usually,Benign Apocrine Neoplasm,0
4107,*Type - Kind of quantity,Recurrent Testicular Lymphoma,0
4108,Human body,Granular Cell Leiomyosarcoma,0
4109,data type - ratio,Angiosarcoma of liver,0
4110,Affecting,Localized Askin Tumor,0
4111,Mass of body structure,benign mature teratoma of pancreas,0
4112,Intercellular Junctions,Hemangioma,0
4113,Protein Digestion (research activity),mucinous adenocarcinoma of gallbladder,0
4114,Intestines,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4115,Adipose tissue,Thymic Clear Cell Carcinoma,0
4116,Increased risk,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4117,Frequently,Pancreatic Intraepithelial Neoplasia-3,0
4118,Frequently,Hodgkin lymphoma,0
4119,Type - attribute,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4120,Third,Childhood Thyroid Gland Follicular Carcinoma,0
4121,Fusion procedure,Pilocytic astrocytoma of cerebellum,0
4122,Glycation End Products,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4123,Telephone Extension Number,Rhabdomyosarcoma with ganglionic differentiation,0
4124,suggestion,Pancreatic Intraepithelial Neoplasia-3,0
4125,Operative Surgical Procedures,Refractory Barrett Esophagus,0
4126,Communication Contact,Human Papillomavirus-Related Carcinoma,0
4127,Carcinoma,Tonsillar Carcinoma,0
4128,month,benign mature teratoma of pancreas,0
4129,Ultraviolet Light Sterilization,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4130,Parenchyma,Carcinoma ex pleomorphic adenoma of parotid gland,0
4131,Massive,Unresectable Rhabdomyosarcoma,0
4132,Pallor of skin,Acute Undifferentiated Leukemia,0
4133,60%,Mucinous adenocarcinoma gastric,0
4134,Primary,Digestive System Hodgkin Lymphoma,0
4135,Fallopian Tubes,FIGO Stage II Ovarian Cancer,0
4136,Well Differentiated,Metastatic Ductal Breast Carcinoma,0
4137,Molecular Mass,benign mature teratoma of pancreas,0
4138,Concept model range (foundation metadata concept),Ichthyoses,0
4139,Lymphocyte component of blood,Childhood Lymphoma,0
4140,Adolescent (age group),Localized Askin Tumor,0
4141,Screening,Endometrial Small Cell Carcinoma,0
4142,Malignant Neoplasms,Diffuse malignant mesothelioma,0
4143,defective,Mastocytosis,0
4144,Including (qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4145,Term Birth,Adenocarcinoma of the prostate metastatic,0
4146,Bothered by Night Sweats,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4147,Infertility,Malignant Testicular Sertoli Cell Tumor,0
4148,Only - dosing instruction fragment,Anterior Urethral Malignant Neoplasm,0
4149,Human papillomavirus 16,Human Papillomavirus-Related Carcinoma,0
4150,Usual,Airway Hemangioma,0
4151,Usual,Pancreatic Intraepithelial Neoplasia-3,0
4152,One,Testicular cancer metastatic,0
4153,Cessation of life,Diffuse malignant mesothelioma,0
4154,Neoplasms,Testicular cancer metastatic,0
4155,Subtype (attribute),Neonatal leukemia,0
4156,Pressure (finding),Anterior Urethral Malignant Neoplasm,0
4157,Human Cells,Serous cystadenocarcinoma ovary,0
4158,Sore sensation,Stage II Carcinoma of Penis,0
4159,Lymphocyte Activation,Digestive System Hodgkin Lymphoma,0
4160,Primary malignant neoplasm,FIGO Stage II Ovarian Cancer,0
4161,b cell differentiation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4162,Surrounding (qualifier value),Diffuse malignant mesothelioma,0
4163,Polypeptide Hormones,Intestinal Neuroendocrine Carcinoma,0
4164,Surgery specialty,Localized Askin Tumor,0
4165,Long-term Follow-up,Benign neoplasm of thorax,0
4166,1950s,Diffuse malignant mesothelioma,0
4167,Benign Vascular Neoplasm,Airway Hemangioma,0
4168,Upper arm,Hodgkin lymphoma,0
4169,Concept model domain,Intracortical osteosarcoma,0
4170,Difficulty walking,Malignant neoplasm of thalamus,0
4171,Referring,Hemangioma,0
4172,MOSTLY,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4173,Pharmacotherapy,Uterine Cancer,0
4174,Sometimes,Cartilaginous exostosis,0
4175,Occurrence,Pancreatic Intraepithelial Neoplasia-3,0
4176,Cancer Genus,Unresectable Rhabdomyosarcoma,0
4177,Government,Advanced Uterine Corpus Carcinosarcoma,0
4178,BRCA2 protein,BRCA2 Syndrome,0
4179,United States,Uterine Cancer,0
4180,Have Shortness of Breath question,Stage IB Lung Cancer AJCC v7,0
4181,Lobe of cerebellum,Childhood Cerebellar Neoplasm,0
4182,Atypical ductal hyperplasia (qualifier value),Atypical Lobular Breast Hyperplasia,0
4183,Formation,Airway Hemangioma,0
4184,Sometimes,Refractory Barrett Esophagus,0
4185,United States,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4186,Twice (Numerical Qualifier),gliosarcoma,0
4187,Occurrence Indicator,adenoid cystic carcinoma of lung,0
4188,Increasing,Cancer of Urinary Tract,0
4189,Carcinoma,Metastatic Carcinoma in the Lung,0
4190,Occur (action),Leiomyoma of Gallbladder,0
4191,Solid organ transplant,Tonsillar Carcinoma,0
4192,Case unit dose,Localized Askin Tumor,0
4193,Aspects of signs,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4194,diagnosis aspect,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4195,eTMF Content Model Code,Leptomeningeal sarcoma,0
4196,Similarity,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4197,Supportive assistance,Anterior Urethral Malignant Neoplasm,0
4198,Togo,Mucinous adenocarcinoma gastric,0
4199,Associated topography,Benign neoplasm of thorax,0
4200,Endometrial scraping,Undifferentiated Endocervical Sarcoma,0
4201,Anatomic Site,Anterior Urethral Malignant Neoplasm,0
4202,Biological Response Modifiers,Carcinoma of urinary bladder,0
4203,Antibodies,ALK positive large B-cell lymphoma,0
4204,Over (spatial),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4205,White color,Extracranial Neuroblastoma,0
4206,Decision,Undifferentiated Endocervical Sarcoma,0
4207,Long-term,Refractory Barrett Esophagus,0
4208,Xeroderma Pigmentosum,Recurrent Uveal Melanoma,0
4209,Primary,Acantholytic squamous cell carcinoma,0
4210,Africa,Recurrent Uveal Melanoma,0
4211,Greatly,Testicular cancer metastatic,0
4212,Collection (action),Digestive System Hodgkin Lymphoma,0
4213,Family member,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4214,other medicated shampoos in ATC,Blepharal carcinoma,0
4215,Axilla,Benign Apocrine Neoplasm,0
4216,75,Carcinoma of urinary bladder,0
4217,Interferes with,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4218,Science of Morphology,Leptomeningeal sarcoma,0
4219,Slight (qualifier value),Recurrent Uveal Melanoma,0
4220,heterochromatin domain,Extracranial Neuroblastoma,0
4221,Males,Diffuse malignant mesothelioma,0
4222,Population Group,Neonatal leukemia,0
4223,What subject filter - Result,Placental aromatase deficiency,0
4224,Acid reflux,Refractory Barrett Esophagus,0
4225,Diagnosis Study,Localized Askin Tumor,0
4226,Treating,Intestinal Metaplasia of Bladder Urothelium,0
4227,Process,Serous cystadenocarcinoma ovary,0
4228,H2 receptor blockers,Refractory Barrett Esophagus,0
4229,Diabetes,Endometrial Small Cell Carcinoma,0
4230,Neoplasms,Intracortical osteosarcoma,0
4231,research subject screening,Human Papillomavirus-Related Carcinoma,0
4232,Two,Thymic Clear Cell Carcinoma,0
4233,Decision,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4234,Basis - conceptual entity,Granular Cell Leiomyosarcoma,0
4235,Clinical,mucinous adenocarcinoma of gallbladder,0
4236,Treating,Maxillary Sinus Adenocarcinoma,0
4237,Entire great blood vessel (organ),Digestive System Hodgkin Lymphoma,0
4238,Initially,Digestive System Hodgkin Lymphoma,0
4239,Removed,Human Papillomavirus-Related Carcinoma,0
4240,Rating (action),Malignant Testicular Sertoli Cell Tumor,0
4241,Subcutaneous Tissue,Spongiotic dermatitis,0
4242,Best Case Imputation Technique,Cancer of Urinary Tract,0
4243,Cells,Breast Ductal Adenoma,0
4244,Present,Clonal Hematopoiesis of Indeterminate Potential,0
4245,Science of Etiology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4246,Three,Extracranial Neuroblastoma,0
4247,Therapeutic procedure,Advanced Uterine Corpus Carcinosarcoma,0
4248,Skin,Stage II Carcinoma of Penis,0
4249,Angioma,Hemangioma,0
4250,Percent of Abnormal Cells,Undifferentiated Endocervical Sarcoma,0
4251,Adenoid Cystic Carcinoma,adenoid cystic carcinoma of lung,0
4252,Genetic,Clonal Hematopoiesis of Indeterminate Potential,0
4253,Several,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4254,Body site,adenoid cystic carcinoma of lung,0
4255,include - SetOperator,Refractory Barrett Esophagus,0
4256,Decision,Thymic Clear Cell Carcinoma,0
4257,Acute leukemia,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4258,Cells,Atypical Lobular Breast Hyperplasia,0
4259,Palliative Care,Mucinous adenocarcinoma gastric,0
4260,Common (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
4261,bony process,Rhabdomyosarcoma with ganglionic differentiation,0
4262,Antimicrobial Intermediate Susceptibility Result,Blepharal carcinoma,0
4263,How Often Shortness of Breath,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4264,Involvement with,Primary Cutaneous Plasmablastic Lymphoma,0
4265,Financial Account,Pancreatic Intraepithelial Neoplasia-3,0
4266,Representation (action),Pancreatic Intraepithelial Neoplasia-3,0
4267,Occurrence Indicator,Diffuse malignant mesothelioma,0
4268,Africa,Malignant melanoma of eyelid,0
4269,Therapeutic procedure,Spermatocytic seminoma,0
4270,Physical assessment findings,Breast Ductal Adenoma,0
4271,Gamma globulin,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4272,Cancer Etiology,Acute Undifferentiated Leukemia,0
4273,Occurrence,Malignant neoplasm of thalamus,0
4274,various other agents for local oral treatment in ATC,Neonatal leukemia,0
4275,Pharmacotherapy,Acantholytic squamous cell carcinoma,0
4276,Hepatitis Viruses,Adult Hepatocellular Carcinoma,0
4277,Medical Device Emits Smoke,Human Papillomavirus-Related Carcinoma,0
4278,Problems - What subject filter,Refractory Barrett Esophagus,0
4279,Science of Etiology,Recurrent Uveal Melanoma,0
4280,More Often than Once a Day,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4281,Biological Response Modifiers,Unresectable Rhabdomyosarcoma,0
4282,fluid - substance,Digestive System Hodgkin Lymphoma,0
4283,Dysphagia,Tonsillar Carcinoma,0
4284,Known,Testicular cancer metastatic,0
4285,Smear - instruction imperative,Undifferentiated Endocervical Sarcoma,0
4286,Neoplasm Metastasis,Malignant melanoma of eyelid,0
4287,Etiology aspects,Hemangioma,0
4288,International Classification of Disease for Oncology,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4289,Science of Etiology,Endometrial Small Cell Carcinoma,0
4290,Medical Device Emits Smoke,Carcinoma of urinary bladder,0
4291,government - ActInformationManagementReason,Advanced Uterine Corpus Carcinosarcoma,0
4292,Status post,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4293,Accessory,Digestive System Hodgkin Lymphoma,0
4294,Abdominal Cavity,mucinous adenocarcinoma of gallbladder,0
4295,Breast Carcinoma,Testicular cancer metastatic,0
4296,shared attribute,Acute lymphadenitis,0
4297,Means,Metastatic Ductal Breast Carcinoma,0
4298,Worsening pattern,Malignant neoplasm of thalamus,0
4299,Several,Collecting Duct Carcinoma of the Kidney,0
4300,Firstly,Airway Hemangioma,0
4301,Pediculus (eukaryote),Adult Alveolar Soft Part Sarcoma,0
4302,Manual pelvic examination (procedure),Uterine Cancer,0
4303,Lower - spatial qualifier,Cancer of Urinary Tract,0
4304,Human body,Colorectal Neuroendocrine Tumor G2,0
4305,CDISC Findings Class,Diffuse malignant mesothelioma,0
4306,Tissue Specimen Code,Thymic Clear Cell Carcinoma,0
4307,1000000,Bladder squamous cell carcinoma stage I,0
4308,Southern Europe,Carcinoma of urinary bladder,0
4309,Body tissue,Stage IB Lung Cancer AJCC v7,0
4310,Analysis of substances,Recurrent Uveal Melanoma,0
4311,Basis - conceptual entity,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4312,Occurrence Indicator,Intestinal Neuroendocrine Carcinoma,0
4313,Esthesia,Choroid Necrotic Melanoma,0
4314,Therapeutic procedure,Ichthyosis,0
4315,Characterization,adenosquamous carcinoma of breast,0
4316,How Often Itching,Malignant Neoplasm with Regional Lymph Node Involvement,0
4317,Immunoglobulins,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4318,Biomaterial Treatment,Spermatocytic seminoma,0
4319,Immune system,Acantholytic squamous cell carcinoma,0
4320,Medical problem:Finding:Point in time:^Patient:Nominal,Airway Hemangioma,0
4321,Structure of minor calyx,Collecting Duct Carcinoma of the Kidney,0
4322,Time (foundation metadata concept),Thymic Clear Cell Carcinoma,0
4323,Lymphoma,Methotrexate-Associated Hodgkin Lymphoma,0
4324,Basis - conceptual entity,Localized Askin Tumor,0
4325,Infection of bone,Cartilaginous exostosis,0
4326,IPSS Risk Category Low,Human Papillomavirus-Related Carcinoma,0
4327,Patients,adenoid cystic carcinoma of lung,0
4328,Base - General Qualifier,Acantholytic squamous cell carcinoma,0
4329,Activities,Thymic Clear Cell Carcinoma,0
4330,Duct Device,Collecting Duct Carcinoma of the Kidney,0
4331,Mental concentration,Digestive System Hodgkin Lymphoma,0
4332,Frequently,Endometrial Small Cell Carcinoma,0
4333,Case unit dose,Stage IB Pancreatic Cancer AJCC v8,0
4334,Include (action),Primary Cutaneous Plasmablastic Lymphoma,0
4335,Treating,Unresectable Rhabdomyosarcoma,0
4336,site-specific telomere resolvase activity,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
4337,Entity Determiner - specific,Leptomeningeal sarcoma,0
4338,Blocking,Unresectable Rhabdomyosarcoma,0
4339,Biomaterial Treatment,Bladder squamous cell carcinoma stage I,0
4340,Variety (taxon),Liver Cavernous Hemangioma,0
4341,therapeutic aspects,Ichthyosis,0
4342,Nausea,Unfavorable Non-Hodgkin Lymphoma,0
4343,>40 years,Diffuse malignant mesothelioma,0
4344,Include (action),Stage II Carcinoma of Penis,0
4345,Often - answer to question,gliosarcoma,0
4346,risk factors - observation list,Pancreatic Intraepithelial Neoplasia-3,0
4347,Time,Cancer of Urinary Tract,0
4348,Plasma,Heavy Chain Deposition Disease,0
4349,Linear,Mucinous adenocarcinoma gastric,0
4350,Examination finding,Atypical Mesothelial Hyperplasia,0
4351,Childhood Non-Hodgkin Lymphoma,Methotrexate-Associated Hodgkin Lymphoma,0
4352,Hematopoietic stem cells,Neonatal leukemia,0
4353,Papillomaviridae,Human Papillomavirus-Related Carcinoma,0
4354,Primary malignant neoplasm,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4355,Long Term Survivorship,Primary Cutaneous Plasmablastic Lymphoma,0
4356,Greater,Recurrent Uveal Melanoma,0
4357,Before,Recurrent Testicular Lymphoma,0
4358,Report (document),Tonsillar Carcinoma,0
4359,Metastasis,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4360,Mucous Membrane,Giant cell angiofibroma,0
4361,Connect,Childhood Thyroid Gland Follicular Carcinoma,0
4362,To,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4363,Symptoms,adenosquamous carcinoma of breast,0
4364,Diagnostic Imaging,Anterior Urethral Malignant Neoplasm,0
4365,Therapeutic radiology procedure,Localized Askin Tumor,0
4366,Fever symptoms (finding),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4367,<90,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4368,Specimen Source Codes - Lesion,Giant cell angiofibroma,0
4369,Grouping,Adenocarcinoma of the prostate metastatic,0
4370,Base - General Qualifier,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4371,Fever symptoms (finding),Stage I Adult Non-Hodgkin Lymphoma,0
4372,Subacute,Spongiotic dermatitis,0
4373,Age of Onset,Malignant Testicular Sertoli Cell Tumor,0
4374,Abnormal cell,Human Papillomavirus-Related Carcinoma,0
4375,Term Source,mucinous adenocarcinoma of gallbladder,0
4376,Including (qualifier),Diffuse malignant mesothelioma,0
4377,Obesity,Uterine Cancer,0
4378,various other intestinal adsorbents in ATC,Neonatal leukemia,0
4379,<90,Malignant Neoplasm with Regional Lymph Node Involvement,0
4380,Continuance of life,Benign Carotid Body Paraganglioma,0
4381,Biological Transport,Grade 1 Clear Cell Renal Cell Carcinoma,0
4382,Neuroglia,Refractory Glioma,0
4383,Age of onset of symptoms:Time:Pt:^Patient:Qn,gliosarcoma,0
4384,Adult,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4385,Various patch test substance,Extra-Adrenal Paraganglioma,0
4386,Third revision,Intracortical osteosarcoma,0
4387,1960s,Recurrent Uveal Melanoma,0
4388,contextual factors,Extra-Adrenal Paraganglioma,0
4389,high - ActExposureLevelCode,Recurrent Uveal Melanoma,0
4390,Statistical Prevalence,Blepharal carcinoma,0
4391,Known,Hemangioma,0
4392,Malignant Neoplasms,Acute Undifferentiated Leukemia,0
4393,{Setting},Adult Hepatocellular Carcinoma,0
4394,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,mucinous adenocarcinoma of gallbladder,0
4395,Study Site,Human Papillomavirus-Related Carcinoma,0
4396,PSA Level Less than Two,Acantholytic squamous cell carcinoma,0
4397,Adult,Adult Hepatocellular Carcinoma,0
4398,Include (action),papillary carcinoma of penis,0
4399,Proton Pump Inhibitors [MoA],Refractory Barrett Esophagus,0
4400,structure,Hemangioma,0
4401,Occur (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4402,Cessation of life,mucinous adenocarcinoma of gallbladder,0
4403,Biopsy,Colorectal High Grade B-Cell Lymphoma,0
4404,Homo sapiens,Human Papillomavirus-Related Carcinoma,0
4405,Derivative,Secondary malignant neoplasm of lymph node,0
4406,Sunscreening Agents,Malignant melanoma of eyelid,0
4407,Leukemic Cells Measurement,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4408,Before,Lung squamous cell carcinoma stage I,0
4409,Childhood Non-Hodgkin Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
4410,Northern Europe,Recurrent Uveal Melanoma,0
4411,Two,Stage IB Lung Cancer AJCC v7,0
4412,Therapeutic radiology procedure,Acantholytic squamous cell carcinoma,0
4413,Etiology aspects,BRCA2 Syndrome,0
4414,Substance,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4415,Clinical Trials,Female Breast Carcinoma,0
4416,Widening,Granular Cell Leiomyosarcoma,0
4417,Carcinoma of bladder,Carcinoma of urinary bladder,0
4418,Blood Vessel,Digestive System Hodgkin Lymphoma,0
4419,Block Specimens,Unresectable Rhabdomyosarcoma,0
4420,Occurrence Indicator,Metastatic Neoplasm to the Gallbladder,0
4421,Component (part),Testicular cancer metastatic,0
4422,Damage,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4423,Often - answer to question,Undifferentiated Endocervical Sarcoma,0
4424,respiratory,squamous cell carcinoma of the thyroid gland,0
4425,GORAB gene,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4426,Relationships,Heavy Chain Deposition Disease,0
4427,Name,Malignant Neoplasm with Regional Lymph Node Involvement,0
4428,Electrolytes,Collecting Duct Carcinoma of the Kidney,0
4429,Painless,Methotrexate-Associated Hodgkin Lymphoma,0
4430,Accumulation of fluid,Spongiotic dermatitis,0
4431,Involvement with,Uterine Cancer,0
4432,various other intestinal adsorbents in ATC,Benign neoplasm of thorax,0
4433,Age,Acute Undifferentiated Leukemia,0
4434,Ultraviolet Rays,Recurrent Uveal Melanoma,0
4435,Germ cell tumor,Malignant Testicular Sertoli Cell Tumor,0
4436,Decision,Intestinal Neuroendocrine Carcinoma,0
4437,Enzymes,Ichthyosis,0
4438,primary tumor,Testicular cancer metastatic,0
4439,Increased,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4440,Primary lymphoid organ,Thymic Clear Cell Carcinoma,0
4441,mole changes,Malignant melanoma of eyelid,0
4442,Trachea (moth),Larynx carcinoma recurrent,0
4443,Symptoms aspect,FIGO Stage II Ovarian Cancer,0
4444,Skin Specimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4445,Usual,Cancer of Urinary Tract,0
4446,Inferior,Familial Hemophagocytic Lymphocytosis,0
4447,Condition:Find:Pt:^Patient:Nom,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4448,put - instruction imperative,Testicular cancer metastatic,0
4449,intrathecal chemotherapy,Acute Undifferentiated Leukemia,0
4450,Life,Pilocytic astrocytoma of cerebellum,0
4451,Requirement,Unfavorable Non-Hodgkin Lymphoma,0
4452,Hemorrhagic,Cancer of Urinary Tract,0
4453,What subject filter - Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4454,Body Fluids,Digestive System Hodgkin Lymphoma,0
4455,Mutation Abnormality,Clonal Hematopoiesis of Indeterminate Potential,0
4456,Liquid substance,Anterior Urethral Malignant Neoplasm,0
4457,Approximate,Clonal Hematopoiesis of Indeterminate Potential,0
4458,Definitely Related to Intervention,Stage IB Pancreatic Cancer AJCC v8,0
4459,Procedures involving the use of pharmaceuticals,de novo Myelodysplastic Syndrome,0
4460,Premalignant,Recurrent Testicular Lymphoma,0
4461,Tryptophanase,Hemangioma,0
4462,Frequently,Pilocytic astrocytoma of cerebellum,0
4463,Cervical lymph node group,Hodgkin lymphoma,0
4464,Brain part,Choroid Necrotic Melanoma,0
4465,Oropharyngeal Carcinoma,Tonsillar Carcinoma,0
4466,Involvement with,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4467,Neoplasms,Malignant neoplasm of choroid,0
4468,Common Specifications in HL7 V3 Publishing,Localized Askin Tumor,0
4469,Human Cells,adenosquamous carcinoma of breast,0
4470,Occurrence Indicator,Recurrent Uveal Melanoma,0
4471,Occurrence,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4472,Platelets,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4473,Affecting,Female Breast Carcinoma,0
4474,include - SetOperator,Unfavorable Non-Hodgkin Lymphoma,0
4475,Cytoplasm,Angiosarcoma of liver,0
4476,Therapeutic radiology procedure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4477,Worker,Diffuse malignant mesothelioma,0
4478,include - SetOperator,Intestinal Metaplasia of Bladder Urothelium,0
4479,Smaller,Breast Ductal Adenoma,0
4480,depend,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4481,Name (property) (qualifier value),papillary carcinoma of penis,0
4482,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,Unfavorable Non-Hodgkin Lymphoma,0
4483,pharmacotherapeutic,Malignant melanoma of eyelid,0
4484,Person Name,Malignant Neoplasm with Regional Lymph Node Involvement,0
4485,Time (foundation metadata concept),Intracortical osteosarcoma,0
4486,Specimen Source Codes - Respiratory,papillary carcinoma of penis,0
4487,Thick,Malignant melanoma of eyelid,0
4488,Data Transformation,Recurrent Testicular Lymphoma,0
4489,Hepatitis C virus,Adult Hepatocellular Carcinoma,0
4490,Treatment Epoch,Breast Ductal Adenoma,0
4491,research subject screening,FIGO Stage II Ovarian Cancer,0
4492,diagnosis aspect,Cancer of Urinary Tract,0
4493,Control function,Stage IB Pancreatic Cancer AJCC v8,0
4494,Glycation End Products,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4495,Malignant Female Reproductive System Neoplasm,Endometrial Small Cell Carcinoma,0
4496,Skin,Colorectal cancer,0
4497,Talc,Diffuse malignant mesothelioma,0
4498,Tumor type,Recurrent Diffuse Intrinsic Pontine Glioma,0
4499,90%,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4500,biopsy characteristics,Diffuse malignant mesothelioma,0
4501,Malignant - descriptor,Recurrent Diffuse Intrinsic Pontine Glioma,0
4502,potential,Clonal Hematopoiesis of Indeterminate Potential,0
4503,Greater than one,Metastatic Neoplasm to the Gallbladder,0
4504,Togo,Localized Askin Tumor,0
4505,Means,Blepharal carcinoma,0
4506,Anatomic Site,Testicular cancer metastatic,0
4507,filtration,Digestive System Hodgkin Lymphoma,0
4508,Cancer Genus,Childhood Lymphoma,0
4509,Cultured Cell Line,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4510,White Blood Cell Count procedure,Acute Undifferentiated Leukemia,0
4511,South,Intestinal Metaplasia of Bladder Urothelium,0
4512,Tumor Mass,Rhabdomyosarcoma with ganglionic differentiation,0
4513,Egg of order Phthiraptera,Intracortical osteosarcoma,0
4514,Involvement with,Carcinoma of urinary bladder,0
4515,chronic,Cartilaginous exostosis,0
4516,Hepatic Involvement,Mucinous adenocarcinoma gastric,0
4517,Structure of left half of body,Digestive System Hodgkin Lymphoma,0
4518,Interstitial Fluid,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4519,The Sun,Malignant melanoma of eyelid,0
4520,Characterization,Atypical Lobular Breast Hyperplasia,0
4521,Disease,Advanced Uterine Corpus Carcinosarcoma,0
4522,Disease,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4523,Symptoms,Pancreatic Intraepithelial Neoplasia-3,0
4524,Symptoms,Hodgkin lymphoma,0
4525,described,Papillary cystic tumor,0
4526,described,Adult Alveolar Soft Part Sarcoma,0
4527,Neoplasms,Unresectable Rhabdomyosarcoma,0
4528,Lumpectomy of breast,Breast Ductal Adenoma,0
4529,Cellular Debris,Digestive System Hodgkin Lymphoma,0
4530,Late,adenoid cystic carcinoma of lung,0
4531,Inguinal part of abdomen,Hodgkin lymphoma,0
4532,Treatment Epoch,Intestinal Metaplasia of Bladder Urothelium,0
4533,Result,Acute Undifferentiated Leukemia,0
4534,MYELODYSPLASTIC SYNDROME,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4535,various other intestinal adsorbents in ATC,Recurrent Testicular Lymphoma,0
4536,N not otherwise specified Antibody,papillary carcinoma of penis,0
4537,Several,Stage IB Pancreatic Cancer AJCC v8,0
4538,Secondary Neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4539,Chemotherapy Regimen,Localized Askin Tumor,0
4540,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Endometrial Small Cell Carcinoma,0
4541,Chest wall structure,Diffuse malignant mesothelioma,0
4542,Excision,Recurrent Uveal Melanoma,0
4543,Clinical Study Case,Acantholytic squamous cell carcinoma,0
4544,*Type - Kind of quantity,Pancreatic Intraepithelial Neoplasia-3,0
4545,TNM Staging System,Testicular cancer metastatic,0
4546,Disease Management,Mucinous neoplasm,0
4547,various allergen extracts,Benign Carotid Body Paraganglioma,0
4548,consider,Cartilaginous exostosis,0
4549,United States,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4550,200,Carcinoma of urinary bladder,0
4551,Intestines,Colorectal cancer,0
4552,Biopsy,Diffuse malignant mesothelioma,0
4553,pharmacotherapeutic,FIGO Stage II Ovarian Cancer,0
4554,Term (lexical),Stage IB Pancreatic Cancer AJCC v8,0
4555,Common Specifications in HL7 V3 Publishing,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4556,include - SetOperator,Adenocarcinoma,0
4557,Options,Intestinal Metaplasia of Bladder Urothelium,0
4558,Death (finding),Mucinous adenocarcinoma gastric,0
4559,High risk of,Colorectal cancer,0
4560,Reported Term,Recurrent Testicular Lymphoma,0
4561,Main,FIGO Stage II Ovarian Cancer,0
4562,Case (situation),FIGO Stage II Ovarian Cancer,0
4563,Pathological Dilatation,Endometrial Small Cell Carcinoma,0
4564,More,benign mature teratoma of pancreas,0
4565,Benign melanocytic nevus,Recurrent Uveal Melanoma,0
4566,Increase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4567,Highest,Malignant melanoma of eyelid,0
4568,Uterine Fibroids,Metastatic Neoplasm to the Gallbladder,0
4569,Tissue of urinary bladder,Bladder squamous cell carcinoma stage I,0
4570,Units Of Measure - lumen,Childhood Thyroid Gland Follicular Carcinoma,0
4571,Medical Imaging,Intestinal Metaplasia of Bladder Urothelium,0
4572,Screening Study,Endometrial Small Cell Carcinoma,0
4573,include - SetOperator,Uterine Cancer,0
4574,Leukemia,Neonatal leukemia,0
4575,Diagnosis,FIGO Stage II Ovarian Cancer,0
4576,Specific qualifier value,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4577,Direct (qualifier),Collecting Duct Carcinoma of the Kidney,0
4578,Condition:Find:Pt:^Patient:Nom,Refractory Barrett Esophagus,0
4579,brain cell,Recurrent Diffuse Intrinsic Pontine Glioma,0
4580,Occur (action),Giant cell angiofibroma,0
4581,Free (available (qualifier)),Female Breast Carcinoma,0
4582,Stem cell transplant,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4583,Favorable,Undifferentiated Endocervical Sarcoma,0
4584,Occur (action),Acantholytic squamous cell carcinoma,0
4585,Including (qualifier),Tonsillar Carcinoma,0
4586,Cell (compartment),Female Breast Carcinoma,0
4587,Temporal Lobe,gliosarcoma,0
4588,Classification,Female Breast Carcinoma,0
4589,therapeutic aspects,Malignant Testicular Sertoli Cell Tumor,0
4590,Count of entities,Pancreatic Intraepithelial Neoplasia-3,0
4591,Usual Severity Vomiting,Choroid Necrotic Melanoma,0
4592,Tumor Mass,Anterior Urethral Malignant Neoplasm,0
4593,Cell Count,Malignant melanoma of eyelid,0
4594,Genes,Endometrial Small Cell Carcinoma,0
4595,Vaginal Sarcoma,Anterior Urethral Malignant Neoplasm,0
4596,Hollings Cancer Center,Adult Hepatocellular Carcinoma,0
4597,Rest,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
4598,National Cancer Institute,Advanced Uterine Corpus Carcinosarcoma,0
4599,World,FIGO Stage II Ovarian Cancer,0
4600,Urinary Bladder,Carcinoma of urinary bladder,0
4601,Dry,Ichthyoses,0
4602,Structure of germinal center of lymph node,Recurrent Testicular Lymphoma,0
4603,Hollow shape,papillary carcinoma of penis,0
4604,Body part,Localized Askin Tumor,0
4605,Post,Tonsillar Carcinoma,0
4606,Face (spatial concept),Maxillary Sinus Adenocarcinoma,0
4607,Antibiotics,Cancer of Urinary Tract,0
4608,Form:Finding:Point in time:{Setting}:Document:{Role},Colorectal High Grade B-Cell Lymphoma,0
4609,Aggressive course,Female Breast Carcinoma,0
4610,Growth,adenosquamous carcinoma of breast,0
4611,Interferes with,Airway Hemangioma,0
4612,Scrotum,Maxillary Sinus Adenocarcinoma,0
4613,Body Site Modifier - Lower,Cancer of Urinary Tract,0
4614,Presentation,Pilocytic astrocytoma of cerebellum,0
4615,Logical Condition,Maxillary Sinus Adenocarcinoma,0
4616,Leads (device),FIGO Stage II Ovarian Cancer,0
4617,Childhood Diffuse Large B-Cell Lymphoma,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
4618,Death Related to Adverse Event,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4619,Center of town,Advanced Uterine Corpus Carcinosarcoma,0
4620,Call (Instruction),Larynx carcinoma recurrent,0
4621,Esophageal,papillary carcinoma of penis,0
4622,Blood,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4623,Classification,Breast Ductal Adenoma,0
4624,Term (temporal),Adenocarcinoma of the prostate metastatic,0
4625,Specimen Source Codes - Lesion,Cartilaginous exostosis,0
4626,PSA Level Greater than Fifty,Extracranial Neuroblastoma,0
4627,Liver carcinoma,Adult Fibrolamellar Carcinoma,0
4628,Agenesis of corpus callosum,adenoid cystic carcinoma of lung,0
4629,Short Value,Cancer of Urinary Tract,0
4630,Definitive,Anterior Urethral Malignant Neoplasm,0
4631,Common (qualifier value),adenosquamous carcinoma of breast,0
4632,Half,Cancer of Urinary Tract,0
4633,Cells,papillary carcinoma of penis,0
4634,Urinary Diversion,Carcinoma of urinary bladder,0
4635,Left sided,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4636,Both ovaries,Serous cystadenocarcinoma ovary,0
4637,Cervical lymph node group,Tonsillar Carcinoma,0
4638,Mesothelial cell count,Atypical Mesothelial Hyperplasia,0
4639,Free of (attribute),Familial Hemophagocytic Lymphocytosis,0
4640,Specimen Source Codes - tumor,Adult Hepatocellular Carcinoma,0
4641,Female Phenotype,Cancer of Urinary Tract,0
4642,Metastatic Neoplasm,Benign neoplasm of thorax,0
4643,New,Carcinoma of urinary bladder,0
4644,Administration procedure,Malignant melanoma of eyelid,0
4645,Form of uterus,Uterine Cancer,0
4646,Infrequent,Stage II Carcinoma of Penis,0
4647,Impaired skin integrity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4648,Overall Survival,Breast Ductal Adenoma,0
4649,Talpidae,Recurrent Uveal Melanoma,0
4650,Firstly,Refractory Barrett Esophagus,0
4651,combination - answer to question,Mucinous adenocarcinoma gastric,0
4652,Population Group,Refractory Barrett Esophagus,0
4653,United States,Mucinous adenocarcinoma gastric,0
4654,Hodgkin Disease,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4655,Similarity,Colorectal Neuroendocrine Tumor G2,0
4656,Image Feature,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
4657,Renal collecting tube,Collecting Duct Carcinoma of the Kidney,0
4658,Imaging Techniques,Uterine Cancer,0
4659,Cardiac Lead Procedure,Placental aromatase deficiency,0
4660,Assortment,Liver Cavernous Hemangioma,0
4661,Aflatoxins,Adult Hepatocellular Carcinoma,0
4662,Lower urinary tract,Cancer of Urinary Tract,0
4663,All of the Time,Female Breast Carcinoma,0
4664,More Often than Once a Day,Localized Askin Tumor,0
4665,Phenotype,Testicular cancer metastatic,0
4666,Weight decreased,Stage IB Lung Cancer AJCC v7,0
4667,Rare,Spermatocytic seminoma,0
4668,Chemotherapy Regimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4669,Administration procedure,Female Breast Carcinoma,0
4670,Often - answer to question,adenoid cystic carcinoma of lung,0
4671,Malignant neoplasm of pancreas,Mucinous neoplasm,0
4672,Possible,Lung squamous cell carcinoma stage I,0
4673,Occurrence,Metastatic Neoplasm to the Gallbladder,0
4674,Spreading (qualifier value),Anterior Urethral Malignant Neoplasm,0
4675,Histopathologic Grade,Primary Cutaneous Plasmablastic Lymphoma,0
4676,Tumor cells,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4677,B-Cell Lymphomas,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4678,Cystoscopy,Carcinoma of urinary bladder,0
4679,Childhood Extracranial Germ Cell Tumor,Childhood Central Nervous System Immature Teratoma,0
4680,Acute Myeloid Leukemia Pathway,Neonatal leukemia,0
4681,Antimicrobial Susceptibility Result,Mastocytosis,0
4682,Unusual,Uterine Cancer,0
4683,skin color,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4684,Chemotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4685,Intracranial Hypertension,Malignant neoplasm of choroid,0
4686,Geographic Locations,Diffuse malignant mesothelioma,0
4687,Smooth Muscle Tumor,Leiomyoma of Gallbladder,0
4688,Lymphoma,Methotrexate-Associated Hodgkin Lymphoma,0
4689,Nausea,Mucinous adenocarcinoma gastric,0
4690,Mixed Cell Morphology,Anterior Urethral Malignant Neoplasm,0
4691,99,Malignant melanoma of eyelid,0
4692,Occurrence Indicator,Malignant melanoma of eyelid,0
4693,Bladder Cancer Pathway,Carcinoma of urinary bladder,0
4694,Etiology aspects,Ichthyosis,0
4695,Experimental Result,FIGO Stage II Ovarian Cancer,0
4696,History,Malignant melanoma of eyelid,0
4697,Melanins,Recurrent Uveal Melanoma,0
4698,Abdominal hysterectomy,Endometrial Small Cell Carcinoma,0
4699,Western Europe,Intestinal Metaplasia of Bladder Urothelium,0
4700,Cessation of life,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4701,Brain Stem,Pilocytic astrocytoma of cerebellum,0
4702,Primary malignant neoplasm,Childhood Lymphoma,0
4703,Third revision,Rhabdomyosarcoma with ganglionic differentiation,0
4704,Contain (action),Colorectal High Grade B-Cell Lymphoma,0
4705,Occur (action),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4706,Abundance,Papillary cystic tumor,0
4707,Hematologic Tests,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4708,Adult Diffuse Large B-Cell Lymphoma,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
4709,Air,Adult Alveolar Soft Part Sarcoma,0
4710,Biomaterial Treatment,Cancer of Urinary Tract,0
4711,Main,Digestive System Hodgkin Lymphoma,0
4712,Developed Countries,Undifferentiated Endocervical Sarcoma,0
4713,Cover (physical object),Diffuse malignant mesothelioma,0
4714,Primary malignant neoplasm,Childhood Central Nervous System Immature Teratoma,0
4715,Common Specifications in HL7 V3 Publishing,Unfavorable Non-Hodgkin Lymphoma,0
4716,high - ActExposureLevelCode,Malignant melanoma of eyelid,0
4717,Pleural effusion disorder,Localized Askin Tumor,0
4718,Etiology aspects,Cancer of Urinary Tract,0
4719,Fever,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4720,Malignant lymphoma,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4721,Usual Severity Nausea,Unfavorable Non-Hodgkin Lymphoma,0
4722,radiotherapeutic,Recurrent Uveal Melanoma,0
4723,Negation,Testicular cancer metastatic,0
4724,Stratified squamous epithelium,Giant cell angiofibroma,0
4725,Incidence,Benign Carotid Body Paraganglioma,0
4726,Death (finding),Bladder squamous cell carcinoma stage I,0
4727,1+,Mucinous adenocarcinoma gastric,0
4728,Pathogenic organism,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4729,Unmarried person,adenoid cystic carcinoma of lung,0
4730,Recurrent infections,Intestinal Metaplasia of Bladder Urothelium,0
4731,Fever,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4732,Involvement with,Refractory Barrett Esophagus,0
4733,Name,Extracranial Neuroblastoma,0
4734,Diagnostic Imaging,Bladder squamous cell carcinoma stage I,0
4735,Less Than,Diffuse malignant mesothelioma,0
4736,Primary malignant neoplasm,Anterior Urethral Malignant Neoplasm,0
4737,Obesity,Mucinous adenocarcinoma gastric,0
4738,Childhood Alveolar Soft Part Sarcoma,Adult Alveolar Soft Part Sarcoma,0
4739,Common Specifications in HL7 V3 Publishing,Extracranial Neuroblastoma,0
4740,Removed,Colorectal High Grade B-Cell Lymphoma,0
4741,Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4742,Platelet Glycoprotein 4,Granular Cell Leiomyosarcoma,0
4743,Time,Extracranial Neuroblastoma,0
4744,Primary malignant neoplasm,Malignant melanoma of eyelid,0
4745,North America,Recurrent Uveal Melanoma,0
4746,Case unit dose,Adult Fibrolamellar Carcinoma,0
4747,Affect (mental function),Endometrial Small Cell Carcinoma,0
4748,Form:Finding:Point in time:{Setting}:Document:{Role},squamous cell carcinoma of the thyroid gland,0
4749,Percent of Abnormal Cells,Recurrent Testicular Lymphoma,0
4750,One,BRCA2 Syndrome,0
4751,Unknown,Adult Alveolar Soft Part Sarcoma,0
4752,Milliampere second,Pancreatic Intraepithelial Neoplasia-3,0
4753,Vascular,Granular Cell Leiomyosarcoma,0
4754,human MUC1 protein,mucinous adenocarcinoma of gallbladder,0
4755,Sclera,Mucinous adenocarcinoma gastric,0
4756,Approximate,Unfavorable Non-Hodgkin Lymphoma,0
4757,Completely Able,Clonal Hematopoiesis of Indeterminate Potential,0
4758,Account number:Identifier:Point in time:^Patient:Nominal,Stage IB Pancreatic Cancer AJCC v8,0
4759,Retinoic Acid Response Element,Anterior Urethral Malignant Neoplasm,0
4760,Osteophyte,Cartilaginous exostosis,0
4761,Name,Carcinoma ex pleomorphic adenoma of parotid gland,0
4762,Neoplasm Metastasis,gliosarcoma,0
4763,Cultured Cell Line,Acute Undifferentiated Leukemia,0
4764,Along edge (qualifier value),Recurrent Uveal Melanoma,0
4765,Study Control,Primary Cutaneous Plasmablastic Lymphoma,0
4766,Frequency of Pain Question,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4767,Reference Object,BRCA2 Syndrome,0
4768,Fresh Specimen,Mucinous adenocarcinoma gastric,0
4769,10%,Acute Undifferentiated Leukemia,0
4770,Exposure to,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4771,Most,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4772,90%,Pancreatic Intraepithelial Neoplasia-3,0
4773,CYP19A1 wt Allele,Placental aromatase deficiency,0
4774,Sarcoma - category (morphologic abnormality),Granular Cell Leiomyosarcoma,0
4775,Edema,Localized Askin Tumor,0
4776,Primary malignant neoplasm of endometrium,Uterine Cancer,0
4777,Death (finding),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4778,Pharmaceutical Preparations,Unresectable Rhabdomyosarcoma,0
4779,Malignant epithelioma,Breast Ductal Adenoma,0
4780,Known,Liver Cavernous Hemangioma,0
4781,Cell Differentiation process,Germinoma,0
4782,pharmacotherapeutic,Malignant Testicular Sertoli Cell Tumor,0
4783,Science of Etiology,Ichthyoses,0
4784,Fever symptoms (finding),Hodgkin lymphoma,0
4785,Recommendation,Undifferentiated Endocervical Sarcoma,0
4786,M Protein,Heavy Chain Deposition Disease,0
4787,Lower (action),Cancer of Urinary Tract,0
4788,Call (Instruction),Childhood Lymphoma,0
4789,Esophageal manometry,Refractory Barrett Esophagus,0
4790,Distant,Acantholytic squamous cell carcinoma,0
4791,Structure of germinal center of lymph node,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4792,Include (action),Malignant neoplasm of thalamus,0
4793,Malignant Neoplasms,Neonatal leukemia,0
4794,Negation,Serous cystadenocarcinoma ovary,0
4795,Hydrocephalus,Malignant neoplasm of choroid,0
4796,Lacrimal canaliculus structure,Benign Apocrine Neoplasm,0
4797,diagnosis aspect,Acute Undifferentiated Leukemia,0
4798,Woman,Uterine Cancer,0
4799,Endocrine,Childhood Thyroid Gland Follicular Carcinoma,0
4800,Body Site Modifier - Lower,Mucinous adenocarcinoma gastric,0
4801,Surgical aspects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4802,Mutation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4803,T-Lymphocytopenia,Thymic Clear Cell Carcinoma,0
4804,Type - attribute,Metastatic Ductal Breast Carcinoma,0
4805,Variant,Female Breast Carcinoma,0
4806,Persons,Cancer of Urinary Tract,0
4807,Usually,Methotrexate-Associated Hodgkin Lymphoma,0
4808,Advance -- medical device,Recurrent Testicular Lymphoma,0
4809,Clear,Thymic Clear Cell Carcinoma,0
4810,Complication Aspects,Refractory Barrett Esophagus,0
4811,Complete,Carcinoma of urinary bladder,0
4812,Have Weight Loss,Malignant Neoplasm with Regional Lymph Node Involvement,0
4813,Weight Loss,Stage I Adult Non-Hodgkin Lymphoma,0
4814,General surgery specialty,Localized Askin Tumor,0
4815,Exposure to,Intestinal Metaplasia of Bladder Urothelium,0
4816,Enlargement procedure,Hodgkin lymphoma,0
4817,Specific qualifier value,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4818,Adenolymphoma,Papillary cystic tumor,0
4819,Primary malignant neoplasm,Metastatic Neoplasm to the Gallbladder,0
4820,corticosteroids cream,Spongiotic dermatitis,0
4821,Nasolacrimal duct structure,Benign Apocrine Neoplasm,0
4822,Quantity,Tonsillar Carcinoma,0
4823,Linear,Endometrial Small Cell Carcinoma,0
4824,Primary malignant neoplasm,Testicular cancer metastatic,0
4825,Known,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4826,Human body structure,Granular Cell Leiomyosarcoma,0
4827,Radioactive Seed Implant Dosing Unit,Extracranial Neuroblastoma,0
4828,Tissue Specimen Code,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4829,alone - group size,Undifferentiated Endocervical Sarcoma,0
4830,Food,Refractory Barrett Esophagus,0
4831,Histologic,Female Breast Carcinoma,0
4832,Low Level,Clonal Hematopoiesis of Indeterminate Potential,0
4833,Several,Pancreatic Intraepithelial Neoplasia-3,0
4834,peripheral blood,Cancer of Urinary Tract,0
4835,Leg,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4836,Lesion,Cartilaginous exostosis,0
4837,Patient currently pregnant,Placental aromatase deficiency,0
4838,World,Undifferentiated Endocervical Sarcoma,0
4839,Second Suffix,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4840,Collecting system,Collecting Duct Carcinoma of the Kidney,0
4841,Specimen Source Codes - Lesion,Hemangioma,0
4842,Inguinal part of abdomen,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4843,Exposure to,Diffuse malignant mesothelioma,0
4844,Area,Recurrent Uveal Melanoma,0
4845,hand - unit of measure,Adult Alveolar Soft Part Sarcoma,0
4846,Diagnosis Study,Pancreatic Intraepithelial Neoplasia-3,0
4847,Term (lexical),Ampulla of Vater Tubular Adenoma,0
4848,Device system,Collecting Duct Carcinoma of the Kidney,0
4849,patient condition,Pilocytic astrocytoma of cerebellum,0
4850,Splitting,Larynx carcinoma recurrent,0
4851,Caucasoid Race,Localized Askin Tumor,0
4852,HLA Class II Histocompatibility Antigen Gamma Chain,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4853,Contribution,Airway Hemangioma,0
4854,Include (action),Adenocarcinoma,0
4855,Code,Intracortical osteosarcoma,0
4856,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Neonatal leukemia,0
4857,Pharmacokinetics: Excretion,Collecting Duct Carcinoma of the Kidney,0
4858,Reflux,Refractory Barrett Esophagus,0
4859,bony process,Noninfiltrating Intraductal Carcinoma,0
4860,VARIOUS DRUG CLASSES IN ATC,Benign neoplasm of thorax,0
4861,Categories,Localized Askin Tumor,0
4862,Therapeutic procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4863,Measures,Refractory Barrett Esophagus,0
4864,medication - HL7 publishing domain,Spongiotic dermatitis,0
4865,Mitosis,Testicular cancer metastatic,0
4866,Regular,Endometrial Small Cell Carcinoma,0
4867,Pleura,Atypical Mesothelial Hyperplasia,0
4868,Infected,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4869,Third,Mucinous adenocarcinoma gastric,0
4870,How Much Distress Itching,Methotrexate-Associated Hodgkin Lymphoma,0
4871,Colon <insect>,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4872,Endometrial Carcinoma,Uterine Cancer,0
4873,Stomach structure,Mucinous adenocarcinoma gastric,0
4874,Characterization,Clonal Hematopoiesis of Indeterminate Potential,0
4875,Adult,Malignant neoplasm of choroid,0
4876,Rapid,Recurrent Uveal Melanoma,0
4877,Low Mitosis-Karyorrhexis Index,Human Papillomavirus-Related Carcinoma,0
4878,Responsible to,Advanced Uterine Corpus Carcinosarcoma,0
4879,pharmacotherapeutic,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4880,Term (lexical),Heavy Chain Deposition Disease,0
4881,Blood Circulation,mucinous adenocarcinoma of gallbladder,0
4882,Time (foundation metadata concept),Stage IB Pancreatic Cancer AJCC v8,0
4883,Large,Digestive System Hodgkin Lymphoma,0
4884,Viola tricolor,Extracranial Neuroblastoma,0
4885,Nodule,Airway Hemangioma,0
4886,Entity,Recurrent Testicular Lymphoma,0
4887,GDF15 protein,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4888,Upper abdominal pain,Mucinous adenocarcinoma gastric,0
4889,white blood cell type,Methotrexate-Associated Hodgkin Lymphoma,0
4890,Known,squamous cell carcinoma of the thyroid gland,0
4891,Group A (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
4892,VIPR1 wt Allele,Secondary malignant neoplasm of lymph node,0
4893,Rare,Serous cystadenocarcinoma ovary,0
4894,Color change,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4895,Neoadjuvant Therapy,Lung squamous cell carcinoma stage I,0
4896,Sequence Data Type,Ampulla of Vater Tubular Adenoma,0
4897,International Statistical Classification of Diseases and Related Health Problems,Leptomeningeal sarcoma,0
4898,True Control Status,Stage IB Pancreatic Cancer AJCC v8,0
4899,Result,Contact dermatitis due to alkali,0
4900,Relationships,Rhabdomyosarcoma with ganglionic differentiation,0
4901,United States,Recurrent Testicular Lymphoma,0
4902,Outer cortex of kidney,Thymic Clear Cell Carcinoma,0
4903,include - SetOperator,Cancer of Urinary Tract,0
4904,Cell Count,Bladder squamous cell carcinoma stage I,0
4905,Togo,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4906,Immature,Thymic Clear Cell Carcinoma,0
4907,Asians,Localized Askin Tumor,0
4908,Tumor stage,Breast Ductal Adenoma,0
4909,Type - attribute,Adenocarcinoma,0
4910,Cell Device,Female Breast Carcinoma,0
4911,Detection,Heavy Chain Deposition Disease,0
4912,Current (present time),BRCA2 Syndrome,0
4913,Time,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4914,Psyche structure,Malignant neoplasm of thalamus,0
4915,Mastocytosis,Mastocytosis,0
4916,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
4917,Swollen Lymph Node,Acute Undifferentiated Leukemia,0
4918,Acetic Acid,Human Papillomavirus-Related Carcinoma,0
4919,Infrequent,Uterine Cancer,0
4920,child survival,Acute Undifferentiated Leukemia,0
4921,per year,Human Papillomavirus-Related Carcinoma,0
4922,per year,Benign Carotid Body Paraganglioma,0
4923,Rare,Urethral Carcinoma,0
4924,Various patch test substance,Placental aromatase deficiency,0
4925,Metastatic Neoplasm,Tonsillar Carcinoma,0
4926,To,Endometrial Small Cell Carcinoma,0
4927,Slightly Able,Recurrent Uveal Melanoma,0
4928,Growth abnormality,Stage II Carcinoma of Penis,0
4929,System One,Digestive System Hodgkin Lymphoma,0
4930,low exposure,mucinous adenocarcinoma of gallbladder,0
4931,Childhood Burkitt Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
4932,Surrounding (qualifier value),Thymic Clear Cell Carcinoma,0
4933,United States Military Commissioned Officer O4,Hodgkin lymphoma,0
4934,Skin,Angiosarcoma of liver,0
4935,Five,Endometrial Small Cell Carcinoma,0
4936,Case unit dose,Intestinal Metaplasia of Bladder Urothelium,0
4937,Study Variable,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4938,Problems - What subject filter,Leptomeningeal sarcoma,0
4939,Diffuse Large B-Cell Lymphoma,Recurrent Testicular Lymphoma,0
4940,How Often Felt Normal question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4941,84,Carcinoma of urinary bladder,0
4942,Abnormally high,BRCA2 Syndrome,0
4943,Contain (action),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
4944,Benign Neoplasm,Anterior Urethral Malignant Neoplasm,0
4945,Family history,Recurrent Uveal Melanoma,0
4946,Dermis,Spongiotic dermatitis,0
4947,Type - attribute,Carcinoma of urinary bladder,0
4948,Count of entities,Localized Askin Tumor,0
4949,Application (Document),Acantholytic squamous cell carcinoma,0
4950,Inguinal region,Benign Apocrine Neoplasm,0
4951,Delayed Puberty,Placental aromatase deficiency,0
4952,include - SetOperator,Diffuse malignant mesothelioma,0
4953,Egg of order Phthiraptera,Noninfiltrating Intraductal Carcinoma,0
4954,Reduced,Human Papillomavirus-Related Carcinoma,0
4955,Usual,Acantholytic squamous cell carcinoma,0
4956,Cessation of life,Malignant Testicular Sertoli Cell Tumor,0
4957,Most,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
4958,Secondary Neoplasm,Benign Carotid Body Paraganglioma,0
4959,Symptoms,Malignant Neoplasm with Regional Lymph Node Involvement,0
4960,Usually,Recurrent Testicular Lymphoma,0
4961,Red Blood Cell Count measurement,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4962,low exposure,Placental aromatase deficiency,0
4963,Cultured Cell Line,Childhood Thyroid Gland Follicular Carcinoma,0
4964,Germ-Line Mutation,Colorectal cancer,0
4965,Absence (morphologic abnormality),Breast Ductal Adenoma,0
4966,Lung,Diffuse malignant mesothelioma,0
4967,Occur (action),Malignant neoplasm of thalamus,0
4968,80%,Recurrent Diffuse Intrinsic Pontine Glioma,0
4969,Poor - grade value,Mucinous adenocarcinoma gastric,0
4970,PREVENT (product),Acantholytic squamous cell carcinoma,0
4971,Worsening pattern,Choroid Necrotic Melanoma,0
4972,Malignant Neoplasms,Unresectable Rhabdomyosarcoma,0
4973,Numerous,Metastatic Neoplasm to the Gallbladder,0
4974,Tryptophanase,Thymic Clear Cell Carcinoma,0
4975,Publishing,Intracortical osteosarcoma,0
4976,Digital Content Category,Localized Askin Tumor,0
4977,Manufactured form,Cancer of Urinary Tract,0
4978,Pelvis+,Localized Askin Tumor,0
4979,Morphology,Stage IB Pancreatic Cancer AJCC v8,0
4980,Color change,Malignant melanoma of eyelid,0
4981,radiotherapeutic,Tonsillar Carcinoma,0
4982,Togo,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4983,Hormonal,Intestinal Neuroendocrine Carcinoma,0
4984,Weight Loss,Diffuse malignant mesothelioma,0
4985,Basal Cell Carcinoma Pathway,Testicular cancer metastatic,0
4986,Structure of choroid plexus,Malignant neoplasm of choroid,0
4987,Taken,Colorectal High Grade B-Cell Lymphoma,0
4988,Ovarian Carcinoma,Advanced Uterine Corpus Carcinosarcoma,0
4989,Slightly Agree,Malignant melanoma of eyelid,0
4990,Rating (action),Endometrial Small Cell Carcinoma,0
4991,diagnosis aspect,Refractory Barrett Esophagus,0
4992,Specific qualifier value,Leptomeningeal sarcoma,0
4993,Progress,Primary Cutaneous Plasmablastic Lymphoma,0
4994,Including (qualifier),Primary Cutaneous Plasmablastic Lymphoma,0
4995,Moved to,Digestive System Hodgkin Lymphoma,0
4996,Characterization,Advanced Uterine Corpus Carcinosarcoma,0
4997,Better than Others,Human Papillomavirus-Related Carcinoma,0
4998,unknown vaccine or immune globulin,Acute Undifferentiated Leukemia,0
4999,Carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5000,Etiology,Liver Cavernous Hemangioma,0
5001,Cure (remedy),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5002,Science of Morphology,Noninfiltrating Intraductal Carcinoma,0
5003,Primary malignant neoplasm,papillary carcinoma of penis,0
5004,Melanocytic nevus,Malignant melanoma of eyelid,0
5005,Surgical service,Bladder squamous cell carcinoma stage I,0
5006,Muscle Contraction,Digestive System Hodgkin Lymphoma,0
5007,Rare,Recurrent Uveal Melanoma,0
5008,Central Nervous System Neoplasms,Recurrent Diffuse Intrinsic Pontine Glioma,0
5009,Carcinoma in Situ,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5010,Removed,Pancreatic Intraepithelial Neoplasia-3,0
5011,Tissue Specimen Code,adenosquamous carcinoma of breast,0
5012,Disease,Intestinal Metaplasia of Bladder Urothelium,0
5013,Development,Acute Undifferentiated Leukemia,0
5014,Manufactured sign,Diffuse malignant mesothelioma,0
5015,Abdomen+,Extra-Adrenal Paraganglioma,0
5016,Cardiovascular system,Digestive System Hodgkin Lymphoma,0
5017,Carcinoma,Undifferentiated Endocervical Sarcoma,0
5018,Apply,Extracranial Neuroblastoma,0
5019,50%,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5020,Course,Cancer of Urinary Tract,0
5021,Human body structure,Intestinal Neuroendocrine Carcinoma,0
5022,Site,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5023,Disruptive,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5024,Stress,Spongiotic dermatitis,0
5025,DUOXA1 gene,GIANT PIGMENTED HAIRY NEVUS,0
5026,Cause of death:Find:Pt:^Patient:Nom,Mucinous adenocarcinoma gastric,0
5027,CDISC SDTM Procedure Terminology,Diffuse malignant mesothelioma,0
5028,Tryptophanase,Adult Alveolar Soft Part Sarcoma,0
5029,Head - Component of Device,Benign neoplasm of thorax,0
5030,Diagnosis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5031,Long-term,Primary Cutaneous Plasmablastic Lymphoma,0
5032,Common Specifications in HL7 V3 Publishing,Leiomyoma of Gallbladder,0
5033,Providing presence (regime/therapy),Tonsillar Carcinoma,0
5034,New,Acute Undifferentiated Leukemia,0
5035,Human patch material,Contact dermatitis due to alkali,0
5036,survive,Diffuse malignant mesothelioma,0
5037,Manufactured sign,Mucinous adenocarcinoma gastric,0
5038,Form:Finding:Point in time:{Setting}:Document:{Role},Secondary malignant neoplasm of lymph node,0
5039,Line Unit of Length,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5040,Negation,Refractory Barrett Esophagus,0
5041,Significant,Acute Undifferentiated Leukemia,0
5042,Metastatic Neoplasm,adenosquamous carcinoma of breast,0
5043,Injury due to exposure to external cause,Endometrial Small Cell Carcinoma,0
5044,Malignant Neoplasms,Childhood Central Nervous System Immature Teratoma,0
5045,Vaginal Hemorrhage,Undifferentiated Endocervical Sarcoma,0
5046,Ability,Testicular cancer metastatic,0
5047,Usual,Malignant Testicular Sertoli Cell Tumor,0
5048,Monoclonal Gammopathy of Undetermined Significance,Heavy Chain Deposition Disease,0
5049,Adult Hodgkin Lymphoma,Childhood Lymphoma,0
5050,2+,Localized Askin Tumor,0
5051,Make - Instruction Imperative,Endometrial Small Cell Carcinoma,0
5052,Overall,Benign neoplasm of thorax,0
5053,Usually Need Help from Another Person for Reach,FIGO Stage II Ovarian Cancer,0
5054,MALIGNANT benign,Extra-Adrenal Paraganglioma,0
5055,Include (action),FIGO Stage II Ovarian Cancer,0
5056,Entity Determiner - specific,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5057,History,Uterine Cancer,0
5058,Percent (qualifier value),Undifferentiated Endocervical Sarcoma,0
5059,Cell Differentiation process,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5060,Drain device,Benign Apocrine Neoplasm,0
5061,Persons,Acute Undifferentiated Leukemia,0
5062,Biomaterial Treatment,Female Breast Carcinoma,0
5063,Parameterized Data Type - Set,Benign Carotid Body Paraganglioma,0
5064,Additional,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5065,Protein complex,BRCA2 Syndrome,0
5066,Two,Acute Undifferentiated Leukemia,0
5067,Often - answer to question,Malignant Neoplasm with Regional Lymph Node Involvement,0
5068,Axilla,Recurrent Testicular Lymphoma,0
5069,Nobel Prize,Unresectable Rhabdomyosarcoma,0
5070,Primary,Stage IB Lung Cancer AJCC v7,0
5071,Spinal meningocele,benign mature teratoma of pancreas,0
5072,Embryonic tissue,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5073,radiotherapeutic,Uterine Cancer,0
5074,Mutation,FIGO Stage II Ovarian Cancer,0
5075,70%,Mucinous adenocarcinoma gastric,0
5076,Long,Cancer of Urinary Tract,0
5077,Diabetes Mellitus,Stage IB Pancreatic Cancer AJCC v8,0
5078,Orbital region,Malignant melanoma of eyelid,0
5079,Manufactured form,Adult Fibrolamellar Carcinoma,0
5080,Predominate,Giant cell angiofibroma,0
5081,Endocrine Cells,Colorectal Neuroendocrine Tumor G2,0
5082,Occur (action),Endometrial Small Cell Carcinoma,0
5083,Fasting Status Indicator,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5084,Financial Account,Stage IB Pancreatic Cancer AJCC v8,0
5085,biopsy characteristics,Localized Askin Tumor,0
5086,Pediculus humanus capitis (eukaryote),Contact dermatitis due to alkali,0
5087,Common (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
5088,Organ,mucinous adenocarcinoma of gallbladder,0
5089,Generations,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5090,NIN gene,Atypical Lobular Breast Hyperplasia,0
5091,Age of Onset,gliosarcoma,0
5092,Etiology aspects,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5093,Biomaterial Treatment,Breast Ductal Adenoma,0
5094,Excision,Malignant melanoma of eyelid,0
5095,Adult human body,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
5096,Medical Imaging,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5097,Active,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5098,Excision,Metastatic Carcinoma in the Lung,0
5099,70%,Clonal Hematopoiesis of Indeterminate Potential,0
5100,Rating (action),Carcinoma of urinary bladder,0
5101,Shortness of breath:-:Point in time:^Patient:-,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5102,Chemicals,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5103,Type - attribute,Uterine Cancer,0
5104,biomedical tube device,Grade 1 Clear Cell Renal Cell Carcinoma,0
5105,Neoplasms,Rhabdomyosarcoma with ganglionic differentiation,0
5106,Greater than one,Tonsillar Carcinoma,0
5107,Greater than one,Ichthyosis,0
5108,Cancer Genus,Mucinous adenocarcinoma gastric,0
5109,Epithelial ovarian cancer,FIGO Stage II Ovarian Cancer,0
5110,Autosomal dominant hereditary disorder,Colorectal cancer,0
5111,Benign Smooth Muscle Neoplasm,Leiomyoma of Gallbladder,0
5112,Near,Stage IB Lung Cancer AJCC v7,0
5113,Country,Adult Hepatocellular Carcinoma,0
5114,macrophage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5115,Study Variable,Carcinoma ex pleomorphic adenoma of parotid gland,0
5116,Live - Specimen Condition,Extracranial Neuroblastoma,0
5117,Europe,Bladder squamous cell carcinoma stage I,0
5118,human AVP protein,Collecting Duct Carcinoma of the Kidney,0
5119,associated disease,Maxillary Sinus Adenocarcinoma,0
5120,Science of Morphology,Rhabdomyosarcoma with ganglionic differentiation,0
5121,80%,Undifferentiated Endocervical Sarcoma,0
5122,Bone structure of coccyx,benign mature teratoma of pancreas,0
5123,Malignant neoplasm of endometrium,Undifferentiated Endocervical Sarcoma,0
5124,Structure of lymphatic trunk,Digestive System Hodgkin Lymphoma,0
5125,Chest,Benign Carotid Body Paraganglioma,0
5126,Right,Digestive System Hodgkin Lymphoma,0
5127,Most,Intestinal Neuroendocrine Carcinoma,0
5128,Biopsy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5129,Detection,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
5130,Participation Type - origin,Adenocarcinoma of the prostate metastatic,0
5131,Fibrosis,mucinous adenocarcinoma of gallbladder,0
5132,Discharge,Stage II Carcinoma of Penis,0
5133,Common (qualifier value),Uterine Cancer,0
5134,Similarity,Digestive System Hodgkin Lymphoma,0
5135,control aspects,Primary Cutaneous Plasmablastic Lymphoma,0
5136,Estimated,Female Breast Carcinoma,0
5137,Tissue injury,Heavy Chain Deposition Disease,0
5138,contact person,Human Papillomavirus-Related Carcinoma,0
5139,Metastatic malignant neoplasm to brain,Malignant neoplasm of thalamus,0
5140,NCI CTEP SDC Melanoma Sub-Category Terminology,Recurrent Uveal Melanoma,0
5141,Type - attribute,Stage IB Pancreatic Cancer AJCC v8,0
5142,Term (lexical),Adult Alveolar Soft Part Sarcoma,0
5143,Person Name,Atypical Lobular Breast Hyperplasia,0
5144,therapeutic aspects,Carcinoma of urinary bladder,0
5145,Large,Recurrent Uveal Melanoma,0
5146,Singular,Thymic Clear Cell Carcinoma,0
5147,Management Occupations,Mucinous neoplasm,0
5148,Often - answer to question,Malignant melanoma of eyelid,0
5149,Point in time,Acantholytic squamous cell carcinoma,0
5150,Surgical aspects,Localized Askin Tumor,0
5151,Entity,Atypical Lobular Breast Hyperplasia,0
5152,Population Group,Heavy Chain Deposition Disease,0
5153,Incidence,Extra-Adrenal Paraganglioma,0
5154,*Type - Kind of quantity,Urethral Carcinoma,0
5155,Overall Publication Type,Benign neoplasm of thorax,0
5156,Sensation quality,Malignant neoplasm of thalamus,0
5157,Blood Vessel,Granular Cell Leiomyosarcoma,0
5158,Account number:Identifier:Point in time:^Patient:Nominal,Pancreatic Intraepithelial Neoplasia-3,0
5159,parent,Mucinous adenocarcinoma gastric,0
5160,Time (foundation metadata concept),benign mature teratoma of pancreas,0
5161,Africa,Intestinal Metaplasia of Bladder Urothelium,0
5162,Middle,Human Papillomavirus-Related Carcinoma,0
5163,Continuance of life,Localized Askin Tumor,0
5164,Location of Pharyngeal Residue Following Swallowing,Giant cell angiofibroma,0
5165,Immune,Recurrent Uveal Melanoma,0
5166,Metastatic Neoplasm,Recurrent Uveal Melanoma,0
5167,Treated with,Cancer of Urinary Tract,0
5168,Adult human body,papillary carcinoma of penis,0
5169,Brain Neoplasms,Malignant neoplasm of choroid,0
5170,Pale color saturation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5171,Post,Lung squamous cell carcinoma stage I,0
5172,Usually Need Help from Another Person for Arising,Intestinal Metaplasia of Bladder Urothelium,0
5173,Predisposition -- attribute,BRCA2 Syndrome,0
5174,Topical Cream,Spongiotic dermatitis,0
5175,Destruction (action),mucinous adenocarcinoma of gallbladder,0
5176,*Type - Kind of quantity,Mucinous adenocarcinoma gastric,0
5177,Value Above Reference Range,Mucinous adenocarcinoma gastric,0
5178,Histologic type,Female Breast Carcinoma,0
5179,Urinary Bladder,Bladder squamous cell carcinoma stage I,0
5180,Treating,Diffuse malignant mesothelioma,0
5181,epidemiologic,gliosarcoma,0
5182,Regular,Undifferentiated Endocervical Sarcoma,0
5183,Component object,Collecting Duct Carcinoma of the Kidney,0
5184,Reported Term,Maxillary Sinus Adenocarcinoma,0
5185,Infrequent,Pancreatic Intraepithelial Neoplasia-3,0
5186,Contact Dermatitis,Contact dermatitis due to alkali,0
5187,Nose,Benign Apocrine Neoplasm,0
5188,Released (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5189,Bothered by Night Sweats,Hodgkin lymphoma,0
5190,Pickle,Mucinous adenocarcinoma gastric,0
5191,Organ,Diffuse malignant mesothelioma,0
5192,T-Cell Development,Thymic Clear Cell Carcinoma,0
5193,Reflux within Device Medical Device Problem,Refractory Barrett Esophagus,0
5194,Point Name,Cancer of Urinary Tract,0
5195,Completely - dosing instruction fragment,Clonal Hematopoiesis of Indeterminate Potential,0
5196,Time,Acantholytic squamous cell carcinoma,0
5197,development aspects,Mucinous adenocarcinoma gastric,0
5198,Non-Small Cell Lung Carcinoma,Metastatic Carcinoma in the Lung,0
5199,Skin,Acute Undifferentiated Leukemia,0
5200,Family history,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5201,Swollen Lymph Node,Methotrexate-Associated Hodgkin Lymphoma,0
5202,Abdominal mass,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5203,Poor function,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5204,radiotherapeutic,Mucinous adenocarcinoma gastric,0
5205,Frequently,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5206,common types,papillary carcinoma of penis,0
5207,Malignant neoplasm of large intestine,Colorectal High Grade B-Cell Lymphoma,0
5208,More,Angiosarcoma of liver,0
5209,status - In progress,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5210,Lymphoma,Recurrent Testicular Lymphoma,0
5211,Sweat Glands,Benign Apocrine Neoplasm,0
5212,Lethal,mucinous adenocarcinoma of gallbladder,0
5213,gliosarcoma,gliosarcoma,0
5214,Greasy hair,Benign Apocrine Neoplasm,0
5215,Tobacco smoking behavior,Carcinoma of urinary bladder,0
5216,Pelvic cavity structure,Localized Askin Tumor,0
5217,Singular,Tonsillar Carcinoma,0
5218,Abdomen+,Mucinous adenocarcinoma gastric,0
5219,Removed,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5220,Descent,Malignant melanoma of eyelid,0
5221,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5222,Chest wall structure,Localized Askin Tumor,0
5223,Malignant Neoplasms,Choroid Necrotic Melanoma,0
5224,Penetrance,BRCA2 Syndrome,0
5225,Freezing,Human Papillomavirus-Related Carcinoma,0
5226,Upper Respiratory Infections,Acantholytic squamous cell carcinoma,0
5227,*Type - Kind of quantity,Carcinoma of urinary bladder,0
5228,Bladder Cancer Pathway,Intestinal Metaplasia of Bladder Urothelium,0
5229,Additional,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5230,Human papilloma virus infection,Stage II Carcinoma of Penis,0
5231,Fatal,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5232,High Grade Ovarian Serous Adenocarcinoma,FIGO Stage II Ovarian Cancer,0
5233,Symptoms aspect,Intestinal Metaplasia of Bladder Urothelium,0
5234,Lymphadenopathy,Acute Undifferentiated Leukemia,0
5235,Pediculus humanus capitis (eukaryote),Noninfiltrating Intraductal Carcinoma,0
5236,Known,Papillary cystic tumor,0
5237,Lymphatic duct,Digestive System Hodgkin Lymphoma,0
5238,Further,Recurrent Testicular Lymphoma,0
5239,Confirmed by,FIGO Stage II Ovarian Cancer,0
5240,Obesity,Refractory Barrett Esophagus,0
5241,Aggressive behavior,Pancreatic Intraepithelial Neoplasia-3,0
5242,Coding Subtest (WISC-V),BRCA2 Syndrome,0
5243,Usual,Spermatocytic seminoma,0
5244,Gram per Deciliter,Heavy Chain Deposition Disease,0
5245,Diagnosis Study,Intestinal Metaplasia of Bladder Urothelium,0
5246,Brain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5247,Leading,Tonsillar Carcinoma,0
5248,Lymphocyte,Malignant Neoplasm with Regional Lymph Node Involvement,0
5249,Associated with,Colorectal cancer,0
5250,Japan,Diffuse malignant mesothelioma,0
5251,include - SetOperator,Bladder squamous cell carcinoma stage I,0
5252,Hereditary,Undifferentiated Endocervical Sarcoma,0
5253,Can Do Very Little,Sarcomatoid Renal Cell Carcinoma,0
5254,Histamine Release,Mastocytosis,0
5255,Progress,Acute Undifferentiated Leukemia,0
5256,enzyme activity,Placental aromatase deficiency,0
5257,Presence (property),Hemangioma,0
5258,Patch (unit of presentation),Contact dermatitis due to alkali,0
5259,ovarian,FIGO Stage II Ovarian Cancer,0
5260,Pharmacologic Substance,Testicular cancer metastatic,0
5261,Study,Acute Undifferentiated Leukemia,0
5262,Widening,Methotrexate-Associated Hodgkin Lymphoma,0
5263,Make - Instruction Imperative,Testicular cancer metastatic,0
5264,Elderly (population group),Undifferentiated Endocervical Sarcoma,0
5265,Chromosomes,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5266,17th century,Digestive System Hodgkin Lymphoma,0
5267,Skeletal bone,Granular Cell Leiomyosarcoma,0
5268,Chromosomes,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5269,Very,FIGO Stage II Ovarian Cancer,0
5270,Polypeptide Hormones,Colorectal Neuroendocrine Tumor G2,0
5271,Smear - instruction imperative,Adult Hepatocellular Carcinoma,0
5272,Main,Malignant neoplasm of thalamus,0
5273,Exostosis,Cartilaginous exostosis,0
5274,Smaller,Mucinous adenocarcinoma gastric,0
5275,Low Level,mucinous adenocarcinoma of gallbladder,0
5276,Uterus,Metastatic Neoplasm to the Gallbladder,0
5277,Two,Childhood Lymphoma,0
5278,Major,Childhood Lymphoma,0
5279,Head - Component of Device,Benign Carotid Body Paraganglioma,0
5280,Tobacco smoking behavior,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5281,Site of primary lesion,Testicular cancer metastatic,0
5282,1+ Score,Leiomyoma of Gallbladder,0
5283,Base - General Qualifier,Acute Undifferentiated Leukemia,0
5284,Affecting,Breast Ductal Adenoma,0
5285,How Often Weight Loss,Diffuse malignant mesothelioma,0
5286,Breaking down,Recurrent Uveal Melanoma,0
5287,month,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5288,Tissue Specimen Code,Liver Cavernous Hemangioma,0
5289,unknown vaccine or immune globulin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5290,Spur - plant part,Cartilaginous exostosis,0
5291,Late,Mucinous adenocarcinoma gastric,0
5292,cancer location,Urethral Carcinoma,0
5293,Pregnancy,Human Papillomavirus-Related Carcinoma,0
5294,Symptoms,Childhood Lymphoma,0
5295,Hepatitis B,Adult Hepatocellular Carcinoma,0
5296,Tanning of leather,Acantholytic squamous cell carcinoma,0
5297,Clinical Trials,Breast Ductal Adenoma,0
5298,Possibly Related to Intervention,Refractory Barrett Esophagus,0
5299,include - SetOperator,Pancreatic Intraepithelial Neoplasia-3,0
5300,include - SetOperator,Hodgkin lymphoma,0
5301,Common (qualifier value),Angiosarcoma of liver,0
5302,Make - Instruction Imperative,Pancreatic Intraepithelial Neoplasia-3,0
5303,Teens,Localized Askin Tumor,0
5304,Common Specifications in HL7 V3 Publishing,Methotrexate-Associated Hodgkin Lymphoma,0
5305,Function (attribute),BRCA2 Syndrome,0
5306,Type A,Adenocarcinoma of the prostate metastatic,0
5307,Foot British,Cartilaginous exostosis,0
5308,World Health Organization,Familial Hemophagocytic Lymphocytosis,0
5309,2000,Ichthyosis,0
5310,Indexes,Familial Hemophagocytic Lymphocytosis,0
5311,Numbers,Localized Askin Tumor,0
5312,Overall,adenoid cystic carcinoma of lung,0
5313,CDISC SEND Tumor Findings Results Terminology,Refractory Glioma,0
5314,Tumor Cell Invasion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5315,Presentation,papillary carcinoma of penis,0
5316,Five,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5317,Sex Cord-Stromal Tumor,Malignant Testicular Sertoli Cell Tumor,0
5318,mole changes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5319,Obesity,Undifferentiated Endocervical Sarcoma,0
5320,LYMPHOID Cancers,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5321,Neoplasms,Tonsillar Carcinoma,0
5322,How Often Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
5323,Benign condition,Serous cystadenocarcinoma ovary,0
5324,Platelets Product,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5325,Poor - grade value,Refractory Barrett Esophagus,0
5326,Device system,mucinous adenocarcinoma of gallbladder,0
5327,Smooth muscle (tissue),Liver Cavernous Hemangioma,0
5328,Disseminated Malignant Neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5329,Progress,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5330,Decision,Liver Cavernous Hemangioma,0
5331,Integumentary scale,Acantholytic squamous cell carcinoma,0
5332,Pharmacotherapy,Carcinoma of urinary bladder,0
5333,Include (action),Intracortical osteosarcoma,0
5334,Ultraviolet Light Sterilization,Recurrent Uveal Melanoma,0
5335,Diagnosis Study,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5336,shared attribute,Refractory Barrett Esophagus,0
5337,Dysuria,Bladder squamous cell carcinoma stage I,0
5338,shared attribute,Neonatal leukemia,0
5339,Mechanism Component of Device,Acute Undifferentiated Leukemia,0
5340,Common (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5341,Pleomorphism (morphologic abnormality),Carcinoma ex pleomorphic adenoma of parotid gland,0
5342,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Breast Ductal Adenoma,0
5343,Present,FIGO Stage II Ovarian Cancer,0
5344,Mutation Abnormality,BRCA2 Syndrome,0
5345,Ninein,Atypical Lobular Breast Hyperplasia,0
5346,include - SetOperator,Digestive System Hodgkin Lymphoma,0
5347,Range,Ichthyoses,0
5348,Classification,Noninfiltrating Intraductal Carcinoma,0
5349,Forecast of outcome,squamous cell carcinoma of the thyroid gland,0
5350,Hematopoiesis,Clonal Hematopoiesis of Indeterminate Potential,0
5351,Electromagnetic Spectrum,Heavy Chain Deposition Disease,0
5352,More than 5 years,Uterine Cancer,0
5353,Average of Value Derivation Technique,gliosarcoma,0
5354,Beds,Acantholytic squamous cell carcinoma,0
5355,66,Acantholytic squamous cell carcinoma,0
5356,chapter,Secondary malignant neoplasm of lymph node,0
5357,Cyst,Pilocytic astrocytoma of cerebellum,0
5358,Hematogenous spread,Testicular cancer metastatic,0
5359,Before,Tonsillar Carcinoma,0
5360,low exposure,Malignant melanoma of eyelid,0
5361,Chemotherapy Regimen,Undifferentiated Endocervical Sarcoma,0
5362,Two,Mucinous adenocarcinoma gastric,0
5363,Case unit dose,adenosquamous carcinoma of breast,0
5364,regional,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5365,Wild flowers,Extracranial Neuroblastoma,0
5366,Immune system,Digestive System Hodgkin Lymphoma,0
5367,Subject Risk,Endometrial Small Cell Carcinoma,0
5368,Case unit dose,Papillary cystic tumor,0
5369,Hematuria,Bladder squamous cell carcinoma stage I,0
5370,Surgery specialty,Carcinoma of urinary bladder,0
5371,Entire elbow region,Cartilaginous exostosis,0
5372,Including (qualifier),adenosquamous carcinoma of breast,0
5373,Medical History,Recurrent Uveal Melanoma,0
5374,Thymus <angiosperm>,Thymic Clear Cell Carcinoma,0
5375,Antibodies,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5376,Metastatic Neoplasm,Testicular cancer metastatic,0
5377,stage,FIGO Stage II Ovarian Cancer,0
5378,Anterior,Thymic Clear Cell Carcinoma,0
5379,Name,Atypical Lobular Breast Hyperplasia,0
5380,Common (qualifier value),Endometrial Small Cell Carcinoma,0
5381,Treatment Epoch,mucinous adenocarcinoma of gallbladder,0
5382,Body Weight,Refractory Barrett Esophagus,0
5383,Overall,Benign Carotid Body Paraganglioma,0
5384,Ancestry-Informative Marker,Ichthyosis,0
5385,Hepatitis C Virus Infection,Adult Hepatocellular Carcinoma,0
5386,various antiinfectives and antiseptics for local oral treatment,Benign neoplasm of thorax,0
5387,Small cell carcinoma of lung,Lung squamous cell carcinoma stage I,0
5388,System (unit of presentation),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5389,risk factors,Diffuse malignant mesothelioma,0
5390,Excision,Malignant Testicular Sertoli Cell Tumor,0
5391,Mass of body structure,Anterior Urethral Malignant Neoplasm,0
5392,radiotherapeutic,FIGO Stage II Ovarian Cancer,0
5393,Include (action),Leptomeningeal sarcoma,0
5394,Body tissue,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
5395,>90,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5396,Common Specifications in HL7 V3 Publishing,Undifferentiated Endocervical Sarcoma,0
5397,Skin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5398,Greater Than,Mucinous adenocarcinoma gastric,0
5399,Established,Localized Askin Tumor,0
5400,Long-term,adenosquamous carcinoma of breast,0
5401,Time (foundation metadata concept),Leptomeningeal sarcoma,0
5402,per year,Benign neoplasm of thorax,0
5403,Dyspnea,Stage IB Lung Cancer AJCC v7,0
5404,Discover,Spermatocytic seminoma,0
5405,Domain (area of knowledge),Intracortical osteosarcoma,0
5406,Dominant,Ichthyoses,0
5407,Reported,Serous cystadenocarcinoma ovary,0
5408,Frequently,Acantholytic squamous cell carcinoma,0
5409,Treating,Recurrent Testicular Lymphoma,0
5410,Analysis,Recurrent Uveal Melanoma,0
5411,Blood,Clonal Hematopoiesis of Indeterminate Potential,0
5412,Development,Mucinous adenocarcinoma gastric,0
5413,Family history,Carcinoma of urinary bladder,0
5414,Physical Medical Procedure,Undifferentiated Endocervical Sarcoma,0
5415,Obesity,FIGO Stage II Ovarian Cancer,0
5416,Microorganism,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5417,incidence of cases,Benign neoplasm of thorax,0
5418,Type A,Contact dermatitis due to alkali,0
5419,Solitary leiomyoma,Deep Leiomyoma,0
5420,Comment,Refractory Barrett Esophagus,0
5421,Carcinoma with osteoclast-like giant cells,Metastatic Ductal Breast Carcinoma,0
5422,Etiology aspects,Acute Undifferentiated Leukemia,0
5423,risk factors - observation list,Diffuse malignant mesothelioma,0
5424,shared attribute,Undifferentiated Endocervical Sarcoma,0
5425,risk factors - observation list,Carcinoma of urinary bladder,0
5426,Adult Lymphoma,Recurrent Testicular Lymphoma,0
5427,Special,Intestinal Neuroendocrine Carcinoma,0
5428,Malignant Neoplasms,Malignant melanoma of eyelid,0
5429,Chemical Association,BRCA2 Syndrome,0
5430,Tongue,Giant cell angiofibroma,0
5431,SLC6A2 wt Allele,Colorectal Neuroendocrine Tumor G2,0
5432,Type A,Malignant melanoma of eyelid,0
5433,Descent,Recurrent Uveal Melanoma,0
5434,Disease Steps Questionnaire,Neonatal leukemia,0
5435,Arranged (transportation),Adult Alveolar Soft Part Sarcoma,0
5436,Location,Cartilaginous exostosis,0
5437,diagnosis aspect,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5438,commercial,Diffuse malignant mesothelioma,0
5439,<90,Human Papillomavirus-Related Carcinoma,0
5440,Primary malignant neoplasm,Malignant Neoplasm with Regional Lymph Node Involvement,0
5441,Manufactured form,Mucinous neoplasm,0
5442,Different,Female Breast Carcinoma,0
5443,TP53 gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5444,Cancer Registry,Leptomeningeal sarcoma,0
5445,Net (qualifier),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
5446,Medications,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5447,monoclonal,Heavy Chain Deposition Disease,0
5448,Teratoma,benign mature teratoma of pancreas,0
5449,United States,Malignant Testicular Sertoli Cell Tumor,0
5450,Childhood Teratoma,benign mature teratoma of pancreas,0
5451,Arising,Bladder squamous cell carcinoma stage I,0
5452,Advanced phase,Tonsillar Carcinoma,0
5453,Cystic,Anterior Urethral Malignant Neoplasm,0
5454,Basal Cell Carcinoma Pathway,Acantholytic squamous cell carcinoma,0
5455,How Much Distress Difficulty Swallowing,Mucinous adenocarcinoma gastric,0
5456,Seminoma,Malignant Testicular Sertoli Cell Tumor,0
5457,prior radiation therapy,Bladder squamous cell carcinoma stage I,0
5458,early disease,Primary Cutaneous Plasmablastic Lymphoma,0
5459,Persons,Mastocytosis,0
5460,Increase,BRCA2 Syndrome,0
5461,Sacrifice,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5462,risk factors,Carcinoma of urinary bladder,0
5463,Southern Europe,Bladder squamous cell carcinoma stage I,0
5464,Immature Lymphocytes Measurement,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5465,Immature Platelet,Neonatal leukemia,0
5466,Remetinostat,Cartilaginous exostosis,0
5467,Most,Colorectal cancer,0
5468,Childhood Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
5469,Pure Spanish horse breed (organism),Thymic Clear Cell Carcinoma,0
5470,Type - attribute,Mucinous adenocarcinoma gastric,0
5471,Human papilloma virus infection,Acantholytic squamous cell carcinoma,0
5472,Replacement - supply,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5473,DNA Microarray Chip,Clonal Hematopoiesis of Indeterminate Potential,0
5474,Obstruction,Unresectable Rhabdomyosarcoma,0
5475,Linear,Thymic Clear Cell Carcinoma,0
5476,Deep Resection Margin,Adult Alveolar Soft Part Sarcoma,0
5477,General surgery specialty,Bladder squamous cell carcinoma stage I,0
5478,Cell secretion,Heavy Chain Deposition Disease,0
5479,negative regulation of biological process,Unresectable Rhabdomyosarcoma,0
5480,35,Placental aromatase deficiency,0
5481,Known,Diffuse malignant mesothelioma,0
5482,Including (qualifier),Colorectal High Grade B-Cell Lymphoma,0
5483,Increase,Adult Hepatocellular Carcinoma,0
5484,Armpit,Benign Apocrine Neoplasm,0
5485,Common Specifications in HL7 V3 Publishing,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5486,Cover (physical object),Secondary malignant neoplasm of lymph node,0
5487,Sometimes,Unresectable Rhabdomyosarcoma,0
5488,Primary Malignant Liver Neoplasm,Adult Hepatocellular Carcinoma,0
5489,Precision - temporal,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5490,Concept model domain,Leptomeningeal sarcoma,0
5491,23,Tonsillar Carcinoma,0
5492,(City) Block,Unresectable Rhabdomyosarcoma,0
5493,Internal,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5494,Proliferation,Carcinoma ex pleomorphic adenoma of parotid gland,0
5495,Human body structure,Thymic Clear Cell Carcinoma,0
5496,Only - dosing instruction fragment,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
5497,Specific qualifier value,Noninfiltrating Intraductal Carcinoma,0
5498,Tonsil,Digestive System Hodgkin Lymphoma,0
5499,Proline measurement,Mastocytosis,0
5500,Number of birth,Recurrent Uveal Melanoma,0
5501,Cavitation,Liver Cavernous Hemangioma,0
5502,Plumbum metallicum,FIGO Stage II Ovarian Cancer,0
5503,Intellectual scale,Acantholytic squamous cell carcinoma,0
5504,Pediatric,Neonatal leukemia,0
5505,condom use,Cancer of Urinary Tract,0
5506,Spreading (qualifier value),Malignant melanoma of eyelid,0
5507,Stem of Organ,Rhabdomyosarcoma with ganglionic differentiation,0
5508,Female Reproductive System,Endometrial Small Cell Carcinoma,0
5509,Australia,Giant cell angiofibroma,0
5510,Call (Instruction),Tonsillar Carcinoma,0
5511,Intestines,Adult Alveolar Soft Part Sarcoma,0
5512,Vomiting,Choroid Necrotic Melanoma,0
5513,Primary malignant neoplasm,Angiosarcoma of liver,0
5514,Surrounding (qualifier value),Pilocytic astrocytoma of cerebellum,0
5515,Main,Tonsillar Carcinoma,0
5516,300,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5517,Anatomic Site,Angiosarcoma of liver,0
5518,depend,Adult Hepatocellular Carcinoma,0
5519,Techniques,Advanced Uterine Corpus Carcinosarcoma,0
5520,Biomaterial Treatment,Ichthyosis,0
5521,Known,Digestive System Hodgkin Lymphoma,0
5522,Human body structure,Testicular cancer metastatic,0
5523,Overall Publication Type,Endometrial Small Cell Carcinoma,0
5524,Classification,Rhabdomyosarcoma with ganglionic differentiation,0
5525,lead increased,Clonal Hematopoiesis of Indeterminate Potential,0
5526,Aggressive behavior,Colorectal High Grade B-Cell Lymphoma,0
5527,Percent (qualifier value),Recurrent Testicular Lymphoma,0
5528,FLT3LG wt Allele,Recurrent Testicular Lymphoma,0
5529,Classical Hodgkin's Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5530,epithelial,Metastatic Carcinoma in the Lung,0
5531,Manufactured sign,Recurrent Uveal Melanoma,0
5532,Abundance,mucinous adenocarcinoma of gallbladder,0
5533,Regimen - CHV concept,Recurrent Testicular Lymphoma,0
5534,High Mitosis-Karyorrhexis Index,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5535,Togo,Endometrial Small Cell Carcinoma,0
5536,Pineal germinoma,Germinoma,0
5537,Intraductal papillary mucinous neoplasm,Mucinous neoplasm,0
5538,Decrease,Undifferentiated Endocervical Sarcoma,0
5539,Count of entities,Human Papillomavirus-Related Carcinoma,0
5540,Base - General Qualifier,Diffuse malignant mesothelioma,0
5541,Base - General Qualifier,de novo Myelodysplastic Syndrome,0
5542,Tumor type,Malignant neoplasm of thalamus,0
5543,Male population group,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5544,Exception - Property or Attribute,Cancer of Urinary Tract,0
5545,Adenocarcinoma,Intestinal Metaplasia of Bladder Urothelium,0
5546,bony process,Serous cystadenocarcinoma ovary,0
5547,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5548,Oral cavity,Refractory Barrett Esophagus,0
5549,Negation,Choroid Necrotic Melanoma,0
5550,Diagnostic Neoplasm Staging,Bladder squamous cell carcinoma stage I,0
5551,peripheral blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5552,Cells,Thymic Clear Cell Carcinoma,0
5553,Scar Tissue,Acantholytic squamous cell carcinoma,0
5554,List,Secondary malignant neoplasm of lymph node,0
5555,Thin (qualifier value),Childhood Thyroid Gland Follicular Carcinoma,0
5556,Ovary,FIGO Stage II Ovarian Cancer,0
5557,intent,Metastatic Carcinoma in the Lung,0
5558,How Much Nausea During This Period,Mucinous adenocarcinoma gastric,0
5559,Europe,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5560,Categories,Female Breast Carcinoma,0
5561,Net (qualifier),Colorectal Neuroendocrine Tumor G2,0
5562,Malignant Neoplasms,Recurrent Testicular Lymphoma,0
5563,Papanicolaou Test,Undifferentiated Endocervical Sarcoma,0
5564,member,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5565,Skin tag,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5566,Case unit dose,Acute Undifferentiated Leukemia,0
5567,To,Uterine Cancer,0
5568,Lung,Stage IB Lung Cancer AJCC v7,0
5569,T prime,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
5570,Approximate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5571,Chemotherapy,Lung squamous cell carcinoma stage I,0
5572,Negation,Metastatic Ductal Breast Carcinoma,0
5573,Lymphoplasmacytoid Cell,Heavy Chain Deposition Disease,0
5574,Ultra-violet,Acantholytic squamous cell carcinoma,0
5575,Contain (action),Recurrent Diffuse Intrinsic Pontine Glioma,0
5576,Present,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5577,Disease,Refractory Barrett Esophagus,0
5578,Staining method,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
5579,Li-Fraumeni Syndrome,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5580,Childhood Hodgkin Lymphoma,Hodgkin lymphoma,0
5581,Exposure to,Bladder squamous cell carcinoma stage I,0
5582,Age-Years,Intestinal Metaplasia of Bladder Urothelium,0
5583,Unknown,Choroid Necrotic Melanoma,0
5584,Taste Perception,Refractory Barrett Esophagus,0
5585,Cause of death.underlying,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5586,Areas <moth>,Diffuse malignant mesothelioma,0
5587,Stroma,Metastatic Ductal Breast Carcinoma,0
5588,Usual,Carcinoma of urinary bladder,0
5589,Experimental Result,Acantholytic squamous cell carcinoma,0
5590,Weight decreased,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5591,Squamous cell carcinoma,Colorectal High Grade B-Cell Lymphoma,0
5592,Cell Invasion,Testicular cancer metastatic,0
5593,Neuroendocrine Tumors,Stage IB Pancreatic Cancer AJCC v8,0
5594,Neoplasm Metastasis,adenoid cystic carcinoma of lung,0
5595,Food,Spongiotic dermatitis,0
5596,How Much Distress Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
5597,Blood Platelets,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5598,International Statistical Classification of Diseases and Related Health Problems,Rhabdomyosarcoma with ganglionic differentiation,0
5599,Malignant Neoplasms,Hodgkin lymphoma,0
5600,Malignant Neoplasms,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5601,Singular,Deep Leiomyoma,0
5602,Medical Device Emits Smoke,Intestinal Metaplasia of Bladder Urothelium,0
5603,CD69 protein,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5604,Formations,Pilocytic astrocytoma of cerebellum,0
5605,Variable (uniformity),Neonatal leukemia,0
5606,Egg of order Phthiraptera,Rhabdomyosarcoma with ganglionic differentiation,0
5607,Tumor Mass,Intracortical osteosarcoma,0
5608,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5609,Easy,Pilocytic astrocytoma of cerebellum,0
5610,Have Weight Loss,adenosquamous carcinoma of breast,0
5611,Cell Invasion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5612,Cirrhosis,Adult Hepatocellular Carcinoma,0
5613,1+ Score,Tonsillar Carcinoma,0
5614,1+ Score,Ichthyosis,0
5615,seconds,Secondary malignant neoplasm of lymph node,0
5616,More Often than Once a Day,Pilocytic astrocytoma of cerebellum,0
5617,Publications,Rhabdomyosarcoma with ganglionic differentiation,0
5618,Weight Loss,Unfavorable Non-Hodgkin Lymphoma,0
5619,Cancer Genus,Stage IB Lung Cancer AJCC v7,0
5620,Leukocytes,Acute Undifferentiated Leukemia,0
5621,>90,Uterine Cancer,0
5622,Type - attribute,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
5623,Person Name,Methotrexate-Associated Hodgkin Lymphoma,0
5624,Body surface,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5625,Component object,Carcinoma ex pleomorphic adenoma of parotid gland,0
5626,Skin Specimen,squamous cell carcinoma of the thyroid gland,0
5627,Benign,Atypical Lobular Breast Hyperplasia,0
5628,Decision,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5629,Treating,Uterine Cancer,0
5630,Most of the time,Mucinous adenocarcinoma gastric,0
5631,Organ,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
5632,The Sun,Angiosarcoma of liver,0
5633,Absent,Breast Ductal Adenoma,0
5634,Post Device,Lung squamous cell carcinoma stage I,0
5635,Skin fold,Blepharal carcinoma,0
5636,Treated with,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5637,melanoma,Stage II Carcinoma of Penis,0
5638,PREVENT (product),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5639,diagnosis aspect,Contact dermatitis due to alkali,0
5640,Lung,Adult Alveolar Soft Part Sarcoma,0
5641,Smear - instruction imperative,Choroid Necrotic Melanoma,0
5642,Female,Cancer of Urinary Tract,0
5643,Dysplasia,Testicular cancer metastatic,0
5644,Testis,Diffuse malignant mesothelioma,0
5645,Advance,Recurrent Testicular Lymphoma,0
5646,What subject filter - Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5647,Thymic Tissue,Thymic Clear Cell Carcinoma,0
5648,cell type,Digestive System Hodgkin Lymphoma,0
5649,Percent (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
5650,Contain (action),Childhood Thyroid Gland Follicular Carcinoma,0
5651,Associated topography,adenoid cystic carcinoma of lung,0
5652,Condition,Malignant melanoma of eyelid,0
5653,Histopathological aspects,Adult Alveolar Soft Part Sarcoma,0
5654,Five,Acantholytic squamous cell carcinoma,0
5655,High,Malignant Testicular Sertoli Cell Tumor,0
5656,More,Acantholytic squamous cell carcinoma,0
5657,Science of Morphology,Intracortical osteosarcoma,0
5658,10%,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5659,include - SetOperator,FIGO Stage II Ovarian Cancer,0
5660,Case (situation),Acantholytic squamous cell carcinoma,0
5661,High,Recurrent Uveal Melanoma,0
5662,Microcyst,Serous cystadenocarcinoma ovary,0
5663,year,Mucinous adenocarcinoma gastric,0
5664,Near,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5665,Neurofibromatosis 1,Acute Undifferentiated Leukemia,0
5666,One,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
5667,60%,Human Papillomavirus-Related Carcinoma,0
5668,Forecast of outcome,papillary carcinoma of penis,0
5669,Back,Malignant melanoma of eyelid,0
5670,Affecting,Malignant melanoma of eyelid,0
5671,dendritic spine neck,Benign Carotid Body Paraganglioma,0
5672,Toilet seat,Human Papillomavirus-Related Carcinoma,0
5673,Cancer Other,Endometrial Small Cell Carcinoma,0
5674,N+ (tumor staging),Adenocarcinoma,0
5675,throat cancer,Tonsillar Carcinoma,0
5676,Geographic Locations,adenoid cystic carcinoma of lung,0
5677,Radiotherapy Research,Primary Cutaneous Plasmablastic Lymphoma,0
5678,Chronic inflammation,Stage II Carcinoma of Penis,0
5679,Endodermal,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5680,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5681,Hair follicle structure,Benign Apocrine Neoplasm,0
5682,Cell Count,Atypical Mesothelial Hyperplasia,0
5683,Involvement with,Recurrent Testicular Lymphoma,0
5684,During,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
5685,Tissue Specimen Code,FIGO Stage II Ovarian Cancer,0
5686,Less Than,Breast Ductal Adenoma,0
5687,Array Feature,Intestinal Neuroendocrine Carcinoma,0
5688,Togo,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5689,Occur (action),Familial Adenomatous Polyposis Associated Medulloblastoma,0
5690,Negation,Childhood Lymphoma,0
5691,Heart,Extracranial Neuroblastoma,0
5692,International Classification of Diseases for Oncology,Leptomeningeal sarcoma,0
5693,Affecting,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5694,Icterus,Pancreatic Intraepithelial Neoplasia-3,0
5695,Deferred,Recurrent Testicular Lymphoma,0
5696,Presentation,squamous cell carcinoma of the thyroid gland,0
5697,Neoplasms,Heavy Chain Deposition Disease,0
5698,One,Heavy Chain Deposition Disease,0
5699,Lighter device,Acantholytic squamous cell carcinoma,0
5700,Tryptophanase,Anterior Urethral Malignant Neoplasm,0
5701,Absence (morphologic abnormality),Anterior Urethral Malignant Neoplasm,0
5702,Spreading (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
5703,Thinking,benign mature teratoma of pancreas,0
5704,Smear - instruction imperative,Granular Cell Leiomyosarcoma,0
5705,VARIOUS DRUG CLASSES IN ATC,Benign Carotid Body Paraganglioma,0
5706,Symptoms,Choroid Necrotic Melanoma,0
5707,Term (lexical),Ichthyosis,0
5708,Malignant Childhood Neoplasm,Spermatocytic seminoma,0
5709,Patient need for (contextual qualifier),Spongiotic dermatitis,0
5710,Females,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5711,Neoplasm Metastasis,Choroid Necrotic Melanoma,0
5712,Iodides,Neonatal leukemia,0
5713,Gonadal structure,Spermatocytic seminoma,0
5714,Much,Digestive System Hodgkin Lymphoma,0
5715,Structure of cortex of kidney,Collecting Duct Carcinoma of the Kidney,0
5716,Mutation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5717,Term Birth,Cartilaginous exostosis,0
5718,Death NOS,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5719,Active License,Thymic Clear Cell Carcinoma,0
5720,Risk,Acantholytic squamous cell carcinoma,0
5721,Nervous system structure,Intestinal Neuroendocrine Carcinoma,0
5722,Cellular fibroma,Giant cell angiofibroma,0
5723,Present,Granular Cell Leiomyosarcoma,0
5724,IPSS Risk Category High,Recurrent Uveal Melanoma,0
5725,Feature,mucinous adenocarcinoma of gallbladder,0
5726,Feature,Colorectal Neuroendocrine Tumor G2,0
5727,incidence of cases,Benign Carotid Body Paraganglioma,0
5728,Cover - action,Familial Hemophagocytic Lymphocytosis,0
5729,Increased cerebrospinal fluid production,Malignant neoplasm of choroid,0
5730,Proteins,Heavy Chain Deposition Disease,0
5731,Lymphocyte production,Digestive System Hodgkin Lymphoma,0
5732,Minor (value),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
5733,>90,Human Papillomavirus-Related Carcinoma,0
5734,skin color,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5735,Neoplasms,Benign Apocrine Neoplasm,0
5736,Diagnosis Study,Malignant melanoma of eyelid,0
5737,Numerous,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5738,Neoplasms,adenoid cystic carcinoma of lung,0
5739,Relationships,Endometrial Small Cell Carcinoma,0
5740,Poor function,Acantholytic squamous cell carcinoma,0
5741,Primary malignant neoplasm,Adult Hepatocellular Carcinoma,0
5742,Pressure- physical agent,Anterior Urethral Malignant Neoplasm,0
5743,Leading,Mucinous adenocarcinoma gastric,0
5744,Skin Specimen,Human Papillomavirus-Related Carcinoma,0
5745,Back Pain,Stage IB Pancreatic Cancer AJCC v8,0
5746,Containing (qualifier),Childhood Thyroid Gland Follicular Carcinoma,0
5747,Autoimmune Diseases,Acute lymphadenitis,0
5748,Poor function,Malignant melanoma of eyelid,0
5749,More Often than Once a Day,Diffuse malignant mesothelioma,0
5750,1+ Score,Tonsillar Carcinoma,0
5751,Kidney,Sarcomatoid Renal Cell Carcinoma,0
5752,1+ Score,Ichthyosis,0
5753,Term (temporal),Ichthyosis,0
5754,Living Alone,Undifferentiated Endocervical Sarcoma,0
5755,Inguinal region,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5756,breast.duct,Atypical Lobular Breast Hyperplasia,0
5757,cell type,Tonsillar Carcinoma,0
5758,HEMOCHROMATOSIS,Adult Hepatocellular Carcinoma,0
5759,Antibiotics,Cancer of Urinary Tract,0
5760,Overall Publication Type,Benign Carotid Body Paraganglioma,0
5761,Anorectal Malformations,benign mature teratoma of pancreas,0
5762,Pathogenic organism,Unresectable Rhabdomyosarcoma,0
5763,CD69 wt Allele,Ichthyosis,0
5764,Intact,Spermatocytic seminoma,0
5765,Pelvic Pain,Uterine Cancer,0
5766,31,Mucinous adenocarcinoma gastric,0
5767,Erythropoiesis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5768,1000000,Cancer of Urinary Tract,0
5769,Neuroendocrine Tumors,Pancreatic Intraepithelial Neoplasia-3,0
5770,veterans alcoholism screening test (VAST),Adult Hepatocellular Carcinoma,0
5771,Cell Device,squamous cell carcinoma of the thyroid gland,0
5772,Cessation of life,Uterine Cancer,0
5773,Bacteria present,Digestive System Hodgkin Lymphoma,0
5774,Qualitative form,Secondary malignant neoplasm of lymph node,0
5775,Major,Stage I Adult Non-Hodgkin Lymphoma,0
5776,Smaller,Malignant melanoma of eyelid,0
5777,Unmarried person,Blepharal carcinoma,0
5778,Communicable Diseases,Acute lymphadenitis,0
5779,Type - attribute,Lung squamous cell carcinoma stage I,0
5780,Malignant neoplasm of lung,squamous cell carcinoma of the thyroid gland,0
5781,Type - attribute,Choroid Necrotic Melanoma,0
5782,Blood Platelets,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5783,Back structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5784,True Control Status,Pancreatic Intraepithelial Neoplasia-3,0
5785,Very,Digestive System Hodgkin Lymphoma,0
5786,Part of,Methotrexate-Associated Hodgkin Lymphoma,0
5787,CD69 protein,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5788,2+ Score,Localized Askin Tumor,0
5789,Birth,GIANT PIGMENTED HAIRY NEVUS,0
5790,Spreading (qualifier value),Acute Undifferentiated Leukemia,0
5791,Ability,Unresectable Rhabdomyosarcoma,0
5792,320,Endometrial Small Cell Carcinoma,0
5793,Tests (qualifier value),Benign Carotid Body Paraganglioma,0
5794,Fever,Childhood Lymphoma,0
5795,Subject Risk,Mucinous adenocarcinoma gastric,0
5796,100%,Intestinal Metaplasia of Bladder Urothelium,0
5797,Lower Extremity,Adult Alveolar Soft Part Sarcoma,0
5798,Symptoms aspect,Liver Cavernous Hemangioma,0
5799,Neoplastic disease,Childhood Central Nervous System Immature Teratoma,0
5800,100%,Carcinoma of urinary bladder,0
5801,Treatment intent,Cancer of Urinary Tract,0
5802,Replaced by,Thymic Clear Cell Carcinoma,0
5803,Time,Intracortical osteosarcoma,0
5804,analysis aspect,Recurrent Uveal Melanoma,0
5805,Acute Undifferentiated Leukemia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5806,Involvement with,Malignant neoplasm of thalamus,0
5807,Increase in size since previous mammogram,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5808,Science of Etiology,Ichthyosis,0
5809,Adult human body,Maxillary Sinus Adenocarcinoma,0
5810,Used by,Rhabdomyosarcoma with ganglionic differentiation,0
5811,Dust,Blepharal carcinoma,0
5812,diagnosis aspect,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5813,Manufactured form,Neonatal leukemia,0
5814,Shortness of breath:-:Point in time:^Patient:-,Stage IB Lung Cancer AJCC v7,0
5815,Delta (difference),papillary carcinoma of penis,0
5816,Common Specifications in HL7 V3 Publishing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5817,Hodgkin Disease,Hodgkin lymphoma,0
5818,Frequently,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
5819,Recent,Angiosarcoma of liver,0
5820,Cutaneous leiomyoma,Deep Leiomyoma,0
5821,Pale feces (finding),Stage IB Pancreatic Cancer AJCC v8,0
5822,contact exposure to arsenic (history),Acantholytic squamous cell carcinoma,0
5823,Risk,Undifferentiated Endocervical Sarcoma,0
5824,Rare,Benign Apocrine Neoplasm,0
5825,Human body,squamous cell carcinoma of the thyroid gland,0
5826,Microscopic description,Colorectal High Grade B-Cell Lymphoma,0
5827,Probably,benign mature teratoma of pancreas,0
5828,Testis,Recurrent Testicular Lymphoma,0
5829,Pap smear,Undifferentiated Endocervical Sarcoma,0
5830,Body part,Stage IB Pancreatic Cancer AJCC v8,0
5831,Cancer Genus,Acute Undifferentiated Leukemia,0
5832,MALIGNANT benign,Benign neoplasm of thorax,0
5833,Response process,Neonatal leukemia,0
5834,Including (qualifier),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5835,Disease,Angiosarcoma of liver,0
5836,Manufactured form,Choroid Necrotic Melanoma,0
5837,Therapeutic procedure,Acute Undifferentiated Leukemia,0
5838,Neutral pH,Clonal Hematopoiesis of Indeterminate Potential,0
5839,Problems - What subject filter,Noninfiltrating Intraductal Carcinoma,0
5840,Body part,Adenocarcinoma of the prostate metastatic,0
5841,Tryptophanase,Cancer of Urinary Tract,0
5842,Seizures,Choroid Necrotic Melanoma,0
5843,Improvement,Recurrent Testicular Lymphoma,0
5844,Scientific Study,Giant cell angiofibroma,0
5845,Biomaterial Treatment,Spongiotic dermatitis,0
5846,Communicable Diseases,Cancer of Urinary Tract,0
5847,Squamous cell carcinoma - category,Tonsillar Carcinoma,0
5848,Increased tendency to bruise,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5849,Dorsal,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5850,March (month),de novo Myelodysplastic Syndrome,0
5851,Bothered by Nausea,Unfavorable Non-Hodgkin Lymphoma,0
5852,Evidence,FIGO Stage II Ovarian Cancer,0
5853,diagnosis aspect,Acantholytic squamous cell carcinoma,0
5854,Asleep,Blepharal carcinoma,0
5855,therapeutic aspects,Recurrent Testicular Lymphoma,0
5856,Lymphadenitis,Acute lymphadenitis,0
5857,Case unit dose,Bladder squamous cell carcinoma stage I,0
5858,KAT5 wt Allele,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5859,Reported Term,Heavy Chain Deposition Disease,0
5860,Staging system,Testicular cancer metastatic,0
5861,depend,Spongiotic dermatitis,0
5862,Flowers,Extracranial Neuroblastoma,0
5863,set (group),Malignant Neoplasm of Lung - Multiple Primary Sites,0
5864,Visual Impairment,Choroid Necrotic Melanoma,0
5865,Occurrence Indicator,Human Papillomavirus-Related Carcinoma,0
5866,Code,Malignant Neoplasm of Lung - Multiple Primary Sites,0
5867,Shortened,Extracranial Neuroblastoma,0
5868,shared attribute,Clonal Hematopoiesis of Indeterminate Potential,0
5869,List,Leptomeningeal sarcoma,0
5870,Representation (action),Serous cystadenocarcinoma ovary,0
5871,One,Spermatocytic seminoma,0
5872,Tooth Wear,Refractory Barrett Esophagus,0
5873,Lymphoma,Colorectal High Grade B-Cell Lymphoma,0
5874,Primary malignant neoplasm,Malignant Testicular Sertoli Cell Tumor,0
5875,Treatment Epoch,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5876,Including (qualifier),Uterine Cancer,0
5877,Malignant Neoplasms,Extra-Adrenal Paraganglioma,0
5878,Etiology aspects,Malignant melanoma of eyelid,0
5879,In Blood,Heavy Chain Deposition Disease,0
5880,Plasma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5881,Status post,Acute Undifferentiated Leukemia,0
5882,Germinoma,Germinoma,0
5883,Pelvic cavity structure,Uterine Cancer,0
5884,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
5885,Stem of Organ,Noninfiltrating Intraductal Carcinoma,0
5886,Ancestry-Informative Marker,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5887,Sacrifice,BRCA2 Syndrome,0
5888,therapeutic aspects,mucinous adenocarcinoma of gallbladder,0
5889,Central Nervous System Neoplasms,Refractory Glioma,0
5890,Aromatase deficiency,Placental aromatase deficiency,0
5891,Xeroderma Pigmentosum,Malignant melanoma of eyelid,0
5892,Shortness of breath:-:Point in time:^Patient:-,adenosquamous carcinoma of breast,0
5893,Basis - conceptual entity,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5894,Vocal cord structure,Larynx carcinoma recurrent,0
5895,Scaly skin,Ichthyoses,0
5896,Usual,Pilocytic astrocytoma of cerebellum,0
5897,Both ovaries,Childhood Central Nervous System Immature Teratoma,0
5898,Overweight,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5899,Hemangioma,Hemangioma,0
5900,Target Lesion Identification,Familial Hemophagocytic Lymphocytosis,0
5901,Operative Surgical Procedures,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5902,Eccrine Glands,Benign Apocrine Neoplasm,0
5903,The Sun,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5904,Chemotherapy Regimen,Intestinal Metaplasia of Bladder Urothelium,0
5905,Combined,Carcinoma of urinary bladder,0
5906,Back Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5907,Fatal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5908,Biogenic Amines,Intestinal Neuroendocrine Carcinoma,0
5909,What subject filter - Result,Acute Undifferentiated Leukemia,0
5910,Occurrence Indicator,Cancer of Urinary Tract,0
5911,Firstly,Adult Alveolar Soft Part Sarcoma,0
5912,Malignant Neoplasms,Secondary malignant neoplasm of lymph node,0
5913,Fever,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5914,Lymphocyte component of blood,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5915,65,Intestinal Metaplasia of Bladder Urothelium,0
5916,Frequently,Cancer of Urinary Tract,0
5917,How Much Distress Weight Loss,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5918,Squamous cell carcinoma,squamous cell carcinoma of the thyroid gland,0
5919,diagnostic accuracy,Spongiotic dermatitis,0
5920,Structure of isthmus of thyroid gland,Childhood Thyroid Gland Follicular Carcinoma,0
5921,Act Mood - intent,Primary Cutaneous Plasmablastic Lymphoma,0
5922,Lymphocyte,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5923,Gastrointestinal tract structure,Adult Alveolar Soft Part Sarcoma,0
5924,Group A (blood group),Unfavorable Non-Hodgkin Lymphoma,0
5925,Greatly,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5926,Probable diagnosis,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5927,Site of,papillary carcinoma of penis,0
5928,PSA Level Less than Five,Mucinous adenocarcinoma gastric,0
5929,Screens (device),Mucinous adenocarcinoma gastric,0
5930,Sharing (Social Behavior),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
5931,Singular,Recurrent Testicular Lymphoma,0
5932,Cervical lymph node group,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5933,Exposure to toxin,Adult Hepatocellular Carcinoma,0
5934,What subject filter - Result,Malignant Testicular Sertoli Cell Tumor,0
5935,Sarcoma,Granular Cell Leiomyosarcoma,0
5936,Mutation Abnormality,benign mature teratoma of pancreas,0
5937,Complication,Refractory Barrett Esophagus,0
5938,Increased risk for cancer,BRCA2 Syndrome,0
5939,Africa,FIGO Stage II Ovarian Cancer,0
5940,Tent - Recreation Equipment,Childhood Cerebellar Neoplasm,0
5941,Unit device,Childhood Thyroid Gland Follicular Carcinoma,0
5942,Severe (severity modifier),Stage I Adult Non-Hodgkin Lymphoma,0
5943,Representation (action),Testicular cancer metastatic,0
5944,Environmental risk factor,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5945,Feelings,Anterior Urethral Malignant Neoplasm,0
5946,Biomaterial Treatment,Primary Cutaneous Plasmablastic Lymphoma,0
5947,Malignant Neoplasms,Childhood Lymphoma,0
5948,Application Context,Benign Carotid Body Paraganglioma,0
5949,Base - General Qualifier,Uterine Cancer,0
5950,Malignant - descriptor,Heavy Chain Deposition Disease,0
5951,Cancer invasiveness,Testicular cancer metastatic,0
5952,survival aspects,Benign neoplasm of thorax,0
5953,Decreasing,Mucinous adenocarcinoma gastric,0
5954,geographic population,Refractory Barrett Esophagus,0
5955,Patient Caretaker,BRCA2 Syndrome,0
5956,Malignant neoplasm of breast,Female Breast Carcinoma,0
5957,Protons,Mucinous adenocarcinoma gastric,0
5958,radiotherapeutic,Endometrial Small Cell Carcinoma,0
5959,Assisted (qualifier value),Cancer of Urinary Tract,0
5960,FAP protein,Familial Adenomatous Polyposis Associated Medulloblastoma,0
5961,Following,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5962,Decision,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5963,Varies,Blepharal carcinoma,0
5964,kill - ActRelationshipJoin,Unresectable Rhabdomyosarcoma,0
5965,Feet,Cartilaginous exostosis,0
5966,Smoking,Mucinous adenocarcinoma gastric,0
5967,ancestors,Extracranial Neuroblastoma,0
5968,Tryptophanase,Acantholytic squamous cell carcinoma,0
5969,Malignant Neoplasms,Uterine Cancer,0
5970,Have Weight Loss,Mucinous adenocarcinoma gastric,0
5971,Table Rules - groups,Neonatal leukemia,0
5972,High Risk Acute Leukemia,Colorectal cancer,0
5973,metaplastic cell transformation,Recurrent Testicular Lymphoma,0
5974,Biological Response Modifiers,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5975,Tryptophanase,Atypical Lobular Breast Hyperplasia,0
5976,Gum of mandible,Giant cell angiofibroma,0
5977,Carcinoma,adenosquamous carcinoma of breast,0
5978,Have Shortness of Breath question,adenosquamous carcinoma of breast,0
5979,Death (finding),Undifferentiated Endocervical Sarcoma,0
5980,Fallopian Tubes,Stage II Fallopian Tube Cancer,0
5981,Yellow color,Extracranial Neuroblastoma,0
5982,Area,Pilocytic astrocytoma of cerebellum,0
5983,Patch Dosing Unit,Contact dermatitis due to alkali,0
5984,CD69 protein,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5985,Structure of spermatogenic epithelium,Spermatocytic seminoma,0
5986,Women's Health,Cancer of Urinary Tract,0
5987,Population Group,Metastatic Ductal Breast Carcinoma,0
5988,Used by,Noninfiltrating Intraductal Carcinoma,0
5989,Fill,mucinous adenocarcinoma of gallbladder,0
5990,Administration procedure,Airway Hemangioma,0
5991,Lung,gliosarcoma,0
5992,Weight Loss,adenosquamous carcinoma of breast,0
5993,Lung,adenoid cystic carcinoma of lung,0
5994,Hyperlink,Clonal Hematopoiesis of Indeterminate Potential,0
5995,HLA Class II Histocompatibility Antigen Gamma Chain,Secondary malignant neoplasm of lymph node,0
5996,thiocolchicoside,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
5997,Primary operation,Sarcomatoid Renal Cell Carcinoma,0
5998,Abnormal Cell Count,Testicular cancer metastatic,0
5999,One,Atypical Lobular Breast Hyperplasia,0
6000,Have Pain,Localized Askin Tumor,0
6001,Links List,Tonsillar Carcinoma,0
6002,Proton Pump Inhibitors,Refractory Barrett Esophagus,0
6003,Primary malignant neoplasm,adenosquamous carcinoma of breast,0
6004,Cancer Other,Benign neoplasm of thorax,0
6005,Bluish red color,Deep Leiomyoma,0
6006,Smear - instruction imperative,Recurrent Uveal Melanoma,0
6007,Evidence,Breast Ductal Adenoma,0
6008,Duplicate,Carcinoma ex pleomorphic adenoma of parotid gland,0
6009,Exposure to,Carcinoma of urinary bladder,0
6010,Empty (qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6011,Lymphatic vessel,Acute lymphadenitis,0
6012,skin color,Acute Undifferentiated Leukemia,0
6013,+5,Mucinous adenocarcinoma gastric,0
6014,Contain (action),Digestive System Hodgkin Lymphoma,0
6015,Germ cell tumor,Childhood Central Nervous System Immature Teratoma,0
6016,Requirement,Maxillary Sinus Adenocarcinoma,0
6017,Parameterized Data Type - Set,Extra-Adrenal Paraganglioma,0
6018,Reduced,Thymic Clear Cell Carcinoma,0
6019,Present,mucinous adenocarcinoma of gallbladder,0
6020,Cessation of life,Acantholytic squamous cell carcinoma,0
6021,Spinal Cord,Pilocytic astrocytoma of cerebellum,0
6022,Usual Severity Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
6023,SLC6A2 protein,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6024,Non-Secretory Plasma Cell Myeloma,Heavy Chain Deposition Disease,0
6025,Plasmacytoma,Heavy Chain Deposition Disease,0
6026,High Level,BRCA2 Syndrome,0
6027,Mucous Membrane,Maxillary Sinus Adenocarcinoma,0
6028,AKR1A1 wt Allele,Childhood Lymphoma,0
6029,Fasting,Recurrent Uveal Melanoma,0
6030,Therapeutic procedure,Localized Askin Tumor,0
6031,Probably,Acantholytic squamous cell carcinoma,0
6032,Bothered by Night Sweats,Unfavorable Non-Hodgkin Lymphoma,0
6033,Include (action),Pancreatic Intraepithelial Neoplasia-3,0
6034,Include (action),Hodgkin lymphoma,0
6035,Case (situation),Stage IB Lung Cancer AJCC v7,0
6036,Occur (action),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6037,Distention of blood vessel,Liver Cavernous Hemangioma,0
6038,Time,Recurrent Uveal Melanoma,0
6039,World,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6040,Contain (action),FIGO Stage II Ovarian Cancer,0
6041,Shapes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6042,Neoplasms,Mucinous neoplasm,0
6043,size,Cartilaginous exostosis,0
6044,Acute lymphocytic leukemia,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6045,Case (situation),Endometrial Small Cell Carcinoma,0
6046,Side,Endometrial Small Cell Carcinoma,0
6047,Ephrin Type-B Receptor 1,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6048,Before,Endometrial Small Cell Carcinoma,0
6049,analysis aspect,Adult Alveolar Soft Part Sarcoma,0
6050,DNA,Human Papillomavirus-Related Carcinoma,0
6051,Similarity,Adult Alveolar Soft Part Sarcoma,0
6052,Malignancy,Neonatal leukemia,0
6053,Medications:-:Point in time:^Patient:-,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6054,Ectodermal,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6055,ancestors,Clonal Hematopoiesis of Indeterminate Potential,0
6056,Mental blocking,Unresectable Rhabdomyosarcoma,0
6057,Form:Finding:Point in time:{Setting}:Document:{Role},Familial Adenomatous Polyposis Associated Medulloblastoma,0
6058,Architecture,Atypical Lobular Breast Hyperplasia,0
6059,Previous,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6060,Disease Screening,FIGO Stage II Ovarian Cancer,0
6061,Contain (action),papillary carcinoma of penis,0
6062,Ulcer,Stage II Carcinoma of Penis,0
6063,To,Bladder squamous cell carcinoma stage I,0
6064,Less Than,benign mature teratoma of pancreas,0
6065,Surgical repair,BRCA2 Syndrome,0
6066,Stem of plant,Leptomeningeal sarcoma,0
6067,Loss of appetite (finding),Stage IB Pancreatic Cancer AJCC v8,0
6068,Methods,Mucinous adenocarcinoma gastric,0
6069,Increase,Female Breast Carcinoma,0
6070,Operation excision,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6071,Probably,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6072,Same,Cartilaginous exostosis,0
6073,Certain (qualifier value),Mucinous adenocarcinoma gastric,0
6074,Two,Pancreatic Intraepithelial Neoplasia-3,0
6075,Two,Hodgkin lymphoma,0
6076,Second Suffix,Recurrent Testicular Lymphoma,0
6077,Representation (action),Maxillary Sinus Adenocarcinoma,0
6078,Malignant Childhood Neoplasm,Localized Askin Tumor,0
6079,Mechanism Component of Device,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6080,Carcinoma of bladder,Bladder squamous cell carcinoma stage I,0
6081,75,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6082,Type - attribute,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6083,Togo,Uterine Cancer,0
6084,Therapeutic procedure,Acantholytic squamous cell carcinoma,0
6085,Spreading (qualifier value),Adult Alveolar Soft Part Sarcoma,0
6086,Malignant Neoplasms,Benign neoplasm of thorax,0
6087,Curettage procedure,Undifferentiated Endocervical Sarcoma,0
6088,Radiation Ionizing Radiotherapy,Primary Cutaneous Plasmablastic Lymphoma,0
6089,One,Human Papillomavirus-Related Carcinoma,0
6090,Tumor Cell Invasion,Testicular cancer metastatic,0
6091,Contiguous gene syndrome,Ichthyosis,0
6092,year,Human Papillomavirus-Related Carcinoma,0
6093,year,Benign Carotid Body Paraganglioma,0
6094,Line Unit of Length,Angiosarcoma of liver,0
6095,Upper,Blepharal carcinoma,0
6096,Usual Severity Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6097,Africa,Bladder squamous cell carcinoma stage I,0
6098,United States,Acantholytic squamous cell carcinoma,0
6099,Have Nausea,Unfavorable Non-Hodgkin Lymphoma,0
6100,immunologist,Unresectable Rhabdomyosarcoma,0
6101,Anatomic Site,adenoid cystic carcinoma of lung,0
6102,per year,Extra-Adrenal Paraganglioma,0
6103,Occurrence,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6104,brain cell,gliosarcoma,0
6105,Proliferation (morphologic abnormality),Testicular cancer metastatic,0
6106,Plumbum metallicum,Recurrent Testicular Lymphoma,0
6107,therapeutic aspects,Acantholytic squamous cell carcinoma,0
6108,Main,Methotrexate-Associated Hodgkin Lymphoma,0
6109,Scientific Publication,Noninfiltrating Intraductal Carcinoma,0
6110,Approximate,Malignant melanoma of eyelid,0
6111,CEL gene,Breast Ductal Adenoma,0
6112,Near,Malignant melanoma of eyelid,0
6113,Epstein-Barr Virus Early RNA,Cancer of Urinary Tract,0
6114,To,Benign Apocrine Neoplasm,0
6115,Stem cell transplant,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6116,Urinary Bladder,Intestinal Metaplasia of Bladder Urothelium,0
6117,Americas Ethnicity,Unresectable Rhabdomyosarcoma,0
6118,Term (temporal),Adult Alveolar Soft Part Sarcoma,0
6119,Hematological Disease,Heavy Chain Deposition Disease,0
6120,Hematological Disease,Familial Hemophagocytic Lymphocytosis,0
6121,40%,Undifferentiated Endocervical Sarcoma,0
6122,Present,Cancer of Urinary Tract,0
6123,Known,Endometrial Small Cell Carcinoma,0
6124,Secretory Vesicles,Intestinal Neuroendocrine Carcinoma,0
6125,Body site,Benign neoplasm of thorax,0
6126,Slightly (qualifier value),Recurrent Uveal Melanoma,0
6127,Acute lymphocytic leukemia,Acute Undifferentiated Leukemia,0
6128,Environmental risk factor,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6129,Chemotherapy Regimen,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6130,Exposure to radiation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6131,combination of objects,Mucinous adenocarcinoma gastric,0
6132,Microvolt,Recurrent Uveal Melanoma,0
6133,Survey Foot,Cartilaginous exostosis,0
6134,Fever symptoms (finding),Methotrexate-Associated Hodgkin Lymphoma,0
6135,Pharmacotherapy,Lung squamous cell carcinoma stage I,0
6136,Bladder Continence Question,Carcinoma of urinary bladder,0
6137,Percent (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
6138,Developed Countries,Mucinous adenocarcinoma gastric,0
6139,Science of Etiology,Airway Hemangioma,0
6140,Approach,Female Breast Carcinoma,0
6141,Type - attribute,Recurrent Testicular Lymphoma,0
6142,Pathogenic organism,Testicular cancer metastatic,0
6143,Chemotherapy,Mucinous adenocarcinoma gastric,0
6144,Rare,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6145,Major <insect>,Childhood Lymphoma,0
6146,Forecast of outcome,Primary Cutaneous Plasmablastic Lymphoma,0
6147,Undescended testis (body structure),Malignant Testicular Sertoli Cell Tumor,0
6148,control substance,Stage IB Pancreatic Cancer AJCC v8,0
6149,color additive,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6150,Case (situation),Uterine Cancer,0
6151,Due to,Ichthyosis,0
6152,Cancer Registry,Rhabdomyosarcoma with ganglionic differentiation,0
6153,Arsenic,Angiosarcoma of liver,0
6154,Mechanism (attribute),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6155,various other nasal preparations in ATC,Placental aromatase deficiency,0
6156,include - SetOperator,Human Papillomavirus-Related Carcinoma,0
6157,Ovary,Endometrial Small Cell Carcinoma,0
6158,Body tissue,Neonatal leukemia,0
6159,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Unfavorable Non-Hodgkin Lymphoma,0
6160,Skin symptom,Ichthyosis,0
6161,Family history,Bladder squamous cell carcinoma stage I,0
6162,Aggressive behavior,Stage IB Pancreatic Cancer AJCC v8,0
6163,Include (action),Diffuse malignant mesothelioma,0
6164,Peeling of skin,Ichthyoses,0
6165,Devices,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6166,Oropharyngeal,Tonsillar Carcinoma,0
6167,Obesity,Undifferentiated Endocervical Sarcoma,0
6168,Blood,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6169,Negation,Female Breast Carcinoma,0
6170,Reported Term,Atypical Lobular Breast Hyperplasia,0
6171,United States,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6172,Pleomorphic,Carcinoma ex pleomorphic adenoma of parotid gland,0
6173,Morning,Malignant neoplasm of thalamus,0
6174,Study Site,Testicular cancer metastatic,0
6175,59,Malignant melanoma of eyelid,0
6176,MNX1 gene,benign mature teratoma of pancreas,0
6177,Ovarian Carcinoma,Adenocarcinoma,0
6178,Cell positive for CD34 antigen,Mastocytosis,0
6179,Then,Digestive System Hodgkin Lymphoma,0
6180,Pediculus (eukaryote),Extracranial Neuroblastoma,0
6181,Clinical Effectiveness,Breast Ductal Adenoma,0
6182,Nausea,Unfavorable Non-Hodgkin Lymphoma,0
6183,Call (Instruction),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6184,Formed,Testicular cancer metastatic,0
6185,Tryptophanase,FIGO Stage II Ovarian Cancer,0
6186,Lymphoma,Hodgkin lymphoma,0
6187,Ovarian Carcinoma,FIGO Stage II Ovarian Cancer,0
6188,risk factors,Intestinal Metaplasia of Bladder Urothelium,0
6189,APC gene,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6190,Event Seriousness - Significant,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6191,Mammal liver preparation,Mucinous adenocarcinoma gastric,0
6192,Central,Advanced Uterine Corpus Carcinosarcoma,0
6193,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Bladder squamous cell carcinoma stage I,0
6194,Followed by,Carcinoma of urinary bladder,0
6195,Death NOS,Acute Undifferentiated Leukemia,0
6196,per year,Diffuse malignant mesothelioma,0
6197,Trachea (moth),adenoid cystic carcinoma of lung,0
6198,Extremely Agree,Recurrent Testicular Lymphoma,0
6199,Release - action (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6200,Including (qualifier),Stage II Carcinoma of Penis,0
6201,Hemorrhage,Anterior Urethral Malignant Neoplasm,0
6202,Fever symptoms (finding),Malignant Neoplasm with Regional Lymph Node Involvement,0
6203,Refractory Cytopenia of Childhood,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6204,Fever,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6205,Timepoint,Acantholytic squamous cell carcinoma,0
6206,Operative Surgical Procedures,Carcinoma of urinary bladder,0
6207,60%,Diffuse malignant mesothelioma,0
6208,Blood group antibody I,Atypical Lobular Breast Hyperplasia,0
6209,Papillary,Giant cell angiofibroma,0
6210,Aggressive behavior,Female Breast Carcinoma,0
6211,Practice Experience,Acute lymphadenitis,0
6212,Cachexia,mucinous adenocarcinoma of gallbladder,0
6213,Diagnosis Study,Bladder squamous cell carcinoma stage I,0
6214,classical example,Leiomyoma of Gallbladder,0
6215,High,Mucinous adenocarcinoma gastric,0
6216,Symptoms aspect,Hemangioma,0
6217,veterans alcoholism screening test (VAST),Stage IB Lung Cancer AJCC v7,0
6218,Fourth (suffix),Familial Hemophagocytic Lymphocytosis,0
6219,Cells,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6220,More,Endometrial Small Cell Carcinoma,0
6221,Cancer Genus,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6222,Occurrence Indicator,Pancreatic Intraepithelial Neoplasia-3,0
6223,Common (qualifier value),Intestinal Neuroendocrine Carcinoma,0
6224,Pharyngeal structure,Larynx carcinoma recurrent,0
6225,Present,Atypical Mesothelial Hyperplasia,0
6226,Qualitative form,Maxillary Sinus Adenocarcinoma,0
6227,Major <insect>,Stage I Adult Non-Hodgkin Lymphoma,0
6228,Greater,Diffuse malignant mesothelioma,0
6229,treatment - ActInformationManagementReason,Recurrent Testicular Lymphoma,0
6230,Chemotherapy Regimen,Acantholytic squamous cell carcinoma,0
6231,Egg of order Phthiraptera,Extracranial Neuroblastoma,0
6232,Cancer Genus,Metastatic Neoplasm to the Gallbladder,0
6233,Usually,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6234,Tryptophanase,Bladder squamous cell carcinoma stage I,0
6235,Night sweats,Hodgkin lymphoma,0
6236,color additive,Acute Undifferentiated Leukemia,0
6237,Spongiosis,Spongiotic dermatitis,0
6238,Chemotherapy Regimen,Malignant melanoma of eyelid,0
6239,Macrophage Activation Syndrome,Pancreatic Intraepithelial Neoplasia-3,0
6240,Fracture,Localized Askin Tumor,0
6241,Including (qualifier),Anterior Urethral Malignant Neoplasm,0
6242,Adult Lymphoma,Thymic Clear Cell Carcinoma,0
6243,Suspected diagnosis,Diffuse malignant mesothelioma,0
6244,Pruritus,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6245,Greeks,Thymic Clear Cell Carcinoma,0
6246,Occurrence,Adenocarcinoma of the prostate metastatic,0
6247,Immature Lymphocytes Measurement,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6248,Related personal status,Clonal Hematopoiesis of Indeterminate Potential,0
6249,Subtype (attribute),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6250,Retinoic Acid Response Element,gliosarcoma,0
6251,New,de novo Myelodysplastic Syndrome,0
6252,Did not receive therapy or drug for,mucinous adenocarcinoma of gallbladder,0
6253,Malignant Neoplasms,squamous cell carcinoma of the thyroid gland,0
6254,Malignant neoplasm of breast,Atypical Lobular Breast Hyperplasia,0
6255,Involvement with,Acute lymphadenitis,0
6256,SPINK5 gene,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6257,Malignant neoplasm of kidney,Sarcomatoid Renal Cell Carcinoma,0
6258,Financial Account,Undifferentiated Endocervical Sarcoma,0
6259,Cover - action,Secondary malignant neoplasm of lymph node,0
6260,Cervical Atlas,Advanced Uterine Corpus Carcinosarcoma,0
6261,Breast Cancer Type 1 Susceptibility Protein Measurement,FIGO Stage II Ovarian Cancer,0
6262,production,Leiomyoma of Gallbladder,0
6263,Malignant Neoplasms,Recurrent Uveal Melanoma,0
6264,Adult,Human Papillomavirus-Related Carcinoma,0
6265,Distant,Angiosarcoma of liver,0
6266,Botswana,Cancer of Urinary Tract,0
6267,Hemoptysis,Stage IB Lung Cancer AJCC v7,0
6268,Head,Adult Alveolar Soft Part Sarcoma,0
6269,Tired,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6270,favor,mucinous adenocarcinoma of gallbladder,0
6271,Immune System Processes,Malignant melanoma of eyelid,0
6272,Subject Risk,Diffuse malignant mesothelioma,0
6273,Weight,Refractory Barrett Esophagus,0
6274,Aspects of disease screening,Mucinous adenocarcinoma gastric,0
6275,Persons,Primary Cutaneous Plasmablastic Lymphoma,0
6276,Gingiva,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6277,Life Expectancy Less than Twenty Years,Pilocytic astrocytoma of cerebellum,0
6278,Uncomplicated,Cancer of Urinary Tract,0
6279,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Female Breast Carcinoma,0
6280,Treated with,Spongiotic dermatitis,0
6281,Shortness of Breath Visual Analogue Scale,Stage IB Lung Cancer AJCC v7,0
6282,Three,Cancer of Urinary Tract,0
6283,Usually,Malignant Testicular Sertoli Cell Tumor,0
6284,Aplasia Cutis Congenita,adenoid cystic carcinoma of lung,0
6285,10%,Clonal Hematopoiesis of Indeterminate Potential,0
6286,Teratoma,benign mature teratoma of pancreas,0
6287,Rapid,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6288,Three,Neonatal leukemia,0
6289,W stress,Spongiotic dermatitis,0
6290,*Type - Kind of quantity,Metastatic Carcinoma in the Lung,0
6291,treatment - ActInformationManagementReason,Intestinal Metaplasia of Bladder Urothelium,0
6292,Importance Rating Score 0,BRCA2 Syndrome,0
6293,Characteristics,Recurrent Testicular Lymphoma,0
6294,Due to,adenosquamous carcinoma of breast,0
6295,described,Digestive System Hodgkin Lymphoma,0
6296,World,Mucinous adenocarcinoma gastric,0
6297,Surgery specialty,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6298,South East Asian,Blepharal carcinoma,0
6299,Recommendation,Human Papillomavirus-Related Carcinoma,0
6300,Recommendation,Benign Carotid Body Paraganglioma,0
6301,Smear - instruction imperative,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6302,Uncontrolled,adenosquamous carcinoma of breast,0
6303,Neoplasms,Benign Carotid Body Paraganglioma,0
6304,Portion of urine,Cancer of Urinary Tract,0
6305,Result,Malignant melanoma of eyelid,0
6306,Precipitating Factors,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6307,Benign Smooth Muscle Neoplasm,Metastatic Neoplasm to the Gallbladder,0
6308,Persons,Bladder squamous cell carcinoma stage I,0
6309,Lymphatic,Angiosarcoma of liver,0
6310,Biogenic Amines,Colorectal Neuroendocrine Tumor G2,0
6311,Pharmacotherapy,Bladder squamous cell carcinoma stage I,0
6312,Bone marrow aspiration procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6313,Web Site,Familial Hemophagocytic Lymphocytosis,0
6314,Diffuse Large B-Cell Lymphoma,Recurrent Testicular Lymphoma,0
6315,Diagnostic Neoplasm Staging,Carcinoma of urinary bladder,0
6316,Type - attribute,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6317,Related personal status,FIGO Stage II Ovarian Cancer,0
6318,Contrast Media,Granular Cell Leiomyosarcoma,0
6319,Body structure,Colorectal Neuroendocrine Tumor G2,0
6320,Universal - VocabularyDomainQualifier,Cartilaginous exostosis,0
6321,Secondary Neoplasm,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6322,Sample Range,Recurrent Testicular Lymphoma,0
6323,Vertebrates,BRCA2 Syndrome,0
6324,Division (surgical procedure),Recurrent Testicular Lymphoma,0
6325,Component object,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6326,transmission process,Human Papillomavirus-Related Carcinoma,0
6327,Present,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6328,Add - instruction imperative,Recurrent Testicular Lymphoma,0
6329,To,Malignant Neoplasm with Regional Lymph Node Involvement,0
6330,Call (Instruction),Mastocytosis,0
6331,include - SetOperator,Carcinoma of urinary bladder,0
6332,Usual,Mucinous adenocarcinoma gastric,0
6333,IPSS Risk Category Low,mucinous adenocarcinoma of gallbladder,0
6334,Antidepressive Agents,Refractory Barrett Esophagus,0
6335,Salivary Glands,adenoid cystic carcinoma of lung,0
6336,Living Alone,Endometrial Small Cell Carcinoma,0
6337,Physical shape,Intracortical osteosarcoma,0
6338,History,Recurrent Uveal Melanoma,0
6339,Before,Acantholytic squamous cell carcinoma,0
6340,Adult Lymphoma,Colorectal High Grade B-Cell Lymphoma,0
6341,Biopsy,Bladder squamous cell carcinoma stage I,0
6342,fluid - substance,Diffuse malignant mesothelioma,0
6343,Humor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6344,Usual Severity Weight Loss,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6345,Forecast of outcome,Acantholytic squamous cell carcinoma,0
6346,Application Context,Ichthyosis,0
6347,Injury due to exposure to external cause,Diffuse malignant mesothelioma,0
6348,Biomaterial Treatment,Maxillary Sinus Adenocarcinoma,0
6349,eTMF Content Model Code,Rhabdomyosarcoma with ganglionic differentiation,0
6350,failed,Cancer of Urinary Tract,0
6351,Transformation,Recurrent Testicular Lymphoma,0
6352,status - In progress,Recurrent Testicular Lymphoma,0
6353,Enlargement procedure,Stage I Adult Non-Hodgkin Lymphoma,0
6354,High,Diffuse malignant mesothelioma,0
6355,Hydranencephaly with Renal Aplasia-Dysplasia,de novo Myelodysplastic Syndrome,0
6356,Out (direction),Blepharal carcinoma,0
6357,Symptoms,Stage IB Pancreatic Cancer AJCC v8,0
6358,Act Relationship Type - occurrence,Maxillary Sinus Adenocarcinoma,0
6359,Separate,Diffuse malignant mesothelioma,0
6360,Patient Reported Outcome Stem,Leptomeningeal sarcoma,0
6361,Clear cell carcinoma of lung,Adenocarcinoma,0
6362,Malignant neoplasm of breast,Testicular cancer metastatic,0
6363,Proliferation (morphologic abnormality),Carcinoma ex pleomorphic adenoma of parotid gland,0
6364,Therapeutic radiology procedure,Mucinous adenocarcinoma gastric,0
6365,Fix,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6366,Virus,Human Papillomavirus-Related Carcinoma,0
6367,Unknown,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6368,Cerebral Cavernous Hemangioma,Hemangioma,0
6369,Tonsil,Tonsillar Carcinoma,0
6370,Occurrence Indicator,Angiosarcoma of liver,0
6371,Occur (action),Ichthyosis,0
6372,Adult human body,Digestive System Hodgkin Lymphoma,0
6373,Inguinal part of abdomen,Childhood Lymphoma,0
6374,Stains,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6375,*Type - Kind of quantity,Metastatic Ductal Breast Carcinoma,0
6376,Pleomorphism,Carcinoma ex pleomorphic adenoma of parotid gland,0
6377,Malignant neoplasm of urinary bladder,Carcinoma of urinary bladder,0
6378,Disease,Uterine Cancer,0
6379,Skin lesion,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6380,cell growth,Undifferentiated Endocervical Sarcoma,0
6381,Intercellular Junctions,Liver Cavernous Hemangioma,0
6382,Mean Percent of Normal,Endometrial Small Cell Carcinoma,0
6383,Clothing,Diffuse malignant mesothelioma,0
6384,A Codes,Noninfiltrating Intraductal Carcinoma,0
6385,Malignant neoplasm of lung,Stage IB Lung Cancer AJCC v7,0
6386,adaptive,Thymic Clear Cell Carcinoma,0
6387,Body tissue,FIGO Stage II Ovarian Cancer,0
6388,What subject filter - Result,Contact dermatitis due to alkali,0
6389,Malignant Neoplasms,Human Papillomavirus-Related Carcinoma,0
6390,Malignant Neoplasms,Benign Carotid Body Paraganglioma,0
6391,Nevus,GIANT PIGMENTED HAIRY NEVUS,0
6392,Only - dosing instruction fragment,FIGO Stage II Ovarian Cancer,0
6393,Approximate,Adult Fibrolamellar Carcinoma,0
6394,Administration procedure,Adult Hepatocellular Carcinoma,0
6395,Japanese race,Unresectable Rhabdomyosarcoma,0
6396,Capsule Shape,Thymic Clear Cell Carcinoma,0
6397,Frequently,Tonsillar Carcinoma,0
6398,Test Result,Benign neoplasm of thorax,0
6399,Pelvic Pain,Undifferentiated Endocervical Sarcoma,0
6400,survival aspects,Recurrent Uveal Melanoma,0
6401,Bacteria,Mucinous adenocarcinoma gastric,0
6402,What subject filter - Result,Malignant melanoma of eyelid,0
6403,CDISC SDTM Disease Outcome Terminology,Female Breast Carcinoma,0
6404,Links List,Adult Hepatocellular Carcinoma,0
6405,Variant,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6406,Patient Discharge,Stage II Carcinoma of Penis,0
6407,What subject filter - Result,Thymic Clear Cell Carcinoma,0
6408,Offspring,Malignant neoplasm of choroid,0
6409,chronic,Adult Hepatocellular Carcinoma,0
6410,Slow Growing,adenoid cystic carcinoma of lung,0
6411,Digestive Enzymes,Pancreatic Intraepithelial Neoplasia-3,0
6412,Grade,Breast Ductal Adenoma,0
6413,Muscle (organ),Anterior Urethral Malignant Neoplasm,0
6414,Uterine Cancer,Endometrial Small Cell Carcinoma,0
6415,Malignant neoplasm of skin,Acantholytic squamous cell carcinoma,0
6416,Borg Category-Ratio 10 Perceived Exertion Score 5,Heavy Chain Deposition Disease,0
6417,Cisplatin,Diffuse malignant mesothelioma,0
6418,Acral,Giant cell angiofibroma,0
6419,40%,Human Papillomavirus-Related Carcinoma,0
6420,Make - Instruction Imperative,adenoid cystic carcinoma of lung,0
6421,Hormone Therapy,Uterine Cancer,0
6422,Portion of urine,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6423,Precision - second,Colorectal cancer,0
6424,Spreading (qualifier value),Blepharal carcinoma,0
6425,Primary,adenosquamous carcinoma of breast,0
6426,How Much Distress Shortness of Breath,adenosquamous carcinoma of breast,0
6427,Scrofula,Acute lymphadenitis,0
6428,Bone Growth,Cartilaginous exostosis,0
6429,Polyvinyl Chloride,Angiosarcoma of liver,0
6430,Physical findings,Stage IB Pancreatic Cancer AJCC v8,0
6431,Only - dosing instruction fragment,Thymic Clear Cell Carcinoma,0
6432,Improved - answer to question,Recurrent Testicular Lymphoma,0
6433,Recurrent infections,Carcinoma of urinary bladder,0
6434,Primary malignant neoplasm,Colorectal cancer,0
6435,consider,benign mature teratoma of pancreas,0
6436,peripheral blood,Digestive System Hodgkin Lymphoma,0
6437,Probability,Malignant melanoma of eyelid,0
6438,Cancer Genus,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6439,Latin America,Recurrent Uveal Melanoma,0
6440,Relational and Item-Specific Encoding Task,Clonal Hematopoiesis of Indeterminate Potential,0
6441,Morning,Choroid Necrotic Melanoma,0
6442,Free (available (qualifier)),BRCA2 Syndrome,0
6443,Arsenic measurement,Digestive System Hodgkin Lymphoma,0
6444,Etiology aspects,Airway Hemangioma,0
6445,Shapes,Cartilaginous exostosis,0
6446,include - SetOperator,Anterior Urethral Malignant Neoplasm,0
6447,Age-Years,Bladder squamous cell carcinoma stage I,0
6448,Numbers,squamous cell carcinoma of the thyroid gland,0
6449,Thick,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6450,Human Cells,Mucinous adenocarcinoma gastric,0
6451,Biomaterial Treatment,Airway Hemangioma,0
6452,Etiology aspects,Mucinous adenocarcinoma gastric,0
6453,Common (qualifier value),Mucinous adenocarcinoma gastric,0
6454,Disruptive,Familial Hemophagocytic Lymphocytosis,0
6455,Pylorus,Mucinous adenocarcinoma gastric,0
6456,Receptors,Thymic Clear Cell Carcinoma,0
6457,Chest pain:Finding:Point in time:^Patient:Ordinal,Refractory Barrett Esophagus,0
6458,General surgery specialty,Intestinal Metaplasia of Bladder Urothelium,0
6459,Late,Anterior Urethral Malignant Neoplasm,0
6460,lymph nodes,Recurrent Uveal Melanoma,0
6461,development aspects,Acute Undifferentiated Leukemia,0
6462,Retinoic Acid Response Element,Stage IB Pancreatic Cancer AJCC v8,0
6463,Screening Study,FIGO Stage II Ovarian Cancer,0
6464,United States Military Commissioned Officer O4,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6465,Formation,Adult Fibrolamellar Carcinoma,0
6466,70%,Stage IB Pancreatic Cancer AJCC v8,0
6467,Lymphoid Tissue,Malignant Neoplasm with Regional Lymph Node Involvement,0
6468,Reflecting,adenoid cystic carcinoma of lung,0
6469,Feel Nausea,Unfavorable Non-Hodgkin Lymphoma,0
6470,Diagnosis,Endometrial Small Cell Carcinoma,0
6471,N not otherwise specified Antibody,Anterior Urethral Malignant Neoplasm,0
6472,Pediculus (eukaryote),Leptomeningeal sarcoma,0
6473,Vestigium,Blepharal carcinoma,0
6474,To,Cancer of Urinary Tract,0
6475,Absent,Placental aromatase deficiency,0
6476,Fever,Cancer of Urinary Tract,0
6477,Tract,Endometrial Small Cell Carcinoma,0
6478,Same,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6479,Etiology,Airway Hemangioma,0
6480,Fatigue,Methotrexate-Associated Hodgkin Lymphoma,0
6481,Abnormal Reference Range,Endometrial Small Cell Carcinoma,0
6482,Area,Diffuse malignant mesothelioma,0
6483,Pharmacotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6484,Tumor cells,Angiosarcoma of liver,0
6485,Symptoms,Hemangioma,0
6486,biopsy characteristics,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6487,Representation (action),Stage IB Pancreatic Cancer AJCC v8,0
6488,More,Carcinoma of urinary bladder,0
6489,Chemotherapy,Primary Cutaneous Plasmablastic Lymphoma,0
6490,Feelings,Methotrexate-Associated Hodgkin Lymphoma,0
6491,Local disease,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6492,Fish (substance),Ichthyosis,0
6493,Fasting,Unfavorable Non-Hodgkin Lymphoma,0
6494,Body tissue,BRCA2 Syndrome,0
6495,B-Cell Receptor Complex,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6496,Radiological Exposure Device,Maxillary Sinus Adenocarcinoma,0
6497,Bone Pain,Acute Undifferentiated Leukemia,0
6498,Coughing,Diffuse malignant mesothelioma,0
6499,Common (qualifier value),Tonsillar Carcinoma,0
6500,Result,Malignant Testicular Sertoli Cell Tumor,0
6501,Symptoms,Acute Undifferentiated Leukemia,0
6502,Lesion,Human Papillomavirus-Related Carcinoma,0
6503,Resulting in,Testicular cancer metastatic,0
6504,Multiply - dosing instruction fragment,Testicular cancer metastatic,0
6505,depend,Intestinal Metaplasia of Bladder Urothelium,0
6506,Manufactured form,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6507,Line Unit of Length,Acute Undifferentiated Leukemia,0
6508,1980s,Undifferentiated Endocervical Sarcoma,0
6509,Affect (mental function),Localized Askin Tumor,0
6510,Microscopes,Adult Fibrolamellar Carcinoma,0
6511,Most,Pancreatic Intraepithelial Neoplasia-3,0
6512,Net (qualifier),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6513,Time,Noninfiltrating Intraductal Carcinoma,0
6514,Case unit dose,Carcinoma of urinary bladder,0
6515,Feel Nausea,Mucinous adenocarcinoma gastric,0
6516,Tanning of leather,Recurrent Uveal Melanoma,0
6517,Process (qualifier value),adenosquamous carcinoma of breast,0
6518,Adult Teratoma,benign mature teratoma of pancreas,0
6519,Negative Surgical Margin,Heavy Chain Deposition Disease,0
6520,Leading,FIGO Stage II Ovarian Cancer,0
6521,Have Shortness of Breath question,Diffuse malignant mesothelioma,0
6522,nonspecific,Acute lymphadenitis,0
6523,Increased risk for cancer,Atypical Lobular Breast Hyperplasia,0
6524,ATG5 wt Allele,Adult Alveolar Soft Part Sarcoma,0
6525,SLC35G1 gene,Lung squamous cell carcinoma stage I,0
6526,Including (qualifier),Carcinoma of urinary bladder,0
6527,CDISC SDTM Procedure Terminology,Endometrial Small Cell Carcinoma,0
6528,Lacrimal sac,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6529,NCI CTEP SDC Wilms Tumor Sub-Category Terminology,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6530,Entity Determiner - specific,Stage I Adult Non-Hodgkin Lymphoma,0
6531,Primary malignant neoplasm,Stage IB Lung Cancer AJCC v7,0
6532,Persons,Carcinoma of urinary bladder,0
6533,Malignant neoplasm of thyroid,squamous cell carcinoma of the thyroid gland,0
6534,activate - Data Operation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6535,Rare,Colorectal High Grade B-Cell Lymphoma,0
6536,Manufactured form,Metastatic Neoplasm to the Gallbladder,0
6537,Call (Instruction),Digestive System Hodgkin Lymphoma,0
6538,Function Axis,BRCA2 Syndrome,0
6539,Anatomic Site,Human Papillomavirus-Related Carcinoma,0
6540,Supportive assistance,Contact dermatitis due to alkali,0
6541,Divide,Recurrent Uveal Melanoma,0
6542,Corner Plus,Blepharal carcinoma,0
6543,Tired,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6544,Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6545,Methods,Acantholytic squamous cell carcinoma,0
6546,B-Cell Activation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6547,Symptoms aspect,Unfavorable Non-Hodgkin Lymphoma,0
6548,Gland,Benign Apocrine Neoplasm,0
6549,Referral placed,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6550,65+,Recurrent Uveal Melanoma,0
6551,Spreading (qualifier value),Bladder squamous cell carcinoma stage I,0
6552,Post,Metastatic Carcinoma in the Lung,0
6553,Abnormal number of nucleoli,Giant cell angiofibroma,0
6554,Lifetime,FIGO Stage II Ovarian Cancer,0
6555,Main,Choroid Necrotic Melanoma,0
6556,Vasculature,Digestive System Hodgkin Lymphoma,0
6557,leukemia,Methotrexate-Associated Hodgkin Lymphoma,0
6558,Version (morphologic abnormality),Familial Hemophagocytic Lymphocytosis,0
6559,Cartilage,Granular Cell Leiomyosarcoma,0
6560,include - SetOperator,papillary carcinoma of penis,0
6561,Rare Diseases,Placental aromatase deficiency,0
6562,Japan,Mucinous adenocarcinoma gastric,0
6563,United States,Acute Undifferentiated Leukemia,0
6564,fibroma,Giant cell angiofibroma,0
6565,Oral cavity,Recurrent Uveal Melanoma,0
6566,Poor - qualifier,Malignant melanoma of eyelid,0
6567,Acute monocytic leukemia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6568,Code,Leptomeningeal sarcoma,0
6569,Squamous cell carcinoma - category,papillary carcinoma of penis,0
6570,Science of Etiology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6571,Including (qualifier),FIGO Stage II Ovarian Cancer,0
6572,Breast Cancer Type 1 Susceptibility Protein Measurement,BRCA2 Syndrome,0
6573,Hodgkin Disease,Childhood Lymphoma,0
6574,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Undifferentiated Endocervical Sarcoma,0
6575,Initially,Adult Alveolar Soft Part Sarcoma,0
6576,Telephone Extension Number,Childhood Cerebellar Neoplasm,0
6577,Hormonal,Colorectal Neuroendocrine Tumor G2,0
6578,Etiology aspects,Malignant neoplasm of thalamus,0
6579,True primary (qualifier value),Grade 1 Clear Cell Renal Cell Carcinoma,0
6580,Providing presence (regime/therapy),Atypical Lobular Breast Hyperplasia,0
6581,Cells,BRCA2 Syndrome,0
6582,described,Giant cell angiofibroma,0
6583,X-Ray Computed Tomography,Pilocytic astrocytoma of cerebellum,0
6584,Hormone replacement therapy,FIGO Stage II Ovarian Cancer,0
6585,Malignant - descriptor,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6586,artesunate,Giant cell angiofibroma,0
6587,Effectiveness,Acantholytic squamous cell carcinoma,0
6588,Common Specifications in HL7 V3 Publishing,Anterior Urethral Malignant Neoplasm,0
6589,Surrounding (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6590,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6591,Mechanism Component of Device,Localized Askin Tumor,0
6592,Common Specifications in HL7 V3 Publishing,Adult Hepatocellular Carcinoma,0
6593,Susceptibility (property) (qualifier value),BRCA2 Syndrome,0
6594,Used by,Cancer of Urinary Tract,0
6595,Include (action),Anterior Urethral Malignant Neoplasm,0
6596,Varies,Spongiotic dermatitis,0
6597,Nuclear pleomorphism,Angiosarcoma of liver,0
6598,Symptoms aspect,Methotrexate-Associated Hodgkin Lymphoma,0
6599,shared attribute,Methotrexate-Associated Hodgkin Lymphoma,0
6600,Tracheal aspiration,Larynx carcinoma recurrent,0
6601,Breast Carcinoma,Metastatic Ductal Breast Carcinoma,0
6602,Cause of death.underlying,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6603,Immune system,Thymic Clear Cell Carcinoma,0
6604,Include (action),Malignant melanoma of eyelid,0
6605,Blood Platelets,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6606,Compression,mucinous adenocarcinoma of gallbladder,0
6607,Show,papillary carcinoma of penis,0
6608,History of previous events,Uterine Cancer,0
6609,Germ cell tumor,Germinoma,0
6610,morphological,Noninfiltrating Intraductal Carcinoma,0
6611,Entity Name Part Qualifier - birth,Airway Hemangioma,0
6612,Optic Chiasms,Pilocytic astrocytoma of cerebellum,0
6613,Form of uterus,Undifferentiated Endocervical Sarcoma,0
6614,Immune,Thymic Clear Cell Carcinoma,0
6615,Disease Response,Female Breast Carcinoma,0
6616,Neoplasms,Ampulla of Vater Tubular Adenoma,0
6617,Group A (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
6618,Body Fluids,Spongiotic dermatitis,0
6619,Period (temporal qualifier),Thymic Clear Cell Carcinoma,0
6620,Smooth muscle (tissue),Hemangioma,0
6621,Biological Response Modifiers,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6622,Repair,BRCA2 Syndrome,0
6623,Overall Survival,Female Breast Carcinoma,0
6624,Biogenic Amines,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6625,Complete Trisomy 21 Syndrome,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6626,Pesticides,Acute Undifferentiated Leukemia,0
6627,Science of Etiology,mucinous adenocarcinoma of gallbladder,0
6628,Prior Chemotherapy,Acute Undifferentiated Leukemia,0
6629,International Statistical Classification of Diseases and Related Health Problems,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6630,status - In progress,Acute Undifferentiated Leukemia,0
6631,Rare,Extra-Adrenal Paraganglioma,0
6632,Adult human body,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6633,Occur (action),Intestinal Neuroendocrine Carcinoma,0
6634,Loss of Appetite question,FIGO Stage II Ovarian Cancer,0
6635,First Intercourse,Human Papillomavirus-Related Carcinoma,0
6636,Classification of information,Noninfiltrating Intraductal Carcinoma,0
6637,Slow,Diffuse malignant mesothelioma,0
6638,Rapid,Unfavorable Non-Hodgkin Lymphoma,0
6639,Fatigue,Childhood Lymphoma,0
6640,Unknown GENC,Adult Alveolar Soft Part Sarcoma,0
6641,Pickled food,Mucinous adenocarcinoma gastric,0
6642,Diagnostic Imaging,Uterine Cancer,0
6643,Fatigue,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6644,Burkina Faso,Recurrent Uveal Melanoma,0
6645,Enlarged,Stage I Adult Non-Hodgkin Lymphoma,0
6646,Metastasis,Recurrent Uveal Melanoma,0
6647,Persons,Malignant melanoma of eyelid,0
6648,Involvement with,Larynx carcinoma recurrent,0
6649,Point Name,Human Papillomavirus-Related Carcinoma,0
6650,Time,GIANT PIGMENTED HAIRY NEVUS,0
6651,Cancer Genus,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6652,Layer of dermis,Acantholytic squamous cell carcinoma,0
6653,Endometrial biopsy,Endometrial Small Cell Carcinoma,0
6654,Diagnosis,Advanced Uterine Corpus Carcinosarcoma,0
6655,teratologic,Atypical Lobular Breast Hyperplasia,0
6656,Adenoma,Benign Apocrine Neoplasm,0
6657,Multiple malignancy,Carcinoma of urinary bladder,0
6658,Lifetime,Cancer of Urinary Tract,0
6659,Cancer Genus,Angiosarcoma of liver,0
6660,Occurrence,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6661,Twice - dosing instruction fragment,Mucinous adenocarcinoma gastric,0
6662,intrathecal chemotherapy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6663,Localized,Giant cell angiofibroma,0
6664,Upper urinary tract structure,Cancer of Urinary Tract,0
6665,Genetic,Stage IB Pancreatic Cancer AJCC v8,0
6666,Plant nodule,Deep Leiomyoma,0
6667,Low Level,Human Papillomavirus-Related Carcinoma,0
6668,control substance,Pancreatic Intraepithelial Neoplasia-3,0
6669,Exostoses,Cartilaginous exostosis,0
6670,Neoplasms,Angiosarcoma of liver,0
6671,Smell Perception,Stage II Carcinoma of Penis,0
6672,Occurrence,Ichthyosis,0
6673,spindle assembly checkpoint,Diffuse malignant mesothelioma,0
6674,Males,Carcinoma of urinary bladder,0
6675,Diagnosis,Uterine Cancer,0
6676,Etiology aspects,Localized Askin Tumor,0
6677,Case unit dose,Diffuse malignant mesothelioma,0
6678,Secondary to,Testicular cancer metastatic,0
6679,Including (qualifier),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6680,Country,Mucinous adenocarcinoma gastric,0
6681,Carcinoma,Lung squamous cell carcinoma stage I,0
6682,Hormonal Contraception,FIGO Stage II Ovarian Cancer,0
6683,Physical findings,Malignant Neoplasm with Regional Lymph Node Involvement,0
6684,metaplastic cell transformation,Granular Cell Leiomyosarcoma,0
6685,Laryngeal prominence,Childhood Thyroid Gland Follicular Carcinoma,0
6686,Primary malignant neoplasm,Adenocarcinoma of the prostate metastatic,0
6687,Present,Malignant neoplasm of choroid,0
6688,Specimen Source Codes - Tube,Sarcomatoid Renal Cell Carcinoma,0
6689,Stem of plant,Intracortical osteosarcoma,0
6690,Northern Europe,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6691,Human body structure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6692,Two,Uterine Cancer,0
6693,SPINK5 gene,Intestinal Neuroendocrine Carcinoma,0
6694,Insect Bites,Spongiotic dermatitis,0
6695,Wall of colon,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6696,Contents,Refractory Barrett Esophagus,0
6697,Skin Erosion,Recurrent Uveal Melanoma,0
6698,Example,Cartilaginous exostosis,0
6699,Publishing,Leptomeningeal sarcoma,0
6700,Blood Products Laboratory Testing,Extra-Adrenal Paraganglioma,0
6701,Smear test,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6702,Simple,Acantholytic squamous cell carcinoma,0
6703,Decision,Extracranial Neuroblastoma,0
6704,Symptoms,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6705,Adult Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6706,Tumor type,Mucinous neoplasm,0
6707,Two,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6708,Condition,mucinous adenocarcinoma of gallbladder,0
6709,Thin skin,Blepharal carcinoma,0
6710,Cold Sensation,Acantholytic squamous cell carcinoma,0
6711,Formation,Leiomyoma of Gallbladder,0
6712,Malignancy,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6713,Adult Soft Tissue Sarcoma,Adult Alveolar Soft Part Sarcoma,0
6714,Specific qualifier value,Intracortical osteosarcoma,0
6715,90 - 100%,Extra-Adrenal Paraganglioma,0
6716,Additional,Acute Undifferentiated Leukemia,0
6717,Left,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6718,Recurrent urinary tract infection,Cancer of Urinary Tract,0
6719,Hormonal,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6720,Call (Instruction),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6721,Disease remission,Acute Undifferentiated Leukemia,0
6722,Malignant tumor of cervix,Endometrial Small Cell Carcinoma,0
6723,structure,Adult Alveolar Soft Part Sarcoma,0
6724,Ovary,Undifferentiated Endocervical Sarcoma,0
6725,Death (finding),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6726,Pancreatic Cancer Pathway,Pancreatic Intraepithelial Neoplasia-3,0
6727,curettage specimen,Undifferentiated Endocervical Sarcoma,0
6728,Most,Recurrent Testicular Lymphoma,0
6729,Metabolic Inhibition,Unresectable Rhabdomyosarcoma,0
6730,Base - General Qualifier,Cancer of Urinary Tract,0
6731,Malignant - descriptor,Carcinoma ex pleomorphic adenoma of parotid gland,0
6732,BRCA2 gene,BRCA2 Syndrome,0
6733,low exposure,Human Papillomavirus-Related Carcinoma,0
6734,Relationships,Acantholytic squamous cell carcinoma,0
6735,Associated topography,Extra-Adrenal Paraganglioma,0
6736,90%,Human Papillomavirus-Related Carcinoma,0
6737,Homo sapiens,Angiosarcoma of liver,0
6738,Fever,Acute Undifferentiated Leukemia,0
6739,Decrease,Thymic Clear Cell Carcinoma,0
6740,Occur (action),Adult Hepatocellular Carcinoma,0
6741,Primary,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6742,Common (qualifier value),Colorectal Neuroendocrine Tumor G2,0
6743,Rapid,Acute Undifferentiated Leukemia,0
6744,Respiration,Larynx carcinoma recurrent,0
6745,Three,Digestive System Hodgkin Lymphoma,0
6746,Call (Instruction),Hodgkin lymphoma,0
6747,Due to,Leiomyoma of Gallbladder,0
6748,exception - ResponseLevel,Cancer of Urinary Tract,0
6749,Diabetes,Undifferentiated Endocervical Sarcoma,0
6750,Occurrence Indicator,Malignant Testicular Sertoli Cell Tumor,0
6751,Chemotherapy,Malignant Testicular Sertoli Cell Tumor,0
6752,Form:Finding:Point in time:{Setting}:Document:{Role},Breast Ductal Adenoma,0
6753,Name (property) (qualifier value),Clonal Hematopoiesis of Indeterminate Potential,0
6754,Stem of Organ,Clonal Hematopoiesis of Indeterminate Potential,0
6755,Type - attribute,Urethral Carcinoma,0
6756,Coding Subtest (WAIS-IV),BRCA2 Syndrome,0
6757,Rare,Cancer of Urinary Tract,0
6758,Anabolism,Pilocytic astrocytoma of cerebellum,0
6759,How Often Felt Normal question,Endometrial Small Cell Carcinoma,0
6760,Alternative,BRCA2 Syndrome,0
6761,Cancer Registry,Intracortical osteosarcoma,0
6762,All,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6763,fluid - substance,Anterior Urethral Malignant Neoplasm,0
6764,Cerebral Cavernous Hemangioma,Liver Cavernous Hemangioma,0
6765,Tumor Mass,Noninfiltrating Intraductal Carcinoma,0
6766,Retained,Primary Cutaneous Plasmablastic Lymphoma,0
6767,Autosomal recessive inheritance,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6768,Case (situation),Pancreatic Intraepithelial Neoplasia-3,0
6769,Corner Minus,Blepharal carcinoma,0
6770,Death (finding),Acantholytic squamous cell carcinoma,0
6771,Immunotherapy,Bladder squamous cell carcinoma stage I,0
6772,Orbital region,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6773,With shape,Giant cell angiofibroma,0
6774,Term (lexical),Pancreatic Intraepithelial Neoplasia-3,0
6775,Include (action),Stage IB Pancreatic Cancer AJCC v8,0
6776,African American,Localized Askin Tumor,0
6777,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6778,depend,Recurrent Uveal Melanoma,0
6779,Point,Human Papillomavirus-Related Carcinoma,0
6780,Malignant neoplasm of brain,gliosarcoma,0
6781,65,Bladder squamous cell carcinoma stage I,0
6782,shared attribute,Intestinal Metaplasia of Bladder Urothelium,0
6783,Therapeutic procedure,Spongiotic dermatitis,0
6784,Process (qualifier value),Testicular cancer metastatic,0
6785,Diagnosis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6786,Type A,Stage I Adult Non-Hodgkin Lymphoma,0
6787,Appearance Distress Question,Carcinoma ex pleomorphic adenoma of parotid gland,0
6788,Lymphocyte,Childhood Lymphoma,0
6789,Meningocele,benign mature teratoma of pancreas,0
6790,mast cell,Mastocytosis,0
6791,Lateral ventricle structure,Malignant neoplasm of choroid,0
6792,Renal carcinoma,Sarcomatoid Renal Cell Carcinoma,0
6793,To,Human Papillomavirus-Related Carcinoma,0
6794,potential,Carcinoma ex pleomorphic adenoma of parotid gland,0
6795,Recommendation,FIGO Stage II Ovarian Cancer,0
6796,Retinoic Acid Response Element,Airway Hemangioma,0
6797,Close,Clonal Hematopoiesis of Indeterminate Potential,0
6798,National origin,Adult Alveolar Soft Part Sarcoma,0
6799,Skin Specimen,papillary carcinoma of penis,0
6800,Usual,Recurrent Testicular Lymphoma,0
6801,Numbers,Endometrial Small Cell Carcinoma,0
6802,Formation,Breast Ductal Adenoma,0
6803,Including (qualifier),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6804,Irregular,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6805,Patch - Extended Release Film,Contact dermatitis due to alkali,0
6806,Case (situation),Placental aromatase deficiency,0
6807,Feel Tired question,Methotrexate-Associated Hodgkin Lymphoma,0
6808,Involvement with,Diffuse malignant mesothelioma,0
6809,Room of building - Study,Acute Undifferentiated Leukemia,0
6810,Vagina,Anterior Urethral Malignant Neoplasm,0
6811,radiotherapeutic,Acantholytic squamous cell carcinoma,0
6812,Supportive assistance,Uterine Cancer,0
6813,Clear,Heavy Chain Deposition Disease,0
6814,Involvement with,Female Breast Carcinoma,0
6815,Surgical aspects,Intestinal Metaplasia of Bladder Urothelium,0
6816,Skeletal bone,Cartilaginous exostosis,0
6817,burrow wound,Adult Alveolar Soft Part Sarcoma,0
6818,Characteristics,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6819,Abdomen,Benign Carotid Body Paraganglioma,0
6820,Hemorrhage,Stage II Carcinoma of Penis,0
6821,Anatomic Site,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6822,How Often Weight Loss,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6823,various other intestinal adsorbents in ATC,Placental aromatase deficiency,0
6824,Smear - instruction imperative,Carcinoma of urinary bladder,0
6825,month,Acantholytic squamous cell carcinoma,0
6826,Due to,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
6827,Liquid substance,Digestive System Hodgkin Lymphoma,0
6828,Visceral,Angiosarcoma of liver,0
6829,Response (communication),Breast Ductal Adenoma,0
6830,include - SetOperator,Childhood Lymphoma,0
6831,Cell Count,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6832,Body Fluids,Anterior Urethral Malignant Neoplasm,0
6833,Metastasis,Tonsillar Carcinoma,0
6834,Time,Recurrent Testicular Lymphoma,0
6835,Tryptophanase,Cartilaginous exostosis,0
6836,Uveal melanoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6837,Back Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6838,Certainties,Carcinoma of urinary bladder,0
6839,Coughing,adenosquamous carcinoma of breast,0
6840,Less Than,FIGO Stage II Ovarian Cancer,0
6841,Referring,Endometrial Small Cell Carcinoma,0
6842,Associated topography,Testicular cancer metastatic,0
6843,Cancer Genus,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6844,Aldosterone,Collecting Duct Carcinoma of the Kidney,0
6845,Serous,Atypical Mesothelial Hyperplasia,0
6846,Study of epidemiology,gliosarcoma,0
6847,Paraganglioma,Benign neoplasm of thorax,0
6848,ACACA wt Allele,adenoid cystic carcinoma of lung,0
6849,Lead,FIGO Stage II Ovarian Cancer,0
6850,Bone Marrow Cells,Heavy Chain Deposition Disease,0
6851,Uterus,Uterine Cancer,0
6852,International Aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6853,Following,Acantholytic squamous cell carcinoma,0
6854,Cystic,Papillary cystic tumor,0
6855,How Much Distress Vomiting,Mucinous adenocarcinoma gastric,0
6856,Histology aspects,Adult Hepatocellular Carcinoma,0
6857,800,Malignant melanoma of eyelid,0
6858,Occurrence Indicator,Acantholytic squamous cell carcinoma,0
6859,Skin tanning,Recurrent Uveal Melanoma,0
6860,Morphology,benign mature teratoma of pancreas,0
6861,Diameter (qualifier value),Maxillary Sinus Adenocarcinoma,0
6862,Adult Diffuse Large B-Cell Lymphoma,ALK positive large B-cell lymphoma,0
6863,Providing presence (regime/therapy),Giant cell angiofibroma,0
6864,Anal Sex,Human Papillomavirus-Related Carcinoma,0
6865,Elderly (population group),Primary Cutaneous Plasmablastic Lymphoma,0
6866,immunoglobulin complex location,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6867,Disease Screening,Undifferentiated Endocervical Sarcoma,0
6868,Worse,Choroid Necrotic Melanoma,0
6869,Lymphatic,Digestive System Hodgkin Lymphoma,0
6870,Numerous,Unfavorable Non-Hodgkin Lymphoma,0
6871,Bladder Infection,Cancer of Urinary Tract,0
6872,Treatment Epoch,Spermatocytic seminoma,0
6873,Further,Cancer of Urinary Tract,0
6874,Early,Human Papillomavirus-Related Carcinoma,0
6875,Metastatic Neoplasm,Stage IB Lung Cancer AJCC v7,0
6876,High Mitosis-Karyorrhexis Index,FIGO Stage II Ovarian Cancer,0
6877,MYOT gene,Leiomyoma of Gallbladder,0
6878,Ductal Carcinoma,Breast Ductal Adenoma,0
6879,Bloating,FIGO Stage II Ovarian Cancer,0
6880,Life threatening - Event Consequence,Neonatal leukemia,0
6881,Hemangioma,Hemangioma,0
6882,3+ Score,BRCA2 Syndrome,0
6883,Feel Tired question,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6884,Metastasis,Testicular cancer metastatic,0
6885,shared attribute,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6886,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Methotrexate-Associated Hodgkin Lymphoma,0
6887,Greasy skin,Benign Apocrine Neoplasm,0
6888,Covered (qualifier value),Giant cell angiofibroma,0
6889,Skin Specimen,Recurrent Uveal Melanoma,0
6890,Symptoms,Liver Cavernous Hemangioma,0
6891,B-Lymphocytes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6892,Tickling sensation quality,Extracranial Neuroblastoma,0
6893,First (number),Cancer of Urinary Tract,0
6894,Disseminated Malignant Neoplasm,Acute Undifferentiated Leukemia,0
6895,Feelings,Diffuse malignant mesothelioma,0
6896,Benign,Extra-Adrenal Paraganglioma,0
6897,Entity Determiner - specific,Pancreatic Intraepithelial Neoplasia-3,0
6898,Specific qualifier value,Pancreatic Intraepithelial Neoplasia-3,0
6899,Entity Determiner - specific,Hodgkin lymphoma,0
6900,Specific qualifier value,Hodgkin lymphoma,0
6901,bony process,Collecting Duct Carcinoma of the Kidney,0
6902,Redness,Maxillary Sinus Adenocarcinoma,0
6903,Form:Finding:Point in time:{Setting}:Document:{Role},Mucinous neoplasm,0
6904,Parameterized Data Type - Set,Benign neoplasm of thorax,0
6905,Qualitative form,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6906,Pancreas,Intestinal Neuroendocrine Carcinoma,0
6907,Dysuria,Cancer of Urinary Tract,0
6908,biopsy characteristics,Mucinous adenocarcinoma gastric,0
6909,Surrounding (qualifier value),Childhood Thyroid Gland Follicular Carcinoma,0
6910,Fever,Hodgkin lymphoma,0
6911,Phimosis,Stage II Carcinoma of Penis,0
6912,Phrase,Cartilaginous exostosis,0
6913,Administration procedure,FIGO Stage II Ovarian Cancer,0
6914,Skin tanning,Malignant melanoma of eyelid,0
6915,Swollen Lymph Node,Recurrent Testicular Lymphoma,0
6916,Often - answer to question,Recurrent Uveal Melanoma,0
6917,CYP19A1 protein,Placental aromatase deficiency,0
6918,Esophagus,Larynx carcinoma recurrent,0
6919,Variety (taxon),Mastocytosis,0
6920,Classification of information,Secondary malignant neoplasm of lymph node,0
6921,Life Threatening,Neonatal leukemia,0
6922,Diagnosis Study,Mucinous adenocarcinoma gastric,0
6923,Including (qualifier),Benign Apocrine Neoplasm,0
6924,pharmacotherapeutic,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6925,How Much Distress Shortness of Breath,Diffuse malignant mesothelioma,0
6926,Magnetic Resonance Imaging,Anterior Urethral Malignant Neoplasm,0
6927,Exostosis,Cartilaginous exostosis,0
6928,Renal carcinoma,Grade 1 Clear Cell Renal Cell Carcinoma,0
6929,majority,Pancreatic Intraepithelial Neoplasia-3,0
6930,Therapeutic procedure,Malignant Testicular Sertoli Cell Tumor,0
6931,Leukemia (category),Neonatal leukemia,0
6932,Biomaterial Treatment,mucinous adenocarcinoma of gallbladder,0
6933,Geographic Locations,Recurrent Testicular Lymphoma,0
6934,Malignant Neoplasms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6935,Occur (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6936,Hemorrhage,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6937,Weight Loss,Childhood Lymphoma,0
6938,Type A,Diffuse malignant mesothelioma,0
6939,Disease,Malignant neoplasm of thalamus,0
6940,Small cell carcinoma of lung,Stage II Carcinoma of Penis,0
6941,Primary malignant neoplasm,Acantholytic squamous cell carcinoma,0
6942,Polyglandular Type I Autoimmune Syndrome,Thymic Clear Cell Carcinoma,0
6943,Related personal status,Endometrial Small Cell Carcinoma,0
6944,Regulatory Application,Acantholytic squamous cell carcinoma,0
6945,Uterus,Leiomyoma of Gallbladder,0
6946,Persons,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6947,Have Itch,Malignant Neoplasm with Regional Lymph Node Involvement,0
6948,biopsy characteristics,Spongiotic dermatitis,0
6949,Prior Medication Usage,Uterine Cancer,0
6950,Beginning,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6951,Type A,Localized Askin Tumor,0
6952,Blood Platelets,Acute Undifferentiated Leukemia,0
6953,*Type - Kind of quantity,Endometrial Small Cell Carcinoma,0
6954,Mechanism (attribute),Clonal Hematopoiesis of Indeterminate Potential,0
6955,Appearance,Female Breast Carcinoma,0
6956,Apply,Acantholytic squamous cell carcinoma,0
6957,Elements,Carcinoma ex pleomorphic adenoma of parotid gland,0
6958,Etiology,Neonatal leukemia,0
6959,World,Malignant melanoma of eyelid,0
6960,Immunotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6961,Common Specifications in HL7 V3 Publishing,Neonatal leukemia,0
6962,Adult Burkitt Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
6963,Form:Finding:Point in time:{Setting}:Document:{Role},Hemangioma,0
6964,biopsy characteristics,Malignant melanoma of eyelid,0
6965,Certain (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6966,Carcinoma of bladder,Intestinal Metaplasia of Bladder Urothelium,0
6967,Gravidity,Placental aromatase deficiency,0
6968,Third,Undifferentiated Endocervical Sarcoma,0
6969,Hematopoietic stem cells,Clonal Hematopoiesis of Indeterminate Potential,0
6970,Estrogen (disposition),Endometrial Small Cell Carcinoma,0
6971,Impaired skin integrity,Recurrent Uveal Melanoma,0
6972,Palpebronasal fold,Blepharal carcinoma,0
6973,Metastatic Neoplasm,mucinous adenocarcinoma of gallbladder,0
6974,Genes,FIGO Stage II Ovarian Cancer,0
6975,Fibrosis Assessment,mucinous adenocarcinoma of gallbladder,0
6976,Cell Count,Neonatal leukemia,0
6977,Providing presence (regime/therapy),Liver Cavernous Hemangioma,0
6978,Occurrence,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6979,Adult Alveolar Soft Part Sarcoma,Adult Alveolar Soft Part Sarcoma,0
6980,Account number:Identifier:Point in time:^Patient:Nominal,Metastatic Carcinoma in the Lung,0
6981,Abnormal cell,FIGO Stage II Ovarian Cancer,0
6982,Living Alone,Primary Cutaneous Plasmablastic Lymphoma,0
6983,Experimental Result,Refractory Barrett Esophagus,0
6984,Confirmed by,Acantholytic squamous cell carcinoma,0
6985,Involvement with,Bladder squamous cell carcinoma stage I,0
6986,Angiosarcoma of liver,Angiosarcoma of liver,0
6987,Surgical extraction,Acantholytic squamous cell carcinoma,0
6988,Carrying,Angiosarcoma of liver,0
6989,Enzyme (disposition),Placental aromatase deficiency,0
6990,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Endometrial Small Cell Carcinoma,0
6991,Chemotherapy Regimen,Lung squamous cell carcinoma stage I,0
6992,65+,Mucinous adenocarcinoma gastric,0
6993,Determined by,Human Papillomavirus-Related Carcinoma,0
6994,Cells,squamous cell carcinoma of the thyroid gland,0
6995,antibody (non-specific) abnormal,Heavy Chain Deposition Disease,0
6996,Abnormal Reference Range,Heavy Chain Deposition Disease,0
6997,Bacteria present,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6998,Blood group antibody I,Heavy Chain Deposition Disease,0
6999,Control function,Pancreatic Intraepithelial Neoplasia-3,0
7000,Glandular,Adenocarcinoma of the prostate metastatic,0
7001,Block Unit of Distance,Unresectable Rhabdomyosarcoma,0
7002,Related personal status,Benign Apocrine Neoplasm,0
7003,Call (Instruction),Testicular cancer metastatic,0
7004,Obesity,FIGO Stage II Ovarian Cancer,0
7005,Intravenous,Cancer of Urinary Tract,0
7006,Primary malignant neoplasm,squamous cell carcinoma of the thyroid gland,0
7007,Birthmark,GIANT PIGMENTED HAIRY NEVUS,0
7008,Body structure,Testicular cancer metastatic,0
7009,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
7010,Neuroendocrine Tumors,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7011,Multiple malignancy,Bladder squamous cell carcinoma stage I,0
7012,Percent inhibition,Unresectable Rhabdomyosarcoma,0
7013,Disorder of lymph node,Acute lymphadenitis,0
7014,Before,Uterine Cancer,0
7015,Percent normal,Endometrial Small Cell Carcinoma,0
7016,Neoplasm Metastasis,Stage IB Lung Cancer AJCC v7,0
7017,Presentation,Cancer of Urinary Tract,0
7018,Sacrococcygeal,benign mature teratoma of pancreas,0
7019,Mantle Zone,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7020,Lymphoma,Recurrent Testicular Lymphoma,0
7021,Vision,Blepharal carcinoma,0
7022,Treating,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7023,Carcinoma,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
7024,Dairy Cream,Spongiotic dermatitis,0
7025,Primary,Tonsillar Carcinoma,0
7026,CDISC Relationship Class,Refractory Barrett Esophagus,0
7027,radiotherapeutic,Malignant Testicular Sertoli Cell Tumor,0
7028,Average of Value Derivation Technique,Diffuse malignant mesothelioma,0
7029,Bothered by Vomiting,Mucinous adenocarcinoma gastric,0
7030,To,Acantholytic squamous cell carcinoma,0
7031,Treatment Epoch,Adult Hepatocellular Carcinoma,0
7032,Only - dosing instruction fragment,Recurrent Testicular Lymphoma,0
7033,Empty (qualifier),Digestive System Hodgkin Lymphoma,0
7034,Congenital ichthyosis,Ichthyoses,0
7035,Benign,Pilocytic astrocytoma of cerebellum,0
7036,99,Recurrent Uveal Melanoma,0
7037,Adverse effects,Breast Ductal Adenoma,0
7038,Pain,Childhood Lymphoma,0
7039,Secondary to,Granular Cell Leiomyosarcoma,0
7040,Administrative Division,Recurrent Testicular Lymphoma,0
7041,unknown vaccine or immune globulin,Malignant neoplasm of thalamus,0
7042,Thought,Clonal Hematopoiesis of Indeterminate Potential,0
7043,How Often Itching,Methotrexate-Associated Hodgkin Lymphoma,0
7044,Have Weight Loss,Unfavorable Non-Hodgkin Lymphoma,0
7045,Gastroesophageal reflux disease,Refractory Barrett Esophagus,0
7046,Descending,Recurrent Uveal Melanoma,0
7047,Science of Etiology,Liver Cavernous Hemangioma,0
7048,Ulcer,Acantholytic squamous cell carcinoma,0
7049,True primary (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7050,Means,Testicular cancer metastatic,0
7051,Stem cells,Heavy Chain Deposition Disease,0
7052,How Much Distress Weight Loss,Methotrexate-Associated Hodgkin Lymphoma,0
7053,Qualitative form,Colorectal High Grade B-Cell Lymphoma,0
7054,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7055,Image Feature,Recurrent Testicular Lymphoma,0
7056,Retinoic Acid Response Element,Serous cystadenocarcinoma ovary,0
7057,Pediatric Neoplasm,Malignant neoplasm of choroid,0
7058,Carcinoid Tumor,Colorectal Neuroendocrine Tumor G2,0
7059,Common (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
7060,Cessation of life,FIGO Stage II Ovarian Cancer,0
7061,Probability,Clonal Hematopoiesis of Indeterminate Potential,0
7062,Synonym,BRCA2 Syndrome,0
7063,Smoking,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7064,Togo,Digestive System Hodgkin Lymphoma,0
7065,Advanced phase,Pancreatic Intraepithelial Neoplasia-3,0
7066,therapeutic aspects,Malignant melanoma of eyelid,0
7067,Common (qualifier value),Anterior Urethral Malignant Neoplasm,0
7068,Description,Cancer of Urinary Tract,0
7069,Benign,Benign neoplasm of thorax,0
7070,Cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7071,Did not receive therapy or drug for,Acute Undifferentiated Leukemia,0
7072,Beginning,Advanced Uterine Corpus Carcinosarcoma,0
7073,Adult Non-Hodgkin Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
7074,Adverse effects,Female Breast Carcinoma,0
7075,Cancer Etiology,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7076,Out (direction),Metastatic Ductal Breast Carcinoma,0
7077,Volume,Larynx carcinoma recurrent,0
7078,Reaching,Pancreatic Intraepithelial Neoplasia-3,0
7079,Type - attribute,Stage I Adult Non-Hodgkin Lymphoma,0
7080,Basis - conceptual entity,Acantholytic squamous cell carcinoma,0
7081,Disease,Maxillary Sinus Adenocarcinoma,0
7082,Primary malignant neoplasm,Advanced Uterine Corpus Carcinosarcoma,0
7083,Pelvic pain female,Endometrial Small Cell Carcinoma,0
7084,Non-Neoplastic Disorder,Giant cell angiofibroma,0
7085,Abnormally high,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7086,Body tissue,Testicular cancer metastatic,0
7087,Tumor type,Choroid Necrotic Melanoma,0
7088,Vertebral column,Refractory Glioma,0
7089,Occurrence,Angiosarcoma of liver,0
7090,Mechanism (attribute),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7091,To,Intestinal Metaplasia of Bladder Urothelium,0
7092,Infrequent,Stage IB Pancreatic Cancer AJCC v8,0
7093,Histology:Find:Pt:Cancer.XXX:Nar,Recurrent Testicular Lymphoma,0
7094,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Colorectal High Grade B-Cell Lymphoma,0
7095,Beginning,Malignant neoplasm of thalamus,0
7096,Eyelid structure,Benign Apocrine Neoplasm,0
7097,depend,Carcinoma of urinary bladder,0
7098,Biomaterial Treatment,Malignant melanoma of eyelid,0
7099,Breast Carcinoma,Breast Ductal Adenoma,0
7100,Early,Spermatocytic seminoma,0
7101,Neoplasm Metastasis,Adult Alveolar Soft Part Sarcoma,0
7102,How Much Distress Weight Loss,Malignant Neoplasm with Regional Lymph Node Involvement,0
7103,Result,Thymic Clear Cell Carcinoma,0
7104,Excessive,Acute Undifferentiated Leukemia,0
7105,Before values,Metastatic Carcinoma in the Lung,0
7106,Childhood Germ Cell Tumor,Childhood Central Nervous System Immature Teratoma,0
7107,Most,Anterior Urethral Malignant Neoplasm,0
7108,campbell,Giant cell angiofibroma,0
7109,Stage IV Breast Cancer AJCC v6 and v7,Testicular cancer metastatic,0
7110,Rate,Malignant Testicular Sertoli Cell Tumor,0
7111,Unmarried,Blepharal carcinoma,0
7112,Commercial Lot,Diffuse malignant mesothelioma,0
7113,Homo sapiens,Blepharal carcinoma,0
7114,dendritic spine neck,Recurrent Testicular Lymphoma,0
7115,majority,Pilocytic astrocytoma of cerebellum,0
7116,Cell secretion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7117,Test - temporal region,Benign Carotid Body Paraganglioma,0
7118,Presentation,mucinous adenocarcinoma of gallbladder,0
7119,Type A,Colorectal Mucin Poor Hyperplastic Polyp,0
7120,cervical cancer,Endometrial Small Cell Carcinoma,0
7121,Very high,FIGO Stage II Ovarian Cancer,0
7122,Event Seriousness - Significant,Acute Undifferentiated Leukemia,0
7123,{Setting},Extra-Adrenal Paraganglioma,0
7124,Overall Publication Type,FIGO Stage II Ovarian Cancer,0
7125,regional,Malignant neoplasm of choroid,0
7126,treatment - ActInformationManagementReason,Breast Ductal Adenoma,0
7127,Type A,Giant cell angiofibroma,0
7128,More,Bladder squamous cell carcinoma stage I,0
7129,NBL1 wt Allele,Primary Cutaneous Plasmablastic Lymphoma,0
7130,Secondary Neoplasm,adenosquamous carcinoma of breast,0
7131,Viola <angiosperm>,Extracranial Neuroblastoma,0
7132,Class (taxonomic),Lung squamous cell carcinoma stage I,0
7133,Decision,Adenocarcinoma of the prostate metastatic,0
7134,Mucoepidermoid Carcinoma,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
7135,contextual factors,Adult Hepatocellular Carcinoma,0
7136,Night sweats,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7137,Act Mood - intent,Metastatic Carcinoma in the Lung,0
7138,include - SetOperator,Recurrent Uveal Melanoma,0
7139,site,Testicular cancer metastatic,0
7140,Dorsal,Malignant melanoma of eyelid,0
7141,Body tissue,Female Breast Carcinoma,0
7142,Therapeutic procedure,Recurrent Testicular Lymphoma,0
7143,CD69 protein,Acute Undifferentiated Leukemia,0
7144,How Often Weight Loss,Methotrexate-Associated Hodgkin Lymphoma,0
7145,Tonsil,Recurrent Testicular Lymphoma,0
7146,Screening,Human Papillomavirus-Related Carcinoma,0
7147,Togo,Cancer of Urinary Tract,0
7148,Has difficulty doing (qualifier value),Cancer of Urinary Tract,0
7149,Rare,Leiomyoma of Gallbladder,0
7150,Increase,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7151,True primary (qualifier value),Sarcomatoid Renal Cell Carcinoma,0
7152,>90,Methotrexate-Associated Hodgkin Lymphoma,0
7153,Trial Screening,Human Papillomavirus-Related Carcinoma,0
7154,Knee,Cartilaginous exostosis,0
7155,bony process,Testicular cancer metastatic,0
7156,Leads (device),Placental aromatase deficiency,0
7157,Africa South of the Sahara,Adult Hepatocellular Carcinoma,0
7158,Loss,BRCA2 Syndrome,0
7159,Lung,Advanced Uterine Corpus Carcinosarcoma,0
7160,Half,Stage IB Pancreatic Cancer AJCC v8,0
7161,shared attribute,Urethral Carcinoma,0
7162,seconds,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7163,Coding,Leptomeningeal sarcoma,0
7164,Scientific Study,Clonal Hematopoiesis of Indeterminate Potential,0
7165,Most,Carcinoma ex pleomorphic adenoma of parotid gland,0
7166,Frequently,Recurrent Testicular Lymphoma,0
7167,Including (qualifier),Acute lymphadenitis,0
7168,Females,Cancer of Urinary Tract,0
7169,Function (attribute),Childhood Thyroid Gland Follicular Carcinoma,0
7170,Thrombocythemia,Giant cell angiofibroma,0
7171,Tumor Mass,Leptomeningeal sarcoma,0
7172,Further,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7173,Neoplasm Metastasis,Testicular cancer metastatic,0
7174,Family history,Intestinal Metaplasia of Bladder Urothelium,0
7175,Rate,Intestinal Metaplasia of Bladder Urothelium,0
7176,Usual,Anterior Urethral Malignant Neoplasm,0
7177,Malignant neoplasm of ovary,Advanced Uterine Corpus Carcinosarcoma,0
7178,Face,Airway Hemangioma,0
7179,Data operation - complete,Carcinoma of urinary bladder,0
7180,Appearance,Breast Ductal Adenoma,0
7181,Future,Mucinous adenocarcinoma gastric,0
7182,Body structure,Granular Cell Leiomyosarcoma,0
7183,School Grade,Female Breast Carcinoma,0
7184,White color,Recurrent Testicular Lymphoma,0
7185,Tryptophanase,Diffuse malignant mesothelioma,0
7186,Tryptophanase,de novo Myelodysplastic Syndrome,0
7187,Body tissue,mucinous adenocarcinoma of gallbladder,0
7188,Cessation of life,Carcinoma of urinary bladder,0
7189,Neoplasms,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7190,Form:Finding:Point in time:{Setting}:Document:{Role},Stage IB Pancreatic Cancer AJCC v8,0
7191,United States,Adult Hepatocellular Carcinoma,0
7192,chance,FIGO Stage II Ovarian Cancer,0
7193,BBS9 wt Allele,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7194,Abnormal result,FIGO Stage II Ovarian Cancer,0
7195,Form:Finding:Point in time:{Setting}:Document:{Role},Neonatal leukemia,0
7196,Artificial (qualifier value),Unresectable Rhabdomyosarcoma,0
7197,Less Than,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7198,Upper,Human Papillomavirus-Related Carcinoma,0
7199,Pallor,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7200,Neoplastic disease,Secondary malignant neoplasm of lymph node,0
7201,structure,Recurrent Testicular Lymphoma,0
7202,Adenocarcinoma,Adenocarcinoma of the prostate metastatic,0
7203,Activity (animal life circumstance),Thymic Clear Cell Carcinoma,0
7204,Endocrine Cells,Intestinal Neuroendocrine Carcinoma,0
7205,Often - answer to question,Carcinoma of urinary bladder,0
7206,Teens,Thymic Clear Cell Carcinoma,0
7207,Sharing (Social Behavior),Intestinal Neuroendocrine Carcinoma,0
7208,Diabetes Mellitus,Pancreatic Intraepithelial Neoplasia-3,0
7209,Infective cystitis,Cancer of Urinary Tract,0
7210,Individual,Benign Carotid Body Paraganglioma,0
7211,Congenital defects,Childhood Central Nervous System Immature Teratoma,0
7212,Headache,Choroid Necrotic Melanoma,0
7213,Adult human body,Intestinal Neuroendocrine Carcinoma,0
7214,Approximate,Cancer of Urinary Tract,0
7215,Disintegration (morphologic abnormality),Cartilaginous exostosis,0
7216,Left sided,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7217,Multiply - dosing instruction fragment,Stage IB Pancreatic Cancer AJCC v8,0
7218,Palatine Tonsil,Digestive System Hodgkin Lymphoma,0
7219,1000000,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7220,Subject Risk,Recurrent Uveal Melanoma,0
7221,Range,Cartilaginous exostosis,0
7222,majority,Stage IB Lung Cancer AJCC v7,0
7223,Adenocarcinoma of pancreas,Stage IB Pancreatic Cancer AJCC v8,0
7224,subapical complex location,Diffuse malignant mesothelioma,0
7225,Regular,Tonsillar Carcinoma,0
7226,Formation,Stage IB Pancreatic Cancer AJCC v8,0
7227,Motor Neuron and Pancreas Homeobox Protein 1,benign mature teratoma of pancreas,0
7228,Togo,Malignant Testicular Sertoli Cell Tumor,0
7229,Therapeutic radiology procedure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7230,allowing,Human Papillomavirus-Related Carcinoma,0
7231,Very Much,Cartilaginous exostosis,0
7232,development aspects,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7233,Type - attribute,Unfavorable Non-Hodgkin Lymphoma,0
7234,Formation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7235,Angioimmunoblastic Lymphadenopathy,Unfavorable Non-Hodgkin Lymphoma,0
7236,Term (temporal),Stage IB Pancreatic Cancer AJCC v8,0
7237,Infrequent,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7238,Involvement with,Malignant melanoma of eyelid,0
7239,Treating,Airway Hemangioma,0
7240,Percent of Bacteria,Digestive System Hodgkin Lymphoma,0
7241,Case unit dose,Mucinous adenocarcinoma gastric,0
7242,Connection,Childhood Thyroid Gland Follicular Carcinoma,0
7243,Two,adenosquamous carcinoma of breast,0
7244,Entity,Cartilaginous exostosis,0
7245,Involvement with,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7246,Togo,Acantholytic squamous cell carcinoma,0
7247,member,Malignant melanoma of eyelid,0
7248,65,Diffuse malignant mesothelioma,0
7249,newly,Malignant melanoma of eyelid,0
7250,Embryonic Development,Adult Alveolar Soft Part Sarcoma,0
7251,Medical Imaging,Uterine Cancer,0
7252,Deglutition Disorders,Tonsillar Carcinoma,0
7253,Dermatologist,Spongiotic dermatitis,0
7254,Benign disorder,Recurrent Testicular Lymphoma,0
7255,Negation,Benign Apocrine Neoplasm,0
7256,Head,Benign neoplasm of thorax,0
7257,3+ Score,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7258,Spreading (qualifier value),Human Papillomavirus-Related Carcinoma,0
7259,Family (taxonomic),Uterine Cancer,0
7260,Advanced phase,Endometrial Small Cell Carcinoma,0
7261,various antiseptic throat preparations,Recurrent Testicular Lymphoma,0
7262,Improving (qualifier value),Unresectable Rhabdomyosarcoma,0
7263,Lymphoma cells,Primary Cutaneous Plasmablastic Lymphoma,0
7264,Blood,Heavy Chain Deposition Disease,0
7265,Extraction,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7266,Biological Response Modifiers,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7267,New,Uterine Cancer,0
7268,Known,Refractory Barrett Esophagus,0
7269,Source,Ampulla of Vater Tubular Adenoma,0
7270,Neuroepithelial,Malignant neoplasm of choroid,0
7271,CEL gene,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
7272,Used by,Anterior Urethral Malignant Neoplasm,0
7273,treatment - ActInformationManagementReason,Primary Cutaneous Plasmablastic Lymphoma,0
7274,Males,Malignant Testicular Sertoli Cell Tumor,0
7275,seconds,Colorectal cancer,0
7276,2+ Score,Acantholytic squamous cell carcinoma,0
7277,Ability,Undifferentiated Endocervical Sarcoma,0
7278,Affect (mental function),Cancer of Urinary Tract,0
7279,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Diffuse malignant mesothelioma,0
7280,Primary malignant neoplasm of appendix,mucinous adenocarcinoma of gallbladder,0
7281,Stem of Organ,Intracortical osteosarcoma,0
7282,*Type - Kind of quantity,Undifferentiated Endocervical Sarcoma,0
7283,Surgery specialty,Refractory Barrett Esophagus,0
7284,Cessation of life,Endometrial Small Cell Carcinoma,0
7285,Infrequent,Serous cystadenocarcinoma ovary,0
7286,Body tissue,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7287,Due to,Colorectal cancer,0
7288,Negation,Maxillary Sinus Adenocarcinoma,0
7289,Fourth,Familial Hemophagocytic Lymphocytosis,0
7290,To,Anterior Urethral Malignant Neoplasm,0
7291,Leading,Undifferentiated Endocervical Sarcoma,0
7292,Obesity,Pancreatic Intraepithelial Neoplasia-3,0
7293,Headache,Malignant neoplasm of thalamus,0
7294,Offspring,FIGO Stage II Ovarian Cancer,0
7295,Benign Neoplasm,Testicular cancer metastatic,0
7296,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7297,Squamous cell carcinoma - category,Intestinal Metaplasia of Bladder Urothelium,0
7298,Including (qualifier),Bladder squamous cell carcinoma stage I,0
7299,Visit,Pilocytic astrocytoma of cerebellum,0
7300,Presentation,Recurrent Testicular Lymphoma,0
7301,Antigens,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7302,Useful,Cancer of Urinary Tract,0
7303,Occurrence,Stage IB Pancreatic Cancer AJCC v8,0
7304,Common Cold,Acantholytic squamous cell carcinoma,0
7305,Symptoms,Stage IB Lung Cancer AJCC v7,0
7306,Rare,Anterior Urethral Malignant Neoplasm,0
7307,Comparison,Metastatic Carcinoma in the Lung,0
7308,include - SetOperator,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7309,Occurrence,Neonatal leukemia,0
7310,1000000,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7311,SLC6A2 wt Allele,Intestinal Neuroendocrine Carcinoma,0
7312,Target,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7313,Malignant tumor of colon,Colorectal High Grade B-Cell Lymphoma,0
7314,Brain Neoplasms,Choroid Necrotic Melanoma,0
7315,Weight decreased,Methotrexate-Associated Hodgkin Lymphoma,0
7316,Five-year Survival Rate,Recurrent Uveal Melanoma,0
7317,TP53 gene,Acute Undifferentiated Leukemia,0
7318,Sarcoma of soft tissue,Adult Alveolar Soft Part Sarcoma,0
7319,Acute leukemia,Acute Undifferentiated Leukemia,0
7320,Color,Acute Undifferentiated Leukemia,0
7321,Study Site,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7322,Mammal liver preparation,gliosarcoma,0
7323,Pharmacologic Substance,de novo Myelodysplastic Syndrome,0
7324,Destruction (action),BRCA2 Syndrome,0
7325,Positioning Attribute,BRCA2 Syndrome,0
7326,Ratio,Angiosarcoma of liver,0
7327,Molecule,Unresectable Rhabdomyosarcoma,0
7328,Referring,Liver Cavernous Hemangioma,0
7329,Halitosis,Refractory Barrett Esophagus,0
7330,Relationships,Ampulla of Vater Tubular Adenoma,0
7331,First (number),Adult Alveolar Soft Part Sarcoma,0
7332,Individual,Angiosarcoma of liver,0
7333,Call (Instruction),Liver Cavernous Hemangioma,0
7334,Numerous,Stage II Carcinoma of Penis,0
7335,CDISC SDTM Disease Outcome Terminology,Breast Ductal Adenoma,0
7336,Hemorrhage,Liver Cavernous Hemangioma,0
7337,Pelvic Pain,Endometrial Small Cell Carcinoma,0
7338,Separated from cohabitee,Diffuse malignant mesothelioma,0
7339,include - SetOperator,Acantholytic squamous cell carcinoma,0
7340,Occur (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7341,treatment - ActInformationManagementReason,Female Breast Carcinoma,0
7342,Combined,Intestinal Metaplasia of Bladder Urothelium,0
7343,Increasing,Adult Hepatocellular Carcinoma,0
7344,Severe (severity modifier),Heavy Chain Deposition Disease,0
7345,Retained,Blepharal carcinoma,0
7346,Brain Neoplasms,Pilocytic astrocytoma of cerebellum,0
7347,oncology field,Unresectable Rhabdomyosarcoma,0
7348,Scientific Control,Pancreatic Intraepithelial Neoplasia-3,0
7349,Antibodies,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7350,Fever,Hodgkin lymphoma,0
7351,Have Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
7352,End,Clonal Hematopoiesis of Indeterminate Potential,0
7353,Lymphoma,Recurrent Testicular Lymphoma,0
7354,Molecular Mass,Recurrent Testicular Lymphoma,0
7355,Show,Undifferentiated Endocervical Sarcoma,0
7356,Bruising,Acute Undifferentiated Leukemia,0
7357,Reported Term,Ichthyosis,0
7358,Urinary Tract Infection,Cancer of Urinary Tract,0
7359,Qualitative form,Choroid Necrotic Melanoma,0
7360,Metastasis,mucinous adenocarcinoma of gallbladder,0
7361,treatment - ActInformationManagementReason,Adult Hepatocellular Carcinoma,0
7362,LINC01194 gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7363,Direct Extension,Testicular cancer metastatic,0
7364,Larynx,Larynx carcinoma recurrent,0
7365,Australia,Digestive System Hodgkin Lymphoma,0
7366,Target Awareness - partial,Intestinal Metaplasia of Bladder Urothelium,0
7367,Left,Primary Cutaneous Plasmablastic Lymphoma,0
7368,PREVENT (product),Human Papillomavirus-Related Carcinoma,0
7369,Hardness,Acantholytic squamous cell carcinoma,0
7370,Operative Surgical Procedures,Uterine Cancer,0
7371,Estimated,Benign neoplasm of thorax,0
7372,Obesity,Pancreatic Intraepithelial Neoplasia-3,0
7373,Cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7374,Chest Pain,Stage IB Lung Cancer AJCC v7,0
7375,Usual Severity Vomiting,Mucinous adenocarcinoma gastric,0
7376,Specific qualifier value,Breast Ductal Adenoma,0
7377,Persons,Extra-Adrenal Paraganglioma,0
7378,Removed,Digestive System Hodgkin Lymphoma,0
7379,Term (temporal),Ampulla of Vater Tubular Adenoma,0
7380,Symptoms aspect,Mucinous adenocarcinoma gastric,0
7381,Referring,Undifferentiated Endocervical Sarcoma,0
7382,Cancer Genus,Malignant melanoma of eyelid,0
7383,Status post,Uterine Cancer,0
7384,Long-term,Stage IB Lung Cancer AJCC v7,0
7385,200,Bladder squamous cell carcinoma stage I,0
7386,Characterization,Adult Alveolar Soft Part Sarcoma,0
7387,low confidentiality,Human Papillomavirus-Related Carcinoma,0
7388,Major <insect>,Breast Ductal Adenoma,0
7389,Container status - Identified,Angiosarcoma of liver,0
7390,Rare,Benign neoplasm of thorax,0
7391,English race,Leiomyoma of Gallbladder,0
7392,Relationships,Clonal Hematopoiesis of Indeterminate Potential,0
7393,Mental association,BRCA2 Syndrome,0
7394,Status post,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7395,Compressed structure,mucinous adenocarcinoma of gallbladder,0
7396,Painless,Malignant Neoplasm with Regional Lymph Node Involvement,0
7397,Immune,Malignant melanoma of eyelid,0
7398,Occur (action),Granular Cell Leiomyosarcoma,0
7399,Neonatal (qualifier value),Thymic Clear Cell Carcinoma,0
7400,per year,Mucinous adenocarcinoma gastric,0
7401,Irritant (disposition),Contact dermatitis due to alkali,0
7402,Malignant - descriptor,Neonatal leukemia,0
7403,Growth action,Stage IB Lung Cancer AJCC v7,0
7404,Diagnosis,Anterior Urethral Malignant Neoplasm,0
7405,True,Female Breast Carcinoma,0
7406,year,gliosarcoma,0
7407,CD5L wt Allele,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7408,Associated topography,Benign Carotid Body Paraganglioma,0
7409,Acquisition (action),Clonal Hematopoiesis of Indeterminate Potential,0
7410,Entity Determiner - specific,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7411,Including (qualifier),Malignant Testicular Sertoli Cell Tumor,0
7412,Egg of order Phthiraptera,adenoid cystic carcinoma of lung,0
7413,Syndrome,Colorectal cancer,0
7414,Targeted Therapy,Uterine Cancer,0
7415,Microvolt,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7416,Liver carcinoma,Adult Hepatocellular Carcinoma,0
7417,Smear - instruction imperative,Mucinous adenocarcinoma gastric,0
7418,How Often Weight Loss,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7419,Surgical aspects,Colorectal High Grade B-Cell Lymphoma,0
7420,Term (temporal),Heavy Chain Deposition Disease,0
7421,Topical form corticosteroids,Spongiotic dermatitis,0
7422,Clinical Study Case,Spongiotic dermatitis,0
7423,Immune system,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7424,% live,Diffuse malignant mesothelioma,0
7425,Name,Clonal Hematopoiesis of Indeterminate Potential,0
7426,Carcinoma of lung,papillary carcinoma of penis,0
7427,General surgery specialty,Mucinous adenocarcinoma gastric,0
7428,PSA Level Less than Two,Localized Askin Tumor,0
7429,Low Back Pain,Intestinal Metaplasia of Bladder Urothelium,0
7430,Common Specifications in HL7 V3 Publishing,Malignant Neoplasm with Regional Lymph Node Involvement,0
7431,Antibiotic Resistance,Cancer of Urinary Tract,0
7432,Cancer Genus,Malignant Neoplasm with Regional Lymph Node Involvement,0
7433,Sex Cord-Stromal Tumor,FIGO Stage II Ovarian Cancer,0
7434,Case unit dose,Cancer of Urinary Tract,0
7435,Common Specifications in HL7 V3 Publishing,Clonal Hematopoiesis of Indeterminate Potential,0
7436,Complicated,Cancer of Urinary Tract,0
7437,Therapeutic procedure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7438,Tumor Suppression,BRCA2 Syndrome,0
7439,Condition,Recurrent Uveal Melanoma,0
7440,Organ,Leiomyoma of Gallbladder,0
7441,Males,Bladder squamous cell carcinoma stage I,0
7442,Mass,Stage IB Pancreatic Cancer AJCC v8,0
7443,Form:Finding:Point in time:{Setting}:Document:{Role},Liver Cavernous Hemangioma,0
7444,Incidence,Adult Hepatocellular Carcinoma,0
7445,Hemopoietic tissue,Granular Cell Leiomyosarcoma,0
7446,Unexplained weight loss,Stage IB Pancreatic Cancer AJCC v8,0
7447,Fever symptoms (finding),Cancer of Urinary Tract,0
7448,Example,Testicular cancer metastatic,0
7449,High Mitosis-Karyorrhexis Index,Malignant melanoma of eyelid,0
7450,Progress,Mucinous neoplasm,0
7451,Type - attribute,Benign neoplasm of thorax,0
7452,Paraneoplastic Syndromes,Leiomyoma of Gallbladder,0
7453,Linear,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7454,Count of entities,Endometrial Small Cell Carcinoma,0
7455,Benign Neoplasm,Mucinous neoplasm,0
7456,DNA Damage,BRCA2 Syndrome,0
7457,Therapy Object (animal model),Female Breast Carcinoma,0
7458,Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7459,treatment - ActInformationManagementReason,Localized Askin Tumor,0
7460,Due to,Metastatic Neoplasm to the Gallbladder,0
7461,Carcinoma of lung,adenosquamous carcinoma of breast,0
7462,Lesion,Benign Apocrine Neoplasm,0
7463,IPSS Risk Category High,Malignant melanoma of eyelid,0
7464,Germ Cells,Adult Alveolar Soft Part Sarcoma,0
7465,shared attribute,Acute Undifferentiated Leukemia,0
7466,Borg Category-Ratio 10 Perceived Exertion Score 5,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7467,Feature,Recurrent Testicular Lymphoma,0
7468,Medullary - body parts,Collecting Duct Carcinoma of the Kidney,0
7469,Effectiveness,Breast Ductal Adenoma,0
7470,Related personal status,Undifferentiated Endocervical Sarcoma,0
7471,Forecast of outcome,mucinous adenocarcinoma of gallbladder,0
7472,New Zealand Rabbits,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7473,Value Above Reference Range,Acantholytic squamous cell carcinoma,0
7474,Nausea Visual Analogue Scale,Unfavorable Non-Hodgkin Lymphoma,0
7475,Slight (qualifier value),Malignant melanoma of eyelid,0
7476,depend,Bladder squamous cell carcinoma stage I,0
7477,Cell (compartment),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7478,genetic risk factors,Acute Undifferentiated Leukemia,0
7479,Unconscious State,Malignant neoplasm of thalamus,0
7480,Chest Wall Pain,Diffuse malignant mesothelioma,0
7481,Categories,Breast Ductal Adenoma,0
7482,Age,Neonatal leukemia,0
7483,One,Cancer of Urinary Tract,0
7484,Five,Diffuse malignant mesothelioma,0
7485,Symptoms aspect,Stage I Adult Non-Hodgkin Lymphoma,0
7486,Formation,Liver Cavernous Hemangioma,0
7487,Colon structure (body structure),Anterior Urethral Malignant Neoplasm,0
7488,Packaging Case,Acantholytic squamous cell carcinoma,0
7489,Symptoms aspect,squamous cell carcinoma of the thyroid gland,0
7490,Choose (action),Female Breast Carcinoma,0
7491,75,benign mature teratoma of pancreas,0
7492,Standard (document),Recurrent Testicular Lymphoma,0
7493,Glycation End Products,Acute Undifferentiated Leukemia,0
7494,Child,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7495,Togo,Bladder squamous cell carcinoma stage I,0
7496,Aggressive course,Stage IB Pancreatic Cancer AJCC v8,0
7497,Frequently,Bladder squamous cell carcinoma stage I,0
7498,Africa,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7499,Liver,FIGO Stage II Ovarian Cancer,0
7500,Secondary Neoplasm,Stage IB Lung Cancer AJCC v7,0
7501,Hematologic Neoplasms,Clonal Hematopoiesis of Indeterminate Potential,0
7502,Species,Extracranial Neuroblastoma,0
7503,oncology field,Ampulla of Vater Tubular Adenoma,0
7504,Case (situation),Mucinous adenocarcinoma gastric,0
7505,MYOT gene,Metastatic Neoplasm to the Gallbladder,0
7506,North America,Extracranial Neuroblastoma,0
7507,Insecticides,Angiosarcoma of liver,0
7508,Options,Carcinoma of urinary bladder,0
7509,Part of,Adult Alveolar Soft Part Sarcoma,0
7510,Males,Ichthyosis,0
7511,Hereditary,Endometrial Small Cell Carcinoma,0
7512,Carrying,Digestive System Hodgkin Lymphoma,0
7513,Onset of (contextual qualifier),Diffuse malignant mesothelioma,0
7514,Contribution,Clonal Hematopoiesis of Indeterminate Potential,0
7515,*Type - Kind of quantity,Unfavorable Non-Hodgkin Lymphoma,0
7516,Lymphoid system structure,Digestive System Hodgkin Lymphoma,0
7517,Liver Flavor,gliosarcoma,0
7518,Proliferation (morphologic abnormality),Heavy Chain Deposition Disease,0
7519,Application Context,Atypical Lobular Breast Hyperplasia,0
7520,Case unit dose,mucinous adenocarcinoma of gallbladder,0
7521,Neuroendocrine Tumors,Intestinal Neuroendocrine Carcinoma,0
7522,Known,Metastatic Ductal Breast Carcinoma,0
7523,Cancer Genus,Stage I Adult Non-Hodgkin Lymphoma,0
7524,Cessation of life,Human Papillomavirus-Related Carcinoma,0
7525,Slide (glass microscope),Adult Alveolar Soft Part Sarcoma,0
7526,Cell Device,Adenocarcinoma,0
7527,Entity Name Part Qualifier - birth,Adult Hepatocellular Carcinoma,0
7528,Carcinoma,Stage IB Lung Cancer AJCC v7,0
7529,VARIOUS DRUG CLASSES IN ATC,Placental aromatase deficiency,0
7530,Biological Response Modifiers,Malignant melanoma of eyelid,0
7531,Benign tumor of salivary gland,Carcinoma ex pleomorphic adenoma of parotid gland,0
7532,Throat,Human Papillomavirus-Related Carcinoma,0
7533,Image Feature,Metastatic Ductal Breast Carcinoma,0
7534,Child,Mastocytosis,0
7535,Empty (qualifier),Female Breast Carcinoma,0
7536,User Group,Neonatal leukemia,0
7537,Statistical mean,Cartilaginous exostosis,0
7538,Lung,Testicular cancer metastatic,0
7539,Frequently,Recurrent Uveal Melanoma,0
7540,Physical shape,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7541,Social group,Neonatal leukemia,0
7542,Midline (qualifier value),Human Papillomavirus-Related Carcinoma,0
7543,Mature Teratoma,benign mature teratoma of pancreas,0
7544,Generation (action),Digestive System Hodgkin Lymphoma,0
7545,Affecting,Human Papillomavirus-Related Carcinoma,0
7546,Abdomen distended,Diffuse malignant mesothelioma,0
7547,Treated with,Primary Cutaneous Plasmablastic Lymphoma,0
7548,Poor - qualifier,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7549,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7550,Determined by,Heavy Chain Deposition Disease,0
7551,Kind of quantity - Consistency,Acute lymphadenitis,0
7552,Two,Methotrexate-Associated Hodgkin Lymphoma,0
7553,Surgical service,Carcinoma of urinary bladder,0
7554,Germ cell tumor,FIGO Stage II Ovarian Cancer,0
7555,CEL gene,papillary carcinoma of penis,0
7556,Reported Term,Pancreatic Intraepithelial Neoplasia-3,0
7557,Rare,Airway Hemangioma,0
7558,Therapeutic radiology procedure,FIGO Stage II Ovarian Cancer,0
7559,Parameterized Data Type - Set,Adult Hepatocellular Carcinoma,0
7560,Brain,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7561,Body part,Mucinous adenocarcinoma gastric,0
7562,Often - answer to question,Blepharal carcinoma,0
7563,Sequence Data Type,Noninfiltrating Intraductal Carcinoma,0
7564,Biomaterial Treatment,Localized Askin Tumor,0
7565,Rare,Adult Fibrolamellar Carcinoma,0
7566,Primary,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7567,Infective cystitis,Bladder squamous cell carcinoma stage I,0
7568,Involvement with,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7569,Established,Anterior Urethral Malignant Neoplasm,0
7570,Place,Testicular cancer metastatic,0
7571,Type - attribute,Undifferentiated Endocervical Sarcoma,0
7572,high - ActExposureLevelCode,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7573,Common (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
7574,Less Than,Clonal Hematopoiesis of Indeterminate Potential,0
7575,Diabetes,Pancreatic Intraepithelial Neoplasia-3,0
7576,Lung,adenosquamous carcinoma of breast,0
7577,Oral cavity,Human Papillomavirus-Related Carcinoma,0
7578,Easy bleeding,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7579,Obesity,Endometrial Small Cell Carcinoma,0
7580,Response process,Breast Ductal Adenoma,0
7581,cell type,Mastocytosis,0
7582,Negation,Neonatal leukemia,0
7583,Taxonomic,Secondary malignant neoplasm of lymph node,0
7584,shared attribute,Stage IB Pancreatic Cancer AJCC v8,0
7585,Squamous Epithelial Cells,Acantholytic squamous cell carcinoma,0
7586,Site,Urethral Carcinoma,0
7587,One,Secondary malignant neoplasm of lymph node,0
7588,Time,Thymic Clear Cell Carcinoma,0
7589,Free (available (qualifier)),Breast Ductal Adenoma,0
7590,Asians,Blepharal carcinoma,0
7591,Appearance,Localized Askin Tumor,0
7592,color additive,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7593,One,Acantholytic squamous cell carcinoma,0
7594,Tissue Specimen Code,Colorectal Neuroendocrine Tumor G2,0
7595,Tissue Specimen Code,Hemangioma,0
7596,Short,Extracranial Neuroblastoma,0
7597,Human body,Thymic Clear Cell Carcinoma,0
7598,Internal,Diffuse malignant mesothelioma,0
7599,Immune System Finding,Unresectable Rhabdomyosarcoma,0
7600,Person 1,Malignant melanoma of eyelid,0
7601,Age at menopause,FIGO Stage II Ovarian Cancer,0
7602,Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
7603,Negation,Pancreatic Intraepithelial Neoplasia-3,0
7604,Negation,Hodgkin lymphoma,0
7605,Renal Cell Carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7606,Disease,mucinous adenocarcinoma of gallbladder,0
7607,Long Variable,BRCA2 Syndrome,0
7608,Better than Others,Advanced Uterine Corpus Carcinosarcoma,0
7609,Response to treatment,papillary carcinoma of penis,0
7610,Form of muscle,Uterine Cancer,0
7611,Borg Category-Ratio 10 Perceived Exertion Score 5,Cartilaginous exostosis,0
7612,Offspring,Neonatal leukemia,0
7613,Smoking,Human Papillomavirus-Related Carcinoma,0
7614,Hematopoietic Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
7615,Eye,Blepharal carcinoma,0
7616,Enhance (action),Malignant Neoplasm of Lung - Multiple Primary Sites,0
7617,Contact with,Human Papillomavirus-Related Carcinoma,0
7618,Therapeutic radiology procedure,Acute Undifferentiated Leukemia,0
7619,Endometrial scraping,Endometrial Small Cell Carcinoma,0
7620,membrane attack complex location,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7621,Several,Unfavorable Non-Hodgkin Lymphoma,0
7622,Relationships,Refractory Barrett Esophagus,0
7623,Site,Human Papillomavirus-Related Carcinoma,0
7624,Vermilion border of lip,Maxillary Sinus Adenocarcinoma,0
7625,Sternum,Thymic Clear Cell Carcinoma,0
7626,Males,Mucinous adenocarcinoma gastric,0
7627,Incidence,Clonal Hematopoiesis of Indeterminate Potential,0
7628,Include (action),Methotrexate-Associated Hodgkin Lymphoma,0
7629,Tobacco smoking behavior,Intestinal Metaplasia of Bladder Urothelium,0
7630,Decision,Colorectal Neuroendocrine Tumor G2,0
7631,Decision,Hemangioma,0
7632,Estimated,Human Papillomavirus-Related Carcinoma,0
7633,Estimated,Benign Carotid Body Paraganglioma,0
7634,Bladder Continence Question,Bladder squamous cell carcinoma stage I,0
7635,Dimple,Adult Alveolar Soft Part Sarcoma,0
7636,Longitudinal Studies,Primary Cutaneous Plasmablastic Lymphoma,0
7637,solid substance,Anterior Urethral Malignant Neoplasm,0
7638,Symptoms,Human Papillomavirus-Related Carcinoma,0
7639,Low Back Pain,Carcinoma of urinary bladder,0
7640,Condition,Uterine Cancer,0
7641,Synonym (core metadata concept),Acute lymphadenitis,0
7642,Elderly (population group),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7643,Exist,adenoid cystic carcinoma of lung,0
7644,Person Observer,Clonal Hematopoiesis of Indeterminate Potential,0
7645,Statistical Significance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7646,Malignant Neoplasms,Testicular cancer metastatic,0
7647,Usually,Pilocytic astrocytoma of cerebellum,0
7648,Severe (severity modifier),Primary Cutaneous Plasmablastic Lymphoma,0
7649,Related personal status,Rhabdomyosarcoma with ganglionic differentiation,0
7650,Physical Medical Procedure,Endometrial Small Cell Carcinoma,0
7651,Alveolar,Adult Alveolar Soft Part Sarcoma,0
7652,Sacral dysgenesis,benign mature teratoma of pancreas,0
7653,20%,Refractory Barrett Esophagus,0
7654,Most,Endometrial Small Cell Carcinoma,0
7655,Following,Uterine Cancer,0
7656,Occurrence Indicator,Airway Hemangioma,0
7657,Then,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7658,status - In progress,Primary Cutaneous Plasmablastic Lymphoma,0
7659,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
7660,SLC35G1 gene,Tonsillar Carcinoma,0
7661,Collection (action),Collecting Duct Carcinoma of the Kidney,0
7662,Rate,Malignant melanoma of eyelid,0
7663,Sample Range,Ichthyoses,0
7664,Purpose,Female Breast Carcinoma,0
7665,Stomach structure,Colorectal cancer,0
7666,Form:Finding:Point in time:{Setting}:Document:{Role},Female Breast Carcinoma,0
7667,MUTYH-Associate Polyposis,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7668,<90,Blepharal carcinoma,0
7669,Intravascular line,Acute Undifferentiated Leukemia,0
7670,Marrow plasma cell,Heavy Chain Deposition Disease,0
7671,Morphology,Rhabdomyosarcoma with ganglionic differentiation,0
7672,Injury wounds,Acantholytic squamous cell carcinoma,0
7673,Benign Neoplasm,Benign Apocrine Neoplasm,0
7674,Liver Flavor,FIGO Stage II Ovarian Cancer,0
7675,Presentation,Digestive System Hodgkin Lymphoma,0
7676,Medical History,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7677,Hereditary,Ichthyosis,0
7678,Chemotherapy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7679,Out (direction),Pancreatic Intraepithelial Neoplasia-3,0
7680,Mechanism (attribute),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7681,>90,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7682,Tumor Mass,Angiosarcoma of liver,0
7683,70%,Primary Cutaneous Plasmablastic Lymphoma,0
7684,Infection,Acute Undifferentiated Leukemia,0
7685,Extension,Childhood Cerebellar Neoplasm,0
7686,Induce (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7687,Deoxyribonucleic Acid Measurement,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7688,Manufactured form,papillary carcinoma of penis,0
7689,Primary malignant neoplasm,Undifferentiated Endocervical Sarcoma,0
7690,Secondary Neoplasm,Recurrent Uveal Melanoma,0
7691,/mm3,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7692,Beginning,FIGO Stage II Ovarian Cancer,0
7693,Family history,Cancer of Urinary Tract,0
7694,Greater,Malignant melanoma of eyelid,0
7695,Experimental Result,Uterine Cancer,0
7696,Class,Lung squamous cell carcinoma stage I,0
7697,Cells,FIGO Stage II Ovarian Cancer,0
7698,shared attribute,Recurrent Testicular Lymphoma,0
7699,Europe,Mucinous adenocarcinoma gastric,0
7700,Have Itch,Mastocytosis,0
7701,Call (Instruction),Colorectal Neuroendocrine Tumor G2,0
7702,Call (Instruction),Hemangioma,0
7703,Taxonomic,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7704,Reported Term,Granular Cell Leiomyosarcoma,0
7705,65+,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7706,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Acantholytic squamous cell carcinoma,0
7707,Early,Thymic Clear Cell Carcinoma,0
7708,week,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7709,Follicle,Recurrent Testicular Lymphoma,0
7710,Hidrocystoma,Benign Apocrine Neoplasm,0
7711,Including (qualifier),Malignant melanoma of eyelid,0
7712,Feel Tired question,Diffuse malignant mesothelioma,0
7713,Smear - instruction imperative,Acute Undifferentiated Leukemia,0
7714,Ultrasonography,Anterior Urethral Malignant Neoplasm,0
7715,Thymus Neoplasms,Thymic Clear Cell Carcinoma,0
7716,Benign,Anterior Urethral Malignant Neoplasm,0
7717,Very rare,Placental aromatase deficiency,0
7718,Involvement with,Breast Ductal Adenoma,0
7719,Benign melanocytic nevus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7720,various other nasal preparations in ATC,Recurrent Testicular Lymphoma,0
7721,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Hodgkin lymphoma,0
7722,Gestational trophoblastic disease,Endometrial Small Cell Carcinoma,0
7723,Hair follicle structure,Recurrent Testicular Lymphoma,0
7724,Neoplasms,Anterior Urethral Malignant Neoplasm,0
7725,Historical aspects qualifier,Malignant melanoma of eyelid,0
7726,Specimen Source Codes - tumor,Leptomeningeal sarcoma,0
7727,BRCA2 protein,FIGO Stage II Ovarian Cancer,0
7728,Lower Urinary Tract Symptoms,Cancer of Urinary Tract,0
7729,Analysis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7730,Immature,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7731,Adult Diffuse Large B-Cell Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
7732,*Type - Kind of quantity,Malignant Testicular Sertoli Cell Tumor,0
7733,Numbers,papillary carcinoma of penis,0
7734,Primary malignant neoplasm of endometrium,Endometrial Small Cell Carcinoma,0
7735,Physical findings,Acute lymphadenitis,0
7736,Diagnosis Study,Cancer of Urinary Tract,0
7737,Pregnancy,Cancer of Urinary Tract,0
7738,best (quality),Female Breast Carcinoma,0
7739,Thinking,Clonal Hematopoiesis of Indeterminate Potential,0
7740,low confidentiality,mucinous adenocarcinoma of gallbladder,0
7741,System,Collecting Duct Carcinoma of the Kidney,0
7742,Multiplication,Pancreatic Intraepithelial Neoplasia-3,0
7743,Bands,Childhood Thyroid Gland Follicular Carcinoma,0
7744,Knowledge,Female Breast Carcinoma,0
7745,Malignant neoplasm of lung,Testicular cancer metastatic,0
7746,device aspects,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7747,To,Female Breast Carcinoma,0
7748,Hepatobiliary System,Colorectal cancer,0
7749,site-specific telomere resolvase activity,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7750,Including (qualifier),Mucinous adenocarcinoma gastric,0
7751,Name,papillary carcinoma of penis,0
7752,History of present illness,Recurrent Uveal Melanoma,0
7753,Involvement with,Intestinal Metaplasia of Bladder Urothelium,0
7754,combination - answer to question,Undifferentiated Endocervical Sarcoma,0
7755,Frequently,Thymic Clear Cell Carcinoma,0
7756,Usual Severity Nausea,Mucinous adenocarcinoma gastric,0
7757,Certain (qualifier value),Tonsillar Carcinoma,0
7758,Special,Colorectal Neuroendocrine Tumor G2,0
7759,Bilateral complete salpingectomy,Endometrial Small Cell Carcinoma,0
7760,NCI CTEP SDC Melanoma Sub-Category Terminology,Stage II Carcinoma of Penis,0
7761,Singular,FIGO Stage II Ovarian Cancer,0
7762,Therapeutic radiology procedure,Endometrial Small Cell Carcinoma,0
7763,Examined,Spongiotic dermatitis,0
7764,Eczema,Spongiotic dermatitis,0
7765,Rule (guideline),Heavy Chain Deposition Disease,0
7766,Domain (area of knowledge),Leptomeningeal sarcoma,0
7767,Function Axis,Thymic Clear Cell Carcinoma,0
7768,Congenital melanocytic nevus,GIANT PIGMENTED HAIRY NEVUS,0
7769,Form:Finding:Point in time:{Setting}:Document:{Role},Choroid Necrotic Melanoma,0
7770,How Often Vomiting,Malignant neoplasm of thalamus,0
7771,Diagnosis,Cancer of Urinary Tract,0
7772,Swollen Lymph Node,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7773,cancer risk,BRCA2 Syndrome,0
7774,Therapeutic procedure,Recurrent Uveal Melanoma,0
7775,Liver,Angiosarcoma of liver,0
7776,Plumbum metallicum,Placental aromatase deficiency,0
7777,Adult,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7778,Mental association,Heavy Chain Deposition Disease,0
7779,Western World,Refractory Barrett Esophagus,0
7780,Deeply,Deep Leiomyoma,0
7781,Therapeutic procedure,mucinous adenocarcinoma of gallbladder,0
7782,Person 1,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7783,Aluminum measurement,Giant cell angiofibroma,0
7784,Antibiotics,Cancer of Urinary Tract,0
7785,Greater,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7786,Childhood Lymphoma,Recurrent Testicular Lymphoma,0
7787,Cell Count,Recurrent Uveal Melanoma,0
7788,Often - answer to question,Bladder squamous cell carcinoma stage I,0
7789,VARIOUS DRUG CLASSES IN ATC,Recurrent Testicular Lymphoma,0
7790,More,Spermatocytic seminoma,0
7791,Surgery specialty,Diffuse malignant mesothelioma,0
7792,Testing,Extra-Adrenal Paraganglioma,0
7793,High risk of,Acantholytic squamous cell carcinoma,0
7794,Beginning,Cancer of Urinary Tract,0
7795,CD5L wt Allele,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7796,Example,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7797,shared attribute,Angiosarcoma of liver,0
7798,Down Syndrome,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7799,Pruritus,Mastocytosis,0
7800,Adult Hodgkin Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7801,90%,Blepharal carcinoma,0
7802,lymph nodes,Mucinous adenocarcinoma gastric,0
7803,low,Primary Cutaneous Plasmablastic Lymphoma,0
7804,Occur (action),Angiosarcoma of liver,0
7805,Occurrence Indicator,Ichthyosis,0
7806,Tears - SpecimenType,Blepharal carcinoma,0
7807,Including (qualifier),Unfavorable Non-Hodgkin Lymphoma,0
7808,Malignant Neoplasms,Granular Cell Leiomyosarcoma,0
7809,Persons,Heavy Chain Deposition Disease,0
7810,Involvement with,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7811,Death (finding),adenoid cystic carcinoma of lung,0
7812,Frequently,Childhood Lymphoma,0
7813,What subject filter - Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7814,Europe,FIGO Stage II Ovarian Cancer,0
7815,Eyelid Diseases,Benign Apocrine Neoplasm,0
7816,1960s,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7817,Definitely Related to Intervention,Pancreatic Intraepithelial Neoplasia-3,0
7818,omit,Adenocarcinoma of the prostate metastatic,0
7819,History of previous events,Recurrent Uveal Melanoma,0
7820,Neuroendocrine Tumors,Colorectal Neuroendocrine Tumor G2,0
7821,Gastric Acid,Refractory Barrett Esophagus,0
7822,Cancer Genus,Maxillary Sinus Adenocarcinoma,0
7823,analysis aspect,Malignant melanoma of eyelid,0
7824,Reported Term,Cartilaginous exostosis,0
7825,Diagnostic Imaging,Carcinoma of urinary bladder,0
7826,200,Adult Fibrolamellar Carcinoma,0
7827,Occur (action),Intestinal Metaplasia of Bladder Urothelium,0
7828,Skin,Acute Undifferentiated Leukemia,0
7829,Fasting Status Indicator,Recurrent Uveal Melanoma,0
7830,View Tunnel,Adult Alveolar Soft Part Sarcoma,0
7831,European Union Notified Body,Primary Cutaneous Plasmablastic Lymphoma,0
7832,Procedure (set of actions),Diffuse malignant mesothelioma,0
7833,peripheral blood,Heavy Chain Deposition Disease,0
7834,Circulating blood,Digestive System Hodgkin Lymphoma,0
7835,Malignant neoplasm of lung,papillary carcinoma of penis,0
7836,drug companies,de novo Myelodysplastic Syndrome,0
7837,Skin,Human Papillomavirus-Related Carcinoma,0
7838,Melanoma Pathway,Recurrent Uveal Melanoma,0
7839,Group Object,Heavy Chain Deposition Disease,0
7840,Common Specifications in HL7 V3 Publishing,Stage IB Lung Cancer AJCC v7,0
7841,Onset of (contextual qualifier),Angiosarcoma of liver,0
7842,Bone pain,Acute Undifferentiated Leukemia,0
7843,shared attribute,Colorectal High Grade B-Cell Lymphoma,0
7844,Viruses ingredient,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7845,Paraganglioma,Extra-Adrenal Paraganglioma,0
7846,Occurrence,Serous cystadenocarcinoma ovary,0
7847,Body structure,Thymic Clear Cell Carcinoma,0
7848,Rest,Testicular cancer metastatic,0
7849,Hematologic Tests,Malignant Testicular Sertoli Cell Tumor,0
7850,early detection of cervical cancer,Human Papillomavirus-Related Carcinoma,0
7851,Mathematical Operator,Blepharal carcinoma,0
7852,10%,BRCA2 Syndrome,0
7853,Often - answer to question,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7854,Relationship by association,Heavy Chain Deposition Disease,0
7855,Lymphatic,Acute lymphadenitis,0
7856,Pass (indicator),Digestive System Hodgkin Lymphoma,0
7857,aggressive cancer,Female Breast Carcinoma,0
7858,High Mitosis-Karyorrhexis Index,Recurrent Uveal Melanoma,0
7859,Bladder Neoplasm,Bladder squamous cell carcinoma stage I,0
7860,Age,Diffuse malignant mesothelioma,0
7861,Decision,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7862,Qualitative form,Cartilaginous exostosis,0
7863,Specific qualifier value,Rhabdomyosarcoma with ganglionic differentiation,0
7864,Presentation,Acantholytic squamous cell carcinoma,0
7865,Unspecified,Cancer of Urinary Tract,0
7866,Ectoderm,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
7867,Color,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7868,Tumor cells,mucinous adenocarcinoma of gallbladder,0
7869,Symptomatic,Cartilaginous exostosis,0
7870,IPSS Risk Category High,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7871,Serous Membrane,Atypical Mesothelial Hyperplasia,0
7872,Tobacco smoking behavior,adenosquamous carcinoma of breast,0
7873,Arising,Carcinoma of urinary bladder,0
7874,Childhood Lymphoma,Mucinous adenocarcinoma gastric,0
7875,Unknown GENC,Adult Hepatocellular Carcinoma,0
7876,European race,Extracranial Neuroblastoma,0
7877,Cover (physical object),Blepharal carcinoma,0
7878,Different,Testicular cancer metastatic,0
7879,Cerebellum,Childhood Cerebellar Neoplasm,0
7880,Agreement,Female Breast Carcinoma,0
7881,risk factors,Stage IB Pancreatic Cancer AJCC v8,0
7882,Known,papillary carcinoma of penis,0
7883,Mobility aid,Sarcomatoid Renal Cell Carcinoma,0
7884,Mobility aid,Grade 1 Clear Cell Renal Cell Carcinoma,0
7885,Neoplasms,Colorectal Neuroendocrine Tumor G2,0
7886,Stem of plant,Clonal Hematopoiesis of Indeterminate Potential,0
7887,Known,Recurrent Testicular Lymphoma,0
7888,therapeutic aspects,Breast Ductal Adenoma,0
7889,Geographic state,Tonsillar Carcinoma,0
7890,84,Bladder squamous cell carcinoma stage I,0
7891,Human body,Testicular cancer metastatic,0
7892,Science of Statistics,Leptomeningeal sarcoma,0
7893,Consistency,Thymic Clear Cell Carcinoma,0
7894,Frequently,gliosarcoma,0
7895,Weight measurement scales,Acantholytic squamous cell carcinoma,0
7896,Mediate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7897,Categories,Methotrexate-Associated Hodgkin Lymphoma,0
7898,Low Level,Placental aromatase deficiency,0
7899,Symptoms aspect,adenosquamous carcinoma of breast,0
7900,Infection,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7901,Pleural Effusion,Localized Askin Tumor,0
7902,Pharmacotherapy,Endometrial Small Cell Carcinoma,0
7903,Subject Risk,Undifferentiated Endocervical Sarcoma,0
7904,65,Recurrent Uveal Melanoma,0
7905,Logical Condition,Recurrent Uveal Melanoma,0
7906,Continuance of life,Acantholytic squamous cell carcinoma,0
7907,Singular,Endometrial Small Cell Carcinoma,0
7908,Cause of death:Find:Pt:^Patient:Nom,FIGO Stage II Ovarian Cancer,0
7909,Part of,Malignant Neoplasm with Regional Lymph Node Involvement,0
7910,Canada,Carcinoma of urinary bladder,0
7911,Including (qualifier),Collecting Duct Carcinoma of the Kidney,0
7912,Logical Condition,mucinous adenocarcinoma of gallbladder,0
7913,Bulbomembranous Urethra,Urethral Carcinoma,0
7914,Skin Specimen,Malignant melanoma of eyelid,0
7915,Appearance Distress Question,Female Breast Carcinoma,0
7916,Common (qualifier value),Undifferentiated Endocervical Sarcoma,0
7917,Cicatrix,Acantholytic squamous cell carcinoma,0
7918,Tumor stage,Female Breast Carcinoma,0
7919,Chicken laying egg for human food,Adult Alveolar Soft Part Sarcoma,0
7920,Togo,Diffuse malignant mesothelioma,0
7921,Togo,de novo Myelodysplastic Syndrome,0
7922,Entity Determiner - specific,Intracortical osteosarcoma,0
7923,Risk,Mucinous adenocarcinoma gastric,0
7924,Congenital meningocele,benign mature teratoma of pancreas,0
7925,Embryonic tissue,Adult Alveolar Soft Part Sarcoma,0
7926,Mohs Surgery,Acantholytic squamous cell carcinoma,0
7927,Orbital region,Blepharal carcinoma,0
7928,Basis - conceptual entity,Cancer of Urinary Tract,0
7929,Spreading (qualifier value),Malignant neoplasm of thalamus,0
7930,Pancreas,Stage IB Pancreatic Cancer AJCC v8,0
7931,shared attribute,Human Papillomavirus-Related Carcinoma,0
7932,Contain (action),Familial Hemophagocytic Lymphocytosis,0
7933,Benign Neoplasm,Benign neoplasm of thorax,0
7934,Grade,Primary Cutaneous Plasmablastic Lymphoma,0
7935,Medications,Diffuse malignant mesothelioma,0
7936,Case (situation),Recurrent Testicular Lymphoma,0
7937,Smear - instruction imperative,adenosquamous carcinoma of breast,0
7938,Case unit dose,Pancreatic Intraepithelial Neoplasia-3,0
7939,Feature,Metastatic Ductal Breast Carcinoma,0
7940,Then,Malignant Testicular Sertoli Cell Tumor,0
7941,Salivary Gland Neoplasms,Carcinoma ex pleomorphic adenoma of parotid gland,0
7942,Skin Specimen,Airway Hemangioma,0
7943,therapeutic aspects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7944,Feature,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7945,Occipital,Childhood Cerebellar Neoplasm,0
7946,mast-,Mastocytosis,0
7947,various other nasal preparations in ATC,Benign Carotid Body Paraganglioma,0
7948,Ultrasonic Shockwave,Malignant Testicular Sertoli Cell Tumor,0
7949,Back Pain,Stage IB Pancreatic Cancer AJCC v8,0
7950,Skull,Cartilaginous exostosis,0
7951,Symptoms,Mucinous adenocarcinoma gastric,0
7952,Elderly (population group),Angiosarcoma of liver,0
7953,Death Related to Adverse Event,Acute Undifferentiated Leukemia,0
7954,Surface,Maxillary Sinus Adenocarcinoma,0
7955,Consistency,Childhood Thyroid Gland Follicular Carcinoma,0
7956,Electrolyte [EPC],Collecting Duct Carcinoma of the Kidney,0
7957,Tissue Growth,adenosquamous carcinoma of breast,0
7958,Time (foundation metadata concept),Pancreatic Intraepithelial Neoplasia-3,0
7959,Primary,Malignant melanoma of eyelid,0
7960,Covers (device),Diffuse malignant mesothelioma,0
7961,International Classification of Disease for Oncology,Intracortical osteosarcoma,0
7962,Chemotherapy,Acantholytic squamous cell carcinoma,0
7963,European Viper,Adult Alveolar Soft Part Sarcoma,0
7964,Present,Familial Hemophagocytic Lymphocytosis,0
7965,Average,gliosarcoma,0
7966,Methods aspects,Advanced Uterine Corpus Carcinosarcoma,0
7967,Include (action),Digestive System Hodgkin Lymphoma,0
7968,Tryptophanase,Malignant Testicular Sertoli Cell Tumor,0
7969,Lymphoma,Thymic Clear Cell Carcinoma,0
7970,Original Regulatory Submission,Testicular cancer metastatic,0
7971,Tests (qualifier value),Contact dermatitis due to alkali,0
7972,Count of entities,Undifferentiated Endocervical Sarcoma,0
7973,To,Pilocytic astrocytoma of cerebellum,0
7974,Weight Loss,Malignant Neoplasm with Regional Lymph Node Involvement,0
7975,Face (spatial concept),Airway Hemangioma,0
7976,Specimen Source Codes - Lesion,Liver Cavernous Hemangioma,0
7977,Concentration measurement,Digestive System Hodgkin Lymphoma,0
7978,Occurrence Indicator,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7979,Categories,Neonatal leukemia,0
7980,Areas <moth>,Malignant melanoma of eyelid,0
7981,Histocompatibility Testing,Granular Cell Leiomyosarcoma,0
7982,Condition:Find:Pt:^Patient:Nom,Malignant melanoma of eyelid,0
7983,Blood Circulation,Heavy Chain Deposition Disease,0
7984,Esophagitis,Refractory Barrett Esophagus,0
7985,Departure - action,Cartilaginous exostosis,0
7986,Leads (device),Recurrent Testicular Lymphoma,0
7987,10%,Cancer of Urinary Tract,0
7988,Neoplasms,Granular Cell Leiomyosarcoma,0
7989,HUGO Gene Nomenclature Committee,BRCA2 Syndrome,0
7990,Rare,Neonatal leukemia,0
7991,Bothered by Night Sweats,Stage I Adult Non-Hodgkin Lymphoma,0
7992,Females,Carcinoma of urinary bladder,0
7993,Primary operation,Serous cystadenocarcinoma ovary,0
7994,Primary,FIGO Stage II Ovarian Cancer,0
7995,Acquired phimosis,Stage II Carcinoma of Penis,0
7996,Negation,Primary Cutaneous Plasmablastic Lymphoma,0
7997,Due to,benign mature teratoma of pancreas,0
7998,Adult human body,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7999,Large,Giant cell angiofibroma,0
8000,More,Human Papillomavirus-Related Carcinoma,0
8001,Psyche structure,Choroid Necrotic Melanoma,0
8002,Common Specifications in HL7 V3 Publishing,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8003,Dangerousness,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8004,year,Acute Undifferentiated Leukemia,0
8005,Chemicals,Bladder squamous cell carcinoma stage I,0
8006,13q12,BRCA2 Syndrome,0
8007,Including (qualifier),Adenocarcinoma,0
8008,Neuropathy,Cartilaginous exostosis,0
8009,Females,Acantholytic squamous cell carcinoma,0
8010,Compleat Liquid Nutrition,Intestinal Metaplasia of Bladder Urothelium,0
8011,Beginning,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8012,How Often Shortness of Breath,Stage IB Lung Cancer AJCC v7,0
8013,Present,Benign Apocrine Neoplasm,0
8014,Common Specifications in HL7 V3 Publishing,Malignant melanoma of eyelid,0
8015,Cells,Bladder squamous cell carcinoma stage I,0
8016,AS virus,Tonsillar Carcinoma,0
8017,Primary malignant neoplasm,Diffuse malignant mesothelioma,0
8018,Colloids,Childhood Thyroid Gland Follicular Carcinoma,0
8019,Aggressive Non-Hodgkin Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
8020,Precursor Cell Lymphoblastic Leukemia Lymphoma,Acute Undifferentiated Leukemia,0
8021,Main,adenosquamous carcinoma of breast,0
8022,Type A,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
8023,Progress,Anterior Urethral Malignant Neoplasm,0
8024,Retinoic Acid Response Element,Recurrent Uveal Melanoma,0
8025,Unit,Childhood Thyroid Gland Follicular Carcinoma,0
8026,Short,Cancer of Urinary Tract,0
8027,Symptoms aspect,Pancreatic Intraepithelial Neoplasia-3,0
8028,Symptoms aspect,Hodgkin lymphoma,0
8029,Part of,Grade 1 Clear Cell Renal Cell Carcinoma,0
8030,Firstly,Giant cell angiofibroma,0
8031,Medical History,Uterine Cancer,0
8032,Oral cavity,Malignant melanoma of eyelid,0
8033,Tryptophanase,Breast Ductal Adenoma,0
8034,Curative - procedure intent,Lung squamous cell carcinoma stage I,0
8035,survival aspects,Localized Askin Tumor,0
8036,Publications,Noninfiltrating Intraductal Carcinoma,0
8037,Hypertensive disease,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8038,Providing presence (regime/therapy),Anterior Urethral Malignant Neoplasm,0
8039,Psychological inhibition,Unresectable Rhabdomyosarcoma,0
8040,Does carry,Digestive System Hodgkin Lymphoma,0
8041,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8042,What subject filter - Result,FIGO Stage II Ovarian Cancer,0
8043,Spreading (qualifier value),gliosarcoma,0
8044,Primary operation,Recurrent Uveal Melanoma,0
8045,To,Undifferentiated Endocervical Sarcoma,0
8046,Back,Recurrent Uveal Melanoma,0
8047,Affecting,Recurrent Uveal Melanoma,0
8048,physiological aspects,Blepharal carcinoma,0
8049,blood forming organ,Familial Hemophagocytic Lymphocytosis,0
8050,Cancer Genus,Adenocarcinoma of the prostate metastatic,0
8051,Known,Airway Hemangioma,0
8052,Gastric Content,Refractory Barrett Esophagus,0
8053,Malignant Neoplasms,Spermatocytic seminoma,0
8054,Benign Neoplasm,Extra-Adrenal Paraganglioma,0
8055,Device tip (physical object),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8056,Complete,Colorectal High Grade B-Cell Lymphoma,0
8057,Stroma,Papillary cystic tumor,0
8058,Melanoma Pathway,Stage II Carcinoma of Penis,0
8059,Pharmacotherapy,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8060,Usual,FIGO Stage II Ovarian Cancer,0
8061,Ankle joint structure,Cartilaginous exostosis,0
8062,Treating,Acute Undifferentiated Leukemia,0
8063,Urine for culture,Cancer of Urinary Tract,0
8064,Australia,Blepharal carcinoma,0
8065,Retinoic Acid Response Element,Malignant melanoma of eyelid,0
8066,Hepatitis,Adult Hepatocellular Carcinoma,0
8067,Extrinsic,Childhood Central Nervous System Immature Teratoma,0
8068,Imaging Techniques,Bladder squamous cell carcinoma stage I,0
8069,Include (action),Malignant Testicular Sertoli Cell Tumor,0
8070,Rating (action),Malignant melanoma of eyelid,0
8071,Chemotherapy,Diffuse malignant mesothelioma,0
8072,Togo,Colorectal High Grade B-Cell Lymphoma,0
8073,Encounter,Pilocytic astrocytoma of cerebellum,0
8074,Cardiac Lead Procedure,Recurrent Testicular Lymphoma,0
8075,Net (qualifier),Intestinal Neuroendocrine Carcinoma,0
8076,Adenocarcinoma,Adenocarcinoma,0
8077,High grade (lymphoma grade) (finding),Unfavorable Non-Hodgkin Lymphoma,0
8078,Sustained,Human Papillomavirus-Related Carcinoma,0
8079,Physical findings,Angiosarcoma of liver,0
8080,Concept Relationship,Malignant neoplasm of choroid,0
8081,survival aspects,Acantholytic squamous cell carcinoma,0
8082,Targeted Therapy,Localized Askin Tumor,0
8083,Data Transformation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8084,Sometimes,Clonal Hematopoiesis of Indeterminate Potential,0
8085,Since,Cancer of Urinary Tract,0
8086,Malignant Testicular Germ Cell Tumor,Malignant Testicular Sertoli Cell Tumor,0
8087,Changing,Choroid Necrotic Melanoma,0
8088,Very,Cartilaginous exostosis,0
8089,include - SetOperator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8090,10%,FIGO Stage II Ovarian Cancer,0
8091,Headache,Choroid Necrotic Melanoma,0
8092,Intestines,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8093,Category Type,Methotrexate-Associated Hodgkin Lymphoma,0
8094,Tryptophanase,Malignant Neoplasm with Regional Lymph Node Involvement,0
8095,Patient need for (contextual qualifier),Cancer of Urinary Tract,0
8096,Include (action),Mucinous neoplasm,0
8097,End,Heavy Chain Deposition Disease,0
8098,Tired,Methotrexate-Associated Hodgkin Lymphoma,0
8099,General surgery specialty,Uterine Cancer,0
8100,European race,Recurrent Uveal Melanoma,0
8101,Li-Fraumeni Syndrome,Acute Undifferentiated Leukemia,0
8102,Sweat gland cyst,Benign Apocrine Neoplasm,0
8103,diagnosis aspect,Stage IB Pancreatic Cancer AJCC v8,0
8104,Numerous,Heavy Chain Deposition Disease,0
8105,Include (action),Stage I Adult Non-Hodgkin Lymphoma,0
8106,Tree Node,Tonsillar Carcinoma,0
8107,Qualitative form,Female Breast Carcinoma,0
8108,Category Type,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
8109,Presentation,Deep Leiomyoma,0
8110,Science of Etiology,Mucinous adenocarcinoma gastric,0
8111,Cancer stage iv,Testicular cancer metastatic,0
8112,Development,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8113,Erythrocytes,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8114,Bilateral complete salpingectomy,Undifferentiated Endocervical Sarcoma,0
8115,Cells,Digestive System Hodgkin Lymphoma,0
8116,+2,Acantholytic squamous cell carcinoma,0
8117,Tissue Specimen Code,Childhood Thyroid Gland Follicular Carcinoma,0
8118,Upper gastrointestinal tract series,Refractory Barrett Esophagus,0
8119,Rapid,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8120,Hemoptysis,adenosquamous carcinoma of breast,0
8121,Symptoms,FIGO Stage II Ovarian Cancer,0
8122,Increased,Breast Ductal Adenoma,0
8123,Mucinous Adenocarcinoma,mucinous adenocarcinoma of gallbladder,0
8124,Neuroectodermal Tumor,Localized Askin Tumor,0
8125,Tissue Type Code - Basal cell carcinoma,Testicular cancer metastatic,0
8126,ASPM wt Allele,Adult Alveolar Soft Part Sarcoma,0
8127,Diagnosis Study,Anterior Urethral Malignant Neoplasm,0
8128,Patient Visit,Pilocytic astrocytoma of cerebellum,0
8129,Spreading (qualifier value),Carcinoma of urinary bladder,0
8130,During,Human Papillomavirus-Related Carcinoma,0
8131,Back structure,Airway Hemangioma,0
8132,Study Variable,Neonatal leukemia,0
8133,Japan,Recurrent Testicular Lymphoma,0
8134,Substance,Diffuse malignant mesothelioma,0
8135,Natural,Unresectable Rhabdomyosarcoma,0
8136,Administration procedure,mucinous adenocarcinoma of gallbladder,0
8137,60%,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8138,Frequently,adenoid cystic carcinoma of lung,0
8139,White blood cells urine (lab test),Cancer of Urinary Tract,0
8140,Mathematical Operator,Thymic Clear Cell Carcinoma,0
8141,More,FIGO Stage II Ovarian Cancer,0
8142,400,Malignant Testicular Sertoli Cell Tumor,0
8143,Different,Diffuse malignant mesothelioma,0
8144,Human body,Airway Hemangioma,0
8145,Known,Cartilaginous exostosis,0
8146,risk factors,Adult Hepatocellular Carcinoma,0
8147,Presentation,Mucinous adenocarcinoma gastric,0
8148,Country number,Undifferentiated Endocervical Sarcoma,0
8149,Account number:Identifier:Point in time:^Patient:Nominal,Unfavorable Non-Hodgkin Lymphoma,0
8150,Tired,Malignant Neoplasm with Regional Lymph Node Involvement,0
8151,Iodides,Heavy Chain Deposition Disease,0
8152,Common Specifications in HL7 V3 Publishing,BRCA2 Syndrome,0
8153,Proteins,Unresectable Rhabdomyosarcoma,0
8154,Internal,Maxillary Sinus Adenocarcinoma,0
8155,Vaginal (intended site),papillary carcinoma of penis,0
8156,Fever,Methotrexate-Associated Hodgkin Lymphoma,0
8157,Carcinoma breast stage IV,Testicular cancer metastatic,0
8158,gene therapy,Stage IB Pancreatic Cancer AJCC v8,0
8159,Togo,Human Papillomavirus-Related Carcinoma,0
8160,Cause of death:Find:Pt:^Patient:Nom,Undifferentiated Endocervical Sarcoma,0
8161,Human body structure,papillary carcinoma of penis,0
8162,Excision,Acantholytic squamous cell carcinoma,0
8163,Usually Need Help from Another Person for Reach,Pancreatic Intraepithelial Neoplasia-3,0
8164,Fasting,Malignant melanoma of eyelid,0
8165,Caucasoid Race,Extracranial Neuroblastoma,0
8166,Beginning,Recurrent Diffuse Intrinsic Pontine Glioma,0
8167,Location,Anterior Urethral Malignant Neoplasm,0
8168,Extension,Intracortical osteosarcoma,0
8169,99,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8170,Homo sapiens,Digestive System Hodgkin Lymphoma,0
8171,First (number),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8172,Increased,BRCA2 Syndrome,0
8173,Rare,Diffuse malignant mesothelioma,0
8174,Natural History,papillary carcinoma of penis,0
8175,Often - answer to question,Uterine Cancer,0
8176,Nutrients,Digestive System Hodgkin Lymphoma,0
8177,Options,Mucinous neoplasm,0
8178,Li-Fraumeni Syndrome,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8179,Intention - mental process,Metastatic Carcinoma in the Lung,0
8180,<90,Methotrexate-Associated Hodgkin Lymphoma,0
8181,Sometimes,Extracranial Neuroblastoma,0
8182,Endometrial Carcinoma,Undifferentiated Endocervical Sarcoma,0
8183,Endocrine Cells,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8184,Type - attribute,Benign Apocrine Neoplasm,0
8185,risk factors - observation list,Adult Hepatocellular Carcinoma,0
8186,CYP19A1 gene,Placental aromatase deficiency,0
8187,T-Lymphocyte,Thymic Clear Cell Carcinoma,0
8188,Most,Giant cell angiofibroma,0
8189,Spreading (qualifier value),Adult Hepatocellular Carcinoma,0
8190,Aim,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8191,Severe (severity modifier),Familial Adenomatous Polyposis Associated Medulloblastoma,0
8192,Body tissue,Recurrent Testicular Lymphoma,0
8193,Breast tissue sample,Granular Cell Leiomyosarcoma,0
8194,Adult human body,Thymic Clear Cell Carcinoma,0
8195,growth aspects,Stage IB Lung Cancer AJCC v7,0
8196,Science of Anatomy,Cancer of Urinary Tract,0
8197,Esophagus,Refractory Barrett Esophagus,0
8198,Present,GIANT PIGMENTED HAIRY NEVUS,0
8199,Medical,Placental aromatase deficiency,0
8200,Cell division,Acute Undifferentiated Leukemia,0
8201,High Level,Tonsillar Carcinoma,0
8202,Refrigeration,Mucinous adenocarcinoma gastric,0
8203,epithelial,Carcinoma ex pleomorphic adenoma of parotid gland,0
8204,various antiinfectives and antiseptics for local oral treatment,Recurrent Testicular Lymphoma,0
8205,Surrounding (qualifier value),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
8206,Skin,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8207,Primary malignant neoplasm,Stage I Adult Non-Hodgkin Lymphoma,0
8208,Referring,Heavy Chain Deposition Disease,0
8209,Endocrine system,Childhood Thyroid Gland Follicular Carcinoma,0
8210,Providing presence (regime/therapy),Hemangioma,0
8211,Family,Human Papillomavirus-Related Carcinoma,0
8212,Adverse Event Associated with Vascular,Granular Cell Leiomyosarcoma,0
8213,shared attribute,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8214,Occurrence Indicator,Colorectal Neuroendocrine Tumor G2,0
8215,Occur (action),Undifferentiated Endocervical Sarcoma,0
8216,90%,Acute Undifferentiated Leukemia,0
8217,Changed status,Malignant neoplasm of thalamus,0
8218,1930s,Mucinous adenocarcinoma gastric,0
8219,Introduces,Extracranial Neuroblastoma,0
8220,Links List,Clonal Hematopoiesis of Indeterminate Potential,0
8221,pharmacotherapeutic,Acantholytic squamous cell carcinoma,0
8222,Science of Etiology,Mastocytosis,0
8223,Increase,Human Papillomavirus-Related Carcinoma,0
8224,fluid - substance,Spongiotic dermatitis,0
8225,Body tissue,Breast Ductal Adenoma,0
8226,Malignant neoplasm of endometrium,Colorectal cancer,0
8227,Common (qualifier value),Giant cell angiofibroma,0
8228,Onset of (contextual qualifier),Malignant Testicular Sertoli Cell Tumor,0
8229,Distention of blood vessel,Hemangioma,0
8230,Tears body substance,Benign Apocrine Neoplasm,0
8231,Including (qualifier),Intestinal Metaplasia of Bladder Urothelium,0
8232,Irritants,Contact dermatitis due to alkali,0
8233,Increase in size since previous mammogram,Recurrent Uveal Melanoma,0
8234,Large,Acute Undifferentiated Leukemia,0
8235,Contain (action),Spongiotic dermatitis,0
8236,Common (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
8237,Common (qualifier value),Extracranial Neuroblastoma,0
8238,Providing (action),Digestive System Hodgkin Lymphoma,0
8239,Formation,Metastatic Neoplasm to the Gallbladder,0
8240,Humoralism,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8241,Screening procedure,Undifferentiated Endocervical Sarcoma,0
8242,Occurrence,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8243,Glioblastoma,Advanced Uterine Corpus Carcinosarcoma,0
8244,Specialized Stand Alone Plan - Vision,Blepharal carcinoma,0
8245,Homo sapiens,Advanced Uterine Corpus Carcinosarcoma,0
8246,Pharmacologic Substance,Tonsillar Carcinoma,0
8247,Referring,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8248,pharmacotherapeutic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8249,Symptoms,Endometrial Small Cell Carcinoma,0
8250,Spreading (qualifier value),Testicular cancer metastatic,0
8251,include - SetOperator,Stage I Adult Non-Hodgkin Lymphoma,0
8252,Very Much,Leiomyoma of Gallbladder,0
8253,Dietary Lead,FIGO Stage II Ovarian Cancer,0
8254,Long Variable,Cancer of Urinary Tract,0
8255,Body tissue,Diffuse malignant mesothelioma,0
8256,obsolete,Recurrent Testicular Lymphoma,0
8257,Occurrence Indicator,Mucinous neoplasm,0
8258,Greece,Human Papillomavirus-Related Carcinoma,0
8259,Infection,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8260,Neutral - answer to question,Clonal Hematopoiesis of Indeterminate Potential,0
8261,Tryptophanase,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8262,Count of entities,Stage IB Pancreatic Cancer AJCC v8,0
8263,Females,Placental aromatase deficiency,0
8264,Injury due to exposure to external cause,Acantholytic squamous cell carcinoma,0
8265,Surrounding (qualifier value),Deep Leiomyoma,0
8266,Tumor Mass,adenoid cystic carcinoma of lung,0
8267,Coitus,Cancer of Urinary Tract,0
8268,Combined,Bladder squamous cell carcinoma stage I,0
8269,Chemotherapy,Intestinal Metaplasia of Bladder Urothelium,0
8270,Singular,Placental aromatase deficiency,0
8271,Evidence,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8272,Frequently,Intestinal Metaplasia of Bladder Urothelium,0
8273,primary tumor,Malignant neoplasm of thalamus,0
8274,Atlases,Advanced Uterine Corpus Carcinosarcoma,0
8275,Frequently,Carcinoma of urinary bladder,0
8276,Cancer Genus,Spermatocytic seminoma,0
8277,allowing,Testicular cancer metastatic,0
8278,Specimen Type - Macrophages,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8279,Common Specifications in HL7 V3 Publishing,Giant cell angiofibroma,0
8280,Version,Malignant Neoplasm with Regional Lymph Node Involvement,0
8281,Patient Monitoring,Primary Cutaneous Plasmablastic Lymphoma,0
8282,Subject Risk,Acantholytic squamous cell carcinoma,0
8283,various other nasal preparations in ATC,Benign neoplasm of thorax,0
8284,New,Intestinal Metaplasia of Bladder Urothelium,0
8285,Leakage,Liver Cavernous Hemangioma,0
8286,PREVENT (product),Malignant melanoma of eyelid,0
8287,Appearance,Airway Hemangioma,0
8288,Base - General Qualifier,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8289,Recurrent infections,Bladder squamous cell carcinoma stage I,0
8290,include - SetOperator,Acute Undifferentiated Leukemia,0
8291,Building caretaker,BRCA2 Syndrome,0
8292,Skin,Human Papillomavirus-Related Carcinoma,0
8293,Basis - conceptual entity,Female Breast Carcinoma,0
8294,Approximate,Methotrexate-Associated Hodgkin Lymphoma,0
8295,Apply (administration method),Human Papillomavirus-Related Carcinoma,0
8296,Condition,FIGO Stage II Ovarian Cancer,0
8297,Carcinoid Tumor,Intestinal Neuroendocrine Carcinoma,0
8298,Manufactured form,Colorectal High Grade B-Cell Lymphoma,0
8299,protein expression,Breast Ductal Adenoma,0
8300,Cancer Genus,Childhood Central Nervous System Immature Teratoma,0
8301,In Urine,Cancer of Urinary Tract,0
8302,peripheral blood,Recurrent Testicular Lymphoma,0
8303,Approximate,gliosarcoma,0
8304,Immunoproliferative Disorders,Methotrexate-Associated Hodgkin Lymphoma,0
8305,Abnormal Reference Range,Spongiotic dermatitis,0
8306,Symptoms,Bladder squamous cell carcinoma stage I,0
8307,Table Cell Horizontal Align - left,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8308,Effect,Female Breast Carcinoma,0
8309,Nasal sinus,adenoid cystic carcinoma of lung,0
8310,Risk,BRCA2 Syndrome,0
8311,Surveys,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8312,Reporting,Serous cystadenocarcinoma ovary,0
8313,Group A (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8314,intent,Lung squamous cell carcinoma stage I,0
8315,Retinoic Acid Response Element,Uterine Cancer,0
8316,Have Weight Loss,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8317,Tryptophanase,Unfavorable Non-Hodgkin Lymphoma,0
8318,Recommendation,Benign neoplasm of thorax,0
8319,Negation,Digestive System Hodgkin Lymphoma,0
8320,Financial Account,Mucinous adenocarcinoma gastric,0
8321,Mediate,Heavy Chain Deposition Disease,0
8322,Surgical advancement - action,Recurrent Testicular Lymphoma,0
8323,76,Undifferentiated Endocervical Sarcoma,0
8324,Ovulation,FIGO Stage II Ovarian Cancer,0
8325,IPSS Risk Category High,Acantholytic squamous cell carcinoma,0
8326,Either,Metastatic Neoplasm to the Gallbladder,0
8327,Caucasoid Race,Recurrent Testicular Lymphoma,0
8328,Numerous,Pancreatic Intraepithelial Neoplasia-3,0
8329,Pediculus humanus capitis (eukaryote),Leptomeningeal sarcoma,0
8330,Occurrence Indicator,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8331,History of present illness,Malignant melanoma of eyelid,0
8332,Large,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8333,Tissue of urinary bladder,Intestinal Metaplasia of Bladder Urothelium,0
8334,Secretory Vesicles,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8335,Area,Localized Askin Tumor,0
8336,Upper arm,Stage I Adult Non-Hodgkin Lymphoma,0
8337,Stomach structure,mucinous adenocarcinoma of gallbladder,0
8338,other medicated shampoos in ATC,FIGO Stage II Ovarian Cancer,0
8339,combination - answer to question,Intestinal Metaplasia of Bladder Urothelium,0
8340,Bladder Neoplasm,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8341,To,Unresectable Rhabdomyosarcoma,0
8342,Age,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8343,Dermatitis,Contact dermatitis due to alkali,0
8344,Call (Instruction),Intestinal Neuroendocrine Carcinoma,0
8345,Infant,Thymic Clear Cell Carcinoma,0
8346,Then,Acute Undifferentiated Leukemia,0
8347,Source,Recurrent Uveal Melanoma,0
8348,Organ,Pancreatic Intraepithelial Neoplasia-3,0
8349,Cystic duct structure,Benign Apocrine Neoplasm,0
8350,Woman,Endometrial Small Cell Carcinoma,0
8351,Follicular,Recurrent Testicular Lymphoma,0
8352,Diet,Mucinous adenocarcinoma gastric,0
8353,Effect,Breast Ductal Adenoma,0
8354,Age of onset of symptoms:Time:Pt:^Patient:Qn,Carcinoma of urinary bladder,0
8355,Fever symptoms (finding),Localized Askin Tumor,0
8356,Therapeutic radiology procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8357,Presence (property),Anterior Urethral Malignant Neoplasm,0
8358,Very High Level,FIGO Stage II Ovarian Cancer,0
8359,Gene Cluster Text Format,Childhood Central Nervous System Immature Teratoma,0
8360,Unmarried,Clonal Hematopoiesis of Indeterminate Potential,0
8361,Tumor cells,Stage IB Pancreatic Cancer AJCC v8,0
8362,Esophageal,squamous cell carcinoma of the thyroid gland,0
8363,Acute lymphocytic leukemia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8364,To,Liver Cavernous Hemangioma,0
8365,Decision,BRCA2 Syndrome,0
8366,Common (qualifier value),Refractory Barrett Esophagus,0
8367,Biomaterial Treatment,Recurrent Uveal Melanoma,0
8368,Trachea,adenoid cystic carcinoma of lung,0
8369,Skin Pigmentation,Recurrent Uveal Melanoma,0
8370,Urinary Diversion,Intestinal Metaplasia of Bladder Urothelium,0
8371,Malignant neoplasm of kidney,Grade 1 Clear Cell Renal Cell Carcinoma,0
8372,Large,Malignant melanoma of eyelid,0
8373,Food,Larynx carcinoma recurrent,0
8374,High Mitosis-Karyorrhexis Index,BRCA2 Syndrome,0
8375,Administration procedure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8376,Occurrence Indicator,Leiomyoma of Gallbladder,0
8377,Males,Intestinal Metaplasia of Bladder Urothelium,0
8378,Biomaterial Treatment,Malignant Testicular Sertoli Cell Tumor,0
8379,biopsy characteristics,Anterior Urethral Malignant Neoplasm,0
8380,Arising in,Thymic Clear Cell Carcinoma,0
8381,Testicular mass,Malignant Testicular Sertoli Cell Tumor,0
8382,year,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8383,At risk of infection,Human Papillomavirus-Related Carcinoma,0
8384,Form:Finding:Point in time:{Setting}:Document:{Role},Adult Fibrolamellar Carcinoma,0
8385,Condylomata Acuminata,Maxillary Sinus Adenocarcinoma,0
8386,Abnormal Virilization,Placental aromatase deficiency,0
8387,Base Pair Unit,BRCA2 Syndrome,0
8388,Decision,Mastocytosis,0
8389,Case unit dose,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8390,bony process,adenosquamous carcinoma of breast,0
8391,Different,squamous cell carcinoma of the thyroid gland,0
8392,Percent normal,Unresectable Rhabdomyosarcoma,0
8393,Condition,Refractory Barrett Esophagus,0
8394,Usually Need Help from Another Person for Eating,Refractory Barrett Esophagus,0
8395,Poor function,Human Papillomavirus-Related Carcinoma,0
8396,Occurrence Indicator,Malignant neoplasm of thalamus,0
8397,Y protein,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8398,Feel Tired question,Stage I Adult Non-Hodgkin Lymphoma,0
8399,Location of Oral Residue Following Swallowing,Giant cell angiofibroma,0
8400,Hereditary,Mucinous adenocarcinoma gastric,0
8401,SPG21 gene,Mastocytosis,0
8402,Condition:Find:Pt:^Patient:Nom,Uterine Cancer,0
8403,Fatigue,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8404,Sunscreening Agents,Acantholytic squamous cell carcinoma,0
8405,Stellate,Giant cell angiofibroma,0
8406,A Codes,Secondary malignant neoplasm of lymph node,0
8407,Reduced,Undifferentiated Endocervical Sarcoma,0
8408,RBM12 gene,Giant cell angiofibroma,0
8409,Disease susceptibility,BRCA2 Syndrome,0
8410,Term Birth,Ampulla of Vater Tubular Adenoma,0
8411,Total,Acantholytic squamous cell carcinoma,0
8412,Unit of radiation dose,Primary Cutaneous Plasmablastic Lymphoma,0
8413,Common Specifications in HL7 V3 Publishing,adenoid cystic carcinoma of lung,0
8414,Ichthyosis,Ichthyosis,0
8415,Medical Drop,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8416,Diabetes,Cancer of Urinary Tract,0
8417,Bone pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8418,per year,Advanced Uterine Corpus Carcinosarcoma,0
8419,Over (spatial),Mucinous adenocarcinoma gastric,0
8420,Treatment Epoch,Malignant melanoma of eyelid,0
8421,Malignancy,Testicular cancer metastatic,0
8422,Characterization,Acute Undifferentiated Leukemia,0
8423,structure,Liver Cavernous Hemangioma,0
8424,Survival Rate,Acute Undifferentiated Leukemia,0
8425,Grade IV Childhood Astrocytic Neoplasm,gliosarcoma,0
8426,Infant,Acute Undifferentiated Leukemia,0
8427,Togo,Intestinal Metaplasia of Bladder Urothelium,0
8428,Primary malignant neoplasm,adenoid cystic carcinoma of lung,0
8429,Providing (action),Anterior Urethral Malignant Neoplasm,0
8430,Science of Statistics,Intracortical osteosarcoma,0
8431,Reaching,Stage IB Pancreatic Cancer AJCC v8,0
8432,Death (finding),mucinous adenocarcinoma of gallbladder,0
8433,Feature,Giant cell angiofibroma,0
8434,Imaging Techniques,Anterior Urethral Malignant Neoplasm,0
8435,Common (qualifier value),Acute lymphadenitis,0
8436,Development,Tonsillar Carcinoma,0
8437,Entity Name Part Qualifier - birth,GIANT PIGMENTED HAIRY NEVUS,0
8438,Aggressive behavior,Primary Cutaneous Plasmablastic Lymphoma,0
8439,Biological Response Modifiers,Acute Undifferentiated Leukemia,0
8440,Cancer Genus,Colorectal cancer,0
8441,Curative - procedure intent,Metastatic Carcinoma in the Lung,0
8442,Lesion of breast,Atypical Lobular Breast Hyperplasia,0
8443,Adult Germ Cell Tumor,Childhood Central Nervous System Immature Teratoma,0
8444,How Much Distress Weight Loss,Stage IB Lung Cancer AJCC v7,0
8445,First (number),Giant cell angiofibroma,0
8446,Papillary transitional cell carcinoma,Urethral Carcinoma,0
8447,risk factors - observation list,Uterine Cancer,0
8448,Live - Specimen Condition,Diffuse malignant mesothelioma,0
8449,Common Specifications in HL7 V3 Publishing,Carcinoma ex pleomorphic adenoma of parotid gland,0
8450,Subject is Randomized,Female Breast Carcinoma,0
8451,Europe,Carcinoma of urinary bladder,0
8452,Stop (qualifier value),Heavy Chain Deposition Disease,0
8453,Histopathology,Adult Alveolar Soft Part Sarcoma,0
8454,Fatal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8455,Neoplasms,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8456,eTMF Content Model Code,Noninfiltrating Intraductal Carcinoma,0
8457,Aspartic Acid Measurement,Adult Alveolar Soft Part Sarcoma,0
8458,Menstruation,Undifferentiated Endocervical Sarcoma,0
8459,55,Uterine Cancer,0
8460,primary tumor,Choroid Necrotic Melanoma,0
8461,Apply (instruction),Human Papillomavirus-Related Carcinoma,0
8462,Smear - instruction imperative,Endometrial Small Cell Carcinoma,0
8463,Occurrence,Acantholytic squamous cell carcinoma,0
8464,Type - attribute,Stage II Carcinoma of Penis,0
8465,Papillomavirus,Human Papillomavirus-Related Carcinoma,0
8466,Diagnosis,Intestinal Metaplasia of Bladder Urothelium,0
8467,Gastrointestinal tract structure,papillary carcinoma of penis,0
8468,Segmental Mastectomy,Female Breast Carcinoma,0
8469,Comfort,Extracranial Neuroblastoma,0
8470,Common Specifications in HL7 V3 Publishing,Diffuse malignant mesothelioma,0
8471,Certainties,Refractory Barrett Esophagus,0
8472,Fragment of (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8473,Togo,Testicular cancer metastatic,0
8474,Devices,Recurrent Uveal Melanoma,0
8475,Table Cell Horizontal Align - left,Primary Cutaneous Plasmablastic Lymphoma,0
8476,Adult,Mastocytosis,0
8477,Call (Instruction),Unresectable Rhabdomyosarcoma,0
8478,Term (temporal),Maxillary Sinus Adenocarcinoma,0
8479,Metastatic Neoplasm,adenoid cystic carcinoma of lung,0
8480,depend,Choroid Necrotic Melanoma,0
8481,Most,Diffuse malignant mesothelioma,0
8482,Weight decreased,Malignant Neoplasm with Regional Lymph Node Involvement,0
8483,Sexual Partners,Stage II Carcinoma of Penis,0
8484,United States,Diffuse malignant mesothelioma,0
8485,Cause of death:Find:Pt:^Patient:Nom,Endometrial Small Cell Carcinoma,0
8486,Lynch Syndrome,Colorectal cancer,0
8487,Transformation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8488,Adenocarcinoma of large intestine,Colorectal High Grade B-Cell Lymphoma,0
8489,Calcium Channel Blockers,Refractory Barrett Esophagus,0
8490,Classification of information,Intracortical osteosarcoma,0
8491,Distant,Recurrent Uveal Melanoma,0
8492,Manifest,Spongiotic dermatitis,0
8493,% index,Familial Hemophagocytic Lymphocytosis,0
8494,Chemotherapy Regimen,Mucinous adenocarcinoma gastric,0
8495,Viral,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8496,Neck,Benign Carotid Body Paraganglioma,0
8497,Ulceration,Stage II Carcinoma of Penis,0
8498,Treating,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8499,Appearance,Adult Alveolar Soft Part Sarcoma,0
8500,Myeloid neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8501,Sometimes,Adenocarcinoma of the prostate metastatic,0
8502,thymocyte,Thymic Clear Cell Carcinoma,0
8503,Response Likelihood,Breast Ductal Adenoma,0
8504,Benign neoplasm of paraganglion,Benign Carotid Body Paraganglioma,0
8505,Sharing (Social Behavior),Clonal Hematopoiesis of Indeterminate Potential,0
8506,Cancer Other,Pancreatic Intraepithelial Neoplasia-3,0
8507,Nitrofurantoin,Cancer of Urinary Tract,0
8508,Adult Non-Hodgkin Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
8509,BRCA1 protein,BRCA2 Syndrome,0
8510,10%,Refractory Barrett Esophagus,0
8511,Scientific Publication,Intracortical osteosarcoma,0
8512,Highest,Recurrent Uveal Melanoma,0
8513,Pharyngeal structure,Human Papillomavirus-Related Carcinoma,0
8514,Male population group,Stage II Carcinoma of Penis,0
8515,Prophylactic behavior,FIGO Stage II Ovarian Cancer,0
8516,Usual Severity Itching,Methotrexate-Associated Hodgkin Lymphoma,0
8517,Breast collecting duct,Collecting Duct Carcinoma of the Kidney,0
8518,Affecting,Carcinoma of urinary bladder,0
8519,What subject filter - Result,Human Papillomavirus-Related Carcinoma,0
8520,Mixed Neoplasm,Carcinoma ex pleomorphic adenoma of parotid gland,0
8521,Grouped (qualifier value),Localized Askin Tumor,0
8522,Most,Acute Undifferentiated Leukemia,0
8523,Hyperplasia,Giant cell angiofibroma,0
8524,Ankle,Cartilaginous exostosis,0
8525,Surgery specialty,Colorectal High Grade B-Cell Lymphoma,0
8526,Cancer Other,Female Breast Carcinoma,0
8527,Microbial anatomical capsule structure,Thymic Clear Cell Carcinoma,0
8528,80%,Endometrial Small Cell Carcinoma,0
8529,Orchiectomy,Spermatocytic seminoma,0
8530,Skin Specimen,Stage II Carcinoma of Penis,0
8531,Tryptophanase,Advanced Uterine Corpus Carcinosarcoma,0
8532,Tryptophanase,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8533,Image Feature,Blepharal carcinoma,0
8534,Country,Human Papillomavirus-Related Carcinoma,0
8535,Cancer Genus,Granular Cell Leiomyosarcoma,0
8536,One,Digestive System Hodgkin Lymphoma,0
8537,Singular,Clonal Hematopoiesis of Indeterminate Potential,0
8538,research subject screening,Undifferentiated Endocervical Sarcoma,0
8539,Common Specifications in HL7 V3 Publishing,Mucinous adenocarcinoma gastric,0
8540,Vulva,Human Papillomavirus-Related Carcinoma,0
8541,peritoneal,Atypical Mesothelial Hyperplasia,0
8542,Retinoic Acid Response Element,Benign Carotid Body Paraganglioma,0
8543,Laboratory Procedures,FIGO Stage II Ovarian Cancer,0
8544,59,Recurrent Uveal Melanoma,0
8545,Precancerous Conditions,Recurrent Testicular Lymphoma,0
8546,FAT1 wt Allele,Anterior Urethral Malignant Neoplasm,0
8547,Volume (publication),Familial Hemophagocytic Lymphocytosis,0
8548,include - SetOperator,Noninfiltrating Intraductal Carcinoma,0
8549,Similarity,Extracranial Neuroblastoma,0
8550,Occur (action),Testicular cancer metastatic,0
8551,Present,Pilocytic astrocytoma of cerebellum,0
8552,Uveal melanoma,Malignant melanoma of eyelid,0
8553,Fragments,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8554,Plasma Product,Heavy Chain Deposition Disease,0
8555,Mole,GIANT PIGMENTED HAIRY NEVUS,0
8556,Hemangioma,Airway Hemangioma,0
8557,Head,Extra-Adrenal Paraganglioma,0
8558,Stem of Organ,Leptomeningeal sarcoma,0
8559,Manufactured form,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8560,Percent (qualifier value),Recurrent Diffuse Intrinsic Pontine Glioma,0
8561,Thick,Recurrent Uveal Melanoma,0
8562,N+ (tumor staging),Anterior Urethral Malignant Neoplasm,0
8563,Sacrifice,mucinous adenocarcinoma of gallbladder,0
8564,Recurrence (disease attribute),Cancer of Urinary Tract,0
8565,Characteristics,Metastatic Ductal Breast Carcinoma,0
8566,Take,Endometrial Small Cell Carcinoma,0
8567,Together,Endometrial Small Cell Carcinoma,0
8568,Tumor Mass,Adult Hepatocellular Carcinoma,0
8569,Tumor cells,Testicular cancer metastatic,0
8570,To,Malignant Testicular Sertoli Cell Tumor,0
8571,Concept model domain,Rhabdomyosarcoma with ganglionic differentiation,0
8572,Nephroblastoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8573,Sunlight,Contact dermatitis due to alkali,0
8574,40%,Stage IB Pancreatic Cancer AJCC v8,0
8575,Swelling,Malignant Testicular Sertoli Cell Tumor,0
8576,Treatment intent,Advanced Uterine Corpus Carcinosarcoma,0
8577,Aggressive course,Pancreatic Intraepithelial Neoplasia-3,0
8578,Severe atopic dermatitis,Spongiotic dermatitis,0
8579,depend,Primary Cutaneous Plasmablastic Lymphoma,0
8580,Leg,Malignant melanoma of eyelid,0
8581,seen,Cartilaginous exostosis,0
8582,Main,BRCA2 Syndrome,0
8583,React,Thymic Clear Cell Carcinoma,0
8584,Effective,Human Papillomavirus-Related Carcinoma,0
8585,Lymph,Digestive System Hodgkin Lymphoma,0
8586,Skin Pigmentation,Acute Undifferentiated Leukemia,0
8587,United States,FIGO Stage II Ovarian Cancer,0
8588,Skin Pigmentation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8589,Patient Outcome - Died,Diffuse malignant mesothelioma,0
8590,Value Above Reference Range,Malignant melanoma of eyelid,0
8591,Classification,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8592,Percent Activity,Thymic Clear Cell Carcinoma,0
8593,Enlarged,Hodgkin lymphoma,0
8594,Event Seriousness - Significant,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8595,Group A (blood group),Intestinal Neuroendocrine Carcinoma,0
8596,How Much Distress Shortness of Breath,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8597,Cell Count,FIGO Stage II Ovarian Cancer,0
8598,Person present,Maxillary Sinus Adenocarcinoma,0
8599,Body structure,papillary carcinoma of penis,0
8600,Ductal Breast Carcinoma,Female Breast Carcinoma,0
8601,Non-Small Cell Lung Carcinoma,adenosquamous carcinoma of breast,0
8602,radiotherapeutic,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8603,Domain (area of knowledge),Rhabdomyosarcoma with ganglionic differentiation,0
8604,laparoscopy (therapeutic),Atypical Mesothelial Hyperplasia,0
8605,Primary malignant neoplasm of lung,Testicular cancer metastatic,0
8606,Code,Rhabdomyosarcoma with ganglionic differentiation,0
8607,Areas <moth>,Mucinous adenocarcinoma gastric,0
8608,various antiseptic throat preparations,Extra-Adrenal Paraganglioma,0
8609,Symptoms,Localized Askin Tumor,0
8610,prior radiation therapy,Carcinoma of urinary bladder,0
8611,Vaginal,Anterior Urethral Malignant Neoplasm,0
8612,cell growth,Endometrial Small Cell Carcinoma,0
8613,Table Cell Horizontal Align - left,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8614,Disease,Pancreatic Intraepithelial Neoplasia-3,0
8615,Togo,Pilocytic astrocytoma of cerebellum,0
8616,Mean Percent of Normal,Undifferentiated Endocervical Sarcoma,0
8617,Smear test,Malignant melanoma of eyelid,0
8618,Malignant neoplasm of liver,Adult Hepatocellular Carcinoma,0
8619,Cystadenocarcinoma,Serous cystadenocarcinoma ovary,0
8620,Most,Stage IB Lung Cancer AJCC v7,0
8621,Primary malignant neoplasm,Localized Askin Tumor,0
8622,Fever,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8623,Mathematical Operator,Digestive System Hodgkin Lymphoma,0
8624,Assortment,Mastocytosis,0
8625,Manufactured form,squamous cell carcinoma of the thyroid gland,0
8626,Pediculus humanus capitis (eukaryote),Adult Alveolar Soft Part Sarcoma,0
8627,Particle,Neonatal leukemia,0
8628,{Setting},Benign Carotid Body Paraganglioma,0
8629,Both kidneys,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8630,Application Context,Benign neoplasm of thorax,0
8631,Imaging Techniques,Carcinoma of urinary bladder,0
8632,How Much Distress Vomiting,Choroid Necrotic Melanoma,0
8633,Blood Vessel,Testicular cancer metastatic,0
8634,Room of building - Study,Localized Askin Tumor,0
8635,Long-term Follow-up,Extra-Adrenal Paraganglioma,0
8636,1+ Score,gliosarcoma,0
8637,Cystoscopy,Bladder squamous cell carcinoma stage I,0
8638,Cure (remedy),Mucinous adenocarcinoma gastric,0
8639,Rating (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8640,Usual Severity Shortness of Breath,Stage IB Lung Cancer AJCC v7,0
8641,STS gene,Ichthyosis,0
8642,Study Control,Stage IB Pancreatic Cancer AJCC v8,0
8643,Form:Finding:Point in time:{Setting}:Document:{Role},Leiomyoma of Gallbladder,0
8644,Punctum,Benign Apocrine Neoplasm,0
8645,Head and neck structure,Recurrent Testicular Lymphoma,0
8646,Sequence Arm,Stage I Adult Non-Hodgkin Lymphoma,0
8647,Biopsy,Carcinoma of urinary bladder,0
8648,Cosmetic procedure,Maxillary Sinus Adenocarcinoma,0
8649,Females,Bladder squamous cell carcinoma stage I,0
8650,Uterine Cancer,Undifferentiated Endocervical Sarcoma,0
8651,Occur (action),Bladder squamous cell carcinoma stage I,0
8652,Young,Cancer of Urinary Tract,0
8653,Completely Able,Colorectal High Grade B-Cell Lymphoma,0
8654,Human body structure,Colorectal Neuroendocrine Tumor G2,0
8655,90 - 100%,Benign Carotid Body Paraganglioma,0
8656,Blink Reflexes,Blepharal carcinoma,0
8657,Malignant Neoplasms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8658,Science of Etiology,Stage II Carcinoma of Penis,0
8659,Use of,Malignant melanoma of eyelid,0
8660,Linear,Sarcomatoid Renal Cell Carcinoma,0
8661,Smear - instruction imperative,Localized Askin Tumor,0
8662,per year,Acantholytic squamous cell carcinoma,0
8663,Variable (uniformity),Carcinoma ex pleomorphic adenoma of parotid gland,0
8664,Cell Device,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8665,Taxonomic,Female Breast Carcinoma,0
8666,Blood,Recurrent Testicular Lymphoma,0
8667,Fatty Liver Disease,Adult Hepatocellular Carcinoma,0
8668,Gait normal,Undifferentiated Endocervical Sarcoma,0
8669,Personal appearance,Intestinal Neuroendocrine Carcinoma,0
8670,76,Endometrial Small Cell Carcinoma,0
8671,Response (communication),Female Breast Carcinoma,0
8672,described,Anterior Urethral Malignant Neoplasm,0
8673,To,Pancreatic Intraepithelial Neoplasia-3,0
8674,Greater than one,gliosarcoma,0
8675,Metastatic to,Testicular cancer metastatic,0
8676,Better,Recurrent Testicular Lymphoma,0
8677,Offspring,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8678,Context,Atypical Lobular Breast Hyperplasia,0
8679,Distal (qualifier value),Acantholytic squamous cell carcinoma,0
8680,Paraneoplastic Syndromes,Metastatic Neoplasm to the Gallbladder,0
8681,Symptoms,Cancer of Urinary Tract,0
8682,Response process,Female Breast Carcinoma,0
8683,Age of Onset,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8684,Three,Giant cell angiofibroma,0
8685,Presentation,Giant cell angiofibroma,0
8686,Inguinal part of abdomen,Stage I Adult Non-Hodgkin Lymphoma,0
8687,Uncontrolled,Recurrent Testicular Lymphoma,0
8688,Epithelium of large intestine,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8689,Increase,Malignant melanoma of eyelid,0
8690,Cure (remedy),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8691,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8692,Genes,Undifferentiated Endocervical Sarcoma,0
8693,survival aspects,Mucinous adenocarcinoma gastric,0
8694,Count of entities,squamous cell carcinoma of the thyroid gland,0
8695,Options,Acantholytic squamous cell carcinoma,0
8696,Does stand alone,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8697,eTMF Content Model Code,Secondary malignant neoplasm of lymph node,0
8698,Occurrence Indicator,Malignant neoplasm of choroid,0
8699,Route of Administration - Mucous Membrane,Giant cell angiofibroma,0
8700,Five,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8701,Manufactured form,Acantholytic squamous cell carcinoma,0
8702,Operative Surgical Procedures,Malignant Testicular Sertoli Cell Tumor,0
8703,Cells,mucinous adenocarcinoma of gallbladder,0
8704,Hemorrhage,Hemangioma,0
8705,Entity,Human Papillomavirus-Related Carcinoma,0
8706,Valid,Rhabdomyosarcoma with ganglionic differentiation,0
8707,Malignant mesothelioma,Diffuse malignant mesothelioma,0
8708,Acute leukemia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8709,Vaginal (intended site),Anterior Urethral Malignant Neoplasm,0
8710,Raised,Maxillary Sinus Adenocarcinoma,0
8711,Arising in,Adult Alveolar Soft Part Sarcoma,0
8712,Occur (action),Mucinous neoplasm,0
8713,dendritic spine neck,Adult Alveolar Soft Part Sarcoma,0
8714,Feelings,Stage I Adult Non-Hodgkin Lymphoma,0
8715,Broken skin,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8716,To,Testicular cancer metastatic,0
8717,Extravasation,Hemangioma,0
8718,Skeletal bone,Mucinous adenocarcinoma gastric,0
8719,30%,Recurrent Diffuse Intrinsic Pontine Glioma,0
8720,Chest,Extra-Adrenal Paraganglioma,0
8721,Poverty,Refractory Barrett Esophagus,0
8722,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Anterior Urethral Malignant Neoplasm,0
8723,Occurrence,Airway Hemangioma,0
8724,System - kit,mucinous adenocarcinoma of gallbladder,0
8725,Complication Aspects,Localized Askin Tumor,0
8726,Fibrous papule of nose,Giant cell angiofibroma,0
8727,Diagnosis Study,Unfavorable Non-Hodgkin Lymphoma,0
8728,Combined,Undifferentiated Endocervical Sarcoma,0
8729,Skin,Deep Leiomyoma,0
8730,Areas <moth>,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8731,Pharmacotherapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8732,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Undifferentiated Endocervical Sarcoma,0
8733,Injury due to exposure to external cause,Contact dermatitis due to alkali,0
8734,genetic risk factors,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8735,Most,Human Papillomavirus-Related Carcinoma,0
8736,Prior Medication Usage,Acantholytic squamous cell carcinoma,0
8737,How Much Distress Itching,Mastocytosis,0
8738,Manufactured form,Liver Cavernous Hemangioma,0
8739,Often - answer to question,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8740,Present,Deep Leiomyoma,0
8741,Survival Rate,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8742,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Childhood Lymphoma,0
8743,Fever symptoms (finding),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8744,Persons,Malignant Testicular Sertoli Cell Tumor,0
8745,unknown vaccine or immune globulin,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8746,lymph nodes,Primary Cutaneous Plasmablastic Lymphoma,0
8747,Synonym,Cartilaginous exostosis,0
8748,Possible diagnosis,Refractory Barrett Esophagus,0
8749,Folded structure,Blepharal carcinoma,0
8750,Related personal status,Leptomeningeal sarcoma,0
8751,Diagnosis Study,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8752,Specimen Source Codes - Lesion,Benign Apocrine Neoplasm,0
8753,Epithelial Cells,Thymic Clear Cell Carcinoma,0
8754,Rare,Malignant melanoma of eyelid,0
8755,Screening,FIGO Stage II Ovarian Cancer,0
8756,Epidermis,Spongiotic dermatitis,0
8757,Dry,Ichthyosis,0
8758,Often - answer to question,Intestinal Metaplasia of Bladder Urothelium,0
8759,Stromal Cells,Digestive System Hodgkin Lymphoma,0
8760,Together,Localized Askin Tumor,0
8761,Cells,Female Breast Carcinoma,0
8762,A Codes,Intracortical osteosarcoma,0
8763,Gram per Deciliter,Ichthyoses,0
8764,low,Clonal Hematopoiesis of Indeterminate Potential,0
8765,Long Variable,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8766,Present,Blepharal carcinoma,0
8767,Recurrent infections,Cancer of Urinary Tract,0
8768,Skin,Airway Hemangioma,0
8769,Cough,Diffuse malignant mesothelioma,0
8770,Infrequent,Refractory Barrett Esophagus,0
8771,Extent of disease,FIGO Stage II Ovarian Cancer,0
8772,Congenital Abnormality,Childhood Central Nervous System Immature Teratoma,0
8773,prior radiation therapy,Uterine Cancer,0
8774,Term (lexical),Testicular cancer metastatic,0
8775,Smear - instruction imperative,Malignant neoplasm of thalamus,0
8776,shared attribute,Leiomyoma of Gallbladder,0
8777,80%,Diffuse malignant mesothelioma,0
8778,Cell division,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8779,Cancer Genus,Diffuse malignant mesothelioma,0
8780,Abnormal Reference Range,Atypical Lobular Breast Hyperplasia,0
8781,Loss of Appetite question,Pancreatic Intraepithelial Neoplasia-3,0
8782,Throat,Tonsillar Carcinoma,0
8783,B-Cell Lymphomas,Primary Cutaneous Plasmablastic Lymphoma,0
8784,Woman,Cancer of Urinary Tract,0
8785,Local disease,Recurrent Uveal Melanoma,0
8786,Morphology,Noninfiltrating Intraductal Carcinoma,0
8787,Melanocytic nevus of skin,GIANT PIGMENTED HAIRY NEVUS,0
8788,1000000,FIGO Stage II Ovarian Cancer,0
8789,Delta (difference),squamous cell carcinoma of the thyroid gland,0
8790,Anatomic Structure,Benign Carotid Body Paraganglioma,0
8791,mole changes,Recurrent Uveal Melanoma,0
8792,List,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8793,Base Pairing,BRCA2 Syndrome,0
8794,newly,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8795,Including (qualifier),Cancer of Urinary Tract,0
8796,Guide device,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8797,What subject filter - Result,Undifferentiated Endocervical Sarcoma,0
8798,Cell (compartment),papillary carcinoma of penis,0
8799,pre-surgery,Mucinous neoplasm,0
8800,Extreme,Placental aromatase deficiency,0
8801,Sometimes,Primary Cutaneous Plasmablastic Lymphoma,0
8802,Mass of body region,Recurrent Testicular Lymphoma,0
8803,Diagnosis,Contact dermatitis due to alkali,0
8804,mucosa-associated lymphoid tissue,Digestive System Hodgkin Lymphoma,0
8805,error,Childhood Central Nervous System Immature Teratoma,0
8806,Study Control,Pancreatic Intraepithelial Neoplasia-3,0
8807,To,FIGO Stage II Ovarian Cancer,0
8808,Symptoms,Stage II Carcinoma of Penis,0
8809,In addition to,Recurrent Testicular Lymphoma,0
8810,Occurrence,Maxillary Sinus Adenocarcinoma,0
8811,Diagnosis,Diffuse malignant mesothelioma,0
8812,Cell Device,Clonal Hematopoiesis of Indeterminate Potential,0
8813,Filter (function),Digestive System Hodgkin Lymphoma,0
8814,cancer therapy,Unresectable Rhabdomyosarcoma,0
8815,Average,Diffuse malignant mesothelioma,0
8816,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Endometrial Small Cell Carcinoma,0
8817,Residue on Tongue,Giant cell angiofibroma,0
8818,Plasma Cells,Heavy Chain Deposition Disease,0
8819,melanotic,Metastatic Ductal Breast Carcinoma,0
8820,Pericardial sac structure,Atypical Mesothelial Hyperplasia,0
8821,Highest,Bladder squamous cell carcinoma stage I,0
8822,Feel Tired question,Hodgkin lymphoma,0
8823,Scaling,Acantholytic squamous cell carcinoma,0
8824,Common Specifications in HL7 V3 Publishing,Endometrial Small Cell Carcinoma,0
8825,C3 gene,Adult Alveolar Soft Part Sarcoma,0
8826,Free of (attribute),Female Breast Carcinoma,0
8827,Second Suffix,Secondary malignant neoplasm of lymph node,0
8828,Infant,Human Papillomavirus-Related Carcinoma,0
8829,Vertebrates,Digestive System Hodgkin Lymphoma,0
8830,List,Ampulla of Vater Tubular Adenoma,0
8831,Onset of (contextual qualifier),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8832,Indication of (contextual qualifier),Adult Hepatocellular Carcinoma,0
8833,Early stage,Undifferentiated Endocervical Sarcoma,0
8834,Study,Angiosarcoma of liver,0
8835,Enhance (action),Secondary malignant neoplasm of lymph node,0
8836,hiv-infection/aids,Acute lymphadenitis,0
8837,Cancer Other,Undifferentiated Endocervical Sarcoma,0
8838,Neoplasm Metastasis,adenosquamous carcinoma of breast,0
8839,Genus Chalazion,Benign Apocrine Neoplasm,0
8840,Stage Grouping,Testicular cancer metastatic,0
8841,lymph nodes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8842,Pieris rapae,Atypical Mesothelial Hyperplasia,0
8843,Spreading (qualifier value),Mucinous adenocarcinoma gastric,0
8844,Smear - instruction imperative,Blepharal carcinoma,0
8845,Divide,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8846,Stem cells,Clonal Hematopoiesis of Indeterminate Potential,0
8847,Malignant neoplasm of skin,papillary carcinoma of penis,0
8848,Occur (action),Airway Hemangioma,0
8849,Malignant Childhood Neoplasm,Recurrent Testicular Lymphoma,0
8850,Tissue specific,Granular Cell Leiomyosarcoma,0
8851,Often - answer to question,FIGO Stage II Ovarian Cancer,0
8852,Form of uterus,Endometrial Small Cell Carcinoma,0
8853,Transurethral Resection,Bladder squamous cell carcinoma stage I,0
8854,Person Name,squamous cell carcinoma of the thyroid gland,0
8855,Classification,Neonatal leukemia,0
8856,Lacking,Female Breast Carcinoma,0
8857,Make - Instruction Imperative,Breast Ductal Adenoma,0
8858,Minor (person),Acute lymphadenitis,0
8859,Name (property) (qualifier value),Methotrexate-Associated Hodgkin Lymphoma,0
8860,Adult,Neonatal leukemia,0
8861,Presentation,Tonsillar Carcinoma,0
8862,In Urine,Grade 1 Clear Cell Renal Cell Carcinoma,0
8863,Vasopressins,Collecting Duct Carcinoma of the Kidney,0
8864,Slow,Adult Alveolar Soft Part Sarcoma,0
8865,70%,Tonsillar Carcinoma,0
8866,Formation,Hemangioma,0
8867,Host (organism),Testicular cancer metastatic,0
8868,Before values,Thymic Clear Cell Carcinoma,0
8869,Decreasing,Acantholytic squamous cell carcinoma,0
8870,Togo,Unresectable Rhabdomyosarcoma,0
8871,Lesion,Hemangioma,0
8872,Liquid Tumor,Primary Cutaneous Plasmablastic Lymphoma,0
8873,Peripheral T-Cell Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
8874,Tryptophanase,Benign Apocrine Neoplasm,0
8875,Bone marrow: lymphocytes (finding),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8876,Primary,Serous cystadenocarcinoma ovary,0
8877,Plasma Cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8878,Menopause present (finding),Undifferentiated Endocervical Sarcoma,0
8879,Decision,Unresectable Rhabdomyosarcoma,0
8880,Clone Cells,Clonal Hematopoiesis of Indeterminate Potential,0
8881,Togo,Malignant Neoplasm with Regional Lymph Node Involvement,0
8882,Lower - spatial qualifier,Malignant Testicular Sertoli Cell Tumor,0
8883,Biomaterial Treatment,Uterine Cancer,0
8884,Term Birth,Adult Alveolar Soft Part Sarcoma,0
8885,Bone Marrow Examination,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8886,Prognosis:Find:Pt:^Patient:Nom,Acantholytic squamous cell carcinoma,0
8887,Publications,Leptomeningeal sarcoma,0
8888,Immune System Processes,Human Papillomavirus-Related Carcinoma,0
8889,Biopsy,Intestinal Metaplasia of Bladder Urothelium,0
8890,survive,adenoid cystic carcinoma of lung,0
8891,Dura Mater,Childhood Cerebellar Neoplasm,0
8892,Basis,Female Breast Carcinoma,0
8893,Circulatory System Process,Digestive System Hodgkin Lymphoma,0
8894,Beginning,Adult Alveolar Soft Part Sarcoma,0
8895,Characterization,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8896,Abdominal hysterectomy,Undifferentiated Endocervical Sarcoma,0
8897,Increased,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8898,Referring,Stage IB Pancreatic Cancer AJCC v8,0
8899,How Much Distress Weight Loss,Diffuse malignant mesothelioma,0
8900,Local disease,Malignant melanoma of eyelid,0
8901,Beginning,adenosquamous carcinoma of breast,0
8902,Nevus,Malignant melanoma of eyelid,0
8903,Absence of Signs or Symptoms,Heavy Chain Deposition Disease,0
8904,Then,Mucinous adenocarcinoma gastric,0
8905,Second Suffix,Colorectal cancer,0
8906,Recommendation,Endometrial Small Cell Carcinoma,0
8907,Ability,FIGO Stage II Ovarian Cancer,0
8908,Head - Component of Device,Extra-Adrenal Paraganglioma,0
8909,Rare,Stage IB Pancreatic Cancer AJCC v8,0
8910,CEL gene,Female Breast Carcinoma,0
8911,Multiplicative Product,Benign Apocrine Neoplasm,0
8912,Negation,Cartilaginous exostosis,0
8913,Dilated,Endometrial Small Cell Carcinoma,0
8914,IPSS Risk Category High,Diffuse malignant mesothelioma,0
8915,Persons,Mucinous adenocarcinoma gastric,0
8916,Radiation,Primary Cutaneous Plasmablastic Lymphoma,0
8917,Form:Finding:Point in time:{Setting}:Document:{Role},Pancreatic Intraepithelial Neoplasia-3,0
8918,Form:Finding:Point in time:{Setting}:Document:{Role},Malignant Neoplasm of Lung - Multiple Primary Sites,0
8919,Prognostic Factors,Breast Ductal Adenoma,0
8920,Childhood Non-Hodgkin Lymphoma,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
8921,Pruritus,Childhood Lymphoma,0
8922,Dietary Lead,Placental aromatase deficiency,0
8923,size,Adult Hepatocellular Carcinoma,0
8924,Special,Metastatic Ductal Breast Carcinoma,0
8925,Adult,Thymic Clear Cell Carcinoma,0
8926,Niobium,Primary Cutaneous Plasmablastic Lymphoma,0
8927,Base - General Qualifier,Female Breast Carcinoma,0
8928,Initially,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8929,Gait normal,Unresectable Rhabdomyosarcoma,0
8930,Ancestry-Informative Marker,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8931,Primary,Choroid Necrotic Melanoma,0
8932,/40,Endometrial Small Cell Carcinoma,0
8933,Only - dosing instruction fragment,Placental aromatase deficiency,0
8934,Aspects of signs,Malignant Neoplasm with Regional Lymph Node Involvement,0
8935,Professional guide,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8936,Aspects of signs,Angiosarcoma of liver,0
8937,Abdomen,Diffuse malignant mesothelioma,0
8938,Manufactured sign,Anterior Urethral Malignant Neoplasm,0
8939,Usual Severity Weight Loss,Unfavorable Non-Hodgkin Lymphoma,0
8940,Medications:-:Point in time:^Patient:-,Refractory Barrett Esophagus,0
8941,Sunlight,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8942,Childhood Hodgkin Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
8943,Intention - mental process,Primary Cutaneous Plasmablastic Lymphoma,0
8944,diagnosis aspect,Localized Askin Tumor,0
8945,Carcinoma in Situ,Secondary malignant neoplasm of lymph node,0
8946,98,Colorectal High Grade B-Cell Lymphoma,0
8947,Involvement with,Human Papillomavirus-Related Carcinoma,0
8948,Area,Malignant melanoma of eyelid,0
8949,Pelvic Pain,Endometrial Small Cell Carcinoma,0
8950,Young Adult,Localized Askin Tumor,0
8951,Nevus,Recurrent Uveal Melanoma,0
8952,Increase,Endometrial Small Cell Carcinoma,0
8953,Pathologic,Testicular cancer metastatic,0
8954,Multiple adenomatous polyps,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8955,Pancreas,Colorectal Neuroendocrine Tumor G2,0
8956,Case unit dose,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8957,Glioblastoma Multiforme Pathway,Recurrent Diffuse Intrinsic Pontine Glioma,0
8958,Hereditary Diseases,Stage IB Pancreatic Cancer AJCC v8,0
8959,Probability,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8960,Pharmaceutical Preparations,Spongiotic dermatitis,0
8961,Often - answer to question,Acute lymphadenitis,0
8962,Negation,Breast Ductal Adenoma,0
8963,Concept Relationship,Refractory Barrett Esophagus,0
8964,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
8965,Bacteria present,Mucinous adenocarcinoma gastric,0
8966,Object Class,Metastatic Carcinoma in the Lung,0
8967,Phase,Primary Cutaneous Plasmablastic Lymphoma,0
8968,Thyroid Gland,Childhood Thyroid Gland Follicular Carcinoma,0
8969,Removed,Blepharal carcinoma,0
8970,BRCA2 gene,FIGO Stage II Ovarian Cancer,0
8971,Chemotherapy,Acute Undifferentiated Leukemia,0
8972,majority,Serous cystadenocarcinoma ovary,0
8973,Eye,Malignant melanoma of eyelid,0
8974,Current (present time),Noninfiltrating Intraductal Carcinoma,0
8975,Associated with,Pilocytic astrocytoma of cerebellum,0
8976,Exposure to radiation,Acute Undifferentiated Leukemia,0
8977,Cultured Cell Line,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8978,Cancer Genus,Recurrent Uveal Melanoma,0
8979,Common Specifications in HL7 V3 Publishing,Recurrent Uveal Melanoma,0
8980,Cause of Death,FIGO Stage II Ovarian Cancer,0
8981,320,Undifferentiated Endocervical Sarcoma,0
8982,Occurrence Indicator,GIANT PIGMENTED HAIRY NEVUS,0
8983,Muscle (organ),Adult Alveolar Soft Part Sarcoma,0
8984,Medical Imaging,Carcinoma of urinary bladder,0
8985,Neuroglia,gliosarcoma,0
8986,Blood Vessel,Anterior Urethral Malignant Neoplasm,0
8987,Removal of bladder,Carcinoma of urinary bladder,0
8988,Pharmacotherapy,Localized Askin Tumor,0
8989,Tryptophanase,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8990,Contain (action),squamous cell carcinoma of the thyroid gland,0
8991,Bone Marrow,Digestive System Hodgkin Lymphoma,0
8992,year,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8993,3+ Score,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8994,Have Been Coughing,Diffuse malignant mesothelioma,0
8995,Did not receive therapy or drug for,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8996,Infratentorial,Malignant neoplasm of choroid,0
8997,Aggressive behavior,Breast Ductal Adenoma,0
8998,Near,Recurrent Uveal Melanoma,0
8999,Combined,FIGO Stage II Ovarian Cancer,0
9000,Case (situation),Unfavorable Non-Hodgkin Lymphoma,0
9001,Increased,Female Breast Carcinoma,0
9002,Alcohols,Adult Hepatocellular Carcinoma,0
9003,CD69 wt Allele,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9004,Case (situation),Intestinal Metaplasia of Bladder Urothelium,0
9005,Followed by,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9006,Common (qualifier value),adenoid cystic carcinoma of lung,0
9007,One,Pilocytic astrocytoma of cerebellum,0
9008,Classification of information,Leptomeningeal sarcoma,0
9009,risk factors,Pancreatic Intraepithelial Neoplasia-3,0
9010,Well,Pilocytic astrocytoma of cerebellum,0
9011,Skin Specimen,Angiosarcoma of liver,0
9012,2+ Score,Localized Askin Tumor,0
9013,CDISC SDTM Route of Administration Terminology,Digestive System Hodgkin Lymphoma,0
9014,Qualitative form,Stage IB Pancreatic Cancer AJCC v8,0
9015,Before values,Lung squamous cell carcinoma stage I,0
9016,Different,Blepharal carcinoma,0
9017,Covered (qualifier value),FIGO Stage II Ovarian Cancer,0
9018,Body part,Stage IB Lung Cancer AJCC v7,0
9019,PFDN5 gene,Maxillary Sinus Adenocarcinoma,0
9020,Benign,Recurrent Testicular Lymphoma,0
9021,Burkina Faso,Malignant melanoma of eyelid,0
9022,Include (action),Childhood Lymphoma,0
9023,Clinical,Recurrent Testicular Lymphoma,0
9024,Symptoms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9025,Tobacco smoking behavior,Refractory Barrett Esophagus,0
9026,Etiology,Human Papillomavirus-Related Carcinoma,0
9027,True,Benign Apocrine Neoplasm,0
9028,Complete,Bladder squamous cell carcinoma stage I,0
9029,Coloring Excipient,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9030,Liquid substance,Spongiotic dermatitis,0
9031,Body tissue,Bladder squamous cell carcinoma stage I,0
9032,Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
9033,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Acute Undifferentiated Leukemia,0
9034,Frequently,Unresectable Rhabdomyosarcoma,0
9035,combination of objects,Carcinoma of urinary bladder,0
9036,Including (qualifier),Methotrexate-Associated Hodgkin Lymphoma,0
9037,Specific qualifier value,Adult Hepatocellular Carcinoma,0
9038,Object Relationship,Refractory Barrett Esophagus,0
9039,Eczema,Spongiotic dermatitis,0
9040,Extremely Agree,Placental aromatase deficiency,0
9041,Science of Statistics,Noninfiltrating Intraductal Carcinoma,0
9042,Japanese language,Unresectable Rhabdomyosarcoma,0
9043,Type A,gliosarcoma,0
9044,Malignant Childhood Neoplasm,Stage II Fallopian Tube Cancer,0
9045,Sarcoma - category (morphologic abnormality),Adult Alveolar Soft Part Sarcoma,0
9046,Manufactured sign,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9047,Gait normal,Endometrial Small Cell Carcinoma,0
9048,Age at menopause:Time:Point in time:^Patient:Quantitative,FIGO Stage II Ovarian Cancer,0
9049,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Human Papillomavirus-Related Carcinoma,0
9050,Back structure,Recurrent Uveal Melanoma,0
9051,removal technique,Malignant Testicular Sertoli Cell Tumor,0
9052,IgY,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9053,Poor oral hygiene,Tonsillar Carcinoma,0
9054,Slightly Able,Malignant melanoma of eyelid,0
9055,Adult human body,Testicular cancer metastatic,0
9056,New Zealand Rabbits,Malignant melanoma of eyelid,0
9057,Vaginal Neoplasms,Anterior Urethral Malignant Neoplasm,0
9058,Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
9059,Then,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9060,Cancer Biology,Female Breast Carcinoma,0
9061,Definition,gliosarcoma,0
9062,Impaired skin integrity,Malignant melanoma of eyelid,0
9063,Tryptophanase,Localized Askin Tumor,0
9064,Medical Device Emits Smoke,Refractory Barrett Esophagus,0
9065,Nephron brand of racepinephrine hydrochloride,Collecting Duct Carcinoma of the Kidney,0
9066,Inguinal region,Hodgkin lymphoma,0
9067,Pancreatic Cyst,Mucinous neoplasm,0
9068,Relationship by association,BRCA2 Syndrome,0
9069,Physical findings,Anterior Urethral Malignant Neoplasm,0
9070,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Childhood Lymphoma,0
9071,Nodular (qualifier value),Recurrent Testicular Lymphoma,0
9072,Skin,Angiosarcoma of liver,0
9073,Value Above Reference Range,Recurrent Uveal Melanoma,0
9074,Basis - conceptual entity,Advanced Uterine Corpus Carcinosarcoma,0
9075,Referral placed,Endometrial Small Cell Carcinoma,0
9076,soft tissue,Angiosarcoma of liver,0
9077,Vaginal neoplasia,Anterior Urethral Malignant Neoplasm,0
9078,Pelvis,Uterine Cancer,0
9079,majority,adenosquamous carcinoma of breast,0
9080,Occurrence Indicator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9081,Result,Mucinous adenocarcinoma gastric,0
9082,Viola tricolor extract,Extracranial Neuroblastoma,0
9083,Tumor cells,ALK positive large B-cell lymphoma,0
9084,Sequence Data Type,Secondary malignant neoplasm of lymph node,0
9085,Skin condition (observable entity),Ichthyosis,0
9086,Usually,Acantholytic squamous cell carcinoma,0
9087,Life Threatening,Breast Ductal Adenoma,0
9088,Etiology,Hemangioma,0
9089,Site,Testicular cancer metastatic,0
9090,Hyperlink,Adult Hepatocellular Carcinoma,0
9091,Frequently,Methotrexate-Associated Hodgkin Lymphoma,0
9092,Gastroesophageal Reflux Disease,Refractory Barrett Esophagus,0
9093,History of previous events,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9094,Liquid Tumor,Clonal Hematopoiesis of Indeterminate Potential,0
9095,shared attribute,Heavy Chain Deposition Disease,0
9096,Abnormal host response,Acute Undifferentiated Leukemia,0
9097,Pelvic Pain,FIGO Stage II Ovarian Cancer,0
9098,Increase in size since previous mammogram,Malignant melanoma of eyelid,0
9099,North America,Bladder squamous cell carcinoma stage I,0
9100,1+ Score,Metastatic Neoplasm to the Gallbladder,0
9101,Individual,Benign neoplasm of thorax,0
9102,Reaction,Benign Apocrine Neoplasm,0
9103,Breast Carcinoma,Female Breast Carcinoma,0
9104,Usually Need Help from Another Person for Reach,Blepharal carcinoma,0
9105,diagnosis aspect,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9106,Squamous cell carcinoma,Tonsillar Carcinoma,0
9107,<50,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9108,Condition:Find:Pt:^Patient:Nom,FIGO Stage II Ovarian Cancer,0
9109,Formation,Cartilaginous exostosis,0
9110,Females,gliosarcoma,0
9111,Academic degree,Blepharal carcinoma,0
9112,Cancer Genus,Human Papillomavirus-Related Carcinoma,0
9113,Name,Papillary cystic tumor,0
9114,Carcinoma,Adult Alveolar Soft Part Sarcoma,0
9115,Gene Mutant,benign mature teratoma of pancreas,0
9116,Presentation,FIGO Stage II Ovarian Cancer,0
9117,Term (lexical),Recurrent Testicular Lymphoma,0
9118,Metastatic Neoplasm,Angiosarcoma of liver,0
9119,research subject screening,Endometrial Small Cell Carcinoma,0
9120,Golden retriever,Angiosarcoma of liver,0
9121,UV Radiation,Acantholytic squamous cell carcinoma,0
9122,Spreading (qualifier value),Localized Askin Tumor,0
9123,Internal,Blepharal carcinoma,0
9124,Qualitative form,Hemangioma,0
9125,Primary,Malignant neoplasm of thalamus,0
9126,Mammal liver preparation,Angiosarcoma of liver,0
9127,Wild,Extracranial Neuroblastoma,0
9128,Two,Papillary cystic tumor,0
9129,Togo,Acute Undifferentiated Leukemia,0
9130,Adult Lymphoma,Childhood Lymphoma,0
9131,1000000,Localized Askin Tumor,0
9132,Aspects of disease screening,FIGO Stage II Ovarian Cancer,0
9133,cancer genetics,Advanced Uterine Corpus Carcinosarcoma,0
9134,Lymphocyte,Papillary cystic tumor,0
9135,Age,Uterine Cancer,0
9136,Specimen Source Codes - tumor,Rhabdomyosarcoma with ganglionic differentiation,0
9137,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
9138,Drop (unit of presentation),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9139,And/Or,Maxillary Sinus Adenocarcinoma,0
9140,Death Related to Adverse Event,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9141,radiotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9142,Adult Classical Hodgkin Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9143,Therapeutic procedure,Breast Ductal Adenoma,0
9144,Gland,Adenocarcinoma of the prostate metastatic,0
9145,Mesothelial cell,Atypical Mesothelial Hyperplasia,0
9146,Stage 3B,Recurrent Testicular Lymphoma,0
9147,More,Neonatal leukemia,0
9148,Food allergenic extracts,Spongiotic dermatitis,0
9149,White Blood Cell Count procedure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9150,Rare,Angiosarcoma of liver,0
9151,Limited stage (cancer stage),Endometrial Small Cell Carcinoma,0
9152,Most,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9153,Primary malignant neoplasm,Granular Cell Leiomyosarcoma,0
9154,Smoking,Carcinoma of urinary bladder,0
9155,Decreasing,Undifferentiated Endocervical Sarcoma,0
9156,Chromosomal deoxyribonucleic acid,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9157,B-Lymphocytes,Heavy Chain Deposition Disease,0
9158,Spreading (qualifier value),mucinous adenocarcinoma of gallbladder,0
9159,Administered Component Designation,Recurrent Testicular Lymphoma,0
9160,Platelets,Acute Undifferentiated Leukemia,0
9161,Negation,BRCA2 Syndrome,0
9162,Adult Non-Hodgkin Lymphoma,Methotrexate-Associated Hodgkin Lymphoma,0
9163,biopsy characteristics,Colorectal High Grade B-Cell Lymphoma,0
9164,Malignant Neoplasms,Stage II Carcinoma of Penis,0
9165,Act Relationship Type - occurrence,Serous cystadenocarcinoma ovary,0
9166,Administration procedure,Carcinoma of urinary bladder,0
9167,risk factors,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9168,Brain,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9169,Occur (action),Stage II Carcinoma of Penis,0
9170,Human body,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9171,Involvement with,Choroid Necrotic Melanoma,0
9172,Human gene,BRCA2 Syndrome,0
9173,Formation,Cancer of Urinary Tract,0
9174,Problems - What subject filter,Rhabdomyosarcoma with ganglionic differentiation,0
9175,Anatomy aspects,Cancer of Urinary Tract,0
9176,Esophagus,Metastatic Neoplasm to the Gallbladder,0
9177,Result,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9178,Usual Severity Weight Loss,Childhood Lymphoma,0
9179,Due to,Heavy Chain Deposition Disease,0
9180,Formation,Anterior Urethral Malignant Neoplasm,0
9181,Urine,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9182,Malignant neoplasm of urinary bladder,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9183,Bladder Continence Question,Cancer of Urinary Tract,0
9184,Causing,Malignant neoplasm of choroid,0
9185,per day,Digestive System Hodgkin Lymphoma,0
9186,Immunoglobulin complex location,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9187,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9188,Estrogen (disposition),Undifferentiated Endocervical Sarcoma,0
9189,Due to,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9190,Detected (finding),Unresectable Rhabdomyosarcoma,0
9191,peripheral blood,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9192,Experimental Organism Basal Cell Carcinoma,Testicular cancer metastatic,0
9193,Occurrence,Endometrial Small Cell Carcinoma,0
9194,newly,Undifferentiated Endocervical Sarcoma,0
9195,Treating,Spermatocytic seminoma,0
9196,Cystadenocarcinoma,Serous cystadenocarcinoma ovary,0
9197,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,FIGO Stage II Ovarian Cancer,0
9198,common types,FIGO Stage II Ovarian Cancer,0
9199,Endoscopy (procedure),Mucinous adenocarcinoma gastric,0
9200,Surface,Atypical Mesothelial Hyperplasia,0
9201,Important,BRCA2 Syndrome,0
9202,therapeutic aspects,Localized Askin Tumor,0
9203,Histology Procedure,Adult Hepatocellular Carcinoma,0
9204,Income,Human Papillomavirus-Related Carcinoma,0
9205,Value Above Reference Range,Diffuse malignant mesothelioma,0
9206,Primary malignant neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9207,risk factors - observation list,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9208,CDISC SEND Tumor Findings Results Terminology,Childhood Central Nervous System Immature Teratoma,0
9209,Endometrial biopsy,Uterine Cancer,0
9210,Intestines,Colorectal Neuroendocrine Tumor G2,0
9211,Aspects of signs,Mucinous adenocarcinoma gastric,0
9212,Singular,Human Papillomavirus-Related Carcinoma,0
9213,High Level,Acantholytic squamous cell carcinoma,0
9214,Treatment Effectiveness,Female Breast Carcinoma,0
9215,Array Feature,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9216,Intestines,mucinous adenocarcinoma of gallbladder,0
9217,Sharing (Social Behavior),squamous cell carcinoma of the thyroid gland,0
9218,Lymphatic vessel,Angiosarcoma of liver,0
9219,Possibly Related to Intervention,Metastatic Carcinoma in the Lung,0
9220,Devices,Malignant melanoma of eyelid,0
9221,Specimen Source Codes - tumor,Noninfiltrating Intraductal Carcinoma,0
9222,Early disease stage,Stage IB Pancreatic Cancer AJCC v8,0
9223,Icterus,Mucinous adenocarcinoma gastric,0
9224,Form:Finding:Point in time:{Setting}:Document:{Role},Cancer of Urinary Tract,0
9225,Part of,Cancer of Urinary Tract,0
9226,Pain,Localized Askin Tumor,0
9227,Case (situation),Diffuse malignant mesothelioma,0
9228,Junctional,Refractory Barrett Esophagus,0
9229,Abdomen distended,FIGO Stage II Ovarian Cancer,0
9230,Qualitative form,Mucinous neoplasm,0
9231,Well,Blepharal carcinoma,0
9232,Subtype (attribute),FIGO Stage II Ovarian Cancer,0
9233,Five-year Survival Rate,FIGO Stage II Ovarian Cancer,0
9234,Occur (action),Uterine Cancer,0
9235,CDISC SEND Tumor Findings Results Terminology,Anterior Urethral Malignant Neoplasm,0
9236,Obesity,Cancer of Urinary Tract,0
9237,Birth defects diagnosis:Find:Pt:^Patient:Nar,Childhood Central Nervous System Immature Teratoma,0
9238,Tobacco smoking behavior,Pancreatic Intraepithelial Neoplasia-3,0
9239,Firstly,Pilocytic astrocytoma of cerebellum,0
9240,Physical findings,Breast Ductal Adenoma,0
9241,Breeding,Angiosarcoma of liver,0
9242,Five,Mucinous adenocarcinoma gastric,0
9243,Stomach Diseases,Refractory Barrett Esophagus,0
9244,Back,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9245,Affecting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9246,Singular,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9247,Pelvis+,Uterine Cancer,0
9248,Overall Publication Type,Clonal Hematopoiesis of Indeterminate Potential,0
9249,Polycythemia,Metastatic Neoplasm to the Gallbladder,0
9250,Macrophage Activation Syndrome,Stage IB Pancreatic Cancer AJCC v8,0
9251,Statistical Significance,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9252,Rare,adenoid cystic carcinoma of lung,0
9253,Proximal,Testicular cancer metastatic,0
9254,Early disease stage,Pancreatic Intraepithelial Neoplasia-3,0
9255,Unmarried person,Heavy Chain Deposition Disease,0
9256,Mathematical Operator,mucinous adenocarcinoma of gallbladder,0
9257,survival aspects,Malignant melanoma of eyelid,0
9258,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9259,Post Device,Metastatic Carcinoma in the Lung,0
9260,Specimen Source Codes - tumor,Localized Askin Tumor,0
9261,Decision,Testicular cancer metastatic,0
9262,Covered (qualifier value),Blepharal carcinoma,0
9263,Togo,Stage IB Pancreatic Cancer AJCC v8,0
9264,Apply,Human Papillomavirus-Related Carcinoma,0
9265,protein expression,Female Breast Carcinoma,0
9266,Personal appearance,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9267,Wounds - qualifier,Acantholytic squamous cell carcinoma,0
9268,Food Consumption,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9269,Determined by,Intestinal Metaplasia of Bladder Urothelium,0
9270,Sexually Transmitted Diseases,Human Papillomavirus-Related Carcinoma,0
9271,Platelets,Neonatal leukemia,0
9272,Line Specimen,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9273,Determined by,Carcinoma of urinary bladder,0
9274,Labrador retriever,Angiosarcoma of liver,0
9275,year,Localized Askin Tumor,0
9276,Symptoms,Malignant neoplasm of thalamus,0
9277,Pharmacotherapy,Undifferentiated Endocervical Sarcoma,0
9278,Membrane,Neonatal leukemia,0
9279,Immunotherapy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9280,United Kingdom,Diffuse malignant mesothelioma,0
9281,Fasting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9282,Skin Specimen,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9283,Complete excision,Endometrial Small Cell Carcinoma,0
9284,DNA,Clonal Hematopoiesis of Indeterminate Potential,0
9285,Adult Non-Hodgkin Lymphoma,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9286,Old,benign mature teratoma of pancreas,0
9287,year,Extra-Adrenal Paraganglioma,0
9288,lymph nodes,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9289,Tumor stage,Primary Cutaneous Plasmablastic Lymphoma,0
9290,Childbirth,GIANT PIGMENTED HAIRY NEVUS,0
9291,Genitalia,Maxillary Sinus Adenocarcinoma,0
9292,Skin cell,squamous cell carcinoma of the thyroid gland,0
9293,Used by,Pancreatic Intraepithelial Neoplasia-3,0
9294,Cancer Biology,Breast Ductal Adenoma,0
9295,Usual Severity Weight Loss,Mucinous adenocarcinoma gastric,0
9296,Recombinant Immune Globulin,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9297,Sunscreening Agents,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9298,active (HL7 RoleLink),Recurrent Uveal Melanoma,0
9299,Neoplastic disease,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9300,Characteristics,Colorectal High Grade B-Cell Lymphoma,0
9301,prior radiation therapy,Intestinal Metaplasia of Bladder Urothelium,0
9302,Cessation of life,Bladder squamous cell carcinoma stage I,0
9303,Form:Finding:Point in time:{Setting}:Document:{Role},Adult Alveolar Soft Part Sarcoma,0
9304,Abnormal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9305,Rapid,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9306,Disease Screening,Human Papillomavirus-Related Carcinoma,0
9307,Tumor Suppressor Genes,BRCA2 Syndrome,0
9308,Spreading (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9309,Southern Europe,Intestinal Metaplasia of Bladder Urothelium,0
9310,Decision,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9311,Long,BRCA2 Syndrome,0
9312,Estimated,GIANT PIGMENTED HAIRY NEVUS,0
9313,Malignant Neoplasms,papillary carcinoma of penis,0
9314,New,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9315,Stop brand of fluoride,Refractory Barrett Esophagus,0
9316,Areas <moth>,Localized Askin Tumor,0
9317,Tumor Mass,Adenocarcinoma of the prostate metastatic,0
9318,Digital Content Category,Neonatal leukemia,0
9319,1+,Leiomyoma of Gallbladder,0
9320,Life Threatening,Female Breast Carcinoma,0
9321,Tests (qualifier value),Female Breast Carcinoma,0
9322,Affecting,Bladder squamous cell carcinoma stage I,0
9323,Did not receive therapy or drug for,Primary Cutaneous Plasmablastic Lymphoma,0
9324,Genes,Female Breast Carcinoma,0
9325,Form of bone,Cartilaginous exostosis,0
9326,Nearly,Human Papillomavirus-Related Carcinoma,0
9327,Human Cells,Testicular cancer metastatic,0
9328,Case unit dose,Undifferentiated Endocervical Sarcoma,0
9329,Tract,Colorectal cancer,0
9330,Aim,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9331,Numerous,Collecting Duct Carcinoma of the Kidney,0
9332,Definition,Breast Ductal Adenoma,0
9333,Treating,Female Breast Carcinoma,0
9334,include - SetOperator,Granular Cell Leiomyosarcoma,0
9335,Pediculus humanus capitis (eukaryote),Intracortical osteosarcoma,0
9336,Rating (action),Intestinal Metaplasia of Bladder Urothelium,0
9337,Therapeutic procedure,Primary Cutaneous Plasmablastic Lymphoma,0
9338,Degree or extent,Blepharal carcinoma,0
9339,Neoplasm Metastasis,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9340,Diagnosis,Bladder squamous cell carcinoma stage I,0
9341,Type A,ALK positive large B-cell lymphoma,0
9342,Singular,Heavy Chain Deposition Disease,0
9343,800,Recurrent Uveal Melanoma,0
9344,Ephrin Type-B Receptor 1,Colorectal Neuroendocrine Tumor G2,0
9345,shared attribute,Pancreatic Intraepithelial Neoplasia-3,0
9346,Pleural effusion fluid,Localized Askin Tumor,0
9347,per period (qualifier value),Thymic Clear Cell Carcinoma,0
9348,Follicle,Benign Apocrine Neoplasm,0
9349,Symptoms aspect,Cancer of Urinary Tract,0
9350,Common (qualifier value),Recurrent Testicular Lymphoma,0
9351,Time,Rhabdomyosarcoma with ganglionic differentiation,0
9352,Symptoms aspect,Diffuse malignant mesothelioma,0
9353,Pancreatic Intraductal Papillary Mucinous Neoplasm,Mucinous neoplasm,0
9354,Lymphocyte,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
9355,Essential,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9356,Progress,Recurrent Testicular Lymphoma,0
9357,allowing,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9358,Time (foundation metadata concept),Noninfiltrating Intraductal Carcinoma,0
9359,colon function,mucinous adenocarcinoma of gallbladder,0
9360,Treating,Adult Hepatocellular Carcinoma,0
9361,Weight decreased,Childhood Lymphoma,0
9362,Death (finding),Stage II Carcinoma of Penis,0
9363,Activation action,Contact dermatitis due to alkali,0
9364,Glycation End Products,Human Papillomavirus-Related Carcinoma,0
9365,Basis - conceptual entity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9366,soluble,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9367,Cutaneous,Deep Leiomyoma,0
9368,Easy,Angiosarcoma of liver,0
9369,depend,FIGO Stage II Ovarian Cancer,0
9370,Extension,Rhabdomyosarcoma with ganglionic differentiation,0
9371,Common (qualifier value),Stage IB Lung Cancer AJCC v7,0
9372,Removed,FIGO Stage II Ovarian Cancer,0
9373,95,Colorectal High Grade B-Cell Lymphoma,0
9374,Common Specifications in HL7 V3 Publishing,Heavy Chain Deposition Disease,0
9375,Platelets,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9376,In Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9377,Due to,Adult Hepatocellular Carcinoma,0
9378,Malignant neoplasm of endometrium,Endometrial Small Cell Carcinoma,0
9379,40%,Clonal Hematopoiesis of Indeterminate Potential,0
9380,Body tissue,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9381,Treating,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9382,Poor - grade value,Human Papillomavirus-Related Carcinoma,0
9383,Type - attribute,Acute lymphadenitis,0
9384,treatment - ActInformationManagementReason,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9385,1960s,Acute Undifferentiated Leukemia,0
9386,Specialized,Thymic Clear Cell Carcinoma,0
9387,Injury due to exposure to external cause,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9388,During,Heavy Chain Deposition Disease,0
9389,Anatomic Site,Urethral Carcinoma,0
9390,Confirmation,FIGO Stage II Ovarian Cancer,0
9391,Special,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9392,Air (substance),Adult Alveolar Soft Part Sarcoma,0
9393,Coding,BRCA2 Syndrome,0
9394,Hyperestrogenism,Undifferentiated Endocervical Sarcoma,0
9395,pharmacotherapeutic,Primary Cutaneous Plasmablastic Lymphoma,0
9396,Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
9397,Name Given at Birth,Airway Hemangioma,0
9398,Malignant neoplasm of breast,BRCA2 Syndrome,0
9399,Childhood Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9400,Plants,Angiosarcoma of liver,0
9401,Occur (action),GIANT PIGMENTED HAIRY NEVUS,0
9402,Concept History,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9403,Core needle biopsy,Atypical Lobular Breast Hyperplasia,0
9404,Breast Feeding,FIGO Stage II Ovarian Cancer,0
9405,First (number),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9406,Human body structure,Digestive System Hodgkin Lymphoma,0
9407,include - SetOperator,Intracortical osteosarcoma,0
9408,Lesion,Liver Cavernous Hemangioma,0
9409,To,Acute Undifferentiated Leukemia,0
9410,Positive Selection,Thymic Clear Cell Carcinoma,0
9411,MOSTLY,Recurrent Uveal Melanoma,0
9412,Groups,Heavy Chain Deposition Disease,0
9413,Cyst,Benign Apocrine Neoplasm,0
9414,Singular,Stage IB Pancreatic Cancer AJCC v8,0
9415,Lymphocyte,ALK positive large B-cell lymphoma,0
9416,Extrinsic,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9417,Atypical,Atypical Lobular Breast Hyperplasia,0
9418,Often - answer to question,Stage IB Pancreatic Cancer AJCC v8,0
9419,Precision - second,Secondary malignant neoplasm of lymph node,0
9420,Result,Acantholytic squamous cell carcinoma,0
9421,Primary malignant neoplasm,Spermatocytic seminoma,0
9422,Pathology,Testicular cancer metastatic,0
9423,Multiple Partners,Stage II Carcinoma of Penis,0
9424,Presentation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9425,Covers (device),Blepharal carcinoma,0
9426,Formation,Colorectal High Grade B-Cell Lymphoma,0
9427,Treating,Spongiotic dermatitis,0
9428,Early,Adult Alveolar Soft Part Sarcoma,0
9429,Main,Giant cell angiofibroma,0
9430,Very,Placental aromatase deficiency,0
9431,Data Compression,mucinous adenocarcinoma of gallbladder,0
9432,Coating (film),Adult Alveolar Soft Part Sarcoma,0
9433,Ovary,Serous cystadenocarcinoma ovary,0
9434,Trauma,Giant cell angiofibroma,0
9435,Present,Thymic Clear Cell Carcinoma,0
9436,Overall Publication Type,Testicular cancer metastatic,0
9437,Interferes with,Acute Undifferentiated Leukemia,0
9438,Standard (qualifier),Recurrent Testicular Lymphoma,0
9439,Follow,Cancer of Urinary Tract,0
9440,include - SetOperator,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9441,Second edition,Intracortical osteosarcoma,0
9442,include - SetOperator,Mucinous adenocarcinoma gastric,0
9443,Telencephalon,gliosarcoma,0
9444,Cyclin A,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9445,Nephrons,Collecting Duct Carcinoma of the Kidney,0
9446,Offspring,Adult Alveolar Soft Part Sarcoma,0
9447,Proton pump inhibitors for peptic ulcer and GORD,Refractory Barrett Esophagus,0
9448,Unique,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9449,Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
9450,gastrointestinal,mucinous adenocarcinoma of gallbladder,0
9451,Late,Primary Cutaneous Plasmablastic Lymphoma,0
9452,form name,Extracranial Neuroblastoma,0
9453,ovarian,mucinous adenocarcinoma of gallbladder,0
9454,Modify status - jump,Extracranial Neuroblastoma,0
9455,Myeloma Proteins,Heavy Chain Deposition Disease,0
9456,Neoplasms,Extra-Adrenal Paraganglioma,0
9457,Spreading (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
9458,peripheral blood,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9459,pemetrexed,Diffuse malignant mesothelioma,0
9460,Case (situation),Cancer of Urinary Tract,0
9461,Pediatric Neoplasm,Anterior Urethral Malignant Neoplasm,0
9462,risk factors,Malignant Testicular Sertoli Cell Tumor,0
9463,Classical Hodgkin's Lymphoma,Stage I Adult Non-Hodgkin Lymphoma,0
9464,Increase,Heavy Chain Deposition Disease,0
9465,Antigens,Unresectable Rhabdomyosarcoma,0
9466,Pelvic Pain,FIGO Stage II Ovarian Cancer,0
9467,Very Much,Digestive System Hodgkin Lymphoma,0
9468,Administration procedure,Breast Ductal Adenoma,0
9469,Laboratory Procedures,Benign neoplasm of thorax,0
9470,Cancer Remission,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9471,Linear,squamous cell carcinoma of the thyroid gland,0
9472,Usually Need Help from Another Person for Reach,Stage IB Pancreatic Cancer AJCC v8,0
9473,Reported,Tonsillar Carcinoma,0
9474,Name Given at Birth,GIANT PIGMENTED HAIRY NEVUS,0
9475,Rare,Malignant Testicular Sertoli Cell Tumor,0
9476,gene therapy,Pancreatic Intraepithelial Neoplasia-3,0
9477,Contraceptives,Undifferentiated Endocervical Sarcoma,0
9478,Bladder Neoplasm,Carcinoma of urinary bladder,0
9479,LATS1 gene,Human Papillomavirus-Related Carcinoma,0
9480,Usual Severity Weight Loss,adenosquamous carcinoma of breast,0
9481,Person Observer,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9482,Dysuria,Undifferentiated Endocervical Sarcoma,0
9483,Greater than one,Leiomyoma of Gallbladder,0
9484,Phenazopyridine,Cancer of Urinary Tract,0
9485,Cause of Death,Adult Hepatocellular Carcinoma,0
9486,Blood Cells,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9487,diagnosis aspect,Carcinoma of urinary bladder,0
9488,Singular,Cancer of Urinary Tract,0
9489,Effectiveness,Female Breast Carcinoma,0
9490,Severe (severity modifier),Childhood Lymphoma,0
9491,melanoma,Acantholytic squamous cell carcinoma,0
9492,South Korea,Mucinous adenocarcinoma gastric,0
9493,immunoglobulin activity,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9494,Tissue damage,Digestive System Hodgkin Lymphoma,0
9495,Malignant Vaginal Neoplasm,papillary carcinoma of penis,0
9496,Rare,Acute lymphadenitis,0
9497,Females,Intestinal Metaplasia of Bladder Urothelium,0
9498,Case (situation),Spongiotic dermatitis,0
9499,Neoplastic disease,Anterior Urethral Malignant Neoplasm,0
9500,Plasma,Digestive System Hodgkin Lymphoma,0
9501,Screening,Mucinous adenocarcinoma gastric,0
9502,Death Related to Adverse Event,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9503,Personal appearance,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9504,Relational and Item-Specific Encoding Task,Undifferentiated Endocervical Sarcoma,0
9505,Exposure to,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9506,LYMPHOID Cancers,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9507,Urethral Carcinoma,Urethral Carcinoma,0
9508,Image Feature,mucinous adenocarcinoma of gallbladder,0
9509,Two,Choroid Necrotic Melanoma,0
9510,Feelings,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9511,Firstly,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9512,Heart,Digestive System Hodgkin Lymphoma,0
9513,Rate,Primary Cutaneous Plasmablastic Lymphoma,0
9514,Platelets Product,Acute Undifferentiated Leukemia,0
9515,Sunlight,Malignant melanoma of eyelid,0
9516,Ability,Endometrial Small Cell Carcinoma,0
9517,Qualitative form,Neonatal leukemia,0
9518,Include (action),Undifferentiated Endocervical Sarcoma,0
9519,Stomach Carcinoma,Mucinous adenocarcinoma gastric,0
9520,Precursor Cell Lymphoblastic Leukemia Lymphoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9521,Improved,Recurrent Testicular Lymphoma,0
9522,Swelling,Acute lymphadenitis,0
9523,Side,Undifferentiated Endocervical Sarcoma,0
9524,Used by,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9525,Frequently,Intestinal Neuroendocrine Carcinoma,0
9526,Disease,Placental aromatase deficiency,0
9527,English [International Organization for Standardization 639-1 code en] language reference set,Leiomyoma of Gallbladder,0
9528,Structure of germinal center of lymph node,Papillary cystic tumor,0
9529,include - SetOperator,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9530,Risk,Human Papillomavirus-Related Carcinoma,0
9531,Obese build,Granular Cell Leiomyosarcoma,0
9532,What subject filter - Result,Recurrent Uveal Melanoma,0
9533,Beginning,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9534,Goes <invertebrate>,Choroid Necrotic Melanoma,0
9535,Often - answer to question,Localized Askin Tumor,0
9536,Acute leukemia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9537,Persons,Acantholytic squamous cell carcinoma,0
9538,Biological Response Modifier Therapy,Recurrent Uveal Melanoma,0
9539,In addition to,Cancer of Urinary Tract,0
9540,Circulating Neoplastic Cells,Testicular cancer metastatic,0
9541,How Much Distress Itching,Malignant Neoplasm with Regional Lymph Node Involvement,0
9542,Approximate,Tonsillar Carcinoma,0
9543,Promegakaryocytes,Neonatal leukemia,0
9544,Diagnosis,Localized Askin Tumor,0
9545,Formation,squamous cell carcinoma of the thyroid gland,0
9546,Follicular,Childhood Thyroid Gland Follicular Carcinoma,0
9547,Benign melanocytic nevus,GIANT PIGMENTED HAIRY NEVUS,0
9548,Money or percentage indicator - Percentage,Recurrent Testicular Lymphoma,0
9549,Rapid,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9550,Papanicolaou Test,Human Papillomavirus-Related Carcinoma,0
9551,Extrinsic,Blepharal carcinoma,0
9552,H/O: malignant neoplasm,Malignant Testicular Sertoli Cell Tumor,0
9553,Helper-Inducer T-Lymphocyte,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9554,All,Acute Undifferentiated Leukemia,0
9555,Symptoms,Tonsillar Carcinoma,0
9556,device aspects,Malignant melanoma of eyelid,0
9557,Adrenal Cortex Hormones,Spongiotic dermatitis,0
9558,Dermatologist,Maxillary Sinus Adenocarcinoma,0
9559,Periungual fibroma,Giant cell angiofibroma,0
9560,Reported Term,Testicular cancer metastatic,0
9561,Most,Stage IB Pancreatic Cancer AJCC v8,0
9562,Unique,Clonal Hematopoiesis of Indeterminate Potential,0
9563,Left sided,Acute Undifferentiated Leukemia,0
9564,Life threatening - Event Consequence,Breast Ductal Adenoma,0
9565,Various patch test substance,Benign neoplasm of thorax,0
9566,Gene Mutation,Placental aromatase deficiency,0
9567,Effective,Female Breast Carcinoma,0
9568,Frequently,Primary Cutaneous Plasmablastic Lymphoma,0
9569,Form:Finding:Point in time:{Setting}:Document:{Role},Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9570,Disease,Adult Hepatocellular Carcinoma,0
9571,Persons,Localized Askin Tumor,0
9572,shared attribute,Endometrial Small Cell Carcinoma,0
9573,Fibrolamellar Hepatocellular Carcinoma,Adult Fibrolamellar Carcinoma,0
9574,Dietary Factors,Tonsillar Carcinoma,0
9575,Epitopes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9576,Negation,Undifferentiated Endocervical Sarcoma,0
9577,Ultraviolet Rays,Acantholytic squamous cell carcinoma,0
9578,Site of,squamous cell carcinoma of the thyroid gland,0
9579,Preventive monitoring,Primary Cutaneous Plasmablastic Lymphoma,0
9580,Togo,Adult Alveolar Soft Part Sarcoma,0
9581,insensitivity,Lung squamous cell carcinoma stage I,0
9582,Respiration,Refractory Barrett Esophagus,0
9583,Favorable,Endometrial Small Cell Carcinoma,0
9584,Retained,Mucinous adenocarcinoma gastric,0
9585,physiological aspects,Thymic Clear Cell Carcinoma,0
9586,Surgical service,Atypical Lobular Breast Hyperplasia,0
9587,Form:Finding:Point in time:{Setting}:Document:{Role},Blepharal carcinoma,0
9588,Historical aspects qualifier,Recurrent Uveal Melanoma,0
9589,Malignant neoplasm of lung,Lung squamous cell carcinoma stage I,0
9590,Financial Account,Unfavorable Non-Hodgkin Lymphoma,0
9591,Empty (qualifier),BRCA2 Syndrome,0
9592,% volume (qualifier value),Larynx carcinoma recurrent,0
9593,Sleeping Pills,Refractory Barrett Esophagus,0
9594,Hematologic Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
9595,Etiology aspects,Undifferentiated Endocervical Sarcoma,0
9596,Group A (blood group),Colorectal Neuroendocrine Tumor G2,0
9597,Science of Etiology,Undifferentiated Endocervical Sarcoma,0
9598,Metastatic Neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9599,anatomical layer,Diffuse malignant mesothelioma,0
9600,Fluid behavior,Spongiotic dermatitis,0
9601,65,Malignant melanoma of eyelid,0
9602,growth aspects,adenosquamous carcinoma of breast,0
9603,SPINK5 gene,Colorectal Neuroendocrine Tumor G2,0
9604,Chemicals,Carcinoma of urinary bladder,0
9605,Hemangiosarcoma,Angiosarcoma of liver,0
9606,Life,Giant cell angiofibroma,0
9607,Malignant neoplasm of testis,Malignant Testicular Sertoli Cell Tumor,0
9608,Ability to Drive,Clonal Hematopoiesis of Indeterminate Potential,0
9609,Greater,Cartilaginous exostosis,0
9610,>90,Acute Undifferentiated Leukemia,0
9611,Degree or extent,Testicular cancer metastatic,0
9612,Mass,Pancreatic Intraepithelial Neoplasia-3,0
9613,Involvement with,Childhood Lymphoma,0
9614,Medial collateral ligament,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9615,How Often Weight Loss,Childhood Lymphoma,0
9616,Tobacco smoking behavior,Stage II Carcinoma of Penis,0
9617,Formation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9618,Unit of Measure,Childhood Thyroid Gland Follicular Carcinoma,0
9619,Representation (action),adenoid cystic carcinoma of lung,0
9620,Autosomal recessive inheritance,Placental aromatase deficiency,0
9621,Occur (action),Metastatic Neoplasm to the Gallbladder,0
9622,Common (qualifier value),Airway Hemangioma,0
9623,Segmental Mastectomy,Breast Ductal Adenoma,0
9624,incidence of cases,Extra-Adrenal Paraganglioma,0
9625,SLC6A2 wt Allele,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9626,Reverse,Malignant neoplasm of choroid,0
9627,SPACA9 gene,Mastocytosis,0
9628,Acquisition (action),Testicular cancer metastatic,0
9629,Treatment Epoch,Maxillary Sinus Adenocarcinoma,0
9630,Out (direction),Familial Adenomatous Polyposis Associated Medulloblastoma,0
9631,Administration procedure,Recurrent Uveal Melanoma,0
9632,Hypertensive disease,Endometrial Small Cell Carcinoma,0
9633,Treatment Epoch,Localized Askin Tumor,0
9634,Type A,Hemangioma,0
9635,Body cavities,Hemangioma,0
9636,capsule (pharmacologic),Thymic Clear Cell Carcinoma,0
9637,Body part,Undifferentiated Endocervical Sarcoma,0
9638,In Urine,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9639,Including (qualifier),papillary carcinoma of penis,0
9640,Web Site,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9641,Canis familiaris,Angiosarcoma of liver,0
9642,Age of Onset,Carcinoma of urinary bladder,0
9643,Usually,Primary Cutaneous Plasmablastic Lymphoma,0
9644,Loss of Appetite question,Stage IB Pancreatic Cancer AJCC v8,0
9645,Bartholin Glands,adenoid cystic carcinoma of lung,0
9646,CEL gene,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9647,Acetic Acids,Human Papillomavirus-Related Carcinoma,0
9648,Lead,Malignant neoplasm of choroid,0
9649,*Type - Kind of quantity,Acute lymphadenitis,0
9650,Biological Processes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9651,More common in women,Cancer of Urinary Tract,0
9652,Hormonal,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9653,Ulceration,Acantholytic squamous cell carcinoma,0
9654,Pathological Dilatation,Undifferentiated Endocervical Sarcoma,0
9655,Epithelial ovarian cancer,Advanced Uterine Corpus Carcinosarcoma,0
9656,Neoplasms,Granular Cell Leiomyosarcoma,0
9657,100%,Bladder squamous cell carcinoma stage I,0
9658,Occurrence,Human Papillomavirus-Related Carcinoma,0
9659,Poor function,Recurrent Uveal Melanoma,0
9660,Similarity,Maxillary Sinus Adenocarcinoma,0
9661,Negation,Human Papillomavirus-Related Carcinoma,0
9662,Fish Flavor,Ichthyosis,0
9663,Due to,Endometrial Small Cell Carcinoma,0
9664,Medications,Spongiotic dermatitis,0
9665,Somatic mutation,Clonal Hematopoiesis of Indeterminate Potential,0
9666,Body tissue patch material,Contact dermatitis due to alkali,0
9667,Application Context,Adult Hepatocellular Carcinoma,0
9668,Type - attribute,Anterior Urethral Malignant Neoplasm,0
9669,Granulomatous,Benign Apocrine Neoplasm,0
9670,ultrasound device,Malignant Testicular Sertoli Cell Tumor,0
9671,Occur (action),Colorectal Neuroendocrine Tumor G2,0
9672,Occurrence Indicator,Undifferentiated Endocervical Sarcoma,0
9673,lobe,Thymic Clear Cell Carcinoma,0
9674,potential,Carcinoma of urinary bladder,0
9675,Drain number:ID:Pt:^Patient:Nom,Benign Apocrine Neoplasm,0
9676,point - UnitsOfMeasure,Human Papillomavirus-Related Carcinoma,0
9677,Classification,Intracortical osteosarcoma,0
9678,shared attribute,Uterine Cancer,0
9679,Pancreas,Pancreatic Intraepithelial Neoplasia-3,0
9680,Symptoms,Clonal Hematopoiesis of Indeterminate Potential,0
9681,Manufactured form,Heavy Chain Deposition Disease,0
9682,Skin,Malignant melanoma of eyelid,0
9683,Biomaterial Treatment,Human Papillomavirus-Related Carcinoma,0
9684,Asia,Bladder squamous cell carcinoma stage I,0
9685,Occurrence Indicator,Choroid Necrotic Melanoma,0
9686,risk factors,Tonsillar Carcinoma,0
9687,Ancestry-Informative Marker,Acute Undifferentiated Leukemia,0
9688,Renal Cell Carcinoma Pathway,Grade 1 Clear Cell Renal Cell Carcinoma,0
9689,Flat shape,Atypical Mesothelial Hyperplasia,0
9690,inflammatory,Acute lymphadenitis,0
9691,Pale color,Acute Undifferentiated Leukemia,0
9692,Malignant Neoplasms,Metastatic Neoplasm to the Gallbladder,0
9693,Inguinal region,Stage I Adult Non-Hodgkin Lymphoma,0
9694,Small,Maxillary Sinus Adenocarcinoma,0
9695,Polypeptide Hormones,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9696,Formation,Pancreatic Intraepithelial Neoplasia-3,0
9697,Formation,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9698,Abnormally high,Acantholytic squamous cell carcinoma,0
9699,inflammatory,Breast Ductal Adenoma,0
9700,1+ Score,gliosarcoma,0
9701,Glioma,Recurrent Diffuse Intrinsic Pontine Glioma,0
9702,Financial Account,Metastatic Carcinoma in the Lung,0
9703,diagnosis aspect,Intestinal Metaplasia of Bladder Urothelium,0
9704,Term (lexical),Atypical Lobular Breast Hyperplasia,0
9705,North America,FIGO Stage II Ovarian Cancer,0
9706,Cells,Neonatal leukemia,0
9707,Glioblastoma Multiforme Pathway,Refractory Glioma,0
9708,Treatment Epoch,Primary Cutaneous Plasmablastic Lymphoma,0
9709,Capillary vessel,Digestive System Hodgkin Lymphoma,0
9710,Dental caries,Hemangioma,0
9711,Occurrence,Giant cell angiofibroma,0
9712,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Stage II Carcinoma of Penis,0
9713,Frequently,Stage I Adult Non-Hodgkin Lymphoma,0
9714,Flank Pain,Cancer of Urinary Tract,0
9715,Related personal status,Intracortical osteosarcoma,0
9716,Hematopoietic Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
9717,Human Papillomavirus,Human Papillomavirus-Related Carcinoma,0
9718,Drug Administration Routes,Digestive System Hodgkin Lymphoma,0
9719,activate biological process,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9720,Family history,Malignant melanoma of eyelid,0
9721,Present,Intestinal Neuroendocrine Carcinoma,0
9722,Formed,Cartilaginous exostosis,0
9723,Most Recent,Secondary malignant neoplasm of lymph node,0
9724,Affecting,Hodgkin lymphoma,0
9725,1+ Score,Leiomyoma of Gallbladder,0
9726,Sounds device,Larynx carcinoma recurrent,0
9727,Oral contraception,Undifferentiated Endocervical Sarcoma,0
9728,New bone formation (morphologic abnormality),Cartilaginous exostosis,0
9729,Followed by,Bladder squamous cell carcinoma stage I,0
9730,risk factors - observation list,Tonsillar Carcinoma,0
9731,59,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9732,Dermatitis,Contact dermatitis due to alkali,0
9733,Developed Countries,Endometrial Small Cell Carcinoma,0
9734,inflammatory,Female Breast Carcinoma,0
9735,65+,Diffuse malignant mesothelioma,0
9736,Coding,Rhabdomyosarcoma with ganglionic differentiation,0
9737,Derivative,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9738,Adjacent,Recurrent Testicular Lymphoma,0
9739,year,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9740,Approximate,Endometrial Small Cell Carcinoma,0
9741,Dietary Arsenic,Angiosarcoma of liver,0
9742,Lymphadenopathy,Acute lymphadenitis,0
9743,Childhood Lymphoma,Methotrexate-Associated Hodgkin Lymphoma,0
9744,Closed,Digestive System Hodgkin Lymphoma,0
9745,Name (property) (qualifier value),squamous cell carcinoma of the thyroid gland,0
9746,Conventional (Clear Cell) Renal Cell Carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9747,Condition:Find:Pt:^Patient:Nom,Recurrent Uveal Melanoma,0
9748,95,Malignant Testicular Sertoli Cell Tumor,0
9749,Taxonomic,Intracortical osteosarcoma,0
9750,treatment - ActInformationManagementReason,Cancer of Urinary Tract,0
9751,Urine,Cancer of Urinary Tract,0
9752,Lymphoid Tissue,Recurrent Testicular Lymphoma,0
9753,Symptoms,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9754,Referring,Methotrexate-Associated Hodgkin Lymphoma,0
9755,Science of Etiology,Choroid Necrotic Melanoma,0
9756,Increase,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9757,Source,Cartilaginous exostosis,0
9758,Aspects of signs,Anterior Urethral Malignant Neoplasm,0
9759,Usually,Pancreatic Intraepithelial Neoplasia-3,0
9760,Infection,Diffuse malignant mesothelioma,0
9761,Including (qualifier),Stage I Adult Non-Hodgkin Lymphoma,0
9762,Malignant neoplasm of skin,Malignant melanoma of eyelid,0
9763,bacteria aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9764,diagnosis aspect,Recurrent Uveal Melanoma,0
9765,Young Adult,Pilocytic astrocytoma of cerebellum,0
9766,seen,Carcinoma ex pleomorphic adenoma of parotid gland,0
9767,International Classification of Diseases,Noninfiltrating Intraductal Carcinoma,0
9768,Analysis of substances,Colorectal High Grade B-Cell Lymphoma,0
9769,diagnosis aspect,Malignant Testicular Sertoli Cell Tumor,0
9770,Occur (action),Malignant melanoma of eyelid,0
9771,Stem cell transplant,Malignant Testicular Sertoli Cell Tumor,0
9772,0%,Metastatic Neoplasm to the Gallbladder,0
9773,Usually,Malignant neoplasm of choroid,0
9774,Process,Stage IB Lung Cancer AJCC v7,0
9775,Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9776,High Grade Lymphoma (neoplasm),Unfavorable Non-Hodgkin Lymphoma,0
9777,status - In progress,FIGO Stage II Ovarian Cancer,0
9778,Squamous Epithelial Cells,squamous cell carcinoma of the thyroid gland,0
9779,Megakaryocytes,Neonatal leukemia,0
9780,Primary malignant neoplasm,Mucinous adenocarcinoma gastric,0
9781,treatment - ActInformationManagementReason,Spongiotic dermatitis,0
9782,Continuance of life,Mucinous adenocarcinoma gastric,0
9783,Occurrence Indicator,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9784,Childhood Acute Megakaryoblastic Leukemia,Neonatal leukemia,0
9785,Advanced phase,Undifferentiated Endocervical Sarcoma,0
9786,Highest,Intestinal Metaplasia of Bladder Urothelium,0
9787,New,Testicular cancer metastatic,0
9788,Eye lid,Benign Apocrine Neoplasm,0
9789,English Language,Metastatic Neoplasm to the Gallbladder,0
9790,Bone Pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9791,Fibrous layer,Adult Fibrolamellar Carcinoma,0
9792,Human Papillomavirus Positive,Human Papillomavirus-Related Carcinoma,0
9793,Within,Thymic Clear Cell Carcinoma,0
9794,Symptoms,Carcinoma of urinary bladder,0
9795,removal technique,Metastatic Carcinoma in the Lung,0
9796,Alternating,Serous cystadenocarcinoma ovary,0
9797,Frequently,Testicular cancer metastatic,0
9798,Taxonomic,Breast Ductal Adenoma,0
9799,Sufficiently defined concept definition status (core metadata concept),Breast Ductal Adenoma,0
9800,mesodermal,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
9801,Case (situation),Bladder squamous cell carcinoma stage I,0
9802,artesunate,Digestive System Hodgkin Lymphoma,0
9803,Abdominal Cavity,Diffuse malignant mesothelioma,0
9804,Source (property) (qualifier value),mucinous adenocarcinoma of gallbladder,0
9805,Lymphocyte,Hodgkin lymphoma,0
9806,Act Relationship Subset - previous,Malignant Testicular Sertoli Cell Tumor,0
9807,Diagnosis,Neonatal leukemia,0
9808,Relationships,Benign Apocrine Neoplasm,0
9809,biopsy characteristics,Acantholytic squamous cell carcinoma,0
9810,Kidney,Grade 1 Clear Cell Renal Cell Carcinoma,0
9811,Internal,Adult Alveolar Soft Part Sarcoma,0
9812,Unmarried person,Clonal Hematopoiesis of Indeterminate Potential,0
9813,Germ Cells,Childhood Central Nervous System Immature Teratoma,0
9814,Lymphoma,Mucinous adenocarcinoma gastric,0
9815,Use of,Acantholytic squamous cell carcinoma,0
9816,Basis,Breast Ductal Adenoma,0
9817,Breast Carcinoma,BRCA2 Syndrome,0
9818,Chemotherapy Regimen,Carcinoma of urinary bladder,0
9819,Condition,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9820,Removed,Testicular cancer metastatic,0
9821,Body structure,Digestive System Hodgkin Lymphoma,0
9822,Uterus,Endometrial Small Cell Carcinoma,0
9823,Subtype (attribute),Recurrent Testicular Lymphoma,0
9824,CDISC SEND Tumor Findings Results Terminology,Mucinous neoplasm,0
9825,Administration procedure,Acantholytic squamous cell carcinoma,0
9826,shared attribute,Carcinoma of urinary bladder,0
9827,cancer immunology,Unresectable Rhabdomyosarcoma,0
9828,Feature,Intestinal Neuroendocrine Carcinoma,0
9829,ethnic european,Recurrent Uveal Melanoma,0
9830,Cells,Malignant melanoma of eyelid,0
9831,Ninein,Unresectable Rhabdomyosarcoma,0
9832,Reside,Diffuse malignant mesothelioma,0
9833,Often - answer to question,Childhood Lymphoma,0
9834,Classic Histology,Refractory Barrett Esophagus,0
9835,Most,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9836,Nervous system structure,Colorectal Neuroendocrine Tumor G2,0
9837,Gastric Adenocarcinoma,Mucinous adenocarcinoma gastric,0
9838,Constant (qualifier),Methotrexate-Associated Hodgkin Lymphoma,0
9839,second (number),Colorectal cancer,0
9840,Oral cavity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9841,Hormone Therapy,Endometrial Small Cell Carcinoma,0
9842,Variety (taxon),Giant cell angiofibroma,0
9843,Ultraviolet Rays,Angiosarcoma of liver,0
9844,Recommendation,Acantholytic squamous cell carcinoma,0
9845,Cervix carcinoma,Undifferentiated Endocervical Sarcoma,0
9846,Shapes,Giant cell angiofibroma,0
9847,Cervical lymph node group,Stage I Adult Non-Hodgkin Lymphoma,0
9848,Function (attribute),Digestive System Hodgkin Lymphoma,0
9849,CYREN gene,Anterior Urethral Malignant Neoplasm,0
9850,include - SetOperator,Malignant Neoplasm with Regional Lymph Node Involvement,0
9851,Cicatrix,Diffuse malignant mesothelioma,0
9852,Precursor,Mastocytosis,0
9853,high throughput analysis,Advanced Uterine Corpus Carcinosarcoma,0
9854,To,Digestive System Hodgkin Lymphoma,0
9855,Severe (severity modifier),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9856,2+,Acantholytic squamous cell carcinoma,0
9857,Greater,Adenocarcinoma of the prostate metastatic,0
9858,Linear,Acute Undifferentiated Leukemia,0
9859,Neoplasms,Secondary malignant neoplasm of lymph node,0
9860,described,Human Papillomavirus-Related Carcinoma,0
9861,Retarded,Unresectable Rhabdomyosarcoma,0
9862,Administration procedure,Localized Askin Tumor,0
9863,Stage 3 lower case b,Recurrent Testicular Lymphoma,0
9864,Taken,Cancer of Urinary Tract,0
9865,Scalp structure,Airway Hemangioma,0
9866,1000000,Intestinal Metaplasia of Bladder Urothelium,0
9867,Replacement,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9868,Diagnosis Study,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9869,Squamous cell carcinoma,papillary carcinoma of penis,0
9870,Pharmaceutical Preparations,Refractory Barrett Esophagus,0
9871,Mature,Neonatal leukemia,0
9872,Regurgitation,Refractory Barrett Esophagus,0
9873,High Mitosis-Karyorrhexis Index,Diffuse malignant mesothelioma,0
9874,Placental Steroid Sulfatase Deficiency,Ichthyosis,0
9875,various other agents for local oral treatment in ATC,Recurrent Testicular Lymphoma,0
9876,Abdominal Cavity,Extra-Adrenal Paraganglioma,0
9877,Macrophage Activation Syndrome,benign mature teratoma of pancreas,0
9878,Infant,GIANT PIGMENTED HAIRY NEVUS,0
9879,Cancer Histology,Recurrent Testicular Lymphoma,0
9880,International Classification of Diseases,Leptomeningeal sarcoma,0
9881,Actinic keratosis,Acantholytic squamous cell carcinoma,0
9882,Anorexia,Mucinous adenocarcinoma gastric,0
9883,Use of,Advanced Uterine Corpus Carcinosarcoma,0
9884,Use of,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9885,United States,Human Papillomavirus-Related Carcinoma,0
9886,Several,Recurrent Testicular Lymphoma,0
9887,Bladder Cancer Pathway,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9888,Function (attribute),Thymic Clear Cell Carcinoma,0
9889,Obesity,Refractory Barrett Esophagus,0
9890,Cardiac Lead Procedure,FIGO Stage II Ovarian Cancer,0
9891,Adapt (substance),Thymic Clear Cell Carcinoma,0
9892,shared attribute,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9893,Large,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9894,PSA Level Greater than Fifty,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9895,include - SetOperator,Leptomeningeal sarcoma,0
9896,Skin Specimen,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9897,Pharmaceutical Preparations,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9898,Skin,squamous cell carcinoma of the thyroid gland,0
9899,Half,Pancreatic Intraepithelial Neoplasia-3,0
9900,Left sided,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9901,incidence of cases,Clonal Hematopoiesis of Indeterminate Potential,0
9902,Malignant neoplasm of breast,Breast Ductal Adenoma,0
9903,Sequence Data Type,Intracortical osteosarcoma,0
9904,Symptoms aspect,Malignant neoplasm of thalamus,0
9905,System - kit,Digestive System Hodgkin Lymphoma,0
9906,Tired,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9907,Manufactured form,Pancreatic Intraepithelial Neoplasia-3,0
9908,Manufactured form,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9909,Site of,Tonsillar Carcinoma,0
9910,Inflammatory cell,Mastocytosis,0
9911,cell activation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9912,Case unit dose,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9913,AKR1A1 wt Allele,Stage I Adult Non-Hodgkin Lymphoma,0
9914,Person 1,Recurrent Uveal Melanoma,0
9915,Common (qualifier value),Metastatic Neoplasm to the Gallbladder,0
9916,Structure of great blood vessel (organ),Digestive System Hodgkin Lymphoma,0
9917,Down Syndrome,Acute Undifferentiated Leukemia,0
9918,Junction Device,Refractory Barrett Esophagus,0
9919,Fused structure,Pilocytic astrocytoma of cerebellum,0
9920,10%,Mucinous adenocarcinoma gastric,0
9921,Have Weight Loss,Stage IB Lung Cancer AJCC v7,0
9922,Calcium Channel Antagonists [MoA],Refractory Barrett Esophagus,0
9923,World,Endometrial Small Cell Carcinoma,0
9924,Carcinoma,Metastatic Ductal Breast Carcinoma,0
9925,Neck,Recurrent Testicular Lymphoma,0
9926,Small,Acantholytic squamous cell carcinoma,0
9927,High Mitotic Activity,Angiosarcoma of liver,0
9928,Most,Urethral Carcinoma,0
9929,Circulatory Process,Testicular cancer metastatic,0
9930,Location of Pharyngeal Residue Following Swallowing,Cartilaginous exostosis,0
9931,Morbidity - disease rate,Mucinous adenocarcinoma gastric,0
9932,Triggered by,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9933,alpha 1-Antitrypsin Deficiency,Adult Hepatocellular Carcinoma,0
9934,Cream,Spongiotic dermatitis,0
9935,Overall,Undifferentiated Endocervical Sarcoma,0
9936,Numbers,Acute Undifferentiated Leukemia,0
9937,Include (action),Acantholytic squamous cell carcinoma,0
9938,Barrett Esophagus,Refractory Barrett Esophagus,0
9939,3+ Answer to Question,Recurrent Uveal Melanoma,0
9940,Hyperplasia,Atypical Lobular Breast Hyperplasia,0
9941,Primary malignant neoplasm,Maxillary Sinus Adenocarcinoma,0
9942,child survival,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9943,Megakaryoblasts,Neonatal leukemia,0
9944,Very Much,Metastatic Neoplasm to the Gallbladder,0
9945,Infrequent,gliosarcoma,0
9946,Surgical patch,Contact dermatitis due to alkali,0
9947,Affect (mental function),Adult Fibrolamellar Carcinoma,0
9948,NCI CTEP SDC Salivary Gland Cancer Sub-Category Terminology,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
9949,Treating,Recurrent Uveal Melanoma,0
9950,Beginning,Stage IB Lung Cancer AJCC v7,0
9951,Treatment Epoch,Carcinoma of urinary bladder,0
9952,Regurgitation - mechanism,Refractory Barrett Esophagus,0
9953,Small cell carcinoma of lung,Metastatic Carcinoma in the Lung,0
9954,Plasma,Digestive System Hodgkin Lymphoma,0
9955,Manufactured sign,Methotrexate-Associated Hodgkin Lymphoma,0
9956,Sweat,Benign Apocrine Neoplasm,0
9957,Approximate,FIGO Stage II Ovarian Cancer,0
9958,Interaction,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9959,white blood cell type,Stage I Adult Non-Hodgkin Lymphoma,0
9960,Neoplasms,Female Breast Carcinoma,0
9961,Manufactured form,Leiomyoma of Gallbladder,0
9962,Occurrence,adenoid cystic carcinoma of lung,0
9963,Intestines,Intestinal Neuroendocrine Carcinoma,0
9964,Loss of appetite (finding),Pancreatic Intraepithelial Neoplasia-3,0
9965,95,FIGO Stage II Ovarian Cancer,0
9966,Estrogen [EPC],Endometrial Small Cell Carcinoma,0
9967,low,Placental aromatase deficiency,0
9968,Malignant Neoplasms,Colorectal High Grade B-Cell Lymphoma,0
9969,Easy bleeding,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9970,<50,Extracranial Neuroblastoma,0
9971,dendritic spine neck,Extra-Adrenal Paraganglioma,0
9972,Rate,Endometrial Small Cell Carcinoma,0
9973,Spherical shape,Adult Alveolar Soft Part Sarcoma,0
9974,control aspects,Pancreatic Intraepithelial Neoplasia-3,0
9975,Adult Classical Hodgkin Lymphoma,Hodgkin lymphoma,0
9976,Lacking,Breast Ductal Adenoma,0
9977,Reduced,Testicular cancer metastatic,0
9978,Test - temporal region,Benign neoplasm of thorax,0
9979,The Sun,Acantholytic squamous cell carcinoma,0
9980,Used by,Cartilaginous exostosis,0
9981,Site,Angiosarcoma of liver,0
9982,Specimen Source Codes - Lesion,Atypical Lobular Breast Hyperplasia,0
9983,Including (qualifier),adenoid cystic carcinoma of lung,0
9984,Most,Malignant melanoma of eyelid,0
9985,New,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9986,Lymphocyte,Recurrent Testicular Lymphoma,0
9987,Usual Severity Cough,Diffuse malignant mesothelioma,0
9988,Therapeutic radiology procedure,Carcinoma of urinary bladder,0
9989,Solid Dose Form,Anterior Urethral Malignant Neoplasm,0
9990,Diffuse Large B-Cell Lymphoma,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
9991,Individual,Primary Cutaneous Plasmablastic Lymphoma,0
9992,Connecticut,de novo Myelodysplastic Syndrome,0
9993,Disease Screening,Mucinous adenocarcinoma gastric,0
9994,Usually,Acute lymphadenitis,0
9995,Soft Tissue Route of Drug Administration,Localized Askin Tumor,0
9996,Treatment Epoch,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9997,Full,Familial Hemophagocytic Lymphocytosis,0
9998,Antibiotics,Cancer of Urinary Tract,0
9999,Skin Pigmentation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10000,Fever symptoms (finding),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10001,Dysuria,Endometrial Small Cell Carcinoma,0
10002,Discover,Unresectable Rhabdomyosarcoma,0
10003,Common Cold,Acute lymphadenitis,0
10004,Frequently,Malignant Neoplasm with Regional Lymph Node Involvement,0
10005,bony process,FIGO Stage II Ovarian Cancer,0
10006,Linear,FIGO Stage II Ovarian Cancer,0
10007,Oral cavity,Maxillary Sinus Adenocarcinoma,0
10008,>40 years,adenoid cystic carcinoma of lung,0
10009,Painful intercourse female,Anterior Urethral Malignant Neoplasm,0
10010,Transurethral Resection,Carcinoma of urinary bladder,0
10011,Phenomenon,Clonal Hematopoiesis of Indeterminate Potential,0
10012,adaptive,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10013,Occurrence,Mucinous neoplasm,0
10014,risk factors,Bladder squamous cell carcinoma stage I,0
10015,Exposure to asbestos,Diffuse malignant mesothelioma,0
10016,Immune System Processes,Recurrent Uveal Melanoma,0
10017,Abdomen,Benign neoplasm of thorax,0
10018,Esophagitis,Refractory Barrett Esophagus,0
10019,Follow - dosing instruction imperative,Cancer of Urinary Tract,0
10020,Synonym (core metadata concept),Cartilaginous exostosis,0
10021,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Intestinal Metaplasia of Bladder Urothelium,0
10022,Rating (action),Undifferentiated Endocervical Sarcoma,0
10023,Continuance of life,Benign neoplasm of thorax,0
10024,Treating,FIGO Stage II Ovarian Cancer,0
10025,Either,Leiomyoma of Gallbladder,0
10026,Cerebellum,Pilocytic astrocytoma of cerebellum,0
10027,Epidemiology,gliosarcoma,0
10028,Kidney,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10029,Affecting,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10030,Occurrence Indicator,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10031,status - In progress,Mucinous neoplasm,0
10032,Time,Localized Askin Tumor,0
10033,Hemangioma,Liver Cavernous Hemangioma,0
10034,Data Change Date,Unresectable Rhabdomyosarcoma,0
10035,Urticaria,Mastocytosis,0
10036,Type - attribute,Bladder squamous cell carcinoma stage I,0
10037,Either,Female Breast Carcinoma,0
10038,North America,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10039,Occur (action),Malignant neoplasm of choroid,0
10040,Persons,Clonal Hematopoiesis of Indeterminate Potential,0
10041,Stomach structure,Refractory Barrett Esophagus,0
10042,Cancer Genus,Adult Hepatocellular Carcinoma,0
10043,Early,FIGO Stage II Ovarian Cancer,0
10044,Application Context,Extra-Adrenal Paraganglioma,0
10045,Feature,benign mature teratoma of pancreas,0
10046,Characterization,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10047,Logical Condition,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10048,Generic Role,BRCA2 Syndrome,0
10049,Togo,Liver Cavernous Hemangioma,0
10050,Vagina,squamous cell carcinoma of the thyroid gland,0
10051,800,Diffuse malignant mesothelioma,0
10052,History of previous events,Malignant melanoma of eyelid,0
10053,Condition,Maxillary Sinus Adenocarcinoma,0
10054,Term Birth,Ichthyosis,0
10055,Enzyme Unit,Childhood Thyroid Gland Follicular Carcinoma,0
10056,Breast,Atypical Lobular Breast Hyperplasia,0
10057,Function Axis,Digestive System Hodgkin Lymphoma,0
10058,AS virus,Human Papillomavirus-Related Carcinoma,0
10059,Lymphocyte component of blood,Hodgkin lymphoma,0
10060,gene therapy,Clonal Hematopoiesis of Indeterminate Potential,0
10061,Lung,Granular Cell Leiomyosarcoma,0
10062,How Often Weight Loss,Stage IB Lung Cancer AJCC v7,0
10063,kidneys and collecting system,Collecting Duct Carcinoma of the Kidney,0
10064,Certain (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
10065,Mass of body structure,Recurrent Testicular Lymphoma,0
10066,Reduced,FIGO Stage II Ovarian Cancer,0
10067,Certainties,Bladder squamous cell carcinoma stage I,0
10068,Virilization,Placental aromatase deficiency,0
10069,shared attribute,Anterior Urethral Malignant Neoplasm,0
10070,Circulating,Testicular cancer metastatic,0
10071,Menopause,Undifferentiated Endocervical Sarcoma,0
10072,International Classification of Diseases,Rhabdomyosarcoma with ganglionic differentiation,0
10073,Affecting,Uterine Cancer,0
10074,Frequently,Acute lymphadenitis,0
10075,Organ,Stage IB Pancreatic Cancer AJCC v8,0
10076,Condylomata Acuminata,Human Papillomavirus-Related Carcinoma,0
10077,Including (qualifier),Leptomeningeal sarcoma,0
10078,shared attribute,Malignant melanoma of eyelid,0
10079,Occurrence,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10080,Links List,Human Papillomavirus-Related Carcinoma,0
10081,More,Stage IB Pancreatic Cancer AJCC v8,0
10082,Worse,FIGO Stage II Ovarian Cancer,0
10083,metaplastic cell transformation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10084,Hollow shape,squamous cell carcinoma of the thyroid gland,0
10085,Caucasians,Extracranial Neuroblastoma,0
10086,Symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10087,Dictionaries as Topic,Ampulla of Vater Tubular Adenoma,0
10088,Mutation,Acute Undifferentiated Leukemia,0
10089,Individual,Extra-Adrenal Paraganglioma,0
10090,Immune System Finding,Digestive System Hodgkin Lymphoma,0
10091,pharmacotherapeutic,Mucinous adenocarcinoma gastric,0
10092,Back structure,Airway Hemangioma,0
10093,Hodgkin Disease,Malignant Neoplasm with Regional Lymph Node Involvement,0
10094,penis,Stage II Carcinoma of Penis,0
10095,Referring,Digestive System Hodgkin Lymphoma,0
10096,Type of complication,mucinous adenocarcinoma of gallbladder,0
10097,Squamous cell carcinoma,Carcinoma of urinary bladder,0
10098,Worse,Malignant neoplasm of thalamus,0
10099,Nevus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10100,Onset of (contextual qualifier),Acantholytic squamous cell carcinoma,0
10101,Sore skin,Stage II Carcinoma of Penis,0
10102,Pancreatic Cancer Pathway,Mucinous neoplasm,0
10103,Physical Activity Measurement,Thymic Clear Cell Carcinoma,0
10104,Placement action,Testicular cancer metastatic,0
10105,shared attribute,Giant cell angiofibroma,0
10106,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Undifferentiated Endocervical Sarcoma,0
10107,treatment - ActInformationManagementReason,Bladder squamous cell carcinoma stage I,0
10108,Brain Neoplasms,Recurrent Diffuse Intrinsic Pontine Glioma,0
10109,Trial Screening,Endometrial Small Cell Carcinoma,0
10110,Views survey,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10111,Pap smear,Human Papillomavirus-Related Carcinoma,0
10112,Slow Growing,Pilocytic astrocytoma of cerebellum,0
10113,Referring,Pancreatic Intraepithelial Neoplasia-3,0
10114,Death Rate,Mucinous adenocarcinoma gastric,0
10115,Face,Benign Apocrine Neoplasm,0
10116,Options,Bladder squamous cell carcinoma stage I,0
10117,Cell Count,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10118,Lower (action),Mucinous adenocarcinoma gastric,0
10119,Both ovaries,Colorectal cancer,0
10120,Clinical Effectiveness,Female Breast Carcinoma,0
10121,80%,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10122,Item Collection,Liver Cavernous Hemangioma,0
10123,Result,FIGO Stage II Ovarian Cancer,0
10124,Pharmacotherapy,Intestinal Metaplasia of Bladder Urothelium,0
10125,Supernumerary,Cartilaginous exostosis,0
10126,Entity Determiner - specific,adenoid cystic carcinoma of lung,0
10127,Small,Cartilaginous exostosis,0
10128,Often - answer to question,Stage I Adult Non-Hodgkin Lymphoma,0
10129,All,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10130,Aromatase,Placental aromatase deficiency,0
10131,Medical service,Placental aromatase deficiency,0
10132,Sunlight,Angiosarcoma of liver,0
10133,Benign,Malignant neoplasm of choroid,0
10134,Manufactured form,Hemangioma,0
10135,Infection,Maxillary Sinus Adenocarcinoma,0
10136,Procedure findings:Finding:Point in time:^Patient:Narrative,Diffuse malignant mesothelioma,0
10137,Pathology report,Colorectal High Grade B-Cell Lymphoma,0
10138,AMINO ACIDS/PROTEINS,BRCA2 Syndrome,0
10139,Strawberry nevus of skin,Airway Hemangioma,0
10140,Spleen,Digestive System Hodgkin Lymphoma,0
10141,include - SetOperator,Tonsillar Carcinoma,0
10142,Treatment intent,Unresectable Rhabdomyosarcoma,0
10143,Major <insect>,Female Breast Carcinoma,0
10144,Categories,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10145,Spur (body structure),Cartilaginous exostosis,0
10146,Pruritus,Stage I Adult Non-Hodgkin Lymphoma,0
10147,Neoplastic Cell Transformation,Testicular cancer metastatic,0
10148,Anatomic Node,Tonsillar Carcinoma,0
10149,Arising in,Carcinoma of urinary bladder,0
10150,associated disease,Liver Cavernous Hemangioma,0
10151,Disease,Diffuse malignant mesothelioma,0
10152,General surgery specialty,Carcinoma of urinary bladder,0
10153,Hodgkin Disease,Methotrexate-Associated Hodgkin Lymphoma,0
10154,Foreskin of penis,Stage II Carcinoma of Penis,0
10155,Smear - instruction imperative,Malignant melanoma of eyelid,0
10156,therapeutic aspects,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10157,product,Benign Apocrine Neoplasm,0
10158,Treating,Breast Ductal Adenoma,0
10159,Dosing Days to Detection,Human Papillomavirus-Related Carcinoma,0
10160,Squamous,Tonsillar Carcinoma,0
10161,Characteristics,Intestinal Neuroendocrine Carcinoma,0
10162,Disease,Undifferentiated Endocervical Sarcoma,0
10163,Milliampere second,Anterior Urethral Malignant Neoplasm,0
10164,Include (action),Human Papillomavirus-Related Carcinoma,0
10165,Palpebral margin,Blepharal carcinoma,0
10166,Feelings,Tonsillar Carcinoma,0
10167,Known,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10168,Secondary Neoplasm,Anterior Urethral Malignant Neoplasm,0
10169,Increase,Diffuse malignant mesothelioma,0
10170,Term (lexical),Leiomyoma of Gallbladder,0
10171,therapeutic aspects,Neonatal leukemia,0
10172,Feature,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10173,Sounding,Benign Apocrine Neoplasm,0
10174,Usual Severity Weight Loss,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10175,diagnosis aspect,Mucinous adenocarcinoma gastric,0
10176,Observation of color of skin,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10177,Diagnosis,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10178,Secondary Neoplasm,Malignant melanoma of eyelid,0
10179,Therapeutic procedure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10180,Intestines,Metastatic Neoplasm to the Gallbladder,0
10181,Abnormal Reference Range,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10182,School Grade,Breast Ductal Adenoma,0
10183,Twice (Numerical Qualifier),Mucinous adenocarcinoma gastric,0
10184,Chromosomes,BRCA2 Syndrome,0
10185,Concern,Maxillary Sinus Adenocarcinoma,0
10186,Occur (action),Cancer of Urinary Tract,0
10187,Lower (action),Acute Undifferentiated Leukemia,0
10188,Science of Etiology,Hemangioma,0
10189,survival aspects,Benign Carotid Body Paraganglioma,0
10190,Increasing,Endometrial Small Cell Carcinoma,0
10191,Human Papillomavirus,Tonsillar Carcinoma,0
10192,Pelvic pain female,Undifferentiated Endocervical Sarcoma,0
10193,Obesity,Cancer of Urinary Tract,0
10194,Condition:Find:Pt:^Patient:Nom,Placental aromatase deficiency,0
10195,Upper,Thymic Clear Cell Carcinoma,0
10196,Including (qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10197,Nuclear (incident type),Angiosarcoma of liver,0
10198,ovarian neoplasm,FIGO Stage II Ovarian Cancer,0
10199,Head,Benign Carotid Body Paraganglioma,0
10200,Limited (extensiveness),Acute lymphadenitis,0
10201,Therapy Object (animal model),Breast Ductal Adenoma,0
10202,Base - General Qualifier,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10203,Childbirth,Adult Hepatocellular Carcinoma,0
10204,Form:Finding:Point in time:{Setting}:Document:{Role},Cartilaginous exostosis,0
10205,Arising,Adult Alveolar Soft Part Sarcoma,0
10206,Characteristics,Spongiotic dermatitis,0
10207,In Blood,Hemangioma,0
10208,types of infections,Human Papillomavirus-Related Carcinoma,0
10209,Inspiration function,Refractory Barrett Esophagus,0
10210,FAT1 wt Allele,Granular Cell Leiomyosarcoma,0
10211,Communicable Diseases,Maxillary Sinus Adenocarcinoma,0
10212,*Type - Kind of quantity,Lung squamous cell carcinoma stage I,0
10213,Determined by,Bladder squamous cell carcinoma stage I,0
10214,Volume Measurement,Familial Hemophagocytic Lymphocytosis,0
10215,seen,Angiosarcoma of liver,0
10216,68,Intestinal Metaplasia of Bladder Urothelium,0
10217,Due to,Childhood Central Nervous System Immature Teratoma,0
10218,Fever,Methotrexate-Associated Hodgkin Lymphoma,0
10219,Malignant - descriptor,Female Breast Carcinoma,0
10220,Cystic,Pilocytic astrocytoma of cerebellum,0
10221,To,Methotrexate-Associated Hodgkin Lymphoma,0
10222,Oral region,Human Papillomavirus-Related Carcinoma,0
10223,Fasting Status Indicator,Unfavorable Non-Hodgkin Lymphoma,0
10224,Flank Pain,Cancer of Urinary Tract,0
10225,Ability,Stage IB Pancreatic Cancer AJCC v8,0
10226,classical example,Metastatic Neoplasm to the Gallbladder,0
10227,Structure of zygote,Adult Alveolar Soft Part Sarcoma,0
10228,Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
10229,Case (situation),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10230,Specialized Stand Alone Plan - Vision,Airway Hemangioma,0
10231,Part,Thymic Clear Cell Carcinoma,0
10232,65,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10233,Specimen Source Codes - Tears,Blepharal carcinoma,0
10234,65,Mucinous adenocarcinoma gastric,0
10235,Colon Carcinoma,Colorectal cancer,0
10236,Secondary Neoplasm,adenoid cystic carcinoma of lung,0
10237,set (group),Secondary malignant neoplasm of lymph node,0
10238,intrathecal chemotherapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10239,Linear,Angiosarcoma of liver,0
10240,Young Adult,Adult Alveolar Soft Part Sarcoma,0
10241,various other nasal preparations in ATC,Neonatal leukemia,0
10242,risk factors,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10243,Examination of skin,Acantholytic squamous cell carcinoma,0
10244,Asia,Carcinoma of urinary bladder,0
10245,Tissue damage,Neonatal leukemia,0
10246,newly,Recurrent Uveal Melanoma,0
10247,Young Adult,Adult Fibrolamellar Carcinoma,0
10248,Areas <moth>,FIGO Stage II Ovarian Cancer,0
10249,Type - attribute,Malignant Testicular Sertoli Cell Tumor,0
10250,Study,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10251,Self,Acute lymphadenitis,0
10252,Diagnosis,Unfavorable Non-Hodgkin Lymphoma,0
10253,Overall Publication Type,adenoid cystic carcinoma of lung,0
10254,various antiinfectives and antiseptics for local oral treatment,Placental aromatase deficiency,0
10255,Tube - unit dose,Sarcomatoid Renal Cell Carcinoma,0
10256,Vagina Carcinoma,Anterior Urethral Malignant Neoplasm,0
10257,Lichenification,Spongiotic dermatitis,0
10258,Triggered by,Acute Undifferentiated Leukemia,0
10259,Africa,Carcinoma of urinary bladder,0
10260,Band form,Childhood Thyroid Gland Follicular Carcinoma,0
10261,Comparison,Lung squamous cell carcinoma stage I,0
10262,Deglutition Disorders,Mucinous adenocarcinoma gastric,0
10263,animal allergen extracts,Blepharal carcinoma,0
10264,Term (temporal),Pancreatic Intraepithelial Neoplasia-3,0
10265,Vomiting,Choroid Necrotic Melanoma,0
10266,Affecting,Intestinal Metaplasia of Bladder Urothelium,0
10267,United States,Undifferentiated Endocervical Sarcoma,0
10268,Spreading (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
10269,Approximate,Spermatocytic seminoma,0
10270,Function (attribute),Blepharal carcinoma,0
10271,Type A,Childhood Lymphoma,0
10272,Condition:Find:Pt:^Patient:Nom,Mucinous adenocarcinoma gastric,0
10273,Autoimmune Diseases,Thymic Clear Cell Carcinoma,0
10274,Electromagnetic Radiation,Primary Cutaneous Plasmablastic Lymphoma,0
10275,Fever,Localized Askin Tumor,0
10276,Primary malignant neoplasm,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10277,Clonality,Clonal Hematopoiesis of Indeterminate Potential,0
10278,Containing (qualifier),Angiosarcoma of liver,0
10279,/40,Undifferentiated Endocervical Sarcoma,0
10280,risk factors - observation list,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10281,In Blood,Digestive System Hodgkin Lymphoma,0
10282,Central,Diffuse malignant mesothelioma,0
10283,Pallor,Acute Undifferentiated Leukemia,0
10284,Decision,Childhood Lymphoma,0
10285,Cancer Genus,Anterior Urethral Malignant Neoplasm,0
10286,Aggressive course,Breast Ductal Adenoma,0
10287,Treating,Human Papillomavirus-Related Carcinoma,0
10288,Physical findings,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10289,Bodily secretions,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10290,Highest,Digestive System Hodgkin Lymphoma,0
10291,Urine,Grade 1 Clear Cell Renal Cell Carcinoma,0
10292,Lymphoma,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10293,Name,Methotrexate-Associated Hodgkin Lymphoma,0
10294,Adult Non-Hodgkin Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
10295,Divide,Choroid Necrotic Melanoma,0
10296,Average of Value Derivation Technique,Digestive System Hodgkin Lymphoma,0
10297,Occur (action),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10298,Platelets Product,Neonatal leukemia,0
10299,Hodgkin Disease,Stage I Adult Non-Hodgkin Lymphoma,0
10300,Make - Instruction Imperative,Thymic Clear Cell Carcinoma,0
10301,Testis,Malignant Testicular Sertoli Cell Tumor,0
10302,Tissue damage,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10303,Area,FIGO Stage II Ovarian Cancer,0
10304,Lymphatic Capillaries,Digestive System Hodgkin Lymphoma,0
10305,pharmacotherapeutic,Bladder squamous cell carcinoma stage I,0
10306,Prevalence aspects,Blepharal carcinoma,0
10307,ATLAS Score Clinical Classification,Advanced Uterine Corpus Carcinosarcoma,0
10308,Occurrence Indicator,Neonatal leukemia,0
10309,Name (property) (qualifier value),BRCA2 Syndrome,0
10310,Experimental Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10311,Prevalence aspects,Recurrent Testicular Lymphoma,0
10312,Togo,Female Breast Carcinoma,0
10313,65+,Malignant melanoma of eyelid,0
10314,Administration procedure,Recurrent Testicular Lymphoma,0
10315,Mother (person),Human Papillomavirus-Related Carcinoma,0
10316,Treatment Epoch,Airway Hemangioma,0
10317,Derived value,Childhood Central Nervous System Immature Teratoma,0
10318,Occur (action),Mucinous adenocarcinoma gastric,0
10319,Have Been Vomiting,Choroid Necrotic Melanoma,0
10320,Physical Appearance,Ichthyoses,0
10321,The Sun,Recurrent Uveal Melanoma,0
10322,Diagnostic Imaging,Intestinal Metaplasia of Bladder Urothelium,0
10323,Malignant Neoplasms,Maxillary Sinus Adenocarcinoma,0
10324,Sore to touch,Stage II Carcinoma of Penis,0
10325,True primary (qualifier value),Recurrent Uveal Melanoma,0
10326,Frequency of Pain Question,Localized Askin Tumor,0
10327,Decision,Endometrial Small Cell Carcinoma,0
10328,Skin tanning,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10329,Old,Cancer of Urinary Tract,0
10330,National Human Genome Research Institute (U.S.),Advanced Uterine Corpus Carcinosarcoma,0
10331,Age,Pancreatic Intraepithelial Neoplasia-3,0
10332,Numerous,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10333,Tumor cells,Recurrent Testicular Lymphoma,0
10334,Stomach,Mucinous adenocarcinoma gastric,0
10335,Tissue Specimen Code,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10336,year,Malignant Testicular Sertoli Cell Tumor,0
10337,International Classification of Diseases for Oncology,Noninfiltrating Intraductal Carcinoma,0
10338,Leukocytes,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10339,Malignant Neoplasms,adenosquamous carcinoma of breast,0
10340,year,Adult Fibrolamellar Carcinoma,0
10341,Fasting Status Indicator,Malignant melanoma of eyelid,0
10342,combination - answer to question,FIGO Stage II Ovarian Cancer,0
10343,Administration procedure,Spongiotic dermatitis,0
10344,Lacrimal duct,Benign Apocrine Neoplasm,0
10345,Symptoms aspect,Anterior Urethral Malignant Neoplasm,0
10346,Basis - conceptual entity,Breast Ductal Adenoma,0
10347,Phenotype determination,Testicular cancer metastatic,0
10348,Surgery specialty,Intestinal Metaplasia of Bladder Urothelium,0
10349,physiological aspects,mucinous adenocarcinoma of gallbladder,0
10350,Place,Cartilaginous exostosis,0
10351,include - SetOperator,Endometrial Small Cell Carcinoma,0
10352,Associated with,Angiosarcoma of liver,0
10353,Unconscious State,Choroid Necrotic Melanoma,0
10354,Precancerous Conditions,Mucinous neoplasm,0
10355,Cancer Genus,adenoid cystic carcinoma of lung,0
10356,Benign,benign mature teratoma of pancreas,0
10357,Choroid plexus of cerebral hemisphere,Malignant neoplasm of choroid,0
10358,shared attribute,Acantholytic squamous cell carcinoma,0
10359,Ultrasonic,Malignant Testicular Sertoli Cell Tumor,0
10360,Old,Malignant Testicular Sertoli Cell Tumor,0
10361,Present,Cartilaginous exostosis,0
10362,Set (Psychology),Secondary malignant neoplasm of lymph node,0
10363,Cultured Cell Line,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10364,Myasthenia Gravis,Thymic Clear Cell Carcinoma,0
10365,Time,benign mature teratoma of pancreas,0
10366,Family,Uterine Cancer,0
10367,IPSS Risk Category High,FIGO Stage II Ovarian Cancer,0
10368,Males,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10369,Goes <invertebrate>,Malignant neoplasm of thalamus,0
10370,Squamous cell carcinoma - category,Colorectal High Grade B-Cell Lymphoma,0
10371,Love,Extracranial Neuroblastoma,0
10372,Trial Screening,FIGO Stage II Ovarian Cancer,0
10373,Beginning,Stage IB Pancreatic Cancer AJCC v8,0
10374,Biological Response Modifiers,Bladder squamous cell carcinoma stage I,0
10375,Pancreas,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
10376,Abnormal host response,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10377,Case (situation),adenosquamous carcinoma of breast,0
10378,seconds,Recurrent Testicular Lymphoma,0
10379,Death (finding),Malignant Testicular Sertoli Cell Tumor,0
10380,pharmacotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10381,Unintentional,Malignant Neoplasm with Regional Lymph Node Involvement,0
10382,Often - answer to question,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10383,Negation,Malignant neoplasm of thalamus,0
10384,Sound - physical agent,Larynx carcinoma recurrent,0
10385,North America,Malignant melanoma of eyelid,0
10386,Increased frequency of micturition,Cancer of Urinary Tract,0
10387,Workers,Diffuse malignant mesothelioma,0
10388,Biological Response Modifiers,Recurrent Uveal Melanoma,0
10389,New,Human Papillomavirus-Related Carcinoma,0
10390,Formation,Blepharal carcinoma,0
10391,Non-Seminomatous Lesion,Malignant Testicular Sertoli Cell Tumor,0
10392,Chromosomal translocation,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10393,Tissue Specimen Code,Anterior Urethral Malignant Neoplasm,0
10394,Massive,Adult Hepatocellular Carcinoma,0
10395,Diagnosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10396,Human body,Intestinal Neuroendocrine Carcinoma,0
10397,LYMPHOID Cancers,Acute Undifferentiated Leukemia,0
10398,Hemorrhage,Angiosarcoma of liver,0
10399,Numerous,Leiomyoma of Gallbladder,0
10400,Abdomen+,Benign Carotid Body Paraganglioma,0
10401,Disease,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10402,40%,Endometrial Small Cell Carcinoma,0
10403,Primary operation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10404,Along edge (qualifier value),Malignant melanoma of eyelid,0
10405,radiotherapeutic,Acute Undifferentiated Leukemia,0
10406,Common Specifications in HL7 V3 Publishing,FIGO Stage II Ovarian Cancer,0
10407,Neck,Adult Alveolar Soft Part Sarcoma,0
10408,Point,Cancer of Urinary Tract,0
10409,History of present illness,Uterine Cancer,0
10410,Common (qualifier value),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10411,Feel Tired question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10412,Most,Localized Askin Tumor,0
10413,NBL1 gene,Primary Cutaneous Plasmablastic Lymphoma,0
10414,Initially,Acute Undifferentiated Leukemia,0
10415,Synonym (core metadata concept),BRCA2 Syndrome,0
10416,Surgical aspects,Diffuse malignant mesothelioma,0
10417,Rare,gliosarcoma,0
10418,site-specific telomere resolvase activity,Testicular cancer metastatic,0
10419,Vision:-:Point in time:^Patient:-,Airway Hemangioma,0
10420,cell type,Recurrent Testicular Lymphoma,0
10421,Body part,FIGO Stage II Ovarian Cancer,0
10422,Sharing (Social Behavior),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10423,Usual Severity Shortness of Breath,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10424,Causing,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10425,Very,Metastatic Neoplasm to the Gallbladder,0
10426,Pancreas,Serous cystadenocarcinoma ovary,0
10427,Body tissue,Uterine Cancer,0
10428,Active,Malignant melanoma of eyelid,0
10429,Smear - instruction imperative,Acantholytic squamous cell carcinoma,0
10430,mucus layer,Mucinous neoplasm,0
10431,Bone marrow: lymphocytes (finding),Acute Undifferentiated Leukemia,0
10432,Science of Etiology,Cartilaginous exostosis,0
10433,various allergen extracts,Benign neoplasm of thorax,0
10434,Abnormal Cell Count,Choroid Necrotic Melanoma,0
10435,Main,Stage IB Lung Cancer AJCC v7,0
10436,Administration procedure,Primary Cutaneous Plasmablastic Lymphoma,0
10437,Multiply - dosing instruction fragment,Pancreatic Intraepithelial Neoplasia-3,0
10438,depend,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10439,Dermatitis,Contact dermatitis due to alkali,0
10440,Percent normal,Undifferentiated Endocervical Sarcoma,0
10441,Body site,Extra-Adrenal Paraganglioma,0
10442,Affecting,Childhood Lymphoma,0
10443,Electromagnetic Fields,Acute Undifferentiated Leukemia,0
10444,Building structure,Diffuse malignant mesothelioma,0
10445,Tissue membrane,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10446,Exposure to radiation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10447,Inferior Colliculus,Recurrent Testicular Lymphoma,0
10448,Purpose,Breast Ductal Adenoma,0
10449,Logical Condition,Placental aromatase deficiency,0
10450,Glioma,Refractory Glioma,0
10451,Effectiveness,Human Papillomavirus-Related Carcinoma,0
10452,One,Clonal Hematopoiesis of Indeterminate Potential,0
10453,DNA Repair,BRCA2 Syndrome,0
10454,Previous,Acantholytic squamous cell carcinoma,0
10455,Storage Unit,Childhood Thyroid Gland Follicular Carcinoma,0
10456,Statistical Significance,Acute Undifferentiated Leukemia,0
10457,National origin,Carcinoma ex pleomorphic adenoma of parotid gland,0
10458,Precision - second,Recurrent Testicular Lymphoma,0
10459,System,Digestive System Hodgkin Lymphoma,0
10460,Cells,Pancreatic Intraepithelial Neoplasia-3,0
10461,radiotherapeutic,Diffuse malignant mesothelioma,0
10462,Arrested progression,Unresectable Rhabdomyosarcoma,0
10463,Subtype (attribute),Unfavorable Non-Hodgkin Lymphoma,0
10464,Excessive,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10465,Due to,Diffuse malignant mesothelioma,0
10466,Contain (action),Refractory Glioma,0
10467,>90,Pancreatic Intraepithelial Neoplasia-3,0
10468,1000000,Uterine Cancer,0
10469,risk factors - observation list,Stage II Carcinoma of Penis,0
10470,Count of entities,Acute Undifferentiated Leukemia,0
10471,Occurrence,Granular Cell Leiomyosarcoma,0
10472,Including (qualifier),Extra-Adrenal Paraganglioma,0
10473,CD69 wt Allele,Acute Undifferentiated Leukemia,0
10474,Weight Loss,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10475,Palate,Giant cell angiofibroma,0
10476,foreign,Thymic Clear Cell Carcinoma,0
10477,Direct (qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10478,1000000,Carcinoma of urinary bladder,0
10479,diabetic,Cartilaginous exostosis,0
10480,50%,FIGO Stage II Ovarian Cancer,0
10481,Case (situation),Malignant Testicular Sertoli Cell Tumor,0
10482,Neutral Charge,Clonal Hematopoiesis of Indeterminate Potential,0
10483,To,Diffuse malignant mesothelioma,0
10484,To,de novo Myelodysplastic Syndrome,0
10485,Brain,Colorectal cancer,0
10486,Monoclonal Gammapathies,Heavy Chain Deposition Disease,0
10487,Lymphadenopathy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10488,Common Specifications in HL7 V3 Publishing,Cancer of Urinary Tract,0
10489,Treating,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10490,Circumscribe (action),Pilocytic astrocytoma of cerebellum,0
10491,Infrequent,Airway Hemangioma,0
10492,Subject is Randomized,Breast Ductal Adenoma,0
10493,Histologic type,Colorectal High Grade B-Cell Lymphoma,0
10494,Age of onset of symptoms:Time:Pt:^Patient:Qn,Intestinal Metaplasia of Bladder Urothelium,0
10495,Pallor,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10496,Caucasians,Localized Askin Tumor,0
10497,Malignant Neoplasms,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10498,Fever,Localized Askin Tumor,0
10499,Shoulder,Cartilaginous exostosis,0
10500,Relationships,Intracortical osteosarcoma,0
10501,Patient Reported Outcome Stem,Rhabdomyosarcoma with ganglionic differentiation,0
10502,Mechanism (attribute),Acute Undifferentiated Leukemia,0
10503,Comprehension,Advanced Uterine Corpus Carcinosarcoma,0
10504,Possibly Related to Intervention,Lung squamous cell carcinoma stage I,0
10505,Malignant neoplasm of pancreas,Pancreatic Intraepithelial Neoplasia-3,0
10506,Does stand alone,Secondary malignant neoplasm of lymph node,0
10507,Cure (remedy),Acute Undifferentiated Leukemia,0
10508,Malignant Neoplasms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10509,Person Name,Carcinoma ex pleomorphic adenoma of parotid gland,0
10510,Adult Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
10511,Operative Surgical Procedures,Colorectal High Grade B-Cell Lymphoma,0
10512,size,Clonal Hematopoiesis of Indeterminate Potential,0
10513,therapeutic aspects,FIGO Stage II Ovarian Cancer,0
10514,Levels (qualifier value),Recurrent Uveal Melanoma,0
10515,Study,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10516,Small cell carcinoma of lung,Stage IB Lung Cancer AJCC v7,0
10517,child survival,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10518,Anterior mediastinum,Thymic Clear Cell Carcinoma,0
10519,Overall Survival,Recurrent Testicular Lymphoma,0
10520,Mesothelial hyperplasia,Atypical Mesothelial Hyperplasia,0
10521,Array Feature,Giant cell angiofibroma,0
10522,Histologic,Breast Ductal Adenoma,0
10523,Surgery specialty,Uterine Cancer,0
10524,Congenital phimosis,Stage II Carcinoma of Penis,0
10525,Body site,Testicular cancer metastatic,0
10526,3+ Score,BRCA2 Syndrome,0
10527,Mesenchymal Stem Cells,Granular Cell Leiomyosarcoma,0
10528,seen,Airway Hemangioma,0
10529,West (direction),Mucinous adenocarcinoma gastric,0
10530,Formed,Adult Alveolar Soft Part Sarcoma,0
10531,Target Lesion Identification,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10532,Ephrin Type-B Receptor 1,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10533,treatment - ActInformationManagementReason,Maxillary Sinus Adenocarcinoma,0
10534,Shortened,Familial Hemophagocytic Lymphocytosis,0
10535,Therapeutic procedure,FIGO Stage II Ovarian Cancer,0
10536,Increase,Angiosarcoma of liver,0
10537,Cessation of life,Stage II Carcinoma of Penis,0
10538,Estimated,Localized Askin Tumor,0
10539,Very Much,Cancer of Urinary Tract,0
10540,Cessation of life,Acute Undifferentiated Leukemia,0
10541,View,Mucinous neoplasm,0
10542,Malignant Neoplasms,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10543,Together,Diffuse malignant mesothelioma,0
10544,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10545,Surrounding (qualifier value),Liver Cavernous Hemangioma,0
10546,Glioblastoma Multiforme Pathway,gliosarcoma,0
10547,Lead,Recurrent Testicular Lymphoma,0
10548,Grouped (foundation metadata concept),Localized Askin Tumor,0
10549,respiratory gaseous exchange in organisms,Refractory Barrett Esophagus,0
10550,2+ Score,FIGO Stage II Ovarian Cancer,0
10551,Cessation of life,Recurrent Uveal Melanoma,0
10552,Give - dosing instruction imperative,Blepharal carcinoma,0
10553,MOSTLY,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10554,Secondary Neoplasm,Tonsillar Carcinoma,0
10555,Type - attribute,Malignant melanoma of eyelid,0
10556,acute,Spongiotic dermatitis,0
10557,A Codes,Leptomeningeal sarcoma,0
10558,Inflammatory Breast Carcinoma,Breast Ductal Adenoma,0
10559,Proline,Mastocytosis,0
10560,Hematuria,Carcinoma of urinary bladder,0
10561,polyps,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10562,Clinical,Acute lymphadenitis,0
10563,Type - attribute,Acantholytic squamous cell carcinoma,0
10564,International Classification of Disease for Oncology,Noninfiltrating Intraductal Carcinoma,0
10565,Body tissue,Stage II Carcinoma of Penis,0
10566,Enzymes,Placental aromatase deficiency,0
10567,Immunoglobulins,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10568,cardiovascular disorder risk,Clonal Hematopoiesis of Indeterminate Potential,0
10569,/40,Human Papillomavirus-Related Carcinoma,0
10570,Importance Weight,Refractory Barrett Esophagus,0
10571,product,Diffuse malignant mesothelioma,0
10572,Prognosis:Find:Pt:^Patient:Nom,mucinous adenocarcinoma of gallbladder,0
10573,Living Alone,Cancer of Urinary Tract,0
10574,A1CF wt Allele,Adult Alveolar Soft Part Sarcoma,0
10575,Human body,Digestive System Hodgkin Lymphoma,0
10576,Usually,Mucinous adenocarcinoma gastric,0
10577,Adult human body,Airway Hemangioma,0
10578,chronic,Spongiotic dermatitis,0
10579,Pediatric Neoplasm,Childhood Central Nervous System Immature Teratoma,0
10580,English Language,Leiomyoma of Gallbladder,0
10581,Treating,Acute lymphadenitis,0
10582,% live,Extracranial Neuroblastoma,0
10583,Have Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10584,Immunotherapy,Intestinal Metaplasia of Bladder Urothelium,0
10585,Therapeutic procedure,Carcinoma of urinary bladder,0
10586,Attack behavior,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10587,Spreading (qualifier value),FIGO Stage II Ovarian Cancer,0
10588,Child,Pilocytic astrocytoma of cerebellum,0
10589,Intestines,Recurrent Uveal Melanoma,0
10590,Occurrence,Recurrent Uveal Melanoma,0
10591,Automobile Driving,Clonal Hematopoiesis of Indeterminate Potential,0
10592,Formation,Acantholytic squamous cell carcinoma,0
10593,Life,Thymic Clear Cell Carcinoma,0
10594,treatment - ActInformationManagementReason,Spermatocytic seminoma,0
10595,Materials,Digestive System Hodgkin Lymphoma,0
10596,Pale color saturation,Maxillary Sinus Adenocarcinoma,0
10597,Formation,Secondary malignant neoplasm of lymph node,0
10598,Including (qualifier),Colorectal cancer,0
10599,High Level,FIGO Stage II Ovarian Cancer,0
10600,shared attribute,Bladder squamous cell carcinoma stage I,0
10601,Cure (remedy),Uterine Cancer,0
10602,Specimen Source Codes - tumor,Intracortical osteosarcoma,0
10603,Examined,Diffuse malignant mesothelioma,0
10604,Malignant Female Reproductive System Neoplasm,Undifferentiated Endocervical Sarcoma,0
10605,Tired,Acute Undifferentiated Leukemia,0
10606,Rare,Benign Carotid Body Paraganglioma,0
10607,Treating,Intestinal Neuroendocrine Carcinoma,0
10608,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10609,floor (object),Human Papillomavirus-Related Carcinoma,0
10610,Immunotherapy,Recurrent Uveal Melanoma,0
10611,Treating,Cancer of Urinary Tract,0
10612,Type - attribute,Childhood Lymphoma,0
10613,Lacrimal gland structure,adenoid cystic carcinoma of lung,0
10614,Abnormal,Undifferentiated Endocervical Sarcoma,0
10615,Surgical service,Intestinal Metaplasia of Bladder Urothelium,0
10616,Initially,Testicular cancer metastatic,0
10617,Macrophage count,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10618,Confirmed by,Diffuse malignant mesothelioma,0
10619,Breast,BRCA2 Syndrome,0
10620,flower allergenic extracts,Extracranial Neuroblastoma,0
10621,Lower - spatial qualifier,Mucinous adenocarcinoma gastric,0
10622,Aim (idea),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10623,Disease,Bladder squamous cell carcinoma stage I,0
10624,Process of secretion,Benign Apocrine Neoplasm,0
10625,Abdominal Cavity,Benign neoplasm of thorax,0
10626,Human body,papillary carcinoma of penis,0
10627,Life Expectancy Less than Ten Years,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10628,Intercellular edema,Spongiotic dermatitis,0
10629,Most,Mucinous adenocarcinoma gastric,0
10630,Include (action),Malignant Neoplasm with Regional Lymph Node Involvement,0
10631,Mucins,mucinous adenocarcinoma of gallbladder,0
10632,Diagnosis,Acute Undifferentiated Leukemia,0
10633,Specimen Source Codes - Respiratory,squamous cell carcinoma of the thyroid gland,0
10634,Myelodysplastic Syndrome,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10635,Early,Acantholytic squamous cell carcinoma,0
10636,Carcinoma,Bladder squamous cell carcinoma stage I,0
10637,Damage,Digestive System Hodgkin Lymphoma,0
10638,1+ Score,Metastatic Neoplasm to the Gallbladder,0
10639,Tobacco smoking behavior,Tonsillar Carcinoma,0
10640,Item Collection,Hemangioma,0
10641,Qualitative form,Metastatic Neoplasm to the Gallbladder,0
10642,Population Mean,Cartilaginous exostosis,0
10643,Lymphatic vessel,Digestive System Hodgkin Lymphoma,0
10644,Anorexia,Pancreatic Intraepithelial Neoplasia-3,0
10645,Obesity,Endometrial Small Cell Carcinoma,0
10646,Containing (qualifier),Diffuse malignant mesothelioma,0
10647,Associated with,Giant cell angiofibroma,0
10648,pharmacotherapeutic,Recurrent Uveal Melanoma,0
10649,More,Malignant melanoma of eyelid,0
10650,therapeutic aspects,Airway Hemangioma,0
10651,Bone structure of cranium,Cartilaginous exostosis,0
10652,pharmacotherapeutic,Carcinoma of urinary bladder,0
10653,Endoscopy of stomach,Refractory Barrett Esophagus,0
10654,Papanicolaou Test,Endometrial Small Cell Carcinoma,0
10655,Term Birth,Atypical Lobular Breast Hyperplasia,0
10656,Common Specifications in HL7 V3 Publishing,Angiosarcoma of liver,0
10657,Trial Subject Replacement,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10658,Gene Mutation,benign mature teratoma of pancreas,0
10659,English [International Organization for Standardization 639-1 code en] language reference set,Metastatic Neoplasm to the Gallbladder,0
10660,What subject filter - Result,Acantholytic squamous cell carcinoma,0
10661,Ductal Breast Carcinoma,Breast Ductal Adenoma,0
10662,Participation Type - origin,Adult Alveolar Soft Part Sarcoma,0
10663,pharmacotherapeutic,Acute Undifferentiated Leukemia,0
10664,Most,Adult Hepatocellular Carcinoma,0
10665,Changing,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10666,Premalignant,Heavy Chain Deposition Disease,0
10667,National origin,Adenocarcinoma of the prostate metastatic,0
10668,Make - Instruction Imperative,Digestive System Hodgkin Lymphoma,0
10669,Tumor cells,Pancreatic Intraepithelial Neoplasia-3,0
10670,Blood flow,Angiosarcoma of liver,0
10671,Sebaceous Glands,Benign Apocrine Neoplasm,0
10672,Oral region,Refractory Barrett Esophagus,0
10673,associated disease,Hemangioma,0
10674,Possible diagnosis,Lung squamous cell carcinoma stage I,0
10675,Hematologic Tests,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10676,Endocrine Cells,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
10677,Science of Etiology,Malignant neoplasm of thalamus,0
10678,newly,Mucinous adenocarcinoma gastric,0
10679,Term (lexical),Adenocarcinoma of the prostate metastatic,0
10680,Knowledge,Breast Ductal Adenoma,0
10681,Medulla,Thymic Clear Cell Carcinoma,0
10682,risk factors,Acantholytic squamous cell carcinoma,0
10683,Malignant Neoplasms,Anterior Urethral Malignant Neoplasm,0
10684,Reduced,Endometrial Small Cell Carcinoma,0
10685,Third,adenoid cystic carcinoma of lung,0
10686,Involvement with,Acute Undifferentiated Leukemia,0
10687,90%,Malignant Neoplasm with Regional Lymph Node Involvement,0
10688,Known,Benign Apocrine Neoplasm,0
10689,Monitor Device,Primary Cutaneous Plasmablastic Lymphoma,0
10690,Malignant Neoplasms,Adult Hepatocellular Carcinoma,0
10691,Continuance of life,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10692,Experimental Result,Granular Cell Leiomyosarcoma,0
10693,Acute Undifferentiated Leukemia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10694,Time,Pancreatic Intraepithelial Neoplasia-3,0
10695,Numerous,Stage IB Pancreatic Cancer AJCC v8,0
10696,Squamous cell carcinoma - category,squamous cell carcinoma of the thyroid gland,0
10697,body system,Digestive System Hodgkin Lymphoma,0
10698,Shortened,Secondary malignant neoplasm of lymph node,0
10699,Elbow,Cartilaginous exostosis,0
10700,Vagina Carcinoma,squamous cell carcinoma of the thyroid gland,0
10701,Lower - spatial qualifier,Acute Undifferentiated Leukemia,0
10702,Cosmetics,Spongiotic dermatitis,0
10703,<3 (qualifier value),Recurrent Uveal Melanoma,0
10704,Cutaneous Melanoma,Recurrent Uveal Melanoma,0
10705,Increase,Recurrent Uveal Melanoma,0
10706,Less Than,Mucinous adenocarcinoma gastric,0
10707,Irritation - emotion,Giant cell angiofibroma,0
10708,Third revision,Noninfiltrating Intraductal Carcinoma,0
10709,Test Method,Mucinous adenocarcinoma gastric,0
10710,Including (qualifier),Granular Cell Leiomyosarcoma,0
10711,T-Cell Receptor,Thymic Clear Cell Carcinoma,0
10712,International Unit,Childhood Thyroid Gland Follicular Carcinoma,0
10713,Source,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10714,Choriocarcinoma,Metastatic Ductal Breast Carcinoma,0
10715,Enzyme (disposition),Ichthyosis,0
10716,Mucous body substance,Mucinous neoplasm,0
10717,Large,Adenocarcinoma of the prostate metastatic,0
10718,Headache,Malignant neoplasm of thalamus,0
10719,How Often Felt Normal question,Unresectable Rhabdomyosarcoma,0
10720,Lung Neoplasms,Testicular cancer metastatic,0
10721,Case unit dose,Recurrent Testicular Lymphoma,0
10722,Type - attribute,Metastatic Carcinoma in the Lung,0
10723,Symptoms,Mastocytosis,0
10724,Etiology aspects,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10725,Waste Products,Digestive System Hodgkin Lymphoma,0
10726,90%,Primary Cutaneous Plasmablastic Lymphoma,0
10727,Malignant neoplasm of soft tissue,Granular Cell Leiomyosarcoma,0
10728,Fluid Leak,Digestive System Hodgkin Lymphoma,0
10729,Receive,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10730,Known,Malignant melanoma of eyelid,0
10731,Specimen,Endometrial Small Cell Carcinoma,0
10732,Usual,Benign Apocrine Neoplasm,0
10733,Microscopes,Adult Alveolar Soft Part Sarcoma,0
10734,Human body,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10735,30%,Human Papillomavirus-Related Carcinoma,0
10736,Primary malignant neoplasm,Neonatal leukemia,0
10737,Dyspnea,adenosquamous carcinoma of breast,0
10738,Hiatal Hernia,Refractory Barrett Esophagus,0
10739,Subject Risk,Human Papillomavirus-Related Carcinoma,0
10740,1000000,Malignant melanoma of eyelid,0
10741,Result,Granular Cell Leiomyosarcoma,0
10742,Bruising,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10743,Pediculus humanus capitis (eukaryote),adenoid cystic carcinoma of lung,0
10744,Volume (publication),Larynx carcinoma recurrent,0
10745,Gonadal structure,Childhood Central Nervous System Immature Teratoma,0
10746,Excretory function,Collecting Duct Carcinoma of the Kidney,0
10747,*Type - Kind of quantity,Malignant melanoma of eyelid,0
10748,Malignant Neoplasms,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10749,Growth,Cartilaginous exostosis,0
10750,Measurement,FIGO Stage II Ovarian Cancer,0
10751,Specimen Source Codes - Mucus,Mucinous neoplasm,0
10752,Cell Count,Atypical Lobular Breast Hyperplasia,0
10753,Clear fluid,Digestive System Hodgkin Lymphoma,0
10754,More,Benign Apocrine Neoplasm,0
10755,Definition,Adenocarcinoma of the prostate metastatic,0
10756,Increasing,Undifferentiated Endocervical Sarcoma,0
10757,Firstly,Cancer of Urinary Tract,0
10758,Specific qualifier value,Stage IB Pancreatic Cancer AJCC v8,0
10759,Tissue Specimen Code,Bladder squamous cell carcinoma stage I,0
10760,Visible,Adult Alveolar Soft Part Sarcoma,0
10761,Cervical lymph node group,Childhood Lymphoma,0
10762,Inflammation,Acute lymphadenitis,0
10763,Greater Than,Malignant Testicular Sertoli Cell Tumor,0
10764,Contusions,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10765,Drop - Unit of Volume,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10766,Rare,Testicular cancer metastatic,0
10767,Increased risk,Clonal Hematopoiesis of Indeterminate Potential,0
10768,Done (qualifier value),Mucinous adenocarcinoma gastric,0
10769,Specimen Source Codes - tumor,Female Breast Carcinoma,0
10770,lymph nodes,Recurrent Testicular Lymphoma,0
10771,How Much Distress Weight Loss,Childhood Lymphoma,0
10772,Genus Homo,Angiosarcoma of liver,0
10773,include - SetOperator,Stage IB Pancreatic Cancer AJCC v8,0
10774,1000000,Recurrent Uveal Melanoma,0
10775,Milliampere second,Stage IB Pancreatic Cancer AJCC v8,0
10776,Top (position),Larynx carcinoma recurrent,0
10777,Age,FIGO Stage II Ovarian Cancer,0
10778,Localized,Malignant Testicular Sertoli Cell Tumor,0
10779,Rate,Carcinoma of urinary bladder,0
10780,Presence (property),Tonsillar Carcinoma,0
10781,Common Specifications in HL7 V3 Publishing,Pancreatic Intraepithelial Neoplasia-3,0
10782,Togo,Advanced Uterine Corpus Carcinosarcoma,0
10783,Togo,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10784,Diagnosis,Adult Fibrolamellar Carcinoma,0
10785,Affect (mental function),Human Papillomavirus-Related Carcinoma,0
10786,Abdomen,Extra-Adrenal Paraganglioma,0
10787,Needs,Spongiotic dermatitis,0
10788,Exclude,Atypical Lobular Breast Hyperplasia,0
10789,Most,Uterine Cancer,0
10790,photoreactivating enzyme activity,Thymic Clear Cell Carcinoma,0
10791,Usually Need Help from Another Person for Arising,Bladder squamous cell carcinoma stage I,0
10792,Known,Stage IB Lung Cancer AJCC v7,0
10793,Representation (action),Uterine Cancer,0
10794,What subject filter - Result,Granular Cell Leiomyosarcoma,0
10795,Pale color,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10796,Cell Count,Pancreatic Intraepithelial Neoplasia-3,0
10797,Anterior,benign mature teratoma of pancreas,0
10798,Natural History,squamous cell carcinoma of the thyroid gland,0
10799,Ductal Carcinoma,Female Breast Carcinoma,0
10800,Rapid,Malignant melanoma of eyelid,0
10801,Include (action),Intestinal Metaplasia of Bladder Urothelium,0
10802,Primary malignant neoplasm,Acute lymphadenitis,0
10803,Extreme Response,Recurrent Testicular Lymphoma,0
10804,<90,Pancreatic Intraepithelial Neoplasia-3,0
10805,Slightly Able,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10806,A Codes,Malignant Neoplasm of Lung - Multiple Primary Sites,0
10807,Relationships,FIGO Stage II Ovarian Cancer,0
10808,M NOS ANTIBODY,Testicular cancer metastatic,0
10809,Spreading (qualifier value),Choroid Necrotic Melanoma,0
10810,month,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10811,treatment - ActInformationManagementReason,Human Papillomavirus-Related Carcinoma,0
10812,Treatment Epoch,FIGO Stage II Ovarian Cancer,0
10813,Primary malignant neoplasm of fallopian tube,Stage II Fallopian Tube Cancer,0
10814,Burkitt Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
10815,Experimental Result,Cancer of Urinary Tract,0
10816,Ovarian Follicle,Recurrent Testicular Lymphoma,0
10817,Time (foundation metadata concept),Localized Askin Tumor,0
10818,Adult Diffuse Large B-Cell Lymphoma,Recurrent Testicular Lymphoma,0
10819,Concept History,Recurrent Uveal Melanoma,0
10820,Occurrence,Testicular cancer metastatic,0
10821,parent,Undifferentiated Endocervical Sarcoma,0
10822,Metastatic Neoplasm,Malignant melanoma of eyelid,0
10823,Diagnostic Imaging,Mucinous adenocarcinoma gastric,0
10824,Proliferation,Testicular cancer metastatic,0
10825,Definitely Related to Intervention,Recurrent Testicular Lymphoma,0
10826,Body Fluid Discharge,Stage II Carcinoma of Penis,0
10827,Old,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10828,Basis - conceptual entity,Diffuse malignant mesothelioma,0
10829,Basis - conceptual entity,de novo Myelodysplastic Syndrome,0
10830,Formation,Testicular cancer metastatic,0
10831,Possible,Testicular cancer metastatic,0
10832,Most,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10833,Serving,Female Breast Carcinoma,0
10834,Base - General Qualifier,Localized Askin Tumor,0
10835,Neoplasms,Breast Ductal Adenoma,0
10836,Fast Growing,Unfavorable Non-Hodgkin Lymphoma,0
10837,Pigment cell,Malignant melanoma of eyelid,0
10838,Disruptive,Secondary malignant neoplasm of lymph node,0
10839,Linear,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10840,Overall Well Being,Adult Hepatocellular Carcinoma,0
10841,Publications,Placental aromatase deficiency,0
10842,Notable,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10843,Completely - dosing instruction fragment,Colorectal High Grade B-Cell Lymphoma,0
10844,High Mitosis-Karyorrhexis Index,Tonsillar Carcinoma,0
10845,Occur (action),Recurrent Uveal Melanoma,0
10846,Pharmacotherapy,Primary Cutaneous Plasmablastic Lymphoma,0
10847,Smear - instruction imperative,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10848,Australia,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10849,Numbers,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10850,Tract,Larynx carcinoma recurrent,0
10851,Secondary tumor site,Testicular cancer metastatic,0
10852,Term (lexical),Maxillary Sinus Adenocarcinoma,0
10853,Often - answer to question,Stage II Fallopian Tube Cancer,0
10854,Bladder Cancer Pathway,Bladder squamous cell carcinoma stage I,0
10855,At risk of infection,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10856,Fever,Cancer of Urinary Tract,0
10857,Colon Carcinoma,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10858,Cell (compartment),Adenocarcinoma,0
10859,Symptoms aspect,Bladder squamous cell carcinoma stage I,0
10860,Hematologic Tests,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10861,Unspecified,Acute lymphadenitis,0
10862,White Blood Cell Count procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10863,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10864,Time (foundation metadata concept),Acantholytic squamous cell carcinoma,0
10865,Neoplasms,Childhood Central Nervous System Immature Teratoma,0
10866,Dorsal,Refractory Barrett Esophagus,0
10867,Experimental Result,Placental aromatase deficiency,0
10868,Common Specifications in HL7 V3 Publishing,Bladder squamous cell carcinoma stage I,0
10869,Smear - instruction imperative,Extracranial Neuroblastoma,0
10870,Percent normal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10871,Ability,Advanced Uterine Corpus Carcinosarcoma,0
10872,Ability,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10873,Highest,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10874,Secondary Neoplasm,Benign neoplasm of thorax,0
10875,Histamine Antagonists,Refractory Barrett Esophagus,0
10876,Oils,Benign Apocrine Neoplasm,0
10877,Humor therapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10878,Precision - characteristic,Adenocarcinoma of the prostate metastatic,0
10879,Abdomen+,FIGO Stage II Ovarian Cancer,0
10880,International Classification of Disease for Oncology,Rhabdomyosarcoma with ganglionic differentiation,0
10881,various other nasal preparations in ATC,Extra-Adrenal Paraganglioma,0
10882,Initially,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10883,Rapid,Testicular cancer metastatic,0
10884,Pain,Stage I Adult Non-Hodgkin Lymphoma,0
10885,Group A (blood group),Methotrexate-Associated Hodgkin Lymphoma,0
10886,Medulla Oblongata,Thymic Clear Cell Carcinoma,0
10887,Out (direction),Digestive System Hodgkin Lymphoma,0
10888,Controlled by,Female Breast Carcinoma,0
10889,Dermatitis,Contact dermatitis due to alkali,0
10890,Alphabet,Familial Hemophagocytic Lymphocytosis,0
10891,Canada,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10892,Diagnosis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10893,Dietary Factors,Mucinous adenocarcinoma gastric,0
10894,Centrocytic lymphoma,Recurrent Testicular Lymphoma,0
10895,More,Pilocytic astrocytoma of cerebellum,0
10896,Groups,Neonatal leukemia,0
10897,Primary malignant neoplasm,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10898,depend,Malignant melanoma of eyelid,0
10899,Swollen Lymph Node,Acute lymphadenitis,0
10900,Pancreatic Cancer Pathway,Stage IB Pancreatic Cancer AJCC v8,0
10901,What subject filter - Result,Mucinous adenocarcinoma gastric,0
10902,Financial Account,Lung squamous cell carcinoma stage I,0
10903,CD44 wt Allele,Granular Cell Leiomyosarcoma,0
10904,Togo,Undifferentiated Endocervical Sarcoma,0
10905,Treatment Epoch,Cancer of Urinary Tract,0
10906,International Classification of Diseases for Oncology,Intracortical osteosarcoma,0
10907,Complete,Clonal Hematopoiesis of Indeterminate Potential,0
10908,Code,Familial Hemophagocytic Lymphocytosis,0
10909,Tetrachloroethylene,Tonsillar Carcinoma,0
10910,Extravasation,Liver Cavernous Hemangioma,0
10911,Characterization,Ichthyoses,0
10912,Medical,FIGO Stage II Ovarian Cancer,0
10913,Free of (attribute),BRCA2 Syndrome,0
10914,Intermediate Mitosis-Karyorrhexis Index,Blepharal carcinoma,0
10915,Then,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10916,Adenocarcinoma,adenoid cystic carcinoma of lung,0
10917,Slow progression,Recurrent Testicular Lymphoma,0
10918,Analysis,Colorectal High Grade B-Cell Lymphoma,0
10919,treatment - ActInformationManagementReason,Diffuse malignant mesothelioma,0
10920,Abnormal Reference Range,Undifferentiated Endocervical Sarcoma,0
10921,cervical cancer,Human Papillomavirus-Related Carcinoma,0
10922,Bacteria present,Cancer of Urinary Tract,0
10923,Togo,Clonal Hematopoiesis of Indeterminate Potential,0
10924,H NOS Antibodies,Mucinous adenocarcinoma gastric,0
10925,Unique,Pilocytic astrocytoma of cerebellum,0
10926,Pedunculated Lesion,Giant cell angiofibroma,0
10927,Immune system,Unresectable Rhabdomyosarcoma,0
10928,Linear,Grade 1 Clear Cell Renal Cell Carcinoma,0
10929,Inguinal region,Childhood Lymphoma,0
10930,Image Feature,Giant cell angiofibroma,0
10931,Two,Atypical Lobular Breast Hyperplasia,0
10932,Used by,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10933,Biopsy,Localized Askin Tumor,0
10934,second (number),Recurrent Testicular Lymphoma,0
10935,Sufficiently defined concept definition status (core metadata concept),Female Breast Carcinoma,0
10936,Include (action),Tonsillar Carcinoma,0
10937,CSNK1D wt Allele,Adult Alveolar Soft Part Sarcoma,0
10938,Mass,Anterior Urethral Malignant Neoplasm,0
10939,Body structure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10940,Progestins,Undifferentiated Endocervical Sarcoma,0
10941,Table Frame - above,Human Papillomavirus-Related Carcinoma,0
10942,Invasive Carcinoma,Metastatic Ductal Breast Carcinoma,0
10943,Ultrasonography,Malignant Testicular Sertoli Cell Tumor,0
10944,Type - attribute,Stage IB Lung Cancer AJCC v7,0
10945,per year,Recurrent Testicular Lymphoma,0
10946,Affecting,Acute Undifferentiated Leukemia,0
10947,Base - General Qualifier,Breast Ductal Adenoma,0
10948,Tissue Specimen Code,BRCA2 Syndrome,0
10949,Associated with,Undifferentiated Endocervical Sarcoma,0
10950,Adrenal Cortex,Collecting Duct Carcinoma of the Kidney,0
10951,Lymphoid neoplasm,Recurrent Testicular Lymphoma,0
10952,Call (Instruction),Undifferentiated Endocervical Sarcoma,0
10953,Cystitis,Cancer of Urinary Tract,0
10954,Pleomorphic carcinoma,Metastatic Ductal Breast Carcinoma,0
10955,Academic degree,Testicular cancer metastatic,0
10956,Certain (qualifier value),Adult Hepatocellular Carcinoma,0
10957,Talpidae,GIANT PIGMENTED HAIRY NEVUS,0
10958,*Type - Kind of quantity,Recurrent Uveal Melanoma,0
10959,Etiology aspects,Endometrial Small Cell Carcinoma,0
10960,Empty (qualifier),Cancer of Urinary Tract,0
10961,Sacrococcygeal teratoma,benign mature teratoma of pancreas,0
10962,Dysuria,Intestinal Metaplasia of Bladder Urothelium,0
10963,Extrinsic,Adult Alveolar Soft Part Sarcoma,0
10964,risk factors - observation list,Bladder squamous cell carcinoma stage I,0
10965,Polypeptide Hormones,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
10966,Uterine Corpus Sarcoma,Endometrial Small Cell Carcinoma,0
10967,How Often Vomiting,Choroid Necrotic Melanoma,0
10968,Form:Finding:Point in time:{Setting}:Document:{Role},Malignant neoplasm of thalamus,0
10969,Painless,Maxillary Sinus Adenocarcinoma,0
10970,List,Rhabdomyosarcoma with ganglionic differentiation,0
10971,Screening Study,Human Papillomavirus-Related Carcinoma,0
10972,CDISC SDTM Procedure Terminology,Undifferentiated Endocervical Sarcoma,0
10973,therapeutic aspects,Adult Hepatocellular Carcinoma,0
10974,curettage specimen,Endometrial Small Cell Carcinoma,0
10975,Apply,Advanced Uterine Corpus Carcinosarcoma,0
10976,Age,Stage II Carcinoma of Penis,0
10977,Plumbum metallicum,Malignant neoplasm of choroid,0
10978,Senile Plaques,Atypical Mesothelial Hyperplasia,0
10979,Has focus,Advanced Uterine Corpus Carcinosarcoma,0
10980,Shortness of Breath Visual Analogue Scale,Diffuse malignant mesothelioma,0
10981,Mixed (qualifier value),Anterior Urethral Malignant Neoplasm,0
10982,Platelet Glycoprotein 4,Anterior Urethral Malignant Neoplasm,0
10983,Bone structure of rib,Cartilaginous exostosis,0
10984,70%,Diffuse malignant mesothelioma,0
10985,Unmarried,Heavy Chain Deposition Disease,0
10986,To,Adult Alveolar Soft Part Sarcoma,0
10987,International Classification of Diseases,Intracortical osteosarcoma,0
10988,Treating,Bladder squamous cell carcinoma stage I,0
10989,Negation,Stage I Adult Non-Hodgkin Lymphoma,0
10990,Either,Breast Ductal Adenoma,0
10991,Malignant Neoplasms,Advanced Uterine Corpus Carcinosarcoma,0
10992,Body structure,Maxillary Sinus Adenocarcinoma,0
10993,Duct (organ) structure,Collecting Duct Carcinoma of the Kidney,0
10994,Cancer Genus,Secondary malignant neoplasm of lymph node,0
10995,consider,Atypical Lobular Breast Hyperplasia,0
10996,Representation (action),Localized Askin Tumor,0
10997,Name (property) (qualifier value),Carcinoma ex pleomorphic adenoma of parotid gland,0
10998,Complication,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10999,Hematuria,Intestinal Metaplasia of Bladder Urothelium,0
11000,Obesity,Mucinous adenocarcinoma gastric,0
11001,Greater,Digestive System Hodgkin Lymphoma,0
11002,Aspect (characteristic),Female Breast Carcinoma,0
11003,Cover - action,Blepharal carcinoma,0
11004,Rating (action),Recurrent Uveal Melanoma,0
11005,Include (action),Granular Cell Leiomyosarcoma,0
11006,Did not receive therapy or drug for,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11007,Five-year Survival Rate,Undifferentiated Endocervical Sarcoma,0
11008,Life,Airway Hemangioma,0
11009,Cells,Atypical Mesothelial Hyperplasia,0
11010,triclocarban,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11011,Semilunar fold of fauces,Blepharal carcinoma,0
11012,Detached,Diffuse malignant mesothelioma,0
11013,Recurrent fevers,Unfavorable Non-Hodgkin Lymphoma,0
11014,Current (present time),Intracortical osteosarcoma,0
11015,Part of,Metastatic Neoplasm to the Gallbladder,0
11016,Block (unit of presentation),Unresectable Rhabdomyosarcoma,0
11017,Basal cell carcinoma,Testicular cancer metastatic,0
11018,Mass of body region,Pancreatic Intraepithelial Neoplasia-3,0
11019,What subject filter - Result,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11020,Decision,Hodgkin lymphoma,0
11021,Squamous cell carcinoma of skin,Acantholytic squamous cell carcinoma,0
11022,How Much Distress Weight Loss,Unfavorable Non-Hodgkin Lymphoma,0
11023,Include (action),squamous cell carcinoma of the thyroid gland,0
11024,Excision,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11025,ethnic european,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11026,Interstitial Fluid,Digestive System Hodgkin Lymphoma,0
11027,Protein Glycosylation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11028,Eyelash,Blepharal carcinoma,0
11029,Cutaneous Melanoma,Malignant melanoma of eyelid,0
11030,Case Study,Anterior Urethral Malignant Neoplasm,0
11031,Dietary Lead,Malignant neoplasm of choroid,0
11032,Experimental Organism Basal Cell Carcinoma,Acantholytic squamous cell carcinoma,0
11033,Back Pain,Pancreatic Intraepithelial Neoplasia-3,0
11034,Average,Digestive System Hodgkin Lymphoma,0
11035,Mast Cell Count,Mastocytosis,0
11036,Row (arrangement),Blepharal carcinoma,0
11037,Firstly,Acute Undifferentiated Leukemia,0
11038,Retinoic Acid Response Element,Pancreatic Intraepithelial Neoplasia-3,0
11039,Epithelioma,Adenocarcinoma of the prostate metastatic,0
11040,Occur (action),Human Papillomavirus-Related Carcinoma,0
11041,Absent,Anterior Urethral Malignant Neoplasm,0
11042,Abdomen+,Benign neoplasm of thorax,0
11043,Concept model range (foundation metadata concept),Cartilaginous exostosis,0
11044,Beginning,Choroid Necrotic Melanoma,0
11045,Related personal status,Noninfiltrating Intraductal Carcinoma,0
11046,Negation,Hemangioma,0
11047,Two,Cartilaginous exostosis,0
11048,peripheral blood,Acute Undifferentiated Leukemia,0
11049,Skin Specimen,Spongiotic dermatitis,0
11050,Aspects of signs,Methotrexate-Associated Hodgkin Lymphoma,0
11051,Renal pelvis,Collecting Duct Carcinoma of the Kidney,0
11052,Increased,Diffuse malignant mesothelioma,0
11053,Certainties,Intestinal Metaplasia of Bladder Urothelium,0
11054,Cavern,Liver Cavernous Hemangioma,0
11055,High,FIGO Stage II Ovarian Cancer,0
11056,Cystadenoma,Serous cystadenocarcinoma ovary,0
11057,Surrounding (qualifier value),Hemangioma,0
11058,Infrequent,Benign Carotid Body Paraganglioma,0
11059,Linear,Undifferentiated Endocervical Sarcoma,0
11060,Immune,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11061,Keratoconjunctivitis Sicca,Blepharal carcinoma,0
11062,Epithelial cell count (procedure),Thymic Clear Cell Carcinoma,0
11063,Residue on Palate,Giant cell angiofibroma,0
11064,Continuance of life,Extra-Adrenal Paraganglioma,0
11065,Usual,Malignant Neoplasm with Regional Lymph Node Involvement,0
11066,Manufactured form,Recurrent Testicular Lymphoma,0
11067,device aspects,Recurrent Uveal Melanoma,0
11068,Most,Acute lymphadenitis,0
11069,Case (situation),Airway Hemangioma,0
11070,Cause of death.underlying,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11071,Reduction procedure,FIGO Stage II Ovarian Cancer,0
11072,To,Atypical Lobular Breast Hyperplasia,0
11073,Pharyngitis,Tonsillar Carcinoma,0
11074,Microplate Well,Blepharal carcinoma,0
11075,Known,Carcinoma ex pleomorphic adenoma of parotid gland,0
11076,Abdominal bloating,FIGO Stage II Ovarian Cancer,0
11077,Pharmacotherapy,Recurrent Uveal Melanoma,0
11078,<90,Primary Cutaneous Plasmablastic Lymphoma,0
11079,Occurrence Indicator,Testicular cancer metastatic,0
11080,Common (qualifier value),Urethral Carcinoma,0
11081,Characteristics,Giant cell angiofibroma,0
11082,Aspiration of food,Larynx carcinoma recurrent,0
11083,United States,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11084,Prevention Study,Diffuse malignant mesothelioma,0
11085,Common (qualifier value),Neonatal leukemia,0
11086,Melanoma Pathway,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11087,Used by,Diffuse malignant mesothelioma,0
11088,size,Thymic Clear Cell Carcinoma,0
11089,Call (Instruction),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11090,complex (molecular entity),Recurrent Testicular Lymphoma,0
11091,Treatment Effectiveness,Breast Ductal Adenoma,0
11092,Immune System Finding,Acantholytic squamous cell carcinoma,0
11093,Mean Percent of Normal,Unresectable Rhabdomyosarcoma,0
11094,Aspects of signs,Diffuse malignant mesothelioma,0
11095,Time (foundation metadata concept),Human Papillomavirus-Related Carcinoma,0
11096,Y base,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11097,Etiology,Acute lymphadenitis,0
11098,Group A (blood group),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11099,Blood,Digestive System Hodgkin Lymphoma,0
11100,Measuring ruler,Heavy Chain Deposition Disease,0
11101,Type A,adenoid cystic carcinoma of lung,0
11102,Mechanism (attribute),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11103,Metastasis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11104,Carcinoma of lung,Testicular cancer metastatic,0
11105,Due to,Refractory Barrett Esophagus,0
11106,Therapeutic procedure,Airway Hemangioma,0
11107,Vomiting,Malignant neoplasm of thalamus,0
11108,Probability,Recurrent Uveal Melanoma,0
11109,Retraction (finding),Blepharal carcinoma,0
11110,Usual Severity Pain,Localized Askin Tumor,0
11111,Erythropoiesis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11112,Possible diagnosis,Metastatic Carcinoma in the Lung,0
11113,Glandular stomach,Stage IB Pancreatic Cancer AJCC v8,0
11114,Ovarian mucinous tumor,mucinous adenocarcinoma of gallbladder,0
11115,Mesenchymal Cell Neoplasm,Mucinous adenocarcinoma gastric,0
11116,A Codes,Rhabdomyosarcoma with ganglionic differentiation,0
11117,Poverty,Human Papillomavirus-Related Carcinoma,0
11118,Silent,Heavy Chain Deposition Disease,0
11119,combination of objects,FIGO Stage II Ovarian Cancer,0
11120,Standard Treatment,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11121,Canada,Bladder squamous cell carcinoma stage I,0
11122,Neuroglia,Recurrent Diffuse Intrinsic Pontine Glioma,0
11123,ADCY10 gene,Diffuse malignant mesothelioma,0
11124,*Type - Kind of quantity,Primary Cutaneous Plasmablastic Lymphoma,0
11125,Abdominal Cavity,Mucinous adenocarcinoma gastric,0
11126,Sensation quality,Choroid Necrotic Melanoma,0
11127,In Blood,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11128,Talpidae,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11129,Disease,Acute Undifferentiated Leukemia,0
11130,Reside,Extracranial Neuroblastoma,0
11131,memory b cell,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11132,Morphology,Pancreatic Intraepithelial Neoplasia-3,0
11133,Scientific Control,Stage IB Pancreatic Cancer AJCC v8,0
11134,Pain,Localized Askin Tumor,0
11135,Exception - Property or Attribute,Heavy Chain Deposition Disease,0
11136,Primary,Malignant Neoplasm with Regional Lymph Node Involvement,0
11137,Containing (qualifier),Papillary cystic tumor,0
11138,Lymphocyte,Methotrexate-Associated Hodgkin Lymphoma,0
11139,include - SetOperator,Malignant melanoma of eyelid,0
11140,Call (Instruction),Acute lymphadenitis,0
11141,Present,adenoid cystic carcinoma of lung,0
11142,Personal appearance,Breast Ductal Adenoma,0
11143,Publishing,Noninfiltrating Intraductal Carcinoma,0
11144,Two,Endometrial Small Cell Carcinoma,0
11145,Have Been Vomiting,Mucinous adenocarcinoma gastric,0
11146,Involvement with,Stage I Adult Non-Hodgkin Lymphoma,0
11147,Occurrence Indicator,Adult Hepatocellular Carcinoma,0
11148,Type - attribute,Recurrent Uveal Melanoma,0
11149,Paraplegia,Localized Askin Tumor,0
11150,Fifth,Mucinous adenocarcinoma gastric,0
11151,SLC6A2 protein,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11152,Bone Pain,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11153,Case unit dose,Colorectal High Grade B-Cell Lymphoma,0
11154,Adenocarcinoma,Stage IB Pancreatic Cancer AJCC v8,0
11155,System (unit of presentation),Digestive System Hodgkin Lymphoma,0
11156,Deoxyribonucleic Acid Measurement,BRCA2 Syndrome,0
11157,More,Ichthyoses,0
11158,Progress,FIGO Stage II Ovarian Cancer,0
11159,Autumn,Neonatal leukemia,0
11160,Include (action),Colorectal High Grade B-Cell Lymphoma,0
11161,Observation of color of skin,Acute Undifferentiated Leukemia,0
11162,Universities,de novo Myelodysplastic Syndrome,0
11163,melanoma,Recurrent Uveal Melanoma,0
11164,Optimistic,mucinous adenocarcinoma of gallbladder,0
11165,various other intestinal adsorbents in ATC,Benign Carotid Body Paraganglioma,0
11166,Most Recent,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11167,Target Awareness - partial,Carcinoma of urinary bladder,0
11168,Squamous cell carcinoma - category,Carcinoma of urinary bladder,0
11169,Morphology,Intracortical osteosarcoma,0
11170,Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11171,Two,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11172,Sequence Data Type,Leptomeningeal sarcoma,0
11173,Name,squamous cell carcinoma of the thyroid gland,0
11174,Specimen Source Codes - tumor,Colorectal High Grade B-Cell Lymphoma,0
11175,Injury due to exposure to external cause,Undifferentiated Endocervical Sarcoma,0
11176,Body tissue,Colorectal High Grade B-Cell Lymphoma,0
11177,Fatal,Acute Undifferentiated Leukemia,0
11178,Low Mitosis-Karyorrhexis Index,Clonal Hematopoiesis of Indeterminate Potential,0
11179,How Often Weight Loss,Unfavorable Non-Hodgkin Lymphoma,0
11180,Biological Response Modifiers,Intestinal Metaplasia of Bladder Urothelium,0
11181,Cell Count,Digestive System Hodgkin Lymphoma,0
11182,various allergen extracts,Extra-Adrenal Paraganglioma,0
11183,Neuroendocrine Tumors,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11184,Gestational trophoblastic disease,Undifferentiated Endocervical Sarcoma,0
11185,Sharing (Social Behavior),papillary carcinoma of penis,0
11186,Update,Breast Ductal Adenoma,0
11187,Blood Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11188,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
11189,Sufficiently defined concept definition status (core metadata concept),gliosarcoma,0
11190,Duct (organ) structure,Breast Ductal Adenoma,0
11191,Scientific Study,Recurrent Testicular Lymphoma,0
11192,include - SetOperator,Mucinous neoplasm,0
11193,Diagnostic Neoplasm Staging,Intestinal Metaplasia of Bladder Urothelium,0
11194,Medical Imaging,Mucinous adenocarcinoma gastric,0
11195,Rare,Cartilaginous exostosis,0
11196,Percent (qualifier value),Endometrial Small Cell Carcinoma,0
11197,Mesothelioma,Diffuse malignant mesothelioma,0
11198,Treating,Colorectal Neuroendocrine Tumor G2,0
11199,Penetration,Testicular cancer metastatic,0
11200,Derivation,Airway Hemangioma,0
11201,Date in time,Cancer of Urinary Tract,0
11202,68,Bladder squamous cell carcinoma stage I,0
11203,CEL gene,Clonal Hematopoiesis of Indeterminate Potential,0
11204,Primary operation,Malignant melanoma of eyelid,0
11205,Active,Thymic Clear Cell Carcinoma,0
11206,Empty (qualifier),Breast Ductal Adenoma,0
11207,Nodule,Deep Leiomyoma,0
11208,Fever,Childhood Lymphoma,0
11209,neural,gliosarcoma,0
11210,Pediculus (eukaryote),Rhabdomyosarcoma with ganglionic differentiation,0
11211,Appearance of breast,Breast Ductal Adenoma,0
11212,Symptoms aspect,Childhood Lymphoma,0
11213,Poor - grade value,Malignant melanoma of eyelid,0
11214,Cell Count,mucinous adenocarcinoma of gallbladder,0
11215,200,Intestinal Metaplasia of Bladder Urothelium,0
11216,50%,Acute Undifferentiated Leukemia,0
11217,Tryptophanase,Pilocytic astrocytoma of cerebellum,0
11218,Chemotherapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11219,DNA,BRCA2 Syndrome,0
11220,Known,Unfavorable Non-Hodgkin Lymphoma,0
11221,Eye,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11222,Pap smear,Endometrial Small Cell Carcinoma,0
11223,Medical pathologist,Papillary cystic tumor,0
11224,Infected,Human Papillomavirus-Related Carcinoma,0
11225,Hypothalamic structure,Pilocytic astrocytoma of cerebellum,0
11226,Males,Localized Askin Tumor,0
11227,Western World,Mucinous adenocarcinoma gastric,0
11228,Fatigue,Malignant Neoplasm with Regional Lymph Node Involvement,0
11229,Similarity,Intestinal Neuroendocrine Carcinoma,0
11230,Recurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11231,Cold Temperature,Acantholytic squamous cell carcinoma,0
11232,Drainage procedure,Benign Apocrine Neoplasm,0
11233,Digestive Enzymes,Stage IB Pancreatic Cancer AJCC v8,0
11234,Smoking,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11235,Better,Advanced Uterine Corpus Carcinosarcoma,0
11236,Lymphocyte component of blood,Recurrent Testicular Lymphoma,0
11237,pharmacotherapeutic,Metastatic Carcinoma in the Lung,0
11238,Tumor type,Refractory Glioma,0
11239,Percent (qualifier value),Refractory Glioma,0
11240,Skin tanning,Acantholytic squamous cell carcinoma,0
11241,Signet ring cell,mucinous adenocarcinoma of gallbladder,0
11242,3+ Answer to Question,BRCA2 Syndrome,0
11243,Lysergic acid diethylamide measurement,Refractory Barrett Esophagus,0
11244,Morphology,Anterior Urethral Malignant Neoplasm,0
11245,Intraepidermal vesicles,Spongiotic dermatitis,0
11246,Table Cell Horizontal Align - left,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11247,Malignant neoplasm of skin,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11248,BRCA1 protein,FIGO Stage II Ovarian Cancer,0
11249,Hoods,Extracranial Neuroblastoma,0
11250,Family member,Recurrent Uveal Melanoma,0
11251,Precipitating Factors,Acute Undifferentiated Leukemia,0
11252,How Much Distress Nausea,Unfavorable Non-Hodgkin Lymphoma,0
11253,Death (finding),Carcinoma of urinary bladder,0
11254,Comprehension,Recurrent Testicular Lymphoma,0
11255,Mechanism Component of Device,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11256,majority,Adult Hepatocellular Carcinoma,0
11257,Death (finding),Recurrent Uveal Melanoma,0
11258,History of present illness,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11259,Medical Device Emits Smoke,Bladder squamous cell carcinoma stage I,0
11260,Surface,Giant cell angiofibroma,0
11261,Function Axis,mucinous adenocarcinoma of gallbladder,0
11262,95,Spermatocytic seminoma,0
11263,Early,Mucinous adenocarcinoma gastric,0
11264,Affecting,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11265,Prophylactic treatment,Diffuse malignant mesothelioma,0
11266,Group A (qualifier value),Metastatic Ductal Breast Carcinoma,0
11267,Bladder Continence Question,Anterior Urethral Malignant Neoplasm,0
11268,Exist,Adenocarcinoma of the prostate metastatic,0
11269,Loss of appetite (finding),FIGO Stage II Ovarian Cancer,0
11270,Followed by,Cancer of Urinary Tract,0
11271,Compression - action,mucinous adenocarcinoma of gallbladder,0
11272,Multiple Myeloma,Malignant Neoplasm with Regional Lymph Node Involvement,0
11273,Provide (product),Anterior Urethral Malignant Neoplasm,0
11274,Structure of lumen of body system,Childhood Thyroid Gland Follicular Carcinoma,0
11275,Personal appearance,Carcinoma ex pleomorphic adenoma of parotid gland,0
11276,Diffuse malignant lymphoma - centroblastic-centrocytic,Recurrent Testicular Lymphoma,0
11277,Upper arm,Childhood Lymphoma,0
11278,Face,Maxillary Sinus Adenocarcinoma,0
11279,Sharing (Social Behavior),Colorectal Neuroendocrine Tumor G2,0
11280,Sarcoma,Adult Alveolar Soft Part Sarcoma,0
11281,Necrotic changes (finding),Angiosarcoma of liver,0
11282,Publications,Intracortical osteosarcoma,0
11283,Population Group,Blepharal carcinoma,0
11284,Neoplasm Metastasis,Benign neoplasm of thorax,0
11285,Manufactured sign,Malignant melanoma of eyelid,0
11286,Including (qualifier),Choroid Necrotic Melanoma,0
11287,Remaining,Digestive System Hodgkin Lymphoma,0
11288,Derived value,Clonal Hematopoiesis of Indeterminate Potential,0
11289,Paraganglioma,Benign Carotid Body Paraganglioma,0
11290,Treatment Epoch,Bladder squamous cell carcinoma stage I,0
11291,Have Weight Loss,Methotrexate-Associated Hodgkin Lymphoma,0
11292,Tissue Specimen Code,Acantholytic squamous cell carcinoma,0
11293,Cells,Adenocarcinoma,0
11294,Pith - plant part,Thymic Clear Cell Carcinoma,0
11295,Edema,Malignant Testicular Sertoli Cell Tumor,0
11296,Include (action),Acute Undifferentiated Leukemia,0
11297,How Much Distress Shortness of Breath,Stage IB Lung Cancer AJCC v7,0
11298,Very large,Pilocytic astrocytoma of cerebellum,0
11299,Ultraviolet Light Sterilization,Malignant melanoma of eyelid,0
11300,All of the Time,Breast Ductal Adenoma,0
11301,Indication of (contextual qualifier),Atypical Lobular Breast Hyperplasia,0
11302,Glioma,gliosarcoma,0
11303,competitive advantage,Clonal Hematopoiesis of Indeterminate Potential,0
11304,Qualitative form,Liver Cavernous Hemangioma,0
11305,Mathematical Factor,FIGO Stage II Ovarian Cancer,0
11306,Metastatic Neoplasm,Benign Carotid Body Paraganglioma,0
11307,Mediastinum,Spermatocytic seminoma,0
11308,Relationships,Malignant neoplasm of choroid,0
11309,Feel Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11310,Auditory pitch,Larynx carcinoma recurrent,0
11311,health and disease,Noninfiltrating Intraductal Carcinoma,0
11312,Term (lexical),Metastatic Neoplasm to the Gallbladder,0
11313,Weight Loss,Stage IB Lung Cancer AJCC v7,0
11314,Surgery specialty,Bladder squamous cell carcinoma stage I,0
11315,Person Observer,Mucinous adenocarcinoma gastric,0
11316,Entity Determiner - specific,Primary Cutaneous Plasmablastic Lymphoma,0
11317,Abdomen,Stage IB Pancreatic Cancer AJCC v8,0
11318,How Often Weight Loss,Stage I Adult Non-Hodgkin Lymphoma,0
11319,Medical Imaging,Bladder squamous cell carcinoma stage I,0
11320,Antibodies,Unresectable Rhabdomyosarcoma,0
11321,Generalization (Psychology),Primary Cutaneous Plasmablastic Lymphoma,0
11322,Type - attribute,Advanced Uterine Corpus Carcinosarcoma,0
11323,Drain device,Digestive System Hodgkin Lymphoma,0
11324,Weight decreased,Mucinous adenocarcinoma gastric,0
11325,Five-year Survival Rate,Bladder squamous cell carcinoma stage I,0
11326,Age of Onset,Intestinal Metaplasia of Bladder Urothelium,0
11327,Referral placed,Undifferentiated Endocervical Sarcoma,0
11328,Very,Cancer of Urinary Tract,0
11329,Shortness of breath:-:Point in time:^Patient:-,Diffuse malignant mesothelioma,0
11330,Malignant Neoplasms,Leiomyoma of Gallbladder,0
11331,Cancer Other,Breast Ductal Adenoma,0
11332,Proteins,Digestive System Hodgkin Lymphoma,0
11333,Variant,Pilocytic astrocytoma of cerebellum,0
11334,Symptoms aspect,Uterine Cancer,0
11335,Disease,Primary Cutaneous Plasmablastic Lymphoma,0
11336,Histology,Adult Hepatocellular Carcinoma,0
11337,Family (taxonomic),Human Papillomavirus-Related Carcinoma,0
11338,production,Metastatic Neoplasm to the Gallbladder,0
11339,The Cancer Genome Atlas,Advanced Uterine Corpus Carcinosarcoma,0
11340,therapeutic aspects,Recurrent Uveal Melanoma,0
11341,Exist,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11342,General surgery specialty,Colorectal High Grade B-Cell Lymphoma,0
11343,Consistency,benign mature teratoma of pancreas,0
11344,Offspring,Mastocytosis,0
11345,Vaginal (intended site),Human Papillomavirus-Related Carcinoma,0
11346,Centroblast,Recurrent Testicular Lymphoma,0
11347,United States,Recurrent Uveal Melanoma,0
11348,Portion of urine,Grade 1 Clear Cell Renal Cell Carcinoma,0
11349,United States,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11350,Qualitative form,squamous cell carcinoma of the thyroid gland,0
11351,Ultraviolet Light Sterilization,Angiosarcoma of liver,0
11352,Manipulation procedure,Larynx carcinoma recurrent,0
11353,Closure,Refractory Barrett Esophagus,0
11354,Predisposition -- attribute,Mastocytosis,0
11355,Repaired,BRCA2 Syndrome,0
11356,Formation,Female Breast Carcinoma,0
11357,Often - answer to question,Contact dermatitis due to alkali,0
11358,Beginning,Adenocarcinoma of the prostate metastatic,0
11359,Most,FIGO Stage II Ovarian Cancer,0
11360,Including (qualifier),Localized Askin Tumor,0
11361,Call (Instruction),Familial Adenomatous Polyposis Associated Medulloblastoma,0
11362,Human papillomavirus typing (procedure),Tonsillar Carcinoma,0
11363,Chemotherapy Regimen,Primary Cutaneous Plasmablastic Lymphoma,0
11364,treatment - ActInformationManagementReason,Airway Hemangioma,0
11365,Pallor,Maxillary Sinus Adenocarcinoma,0
11366,Pressure - action,Anterior Urethral Malignant Neoplasm,0
11367,newly,Testicular cancer metastatic,0
11368,Case unit dose,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11369,Usual Severity Weight Loss,Methotrexate-Associated Hodgkin Lymphoma,0
11370,Science of Etiology,Human Papillomavirus-Related Carcinoma,0
11371,Benign,Malignant neoplasm of thalamus,0
11372,Both ovaries,FIGO Stage II Ovarian Cancer,0
11373,Percent (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
11374,Immune,Digestive System Hodgkin Lymphoma,0
11375,Adult Hodgkin Lymphoma,Hodgkin lymphoma,0
11376,Law enforcement arrest,Unresectable Rhabdomyosarcoma,0
11377,Symptoms aspect,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11378,Removed,Metastatic Ductal Breast Carcinoma,0
11379,Tryptophanase,Stage II Carcinoma of Penis,0
11380,Cancer Genus,Uterine Cancer,0
11381,Tissue Specimen Code,Carcinoma of urinary bladder,0
11382,Inguinal part of abdomen,Recurrent Testicular Lymphoma,0
11383,Approximate,Human Papillomavirus-Related Carcinoma,0
11384,Take,Refractory Barrett Esophagus,0
11385,Common Specifications in HL7 V3 Publishing,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11386,treatment options,Undifferentiated Endocervical Sarcoma,0
11387,30%,Refractory Glioma,0
11388,Occurrence Indicator,Localized Askin Tumor,0
11389,Absent,Female Breast Carcinoma,0
11390,Skin,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11391,Rest,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11392,See,Recurrent Testicular Lymphoma,0
11393,Childhood Myelodysplastic Syndrome,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11394,Both kidneys,Grade 1 Clear Cell Renal Cell Carcinoma,0
11395,68,Carcinoma of urinary bladder,0
11396,Include (action),Cancer of Urinary Tract,0
11397,dendritic spine neck,Benign neoplasm of thorax,0
11398,Scientific Publication,Leptomeningeal sarcoma,0
11399,In Blood,gliosarcoma,0
11400,Tryptophanase,mucinous adenocarcinoma of gallbladder,0
11401,Measles virus genotype D1,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11402,White blood cell count normal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11403,Imaging Techniques,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11404,High,Tonsillar Carcinoma,0
11405,Neoplasms,mucinous adenocarcinoma of gallbladder,0
11406,Structure of lower lobe of lung,Childhood Thyroid Gland Follicular Carcinoma,0
11407,European race,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11408,genome sequencing,Advanced Uterine Corpus Carcinosarcoma,0
11409,Specimen Source Codes - tumor,Anterior Urethral Malignant Neoplasm,0
11410,Nausea,Unfavorable Non-Hodgkin Lymphoma,0
11411,Prior Chemotherapy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11412,Initial (abbreviation),Testicular cancer metastatic,0
11413,Trial Screening,Mucinous adenocarcinoma gastric,0
11414,Magnetic Resonance Imaging,Pilocytic astrocytoma of cerebellum,0
11415,Brain,adenoid cystic carcinoma of lung,0
11416,Part,Heavy Chain Deposition Disease,0
11417,Followed by,Acute Undifferentiated Leukemia,0
11418,Superkingdom (taxonomic category),Noninfiltrating Intraductal Carcinoma,0
11419,Usually,Breast Ductal Adenoma,0
11420,lymph nodes,gliosarcoma,0
11421,1+,Tonsillar Carcinoma,0
11422,1+,Ichthyosis,0
11423,newly,Endometrial Small Cell Carcinoma,0
11424,Occurrence,Undifferentiated Endocervical Sarcoma,0
11425,Science of Statistics,Rhabdomyosarcoma with ganglionic differentiation,0
11426,foreign,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11427,Urine,Sarcomatoid Renal Cell Carcinoma,0
11428,Sexually Transmitted Diseases,Maxillary Sinus Adenocarcinoma,0
11429,Biologic Development,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11430,Most,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11431,Reported Term,Ampulla of Vater Tubular Adenoma,0
11432,include - SetOperator,Benign Apocrine Neoplasm,0
11433,Grouping,Serous cystadenocarcinoma ovary,0
11434,Risk,Adult Hepatocellular Carcinoma,0
11435,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Grade 1 Clear Cell Renal Cell Carcinoma,0
11436,Immune,Human Papillomavirus-Related Carcinoma,0
11437,Two,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11438,Fever,Malignant Neoplasm with Regional Lymph Node Involvement,0
11439,Infrequent,Colorectal High Grade B-Cell Lymphoma,0
11440,Response Likelihood,Female Breast Carcinoma,0
11441,Benign neoplasm of sweat gland,Benign Apocrine Neoplasm,0
11442,Image Feature,Intestinal Neuroendocrine Carcinoma,0
11443,Tryptophanase,Blepharal carcinoma,0
11444,Help document,BRCA2 Syndrome,0
11445,per year,Localized Askin Tumor,0
11446,Colloid,Childhood Thyroid Gland Follicular Carcinoma,0
11447,Classification,mucinous adenocarcinoma of gallbladder,0
11448,Following,Acute Undifferentiated Leukemia,0
11449,Reported Term,Adenocarcinoma of the prostate metastatic,0
11450,low exposure,Primary Cutaneous Plasmablastic Lymphoma,0
11451,Gut,Adult Alveolar Soft Part Sarcoma,0
11452,Coding,Familial Hemophagocytic Lymphocytosis,0
11453,Physical findings,Recurrent Uveal Melanoma,0
11454,Left,mucinous adenocarcinoma of gallbladder,0
11455,Age at diagnosis,Acantholytic squamous cell carcinoma,0
11456,Tobacco smoking behavior,Bladder squamous cell carcinoma stage I,0
11457,Class,Metastatic Carcinoma in the Lung,0
11458,Fever,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11459,Age of onset of symptoms:Time:Pt:^Patient:Qn,Bladder squamous cell carcinoma stage I,0
11460,Bladder Continence Question,Intestinal Metaplasia of Bladder Urothelium,0
11461,Numerous,Recurrent Testicular Lymphoma,0
11462,Qualitative form,Heavy Chain Deposition Disease,0
11463,Brain,Adult Alveolar Soft Part Sarcoma,0
11464,Exposure to,Tonsillar Carcinoma,0
11465,Malignant - descriptor,benign mature teratoma of pancreas,0
11466,Naive Pregerminal Center B-Lymphocyte,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11467,Feelings,Hodgkin lymphoma,0
11468,Primary,Recurrent Uveal Melanoma,0
11469,New Zealand,Recurrent Uveal Melanoma,0
11470,Occur (action),Pancreatic Intraepithelial Neoplasia-3,0
11471,Biomaterial Treatment,Carcinoma of urinary bladder,0
11472,Complete Trisomy 21 Syndrome,Acute Undifferentiated Leukemia,0
11473,Type A,Germinoma,0
11474,Manifest,Ichthyosis,0
11475,Supratentorial,Malignant neoplasm of choroid,0
11476,Histologic,Giant cell angiofibroma,0
11477,Usual,Primary Cutaneous Plasmablastic Lymphoma,0
11478,Smear - instruction imperative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11479,Neoadjuvant Therapy Clinical Trial Setting,Metastatic Carcinoma in the Lung,0
11480,Leakage,Hemangioma,0
11481,Malignant Neoplasms,Angiosarcoma of liver,0
11482,Due to,Stage IB Lung Cancer AJCC v7,0
11483,Characterization,Atypical Mesothelial Hyperplasia,0
11484,Mutation,Ichthyosis,0
11485,Set scale,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11486,Classical Hodgkin's Lymphoma,Hodgkin lymphoma,0
11487,Exposure to,Contact dermatitis due to alkali,0
11488,Specific qualifier value,Stage I Adult Non-Hodgkin Lymphoma,0
11489,Seventh,FIGO Stage II Ovarian Cancer,0
11490,Smear - instruction imperative,Testicular cancer metastatic,0
11491,Known,Undifferentiated Endocervical Sarcoma,0
11492,Life Expectancy Greater than Twenty Years,Pilocytic astrocytoma of cerebellum,0
11493,Part Dosing Unit,Thymic Clear Cell Carcinoma,0
11494,Malignant neoplasm of skin,Recurrent Uveal Melanoma,0
11495,Including (qualifier),Childhood Lymphoma,0
11496,Negation,Malignant melanoma of eyelid,0
11497,Scientific Publication,Rhabdomyosarcoma with ganglionic differentiation,0
11498,treatment options,Malignant Testicular Sertoli Cell Tumor,0
11499,Process (qualifier value),Serous cystadenocarcinoma ovary,0
11500,Term Birth,Stage IB Pancreatic Cancer AJCC v8,0
11501,Cells,Carcinoma of urinary bladder,0
11502,Intention - mental process,Lung squamous cell carcinoma stage I,0
11503,Retinoic Acid Response Element,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11504,Treating,Lung squamous cell carcinoma stage I,0
11505,PSA Level Greater than Fifty,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11506,Name (property) (qualifier value),Atypical Lobular Breast Hyperplasia,0
11507,Common (qualifier value),Localized Askin Tumor,0
11508,Numerous,de novo Myelodysplastic Syndrome,0
11509,Increased risk for cancer,Colorectal cancer,0
11510,Low Mitosis-Karyorrhexis Index,Placental aromatase deficiency,0
11511,Hormones,Collecting Duct Carcinoma of the Kidney,0
11512,Common (qualifier value),Colorectal High Grade B-Cell Lymphoma,0
11513,DNA,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
11514,Experimental Result,papillary carcinoma of penis,0
11515,Infant,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11516,Normal,Unresectable Rhabdomyosarcoma,0
11517,Manufactured form,Cartilaginous exostosis,0
11518,Make - Instruction Imperative,Clonal Hematopoiesis of Indeterminate Potential,0
11519,Future,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11520,Weighing patient,Refractory Barrett Esophagus,0
11521,Alternative,Serous cystadenocarcinoma ovary,0
11522,Cause of Death,Undifferentiated Endocervical Sarcoma,0
11523,Irritation (finding),Giant cell angiofibroma,0
11524,Lung,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11525,Normal,Endometrial Small Cell Carcinoma,0
11526,Five,Localized Askin Tumor,0
11527,Urinary system,Cancer of Urinary Tract,0
11528,Falls,Neonatal leukemia,0
11529,Smooth Muscle Tumor,Metastatic Neoplasm to the Gallbladder,0
11530,Node - plant part,Tonsillar Carcinoma,0
11531,Rate,Recurrent Uveal Melanoma,0
11532,Classification,Cancer of Urinary Tract,0
11533,Specific qualifier value,Metastatic Ductal Breast Carcinoma,0
11534,Tumor stage,Spermatocytic seminoma,0
11535,IPSS Risk Category High,BRCA2 Syndrome,0
11536,Plasma cell dyscrasia,Heavy Chain Deposition Disease,0
11537,Fatigue,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11538,How Often Nausea,Mucinous adenocarcinoma gastric,0
11539,Breathing Distress Question,Airway Hemangioma,0
11540,symbol,BRCA2 Syndrome,0
11541,Dysuria,Carcinoma of urinary bladder,0
11542,week,Acute Undifferentiated Leukemia,0
11543,Asia,FIGO Stage II Ovarian Cancer,0
11544,Spreading (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11545,risk factors,Cancer of Urinary Tract,0
11546,Bone pain,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11547,Adult Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
11548,PREVENT (product),Recurrent Uveal Melanoma,0
11549,Infant,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11550,Treatment Epoch,Uterine Cancer,0
11551,Logical Condition,FIGO Stage II Ovarian Cancer,0
11552,Age,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11553,Coughing,Stage IB Lung Cancer AJCC v7,0
11554,therapeutic aspects,Female Breast Carcinoma,0
11555,contents - HtmlLinkType,Refractory Barrett Esophagus,0
11556,Approximate,Malignant Testicular Sertoli Cell Tumor,0
11557,potential,Intestinal Metaplasia of Bladder Urothelium,0
11558,Hyperlink,Human Papillomavirus-Related Carcinoma,0
11559,Scientific Control,Primary Cutaneous Plasmablastic Lymphoma,0
11560,Type - attribute,Intestinal Neuroendocrine Carcinoma,0
11561,Group A (qualifier value),Colorectal Neuroendocrine Tumor G2,0
11562,Formation,Pilocytic astrocytoma of cerebellum,0
11563,Area,Recurrent Testicular Lymphoma,0
11564,pharmacotherapeutic,Lung squamous cell carcinoma stage I,0
11565,Term Birth,Pancreatic Intraepithelial Neoplasia-3,0
11566,Physical Medical Procedure,Diffuse malignant mesothelioma,0
11567,liter,Digestive System Hodgkin Lymphoma,0
11568,Five,Benign Carotid Body Paraganglioma,0
11569,Life Threatening or Disabling Adverse Event,Female Breast Carcinoma,0
11570,Common Specifications in HL7 V3 Publishing,adenosquamous carcinoma of breast,0
11571,Cells,Testicular cancer metastatic,0
11572,Secondary Neoplasm,mucinous adenocarcinoma of gallbladder,0
11573,Estimated,gliosarcoma,0
11574,Genome,Advanced Uterine Corpus Carcinosarcoma,0
11575,Referring,Malignant Neoplasm with Regional Lymph Node Involvement,0
11576,active (HL7 RoleLink),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11577,Often - answer to question,Pilocytic astrocytoma of cerebellum,0
11578,74,Uterine Cancer,0
11579,Area,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11580,Maintaining (action),BRCA2 Syndrome,0
11581,Oral region,Malignant melanoma of eyelid,0
11582,Tract,Undifferentiated Endocervical Sarcoma,0
11583,Malignant Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11584,Chemicals,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11585,Pain NOS,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11586,Base - General Qualifier,Granular Cell Leiomyosarcoma,0
11587,Array Feature,Recurrent Testicular Lymphoma,0
11588,Sunscreening Agents,Recurrent Uveal Melanoma,0
11589,seen,Bladder squamous cell carcinoma stage I,0
11590,Asia,Recurrent Uveal Melanoma,0
11591,Term (lexical),Neonatal leukemia,0
11592,Cancer Genus,Malignant neoplasm of thalamus,0
11593,Togo,Methotrexate-Associated Hodgkin Lymphoma,0
11594,{Setting},Benign neoplasm of thorax,0
11595,Part of,Sarcomatoid Renal Cell Carcinoma,0
11596,Cause of death.underlying,Localized Askin Tumor,0
11597,95,Stage II Carcinoma of Penis,0
11598,Caucasians,Recurrent Testicular Lymphoma,0
11599,Separate,Childhood Cerebellar Neoplasm,0
11600,Genes,BRCA2 Syndrome,0
11601,Low Mitosis-Karyorrhexis Index,Primary Cutaneous Plasmablastic Lymphoma,0
11602,BRAF gene,Pilocytic astrocytoma of cerebellum,0
11603,week,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11604,Tip,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11605,Carcinoma of lung,Stage IB Lung Cancer AJCC v7,0
11606,Back structure,Malignant melanoma of eyelid,0
11607,Operative Surgical Procedures,Mucinous adenocarcinoma gastric,0
11608,Before,Mucinous adenocarcinoma gastric,0
11609,Set of muscles,Adult Alveolar Soft Part Sarcoma,0
11610,Case (situation),Familial Adenomatous Polyposis Associated Medulloblastoma,0
11611,Pediculus humanus capitis (eukaryote),Rhabdomyosarcoma with ganglionic differentiation,0
11612,shared attribute,Adult Hepatocellular Carcinoma,0
11613,Back,Airway Hemangioma,0
11614,radiotherapeutic,Localized Askin Tumor,0
11615,Feelings,Cancer of Urinary Tract,0
11616,Structure of thyroid parafollicular cell,Childhood Thyroid Gland Follicular Carcinoma,0
11617,Drop British,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11618,Tumor cells,Angiosarcoma of liver,0
11619,Surgical extraction,Malignant Testicular Sertoli Cell Tumor,0
11620,Desiccation,Ichthyoses,0
11621,Oral region,Recurrent Uveal Melanoma,0
11622,Financial Account,Recurrent Testicular Lymphoma,0
11623,Body structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11624,Human Age Group,Clonal Hematopoiesis of Indeterminate Potential,0
11625,Mutation,Clonal Hematopoiesis of Indeterminate Potential,0
11626,Females,Mucinous adenocarcinoma gastric,0
11627,Usual Severity Sweats,Methotrexate-Associated Hodgkin Lymphoma,0
11628,Mutation Abnormality,Localized Askin Tumor,0
11629,Childhood Soft Tissue Sarcoma,Adult Alveolar Soft Part Sarcoma,0
11630,Lung,Intestinal Neuroendocrine Carcinoma,0
11631,Itchiness,Recurrent Uveal Melanoma,0
11632,Malignant - descriptor,Angiosarcoma of liver,0
11633,Primary malignant neoplasm,Choroid Necrotic Melanoma,0
11634,DNA Breaks,BRCA2 Syndrome,0
11635,Tired,Diffuse malignant mesothelioma,0
11636,Most,Colorectal Neuroendocrine Tumor G2,0
11637,Known,Malignant neoplasm of choroid,0
11638,Malignant Vaginal Neoplasm,squamous cell carcinoma of the thyroid gland,0
11639,Cell Count,Intestinal Metaplasia of Bladder Urothelium,0
11640,Then,Cartilaginous exostosis,0
11641,Case (situation),mucinous adenocarcinoma of gallbladder,0
11642,Experimental Result,Acute Undifferentiated Leukemia,0
11643,Therapeutic radiology procedure,Intestinal Metaplasia of Bladder Urothelium,0
11644,Pale color saturation,Acute Undifferentiated Leukemia,0
11645,Negative Surgical Margin,Giant cell angiofibroma,0
11646,Five-year Survival Rate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11647,Make - Instruction Imperative,Acute lymphadenitis,0
11648,Superior mediastinum,Thymic Clear Cell Carcinoma,0
11649,Malignant neoplasm of submandibular gland,adenoid cystic carcinoma of lung,0
11650,Common Specifications in HL7 V3 Publishing,Recurrent Testicular Lymphoma,0
11651,Mass,Recurrent Testicular Lymphoma,0
11652,antigen binding,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11653,Common Specifications in HL7 V3 Publishing,Intestinal Metaplasia of Bladder Urothelium,0
11654,2+ Score,Acantholytic squamous cell carcinoma,0
11655,Levels (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11656,One,Pancreatic Intraepithelial Neoplasia-3,0
11657,One,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11658,Usually Need Help from Another Person for Arising,Thymic Clear Cell Carcinoma,0
11659,Medical Tent,Childhood Cerebellar Neoplasm,0
11660,Weight decreased,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11661,80%,Uterine Cancer,0
11662,Term (lexical),Acute lymphadenitis,0
11663,Shortened,Cancer of Urinary Tract,0
11664,Divide,Malignant melanoma of eyelid,0
11665,Contain (action),Diffuse malignant mesothelioma,0
11666,Occurrence Indicator,Giant cell angiofibroma,0
11667,Evidence,Acute Undifferentiated Leukemia,0
11668,Protection Element Attribute,Refractory Barrett Esophagus,0
11669,Exclusion,Atypical Lobular Breast Hyperplasia,0
11670,Symptoms,Refractory Barrett Esophagus,0
11671,Adenocarcinoma,Carcinoma of urinary bladder,0
11672,Manual pelvic examination (procedure),Anterior Urethral Malignant Neoplasm,0
11673,Malignant neoplasm of lung,adenosquamous carcinoma of breast,0
11674,Abdomen,Mucinous adenocarcinoma gastric,0
11675,Measures (attribute),Refractory Barrett Esophagus,0
11676,Term (temporal),Atypical Lobular Breast Hyperplasia,0
11677,6/3,Clonal Hematopoiesis of Indeterminate Potential,0
11678,biomedical tube device,Sarcomatoid Renal Cell Carcinoma,0
11679,Brain,Malignant neoplasm of thalamus,0
11680,Skin Angiosarcoma,Angiosarcoma of liver,0
11681,dendritic spine neck,Tonsillar Carcinoma,0
11682,Adult human body,Granular Cell Leiomyosarcoma,0
11683,Form:Finding:Point in time:{Setting}:Document:{Role},Airway Hemangioma,0
11684,Sore Throat,Tonsillar Carcinoma,0
11685,Cancer Genus,FIGO Stage II Ovarian Cancer,0
11686,Deterioration of status,Malignant neoplasm of thalamus,0
11687,Cessation of life,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11688,Contraceptives,Endometrial Small Cell Carcinoma,0
11689,Weather,Giant cell angiofibroma,0
11690,Spreading (qualifier value),adenosquamous carcinoma of breast,0
11691,Acrospiroma,Benign Apocrine Neoplasm,0
11692,Often - answer to question,Endometrial Small Cell Carcinoma,0
11693,Tissue Specimen Code,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
11694,Occur (action),Pilocytic astrocytoma of cerebellum,0
11695,Symptoms aspect,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11696,Surface,Blepharal carcinoma,0
11697,Wall of lymphatic vessel,Angiosarcoma of liver,0
11698,Sex Behavior,Human Papillomavirus-Related Carcinoma,0
11699,Human body,Maxillary Sinus Adenocarcinoma,0
11700,Platelets Product,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11701,Contain (action),Tonsillar Carcinoma,0
11702,Pain,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11703,cns lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
11704,Disease,Malignant melanoma of eyelid,0
11705,Aspects of disease screening,Human Papillomavirus-Related Carcinoma,0
11706,Smoking,Refractory Barrett Esophagus,0
11707,Tobacco smoking behavior,Stage IB Lung Cancer AJCC v7,0
11708,Sequence Data Type,Rhabdomyosarcoma with ganglionic differentiation,0
11709,Specimen Source Codes - tumor,Adenocarcinoma of the prostate metastatic,0
11710,survival aspects,Extra-Adrenal Paraganglioma,0
11711,Delayed Puberty,Placental aromatase deficiency,0
11712,Call (Instruction),Thymic Clear Cell Carcinoma,0
11713,Abnormally high,FIGO Stage II Ovarian Cancer,0
11714,Including (qualifier),Pancreatic Intraepithelial Neoplasia-3,0
11715,Including (qualifier),Hodgkin lymphoma,0
11716,Including (qualifier),Malignant Neoplasm of Lung - Multiple Primary Sites,0
11717,mononuclear cells,Giant cell angiofibroma,0
11718,Consortium or Network,Digestive System Hodgkin Lymphoma,0
11719,Primary,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11720,Togo,Anterior Urethral Malignant Neoplasm,0
11721,Clone,Clonal Hematopoiesis of Indeterminate Potential,0
11722,Area,GIANT PIGMENTED HAIRY NEVUS,0
11723,Response (statement),Female Breast Carcinoma,0
11724,Additional,Recurrent Testicular Lymphoma,0
11725,Carcinoma,Stage II Carcinoma of Penis,0
11726,Include (action),Bladder squamous cell carcinoma stage I,0
11727,Human body structure,Placental aromatase deficiency,0
11728,Occurrence Indicator,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11729,Biologic Development,Mucinous adenocarcinoma gastric,0
11730,Biopsy,Recurrent Uveal Melanoma,0
11731,Tiredness Visual Analogue Scale,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11732,Evidence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11733,Only - dosing instruction fragment,Endometrial Small Cell Carcinoma,0
11734,Room of building - Study,Angiosarcoma of liver,0
11735,Latin America,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11736,Pale feces (finding),Pancreatic Intraepithelial Neoplasia-3,0
11737,Pain Distress Question,Localized Askin Tumor,0
11738,Singular,adenoid cystic carcinoma of lung,0
11739,Tissue damage,BRCA2 Syndrome,0
11740,Cancer Other,Extra-Adrenal Paraganglioma,0
11741,Weight Loss,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11742,Dorsal,Recurrent Uveal Melanoma,0
11743,Superkingdom (taxonomic category),Leptomeningeal sarcoma,0
11744,Unknown GENC,Localized Askin Tumor,0
11745,Polycythemia,Leiomyoma of Gallbladder,0
11746,Used by,Acantholytic squamous cell carcinoma,0
11747,risk factors - observation list,Intestinal Metaplasia of Bladder Urothelium,0
11748,Urinary tract infection,Cancer of Urinary Tract,0
11749,Mass,benign mature teratoma of pancreas,0
11750,Communicable Diseases,Diffuse malignant mesothelioma,0
11751,Lymphoma,Malignant Testicular Sertoli Cell Tumor,0
11752,Associated with,Digestive System Hodgkin Lymphoma,0
11753,How Often Shortness of Breath,adenosquamous carcinoma of breast,0
11754,Togo,Metastatic Ductal Breast Carcinoma,0
11755,Preventive monitoring,Mucinous neoplasm,0
11756,New,Recurrent Testicular Lymphoma,0
11757,Response (statement),Breast Ductal Adenoma,0
11758,BRCA2 Protein,BRCA2 Syndrome,0
11759,To,Cartilaginous exostosis,0
11760,Location of Oral Residue Following Swallowing,Cartilaginous exostosis,0
11761,Show,Endometrial Small Cell Carcinoma,0
11762,common types,Human Papillomavirus-Related Carcinoma,0
11763,white blood cell type,Hodgkin lymphoma,0
11764,Primary malignant neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11765,Central Minus,Thymic Clear Cell Carcinoma,0
11766,Occurrence,Acute Undifferentiated Leukemia,0
11767,Diagnosis,Undifferentiated Endocervical Sarcoma,0
11768,Malignant - descriptor,Germinoma,0
11769,Class (taxonomic),Metastatic Carcinoma in the Lung,0
11770,Protocol Agent,Tonsillar Carcinoma,0
11771,Coding,Secondary malignant neoplasm of lymph node,0
11772,>90,Stage IB Pancreatic Cancer AJCC v8,0
11773,Cure (remedy),Lung squamous cell carcinoma stage I,0
11774,Containing (qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11775,Definitely Related to Intervention,Mucinous adenocarcinoma gastric,0
11776,Body Site Modifier - Lower,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11777,Mutation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11778,Person Name,papillary carcinoma of penis,0
11779,Cells,Recurrent Uveal Melanoma,0
11780,ethnic european,Malignant melanoma of eyelid,0
11781,shared attribute,Metastatic Neoplasm to the Gallbladder,0
11782,Dryness (characteristic),Ichthyoses,0
11783,Vision:-:Point in time:^Patient:-,Blepharal carcinoma,0
11784,Malignant Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
11785,How Often Sweats,Methotrexate-Associated Hodgkin Lymphoma,0
11786,Basis - conceptual entity,Uterine Cancer,0
11787,Occurrence,Colorectal Neuroendocrine Tumor G2,0
11788,Mental Recall,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11789,Main,Neonatal leukemia,0
11790,/40,Pancreatic Intraepithelial Neoplasia-3,0
11791,Disease remission,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11792,Rest,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11793,geographic population,Clonal Hematopoiesis of Indeterminate Potential,0
11794,Subcategory,Neonatal leukemia,0
11795,Adenocarcinoma of pancreas,Pancreatic Intraepithelial Neoplasia-3,0
11796,Type - attribute,Primary Cutaneous Plasmablastic Lymphoma,0
11797,Cancer Genus,Undifferentiated Endocervical Sarcoma,0
11798,chapter,Malignant Neoplasm of Lung - Multiple Primary Sites,0
11799,Levels (qualifier value),Malignant melanoma of eyelid,0
11800,Night time,Methotrexate-Associated Hodgkin Lymphoma,0
11801,Computed Tomography Study File,Anterior Urethral Malignant Neoplasm,0
11802,Increased,Endometrial Small Cell Carcinoma,0
11803,Certain (qualifier value),Refractory Barrett Esophagus,0
11804,Fasting,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11805,Skin,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11806,Continuous,Thymic Clear Cell Carcinoma,0
11807,Lung,squamous cell carcinoma of the thyroid gland,0
11808,<90,Acute Undifferentiated Leukemia,0
11809,Easy bleeding,Acute Undifferentiated Leukemia,0
11810,Contain (action),Papillary cystic tumor,0
11811,Penis carcinoma,Stage II Carcinoma of Penis,0
11812,Containing (qualifier),Familial Hemophagocytic Lymphocytosis,0
11813,Filter - medical device,Digestive System Hodgkin Lymphoma,0
11814,List,Intracortical osteosarcoma,0
11815,Body tissue,Colorectal Neuroendocrine Tumor G2,0
11816,Body tissue,Hemangioma,0
11817,Human body,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11818,Juice,Spongiotic dermatitis,0
11819,Appearance Distress Question,Breast Ductal Adenoma,0
11820,Malignant Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
11821,Blood Cells,Airway Hemangioma,0
11822,Melanoma Pathway,Malignant melanoma of eyelid,0
11823,Better,Human Papillomavirus-Related Carcinoma,0
11824,Physical findings,Mucinous adenocarcinoma gastric,0
11825,Anatomic Structure,Extra-Adrenal Paraganglioma,0
11826,Daily Living,Digestive System Hodgkin Lymphoma,0
11827,GDF15 protein,Secondary malignant neoplasm of lymph node,0
11828,Account number:Identifier:Point in time:^Patient:Nominal,Recurrent Testicular Lymphoma,0
11829,diagnosis aspect,Malignant melanoma of eyelid,0
11830,1000000,Acantholytic squamous cell carcinoma,0
11831,Appearance,Maxillary Sinus Adenocarcinoma,0
11832,Complete Trisomy 21 Syndrome,Neonatal leukemia,0
11833,Call (Instruction),Childhood Thyroid Gland Follicular Carcinoma,0
11834,Call (Instruction),Stage I Adult Non-Hodgkin Lymphoma,0
11835,Dental caries,Liver Cavernous Hemangioma,0
11836,Immediate,Unfavorable Non-Hodgkin Lymphoma,0
11837,Etiology aspects,Recurrent Testicular Lymphoma,0
11838,regional,Pilocytic astrocytoma of cerebellum,0
11839,Childhood Non-Hodgkin Lymphoma,Recurrent Testicular Lymphoma,0
11840,Smaller,Recurrent Uveal Melanoma,0
11841,contextual factors,Benign neoplasm of thorax,0
11842,Positive,Metastatic Ductal Breast Carcinoma,0
11843,Clone Cells,Heavy Chain Deposition Disease,0
11844,CD5L wt Allele,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11845,Lymphadenopathy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11846,Combined,Mucinous adenocarcinoma gastric,0
11847,In Urine,Sarcomatoid Renal Cell Carcinoma,0
11848,Icterus,Stage IB Pancreatic Cancer AJCC v8,0
11849,Vague,Cancer of Urinary Tract,0
11850,Distant,Malignant melanoma of eyelid,0
11851,metastatic qualifier,Granular Cell Leiomyosarcoma,0
11852,uti symptoms,Cancer of Urinary Tract,0
11853,Possibly Related to Intervention,Testicular cancer metastatic,0
11854,Retinoic Acid Response Element,Adult Fibrolamellar Carcinoma,0
11855,Hyperestrogenism,Endometrial Small Cell Carcinoma,0
11856,Serum,Heavy Chain Deposition Disease,0
11857,Label (document),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11858,New Zealand,Malignant melanoma of eyelid,0
11859,Persons,Intestinal Metaplasia of Bladder Urothelium,0
11860,Genus Homo,BRCA2 Syndrome,0
11861,Early stage,Primary Cutaneous Plasmablastic Lymphoma,0
11862,Oral region,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11863,Cessation of life,Mucinous adenocarcinoma gastric,0
11864,Diagnosis,Stage IB Pancreatic Cancer AJCC v8,0
11865,<3 (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11866,Numbers,Human Papillomavirus-Related Carcinoma,0
11867,Cutaneous Melanoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11868,Infective cystitis,Carcinoma of urinary bladder,0
11869,*Type - Kind of quantity,Carcinoma ex pleomorphic adenoma of parotid gland,0
11870,Type A,Liver Cavernous Hemangioma,0
11871,Body cavities,Liver Cavernous Hemangioma,0
11872,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Carcinoma of urinary bladder,0
11873,Infrequent,Urethral Carcinoma,0
11874,Definitely Related to Intervention,Adult Hepatocellular Carcinoma,0
11875,Uterine Corpus Sarcoma,Uterine Cancer,0
11876,Presence (property),Atypical Lobular Breast Hyperplasia,0
11877,Plasma,Heavy Chain Deposition Disease,0
11878,1+ Score,Mucinous adenocarcinoma gastric,0
11879,Cell surface,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11880,CDISC SEND Tumor Findings Results Terminology,Recurrent Diffuse Intrinsic Pontine Glioma,0
11881,health and disease,Intracortical osteosarcoma,0
11882,Embryo,Adult Alveolar Soft Part Sarcoma,0
11883,Term Source,Ampulla of Vater Tubular Adenoma,0
11884,Acute monocytic leukemia,Neonatal leukemia,0
11885,Symptoms,Anterior Urethral Malignant Neoplasm,0
11886,Neoplasms,Unfavorable Non-Hodgkin Lymphoma,0
11887,Including (qualifier),Endometrial Small Cell Carcinoma,0
11888,Diagnosis Study,Diffuse malignant mesothelioma,0
11889,Pediculus humanus capitis (eukaryote),Extracranial Neuroblastoma,0
11890,World,Recurrent Uveal Melanoma,0
11891,Specimen Source Codes - Macrophages,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11892,Usual,Stage IB Pancreatic Cancer AJCC v8,0
11893,Diagnosis Study,Contact dermatitis due to alkali,0
11894,Tissue Specimen Code,Colorectal High Grade B-Cell Lymphoma,0
11895,Pseudomyxoma Peritonei,mucinous adenocarcinoma of gallbladder,0
11896,Primary malignant neoplasm,Uterine Cancer,0
11897,Including (qualifier),Malignant neoplasm of thalamus,0
11898,Enneking High Surgical Grade,Primary Cutaneous Plasmablastic Lymphoma,0
11899,Location,Giant cell angiofibroma,0
11900,N+ (tumor staging),papillary carcinoma of penis,0
11901,Known,Malignant neoplasm of thalamus,0
11902,Neoplasms,Intestinal Neuroendocrine Carcinoma,0
11903,Include (action),Uterine Cancer,0
11904,Body tissue,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11905,Cancer Etiology,mucinous adenocarcinoma of gallbladder,0
11906,Chemotherapy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11907,Congenital Abnormality,Atypical Lobular Breast Hyperplasia,0
11908,Present,Liver Cavernous Hemangioma,0
11909,Macrophage Activation Syndrome,Anterior Urethral Malignant Neoplasm,0
11910,Identified,Angiosarcoma of liver,0
11911,Preventive intent,FIGO Stage II Ovarian Cancer,0
11912,Amount type - Percentage,Diffuse malignant mesothelioma,0
11913,300,Benign neoplasm of thorax,0
11914,treatment - ActInformationManagementReason,mucinous adenocarcinoma of gallbladder,0
11915,Common Specifications in HL7 V3 Publishing,Uterine Cancer,0
11916,Testing,Contact dermatitis due to alkali,0
11917,Pale color saturation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11918,Unknown GENC,Choroid Necrotic Melanoma,0
11919,Therapeutic procedure,Intestinal Metaplasia of Bladder Urothelium,0
11920,suggestion,Stage IB Pancreatic Cancer AJCC v8,0
11921,Tryptophanase,Mucinous adenocarcinoma gastric,0
11922,Rating (action),Primary Cutaneous Plasmablastic Lymphoma,0
11923,Case unit dose,FIGO Stage II Ovarian Cancer,0
11924,Tumor Mass,Localized Askin Tumor,0
11925,Benign,Germinoma,0
11926,Type A,squamous cell carcinoma of the thyroid gland,0
11927,Palatine Tonsil,Tonsillar Carcinoma,0
11928,Contrast,Granular Cell Leiomyosarcoma,0
11929,United States,Localized Askin Tumor,0
11930,Interpretation Process,Cartilaginous exostosis,0
11931,Three,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11932,Negation,Germinoma,0
11933,Swollen Lymph Node,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11934,Cover - action,Giant cell angiofibroma,0
11935,Most,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11936,70%,Pancreatic Intraepithelial Neoplasia-3,0
11937,Five-year Survival Rate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11938,One,Stage IB Pancreatic Cancer AJCC v8,0
11939,Skin cell,papillary carcinoma of penis,0
11940,Patient Reported Outcome,Mastocytosis,0
11941,combination of objects,Intestinal Metaplasia of Bladder Urothelium,0
11942,Usual,Methotrexate-Associated Hodgkin Lymphoma,0
11943,Report (document),Serous cystadenocarcinoma ovary,0
11944,Thymus <angiosperm>,Digestive System Hodgkin Lymphoma,0
11945,/40,Stage IB Pancreatic Cancer AJCC v8,0
11946,Endometrial biopsy,Undifferentiated Endocervical Sarcoma,0
11947,Ephrin Type-B Receptor 1,Intestinal Neuroendocrine Carcinoma,0
11948,year,Advanced Uterine Corpus Carcinosarcoma,0
11949,Malignant neoplasm of penis,Stage II Carcinoma of Penis,0
11950,Used by,Lung squamous cell carcinoma stage I,0
11951,Childhood Diffuse Large B-Cell Lymphoma,Unfavorable Non-Hodgkin Lymphoma,0
11952,Cure (remedy),Malignant Testicular Sertoli Cell Tumor,0
11953,Not abnormal,Testicular cancer metastatic,0
11954,Plasma Product,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11955,Embryonic Development,Childhood Central Nervous System Immature Teratoma,0
11956,Process (qualifier value),Collecting Duct Carcinoma of the Kidney,0
11957,Childhood Lymphoma,Thymic Clear Cell Carcinoma,0
11958,Include (action),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
11959,Occurrence,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11960,Testing,Benign neoplasm of thorax,0
11961,Rare Lesion,Malignant neoplasm of choroid,0
11962,Childhood Lymphoma,Hodgkin lymphoma,0
11963,Desmoplastic fibroblastoma,Giant cell angiofibroma,0
11964,Old,Diffuse malignant mesothelioma,0
11965,In Situ Follicular Neoplasia,Recurrent Testicular Lymphoma,0
11966,Symptoms aspect,Carcinoma of urinary bladder,0
11967,Lymphatic,Testicular cancer metastatic,0
11968,Cessation of life,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11969,year,Acantholytic squamous cell carcinoma,0
11970,Therapeutic radiology procedure,Undifferentiated Endocervical Sarcoma,0
11971,Set scale,Secondary malignant neoplasm of lymph node,0
11972,white blood cell type,Childhood Lymphoma,0
11973,macromolecule,Unresectable Rhabdomyosarcoma,0
11974,Good,Acantholytic squamous cell carcinoma,0
11975,Therapy Object (animal model),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11976,Neoplasm Metastasis,Extra-Adrenal Paraganglioma,0
11977,Type - attribute,FIGO Stage II Ovarian Cancer,0
11978,*Susceptibility,BRCA2 Syndrome,0
11979,Times,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11980,Patient Problem,Airway Hemangioma,0
11981,Anatomic Site,Cartilaginous exostosis,0
11982,20%,Tonsillar Carcinoma,0
11983,Dilate procedure,Undifferentiated Endocervical Sarcoma,0
11984,Etiology aspects,Diffuse malignant mesothelioma,0
11985,With shape,Cartilaginous exostosis,0
11986,Science of Etiology,Diffuse malignant mesothelioma,0
11987,active (HL7 RoleLink),Malignant melanoma of eyelid,0
11988,United States Military Commissioned Officer O4,Female Breast Carcinoma,0
11989,Blood in stool,Mucinous adenocarcinoma gastric,0
11990,Include (action),Endometrial Small Cell Carcinoma,0
11991,<3 (qualifier value),Mucinous adenocarcinoma gastric,0
11992,Sex Behavior,Stage II Carcinoma of Penis,0
11993,How Often Weight Loss,Mucinous adenocarcinoma gastric,0
11994,Condyloma,Stage II Carcinoma of Penis,0
11995,Certain (qualifier value),Carcinoma of urinary bladder,0
11996,rituximab,Recurrent Testicular Lymphoma,0
11997,Certain (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
11998,Togo,Breast Ductal Adenoma,0
11999,Most,adenosquamous carcinoma of breast,0
12000,Biospecimen,Undifferentiated Endocervical Sarcoma,0
12001,Mass of body structure,Pancreatic Intraepithelial Neoplasia-3,0
12002,Have Weight Loss,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12003,Distal (qualifier value),Anterior Urethral Malignant Neoplasm,0
12004,Vaginal Hemorrhage,Endometrial Small Cell Carcinoma,0
12005,Canada,Intestinal Metaplasia of Bladder Urothelium,0
12006,Genitalia,Human Papillomavirus-Related Carcinoma,0
12007,Common Specifications in HL7 V3 Publishing,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
12008,Pediculus (eukaryote),adenoid cystic carcinoma of lung,0
12009,Smaller,Diffuse malignant mesothelioma,0
12010,Age,Human Papillomavirus-Related Carcinoma,0
12011,Account number:Identifier:Point in time:^Patient:Nominal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12012,Back Pain,Stage IB Pancreatic Cancer AJCC v8,0
12013,include - SetOperator,Localized Askin Tumor,0
12014,Disease Outcome,Female Breast Carcinoma,0
12015,Most,Digestive System Hodgkin Lymphoma,0
12016,Cover - action,Diffuse malignant mesothelioma,0
12017,Result,Placental aromatase deficiency,0
12018,United States Military Commissioned Officer O4,Breast Ductal Adenoma,0
12019,morphological,Rhabdomyosarcoma with ganglionic differentiation,0
12020,Cancer Genus,mucinous adenocarcinoma of gallbladder,0
12021,Offspring,Acute Undifferentiated Leukemia,0
12022,Science of Etiology,BRCA2 Syndrome,0
12023,Jumping,Extracranial Neuroblastoma,0
12024,Treatment Epoch,Recurrent Testicular Lymphoma,0
12025,Partial,Bladder squamous cell carcinoma stage I,0
12026,Usually Need Help from Another Person for Arising,Carcinoma of urinary bladder,0
12027,Adult Acute Megakaryoblastic Leukemia,Neonatal leukemia,0
12028,prevention aspects,Diffuse malignant mesothelioma,0
12029,Smoking,Bladder squamous cell carcinoma stage I,0
12030,Lymphatic System,Digestive System Hodgkin Lymphoma,0
12031,Occur (action),Localized Askin Tumor,0
12032,Females,Adult Hepatocellular Carcinoma,0
12033,respiratory,papillary carcinoma of penis,0
12034,Adenocarcinoma,Pancreatic Intraepithelial Neoplasia-3,0
12035,Dyspnea,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12036,Human body structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12037,CDISC SEND Body System Terminology,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12038,Labium,Maxillary Sinus Adenocarcinoma,0
12039,Legal Adult,Malignant neoplasm of choroid,0
12040,Capsule Dosing Unit,Thymic Clear Cell Carcinoma,0
12041,100%,Clonal Hematopoiesis of Indeterminate Potential,0
12042,Benign melanocytic nevus,Malignant melanoma of eyelid,0
12043,Occur (action),Diffuse malignant mesothelioma,0
12044,Most,Undifferentiated Endocervical Sarcoma,0
12045,Several,de novo Myelodysplastic Syndrome,0
12046,Continuance of life,Recurrent Uveal Melanoma,0
12047,bacteria aspects,Cancer of Urinary Tract,0
12048,Arsenic measurement,Giant cell angiofibroma,0
12049,Case unit dose,Human Papillomavirus-Related Carcinoma,0
12050,protein complex location,BRCA2 Syndrome,0
12051,Reported Term,Adult Alveolar Soft Part Sarcoma,0
12052,Rare,Metastatic Neoplasm to the Gallbladder,0
12053,Often - answer to question,Unresectable Rhabdomyosarcoma,0
12054,Occurrence,Intestinal Neuroendocrine Carcinoma,0
12055,Subject Risk,BRCA2 Syndrome,0
12056,Antibiotic throat preparations,Cancer of Urinary Tract,0
12057,Malignant Vaginal Neoplasm,Anterior Urethral Malignant Neoplasm,0
12058,Abdomen+,Diffuse malignant mesothelioma,0
12059,Cause of death.underlying,Neonatal leukemia,0
12060,shared attribute,Cancer of Urinary Tract,0
12061,Organ,papillary carcinoma of penis,0
12062,Numerous,Digestive System Hodgkin Lymphoma,0
12063,Precision - temporal,Adenocarcinoma of the prostate metastatic,0
12064,Include (action),Noninfiltrating Intraductal Carcinoma,0
12065,Appearance,Acantholytic squamous cell carcinoma,0
12066,Condition:Find:Pt:^Patient:Nom,mucinous adenocarcinoma of gallbladder,0
12067,>90,Primary Cutaneous Plasmablastic Lymphoma,0
12068,One,Localized Askin Tumor,0
12069,Slight (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12070,Greater Than,Undifferentiated Endocervical Sarcoma,0
12071,Disease,Choroid Necrotic Melanoma,0
12072,Route,Digestive System Hodgkin Lymphoma,0
12073,New,Bladder squamous cell carcinoma stage I,0
12074,Able to Concentrate Question,Digestive System Hodgkin Lymphoma,0
12075,Meaning,Ichthyosis,0
12076,Qualitative form,Airway Hemangioma,0
12077,Metastatic to,Granular Cell Leiomyosarcoma,0
12078,Support,Digestive System Hodgkin Lymphoma,0
12079,Disease,Mastocytosis,0
12080,During,Mucinous adenocarcinoma gastric,0
12081,Spreading (qualifier value),Endometrial Small Cell Carcinoma,0
12082,Divide,Malignant Testicular Sertoli Cell Tumor,0
12083,Experimental Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12084,Disease,Cancer of Urinary Tract,0
12085,Lymphoid Tissue,Digestive System Hodgkin Lymphoma,0
12086,Consistency,Acute lymphadenitis,0
12087,High risk,FIGO Stage II Ovarian Cancer,0
12088,Arising,Thymic Clear Cell Carcinoma,0
12089,Personal appearance,Colorectal Neuroendocrine Tumor G2,0
12090,Night sweats,Unfavorable Non-Hodgkin Lymphoma,0
12091,Hereditary,FIGO Stage II Ovarian Cancer,0
12092,Entity Determiner - specific,Stage IB Pancreatic Cancer AJCC v8,0
12093,Common (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
12094,Only - dosing instruction fragment,Tonsillar Carcinoma,0
12095,Twice - dosing instruction fragment,gliosarcoma,0
12096,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Primary Cutaneous Plasmablastic Lymphoma,0
12097,Cancer Genus,Methotrexate-Associated Hodgkin Lymphoma,0
12098,Plain chest X-ray,Diffuse malignant mesothelioma,0
12099,Occurrence,Adult Hepatocellular Carcinoma,0
12100,Support,FIGO Stage II Ovarian Cancer,0
12101,Coding,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12102,Household composition,Human Papillomavirus-Related Carcinoma,0
12103,Human body structure,squamous cell carcinoma of the thyroid gland,0
12104,Lineage,Neonatal leukemia,0
12105,Smear - instruction imperative,FIGO Stage II Ovarian Cancer,0
12106,Does jump,Extracranial Neuroblastoma,0
12107,Abdominal Cavity,FIGO Stage II Ovarian Cancer,0
12108,Identical,Heavy Chain Deposition Disease,0
12109,Duct system,Collecting Duct Carcinoma of the Kidney,0
12110,Skin,Stage II Carcinoma of Penis,0
12111,*Type - Kind of quantity,Anterior Urethral Malignant Neoplasm,0
12112,Wound Healing,BRCA2 Syndrome,0
12113,Hypertensive disease,Undifferentiated Endocervical Sarcoma,0
12114,Carcinogenesis,Testicular cancer metastatic,0
12115,combination - answer to question,Bladder squamous cell carcinoma stage I,0
12116,Membrane,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12117,Leukemia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12118,shared attribute,Extracranial Neuroblastoma,0
12119,treatment - ActInformationManagementReason,Acantholytic squamous cell carcinoma,0
12120,Common (qualifier value),Leiomyoma of Gallbladder,0
12121,Home environment,Larynx carcinoma recurrent,0
12122,Melanocytic nevus,GIANT PIGMENTED HAIRY NEVUS,0
12123,World,Diffuse malignant mesothelioma,0
12124,Number of birth,Malignant melanoma of eyelid,0
12125,Therapeutic procedure,Adult Hepatocellular Carcinoma,0
12126,Simian virus 40,Diffuse malignant mesothelioma,0
12127,Volume 2,Familial Hemophagocytic Lymphocytosis,0
12128,*Type - Kind of quantity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12129,Known,Cancer of Urinary Tract,0
12130,Bone Infection,Cartilaginous exostosis,0
12131,Survival Rate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12132,Certain (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
12133,Overall,Extra-Adrenal Paraganglioma,0
12134,Acute Undifferentiated Leukemia,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12135,melanocyte,Malignant melanoma of eyelid,0
12136,Loss of appetite (finding),Mucinous adenocarcinoma gastric,0
12137,Disease,Unresectable Rhabdomyosarcoma,0
12138,Irritation,Giant cell angiofibroma,0
12139,Unintentional,Methotrexate-Associated Hodgkin Lymphoma,0
12140,survive,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12141,Randomization,Breast Ductal Adenoma,0
12142,20%,Ichthyoses,0
12143,include - SetOperator,Primary Cutaneous Plasmablastic Lymphoma,0
12144,Negation,Recurrent Uveal Melanoma,0
12145,Binding (Molecular Function),Unresectable Rhabdomyosarcoma,0
12146,Shortness of Breath Visual Analogue Scale,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12147,Entity Determiner - specific,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12148,Adenocarcinoma,Stage II Fallopian Tube Cancer,0
12149,Cessation of life,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12150,Occurrence Indicator,Stage IB Pancreatic Cancer AJCC v8,0
12151,Capsule (unit of presentation),Thymic Clear Cell Carcinoma,0
12152,Sexually Transmitted Diseases,Cancer of Urinary Tract,0
12153,peripheral blood,Hemangioma,0
12154,Histopathologic Grade,Breast Ductal Adenoma,0
12155,Descent,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12156,Code,Noninfiltrating Intraductal Carcinoma,0
12157,aspects of adverse effects,Female Breast Carcinoma,0
12158,Dyspareunia,Undifferentiated Endocervical Sarcoma,0
12159,Occurrence Indicator,Endometrial Small Cell Carcinoma,0
12160,Malignant Neoplasms,Adult Alveolar Soft Part Sarcoma,0
12161,Present,Stage II Carcinoma of Penis,0
12162,Smear - instruction imperative,Bladder squamous cell carcinoma stage I,0
12163,Cartilage,Anterior Urethral Malignant Neoplasm,0
12164,Egg of order Phthiraptera,Contact dermatitis due to alkali,0
12165,Condition:Find:Pt:^Patient:Nom,Cancer of Urinary Tract,0
12166,Uncontrolled,Testicular cancer metastatic,0
12167,Affecting,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12168,Togo,Hemangioma,0
12169,Groups,Metastatic Ductal Breast Carcinoma,0
12170,Biogenic Amines,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12171,Usual Severity Vomiting,Malignant neoplasm of thalamus,0
12172,Superkingdom (taxonomic category),Rhabdomyosarcoma with ganglionic differentiation,0
12173,Symptoms aspect,Refractory Barrett Esophagus,0
12174,First (number),Refractory Barrett Esophagus,0
12175,Experimental Result,squamous cell carcinoma of the thyroid gland,0
12176,Blood Circulation,Digestive System Hodgkin Lymphoma,0
12177,Randomization,Female Breast Carcinoma,0
12178,Chief complaint (finding),Tonsillar Carcinoma,0
12179,Cell Device,papillary carcinoma of penis,0
12180,General surgery specialty,FIGO Stage II Ovarian Cancer,0
